{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.18265"}, {"@name": "filename", "#text": "25127_FlavioVieiraLoures_Doutorado.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "FL\u00c1VIO VIEIRA LOURES \n\n \n\n \n\nO RECEPTOR DE RECONHECIMENTO DE PAT\u00d3GENOS TLR-2 E A \n\nPROT\u00c9INA ADAPTADORA MYD88 APRESENTAM UM IMPORTANTE \n\nPAPEL NA INFEC\u00c7\u00c3O MURINA CONTRA O  \n\nPARACOCCIDIOIDES BRASILIENSIS \n\n \n\n \n\n \n\n \n\n \n\nTese apresentada ao Instituto de \nCi\u00eancias Biom\u00e9dicas da Universidade de \nS\u00e3o Paulo, para obten\u00e7\u00e3o do T\u00edtulo de \nDoutor em Ci\u00eancias (Imunologia). \n\n \n\n \n\n \n \n\nS\u00e3o Paulo \n\n2010 \n\n\n\n \n\n \n\nFL\u00c1VIO VIEIRA LOURES \n\n \n\n \n\n \n\n \n\n \n\nO RECEPTOR DE RECONHECIMENTO DE PAT\u00d3GENOS TLR-2 E A \n\nPROT\u00c9INA ADAPTADORA MYD88 APRESENTAM UM IMPORTANTE \n\nPAPEL NA INFEC\u00c7\u00c3O MURINA CONTRA O  \n\nPARACOCCIDIOIDES BRASILIENSIS \n\n \n\n \n\n \n\nTese apresentada ao Instituto de \nCi\u00eancias Biom\u00e9dicas da Universidade de \nS\u00e3o Paulo, para obten\u00e7\u00e3o do T\u00edtulo de \nDoutor em Ci\u00eancias (Imunologia). \n\n \n\n                                                 \u00c1rea de concentra\u00e7\u00e3o: Imunologia \n\nOrientador(a): Profa. Dra. Vera L\u00facia                       \nGarcia Calich \n\n \n \n \n \n\nS\u00e3o Paulo \n\n2010 \n\n\n\nDADOS DE CATALOGA\u00c7\u00c3O NA PUBLICA\u00c7\u00c3O (CIP) \nServi\u00e7o de Biblioteca e Informa\u00e7\u00e3o Biom\u00e9dica do \n\nInstituto de Ci\u00eancias Biom\u00e9dicas da Universidade de S\u00e3o Paulo \n\n\u00a9 reprodu\u00e7\u00e3o total \n\n \nLoures, Fl\u00e1vio Vieira. \n\n    O receptor de reconhecimento de pat\u00f3genos TLR-2 e a prote\u00edna \nadaptadora MyD88 apresentam um importante papel na infec\u00e7\u00e3o \nmurina contra o Paracoccidioides brasiliensis  /  Fl\u00e1vio Vieira Loures. -- \nS\u00e3o Paulo, 2010. \n\n \n    Orientador: Vera Lucia Garcia Calich. \n \n    Tese (Doutorado) \u2013 Universidade de S\u00e3o Paulo. Instituto de Ci\u00eancias \nBiom\u00e9dicas. Departamento de Imunologia. \u00c1rea de concentra\u00e7\u00e3o: \nImunologia. Linha de pesquisa: Imunologia das micoses. \n \n    Vers\u00e3o do t\u00edtulo para o ingl\u00eas: The pathogen recognition receptor \nTLR-2 and the adaptor protein MyD88 have an important role in the \ninnate and adaptive immunity against Paracoccidioides brasiliensis \ninfection. \n \n    Descritores: 1. Imunologia   2. Imunidade inata   3. Imunidade \nadaptativa   4. Receptores tipo Toll   5. Paracoccidioidomicose   I. \nCalich, Vera Lucia Garcia   II. Universidade de S\u00e3o Paulo. Instituto de \nCi\u00eancias Biom\u00e9dicas. Programa de P\u00f3s Gradua\u00e7\u00e3o em Imunologia   III. \nT\u00edtulo. \n \n \n \n\n    ICB/SBIB09/2010 \n \n\n\n\n UNIVERSIDADE DE S\u00c3O PAULO \n INSTITUTO DE CI\u00caNCIAS BIOM\u00c9DICAS \n\n______________________________________________________________________________________________________________ \n\nCandidato(a): Fl\u00e1vio Vieira Loures. \n\n \nT\u00edtulo da Tese: O receptor de reconhecimento de pat\u00f3genos TLR-2 e a prote\u00edna \n adaptadora MyD88 apresentam um importante papel na infec\u00e7\u00e3o \n murina contra o Paracoccidioides brasiliensis. \n\nOrientador(a): Vera Lucia Garcia Calich. \n\n A Comiss\u00e3o Julgadora dos trabalhos de Defesa da Tese de Doutorado, em sess\u00e3o \n p\u00fablica realizada a ................./................./................., considerou \n\n (  ) Aprovado(a)                (  ) Reprovado(a) \n\nExaminador(a): Assinatura: ............................................................................................... \n Nome: ....................................................................................................... \n Institui\u00e7\u00e3o: ................................................................................................ \n\nExaminador(a): Assinatura: ................................................................................................ \n Nome: ....................................................................................................... \n Institui\u00e7\u00e3o: ................................................................................................ \n\nExaminador(a): Assinatura: ................................................................................................ \n Nome: ....................................................................................................... \n Institui\u00e7\u00e3o: ................................................................................................ \n\nExaminador(a): Assinatura: ................................................................................................ \n Nome: ....................................................................................................... \n Institui\u00e7\u00e3o: ................................................................................................ \n\nPresidente: Assinatura: ................................................................................................ \n Nome: ....................................................................................................... \n Institui\u00e7\u00e3o: ................................................................................................ \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n\n\nAGRADECIMENTOS \n \n \n\n\u00c0 minha fam\u00edlia que me proporcionou condi\u00e7\u00f5es para que eu alcan\u00e7asse meus \n\nobjetivos, apoiando e incentivando o meu trabalho.  \n\n \n\n\u00c0 Professora Dra. Vera Calich por confiar e acreditar na minha capacidade \n\nintelectual. Agrade\u00e7o todos os seus ensinamentos e todas as suas orienta\u00e7\u00f5es que \n\ncontribu\u00edram para meu crescimento acad\u00eamico.  \n\n \n\n\u00c0 toda equipe do laborat\u00f3rio: Adriana Pina, Ma\u00edra Felonato, Simone Bernardino, \n\nEliseu Frank de Ara\u00fajo, Cla\u00fadia Feirotti, Alessandra Schanoski  e T\u00e2nia Alves da \n\nCosta . Pelo conv\u00edvio, pela amizade e pela for\u00e7a que sempre me deram. Obrigado a \n\ntodas voc\u00eas pela ajuda, em especial \u00e0 Adriana, por estar sempre disposta a ajudar \n\nquando precisei. Obrigado \u00e0 voc\u00eas!!! \n\n \n\n\u00c0 equipe do Biot\u00e9rio de Experimenta\u00e7\u00e3o, em especial \u00e0 Silvia Massironi e a Regina De \n\nLucca, pela gentileza e compet\u00eancia com que sempre me atenderam. \n\n \n\n\u00c0s secret\u00e1rias do departamento Jotelma e Eni, pela paci\u00eancia que sempre tiveram com \n\nnossos atrasos e esquecimentos. \n\n \n\n\u00c0 Funda\u00e7\u00e3o de Apoio a Pesquisa do Estado de S\u00e3o Paulo \u2013 FAPESP pelo aux\u00edlio \n\nfinaceiro fornecido. \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nO meu olhar \u00e9 n\u00edtido como um girassol. \n\nTenho o costume de andar pelas estradas \n\nOlhando para a direita e para a esquerda, \n\nE de vez em quando olhando para tr\u00e1s... \n\nE o que vejo a cada momento \n\n\u00c9 aquilo que nunca antes eu tinha visto, \n\nE eu sei dar por isso muito bem... \n\nSei ter o pasmo essencial \n\nQue tem uma crian\u00e7a se, ao nascer, \n\nReparasse que nascera deveras... \n\nSinto-me nascido a cada momento \n\nPara a eterna novidade do Mundo... \n\n \n\n \n\n     Alberto Caeiro \n\n \n\n \n\n \n\n\n\nRESUMO \n\n \n\nLOURES, F. V. O receptor de reconhecimento de pat\u00f3genos TLR-2 e a prot\u00e9ina \n\nadaptadora MyD88 apresentam um importante papel na infec\u00e7\u00e3o murina contra o \n\nParacoccidioides brasiliensis. 2010. 134 p. Tese (Doutorado em Imunologia) \u2013 Instituto \n\nde Ci\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, 2010. \n\n \n\nOs mecanismos imunol\u00f3gicos que governam a intera\u00e7\u00e3o entre o fungo Paracoccidioides \n\nbrasiliensis e o hospedeiro t\u00eam sido pouco estudados. Tanto os componentes do fungo \n\ncomo os receptores dos fag\u00f3citos envolvidos nesta intera\u00e7\u00e3o s\u00e3o pouco conhecidos. \n\nBaseados nestes fatos, nosso trabalho teve por objetivo caracterizar in vitro e in vivo o \n\nenvolvimento do receptor \u201cToll Like\u201d-2 (TLR-2) e da prote\u00edna adaptadora MyD88 \n\n(myeloid differentiation primary response gene 88) na infec\u00e7\u00e3o de camundongos pelo P. \n\nbrasiliensis. O TLR-2 \u00e9 um receptor da imunidade inata envolvido no reconhecimento \n\nde PAMPs (padr\u00f5es moleculares associados aos pat\u00f3genos), enquanto que MyD88 \u00e9 \n\numa mol\u00e9cula envolvida na sinaliza\u00e7\u00e3o celular induzida por muitos TLRs e que culmina \n\ncom a ativa\u00e7\u00e3o de v\u00e1rios fatores de transcri\u00e7\u00e3o, entre eles o NF?B, envolvidos na \n\nativa\u00e7\u00e3o de genes ligados \u00e0 resposta inflamat\u00f3ria. Para tanto, utilizamos camundongos \n\nC57Bl/6 deficientes e normais para TLR-2 e para MyD88. Demonstramos que, \n\ncomparado ao grupo controle, animais TLR2-/- apresentavam uma infec\u00e7\u00e3o pulmonar \n\nmenos grave associada com menor s\u00edntese de \u00f3xido n\u00edtrico (NO). Resultados \n\nequivalentes foram obtidos com macr\u00f3fagos peritoneais e alveolares infectados in vitro. \n\nInesperadamente, apesar das diferen\u00e7as na carga f\u00fangica, ambas as linhagens \n\napresentavam tempo m\u00e9dio de sobrevida semelhante e les\u00f5es pulmonares de gravidade \n\nequivalente. Os estudos com leuc\u00f3citos infiltrantes de pulm\u00e3o revelaram um aumento \n\nde leuc\u00f3citos polimorfonucleares neutr\u00f3filos (PMNs) nos animais TLR-2-/- associado \n\ncom um menor n\u00famero de linf\u00f3citos TCD4+ e TCD8+ ativados. Animais TLR-2-/- \n\ndeficientes apresentaram uma discreta diferen\u00e7a quanto \u00e0 s\u00edntese de citocinas \n\npulmonares dos tipos Th1 e Th2, por\u00e9m estes animais apresentaram maiores n\u00edveis de \n\nKC, uma quimiocina CXC envolvida na quimiotaxia de neutr\u00f3filos, assim com maiores \n\nn\u00edveis de citocinas Th17 (IL-6, IL-17, IL-23 e TGF-?). Al\u00e9m disso, a resposta imune \n\nTh17 desenvolvida por animais TLR-2-/- esteve associada com menor expans\u00e3o de \n\nc\u00e9lulas T regulat\u00f3rias CD4+CD25+FoxP3+. Assim, o TLR-2 controla a imunidade inata \n\ne adaptativa frente ao P. brasiliensis e regula negativamente a resposta imune Th17 e a \n\n\n\npatologia pulmonar.  Em rela\u00e7\u00e3o aos estudos com animais deficientes para a prote\u00edna \n\nadaptadora MyD88 na paracoccidioimicose verificamos que sua aus\u00eancia resultou numa \n\nprodu\u00e7\u00e3o deficiente in vitro e in vivo de NO, al\u00e9m de uma produ\u00e7\u00e3o deficiente in vivo \n\nde citocinas do tipo Th1, Th2 e Th17. Animais MyD88-deficientes infectados \n\ndesenvolveram uma resposta imune prejudicada, evidenciada pelo menor n\u00famero de \n\nmacr\u00f3fagos ativados, assim como uma imunidade adaptativa menos eficiente, \n\nevidenciada pelo menor n\u00famero de c\u00e9lulas T CD4 ativadas que aflu\u00edram aos pulm\u00f5es. \n\nEste quadro culminou com uma carga f\u00fangica maior nos pulm\u00f5es dos animais MyD88-\n\ndeficientes, como tamb\u00e9m permitiu uma exuberante dissemina\u00e7\u00e3o do fungo para outros \n\n\u00f3rg\u00e3os, como f\u00edgado e ba\u00e7o. Os pulm\u00f5es e o f\u00edgado apresentaram graves les\u00f5es com a \n\npresen\u00e7a de granulomas coalescentes e ricos agregados f\u00fangicos. Assim, camundongos \n\nMyD88-deficientes n\u00e3o foram capazes de controlar a doen\u00e7a e morreram em um tempo \n\nmais curto que os animais MyD88-competentes, como evidenciado em experimentos de \n\nsobrevida. Assim, nossos achados demonstram que a sinaliza\u00e7\u00e3o intracelular mediada \n\npela prote\u00edna MyD88 \u00e9 importante para a ativa\u00e7\u00e3o dos mecanismos fungicidas, assim \n\ncomo  para a ativa\u00e7\u00e3o das respostas imunes inata e adaptativa contra o P. brasiliensis. \n\nEm conjunto, nosso trabalho demonstra que tanto o TLR-2 quanto a mol\u00e9cula \n\nadaptadora MyD88 desempenham um papel relevante no controle da infec\u00e7\u00e3o, assim \n\ncomo na indu\u00e7\u00e3o da resposta imune contra este pat\u00f3geno f\u00fangico prim\u00e1rio. \n\n \n\nPalavras-chaves: Paracoccidioidomicose. Imunidade Inata. Imunidade Adaptativa. \n\nReceptores Tipo Toll. Interleucina-17. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nABSTRACT \n\n \n\nLOURES, F. V. The pathogen recognition receptor TLR-2 and the adaptor protein \n\nMyD88 have an important role in the innate and adaptive immunity against \n\nParacoccidioides brasiliensis infection. 2010. 134 p. Ph. D. Thesis (Doctor in \n\nImmunology) \u2013 Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o Paulo, S\u00e3o \n\nPaulo, 2010. \n\n \n\nThe immunological mechanisms that govern the interaction between hosts and the \n\ndimorphic fungus Paracoccidioides brasiliensis have been scarcely studied. Both, \n\nfungal and phagocyte receptors involved in this interaction are poorly understood. \n\nBased on these facts, the aim of our study was to characterize in vitro and in vivo the \n\nrole played by Toll Like Receptor-2 (TLR-2) and the adaptor protein MyD88 (myeloid \n\ndifferentiation primary response gene 88) in murine pulmonary \n\nparacoccidioidomycosis. The TLR-2 is a receptor of innate immunity involved in the \n\nrecognition of PAMPs (pathogen associated molecular patterns), whereas MyD88 is a \n\nmolecule involved in cell signaling induced by many TLRs . TLR-mediated activation \n\nresults in the production of several nuclear transcription factors, including NF?B, which \n\nactivate important genes of the inflammatory response. Wild-type (WT) besides  TLR-\n\n2- and MyD88-deficient C57Bl/6 mice were used in our investigation. We showed that, \n\ncompared to control animals, TLR2-/- mice developed a less severe pulmonary infection \n\nassociated with reduced synthesis of nitric oxide (NO). Equivalent results were obtained \n\nwith in vitro infected peritoneal and alveolar macrophages. Unexpectedly, despite the \n\ndifferences in fungal loads, TLR-2-/- and WT mice showed equivalent survival times \n\nand pulmonary lesions. Studies with lung infiltrating leukocytes revealed an increase of \n\npolymorphonuclear neutrophil leukocytes (PMNs) in TLR-2-/- mice associated with a \n\nlow number of activated T CD4 and T CD8+ lymphocytes. Compared with WT mice, \n\nthe TLR-2-deficient mice showed slight differences in the production of pulmonary Th1 \n\nand Th2 cytokines, but presented higher levels of KC, a CXC chemokine involved in \n\nneutrophil chemotaxis, besides increased levels of Th17 cytokines ( IL-6, IL-17, IL-23 \n\nand TGF-?). Furthermore, the prevalent Th17 immune response developed by TLR-2-/- \n\nmice was associated with lower expansion of regulatory T cells CD4+CD25+FoxP3+. \n\nThus, TLR-2 controls the innate and adaptive immunity against the P. brasiliensis \n\ninfection and negatively regulates Th17 immune response and pulmonary pathology. \n\n\n\nStudies with MyD88-deficient mice showed an impaired production of NO in vivo and \n\nin vitro, and a deficient in vivo production of Th1, Th2 and Th17 cytokines. In addition, \n\ninfected MyD88-deficient mice developed an impaired immune response, evidenced by \n\npoorly activated macrophages, as well as by an inefficient adaptive immunity mediated \n\nby a diminished influx of activated CD4+ T cells to the lungs. These events led to \n\nincreased fungal loads in the lungs of MyD88-deficient mice and allowed a marked \n\ndissemination of the fungus to other organs such as liver and spleen, which presented \n\nsevere lesions composed by coalescent granulomas containing high numbers of fungal \n\ncells. As consequence, MyD88-deficient mice were unable to control fungal growth and \n\npresented a decreased survival time. Our findings demonstrate that MyD88 signaling is \n\nimportant to the activation of fungicidal mechanisms and to the induction of the innate \n\nand adaptive immunity against P. brasiliensis. Altogether, our work shows that both \n\nTLR-2 and the adapter molecule MyD88, play an important role in controlling of P. \n\nbrasiliensis infection, as well as in the induction of immune responses against this \n\nprimary fungal pathogen. \n\n \n\nKeywords: Paracoccidioidomycosis. Innate Immunity. Adaptive Immunity. Toll-Like \n\nReceptors.   Interleukin 17.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nFIGURAS \n\n \n\nTLR2 na PCM \n\n \n\nIn vitro \n\nFigura 01. Avalia\u00e7\u00e3o da atividade fagoc\u00edtica........................................................44 \n\nFigura 02. Avalia\u00e7\u00e3o da atividade fungicida de Mo peritoneais...........................44 \n\nFigura 03. Avalia\u00e7\u00e3o da atividade fungicida de Mo alveolares............................45 \n\nFigura 04. Quantifica\u00e7\u00e3o de NO em Mo peritoneais.............................................46 \n\nFigura 05. Quantifica\u00e7\u00e3o de NO em Mo alveolares..............................................46  \n\nFigura 06. Quantifica\u00e7\u00e3o de citocinas ..................................................................48 \n\n \n\nIn vivo \n\nFigura 07. Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o por UFC..............................................49  \n\nFigura 08. Quantifica\u00e7\u00e3o de NO ...........................................................................50 \n\nFigura 09. Avalia\u00e7\u00e3o da atividade fungicida de leuc\u00f3citos PMNs alveolares......52 \n\nFigura 10. Avalia\u00e7\u00e3o da atividade fungicida de leuc\u00f3citos PMNs peritoneais.... 52  \n\nFigura 11. Caracteriza\u00e7\u00e3o morfol\u00f3gica por Citospim ......................................... 54 \n\nFigura 12. Efeito da deple\u00e7\u00e3o de leuc\u00f3citos PMN por UFC................................. 57 \n\nFigura 13. Sobrevida em animais depletados de leuc\u00f3citos PMNs ...................... 58 \n\nFigura 14. Quantifica\u00e7\u00e3o de citocinas Th1 .......................................................... 60 \n\nFigura 15. Quantifica\u00e7\u00e3o de citocinas Th2 .......................................................... 61  \n\nFigura 16. Quantifica\u00e7\u00e3o de citocinas Th17 ........................................................ 62 \n\nFigura 17. Quantifica\u00e7\u00e3o da quimiocina KC......................................................... 64 \n\nFigura 18. Quantifica\u00e7\u00e3o da quimiocina MCP-1.................................................. 64 \n\nFigura 19. Citometria de fluxo \u2013 macr\u00f3fagos........................................................ 66 \n\nFigura 20. Citometria de fluxo \u2013 linf\u00f3citos............................................................ 67  \n\nFigura 21. Express\u00e3o de IL-17 em linf\u00f3citos T CD4 ............................................. 69 \n\nFigura 22. Express\u00e3o de IL-17 em linf\u00f3citos T CD8.............................................. 70 \n\nFigura 23. An\u00e1lise das c\u00e9lulas T reguladoras ....................................................... 71  \n\nFigura 24. Quantifica\u00e7\u00e3o de anticorpos ................................................................ 72 \n\nFigura 25. Sobrevida .............................................................................................. 73 \n\nFigura 26. Histopatol\u00f3gico ..................................................................................... 74 \n\n\n\nMyD88 na PCM \n\n \n\nIn vitro \n\nFigura 27. Avalia\u00e7\u00e3o da atividade fagoc\u00edtica ........................................................ 76 \n\nFigura 28. Avalia\u00e7\u00e3o da atividade fungicida de Mo peritoneais............................ 77  \n\nFigura 29. Quantifica\u00e7\u00e3o de NO em Mo peritoneais ............................................. 78 \n\n \n\nIn vivo \n\nFase aguda \n\nFigura 30. Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o por UFC .............................................. 80 \n\nFigura 31. Quantifica\u00e7\u00e3o de NO.............................................................................. 80 \n\nFigura 32. Quantifica\u00e7\u00e3o de citocinas .................................................................... 81  \n\n \n\nFase cr\u00f4nica \n\nFigura 33. Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o por UFC ................................................ 82 \n\nFigura 34. Quantifica\u00e7\u00e3o de NO .............................................................................. 83 \n\nFigura 35. Quantifica\u00e7\u00e3o de citocinas no pulm\u00e3o.................................................... 84  \n\nFigura 36. Quantifica\u00e7\u00e3o de citocinas no f\u00edgado ....................................................  85 \n\nFigura 37. Quantifica\u00e7\u00e3o de citocinas no ba\u00e7o ........................................................ 85 \n\nFigura 38. Citometria de fluxo \u2013 macr\u00f3fagos ..........................................................  87 \n\nFigura 39. Citometria de fluxo \u2013 linf\u00f3citos ............................................................... 87  \n\nFigura 40. Caracteriza\u00e7\u00e3o morfol\u00f3gica por Citospim .............................................. 88 \n\nFigura 41. An\u00e1lise das c\u00e9lulas T reguladoras ........................................................... 89 \n\nFigura 42. Sobrevida ................................................................................................. 90 \n\nFigura 43. An\u00e1lise Histopatol\u00f3gica dos pulm\u00f5es ...................................................... 92 \n\nFigura 44. An\u00e1lise Histopatol\u00f3gica do f\u00edgado ..........................................................\\ 94 \n\nFigura 45. An\u00e1lise Histopatol\u00f3gica do ba\u00e7o ............................................................. 95 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nABREVIATURAS \n\n \n\n \n\nAc   Anticorpo \n\nAcM    Anticorpo Monoclonal \n\nAg   Ant\u00edgeno \n\nAP-1   \u201cactivator protein 1\u201d \n\nAPC   C\u00e9lula apresentadora de ant\u00edgeno \n\nBHI   \u201cBrain Heart Infusion\u201d \n\nCARD9  \u201cCaspase recruitment domain-containing protein 9\u201d \n\nCD11b             Marcador de express\u00e3o celular para mon\u00f3citos e c\u00e9lulas miel\u00f3ides \n\nCD11c                       Marcador de express\u00e3o celular para mon\u00f3citos e c\u00e9lulas miel\u00f3ides \n\nCD4                           Marcador da linf\u00f3cito Th1/Th2/Th17, co-receptor para mol\u00e9cula                                           \n\n                                   MHC classe  II                              \n\nCD8                           Marcador da linf\u00f3cito T citot\u00f3xico, co-receptor para mol\u00e9cula                  \n\n                                    MHC classe  I                                          \n\nCD14   \u201cCluster\u201d de diferencia\u00e7\u00e3o 14 \n\nCD25                          Marcador de ativa\u00e7\u00e3o de celular em linf\u00f3citos, cadeia ? do             \n\n   receptor de IL-2                                        \n\nCD40                         Mol\u00e9cula coestimuladora presente em macr\u00f3fagos, c\u00e9lulas    \n\n                                  dendr\u00edticas, linf\u00f3cito B, liga-se ao CD40                   \n\nCD45RO  Isoforma do CD45 \n\nCD80                          Mol\u00e9cula coestimuladora ou B7.1, presente em mon\u00f3citos, liga-se   \n\n                                     ao CD28 e CTLA-4                                \n\nCD86                        Mol\u00e9cula coestimuladora ou B7.2, presente em mon\u00f3citos e               \n\n                                  c\u00e9lulas  dendr\u00edticas, liga-se ao CD28 e CTLA-4                              \n\nCFA   \u201cCell-free antigen\u201d \n\nCTLA-4  \u201cCytotoxic T-lymphocyte-associated protein 4\u201d \n\nCXC   Fam\u00edlia de quimiocinas  \n\nDNA   \u00c0cido desoxirribonucl\u00e9ico \n\nDMEM  \u201cDulbecco's Modified Eagle's M\u00e9dium\u201d \n\nD.O.   Densidade \u00f3ptica \n\nE.P.   Erro padr\u00e3o \n\nELISA  \u201cEnsyme-linked immunosorbent assay\u201d \n\n\n\nFACS                          \u201cFluorescence-activated cell sorting\u201d \n\nFITC                           Isotiocianato de fluoresce\u00edna \n\nFoxP3                          \u201cForkhead family os transcriptional regulator Foxp3\u201d \n\nFSC   \u201cfoward scatter\u201d, tamanho celular \n\nH3PO4   \u00c1cido fosf\u00f3rico \n\nH&amp;E   Hematoxilina e eosina \n\nHTT   Hipersensibilidade do tipo tardio \n\nGM-CSF  \u201cGranulocyte macrophage colony-stimulating factor\u201d \n\nIFN-?   \u201cInterferon \u2013 ?\u201d \n\nIFN-?   \u201cInterferon \u2013 ?\u201d \n\nIFN-?   \u201cInterferon \u2013 ?\u201d \n\nIg   Imunoglobulina \n\nIgA   Imunoglobulina A \n\nIgE   Imunoglobulina E  \n\nIgG   Imunoglobulina G \n\nIgG1   Imunoglobulina G is\u00f3tipo 1 \n\nIgG2a   Imunoglobulina G is\u00f3tipo 2a \n\nIgG2b   Imunoglobulina G is\u00f3tipo 2b \n\nIgG3   Imunoglobulina G is\u00f3tipo 3  \n\nIgG4   Imunoglobulina G is\u00f3tipo 4  \n\nIgM   Imunoglobulina M \n\nIL-1   Interleucina I \n\nIL-1?   Interleucina I? \n\nIL-1?   Interleucina 1? \n\nIL-1R   Receptor para IL-1 \n\nToll/IL-1R8 Membro da fam\u00edlia dos IL-1R, atua como regulador negativo da \n\nsinaliza\u00e7\u00e3o via TLR/IL-1R, tamb\u00e9m conhecido como TIR8 \n\nIL-2   Interleucina 2 \n\nIL-4   Interleucina 4 \n\nIL-5   Interleucina 5 \n\nIL-6   Interleucina 6 \n\nIL-10   Interleucina 10 \n\nIL-12   Interleucina 12 \n\nIL-17   Interleucina 17 \n\n\n\nIL-23   Interleucina 23 \n\ni.p.   Intraperitoneal  \n\nIP-10   \u201cInterferon-inducible protein 10\u201d  \n\ni.t.   Intratraqueal \n\niNOS   \u00d3xido n\u00edtrico sintase induzida \n\nKC   \u201cKeratinocyte chemoattractant\u201d \n\nKO   \u201cKnockout\u201d ou deficiente \n\nLBA   Lavado bronco-alveolar \n\nLIP   Leuc\u00f3citos infiltrante de pulm\u00e3o \n\nLP   Lavado peritoneal \n\nLPS   Lipopolissac\u00e1ride \n\nMAL   \u201cMyD88-adaptor-like protein\u201d \n\nmRNA  \u00c1cido ribonucle\u00edco mensageiro  \n\nMCP-1  \u201cMonocyte chemoattractant protein-1\u201d \n\nMHC   \u201cMajor histocompatibility complex\u201d  \n\nMig   Quimiocina da fam\u00edlia CXC \n\nMIP-1?  \u201cMacrophage inflammatory protein 1 alpha\u201d \n\nMIP-2   \u201cMacrophage-inflammatory protein-2\u201d \n\nM\u00d8   Macr\u00f3fago \n\nMyD88  \u201cMyeloid differentiation primary response gene (88)\u201d \n\nNF-kB   \u201cNuclear factor-kappa B\u201d \n\nNK   \u201cNatural killer\u201d \n\nNO   \u201cnitric oxide\u201d \n\nNOS2   \u201cNitric oxide synthase 2\u201d \n\nOPD   Ortofenilenodiamina \n\nPAMP   \u201cPathogen-associated molecular patterns\u201d \n\nPb   Paracoccidioides brasiliensis \n\nPb 18   Paracoccidioides brasiliensis isolado 18 \n\nP. brasiliensis  Paracoccidioides brasiliensis \n\nPBS   Solu\u00e7\u00e3o salina em tamp\u00e3o fosfato \n\nPCM   Paracoccidioidomicose \n\nPI   Iodeto de prop\u00eddio \n\nPMA   \u201cPhobol 12-myristane 13-acetate\u201d \n\nPMN   Polimorfonucleares \n\n\n\nPRR    \u201cPattern recognition receptor\u201d \n\nROI   Radicais intermedi\u00e1rios do oxig\u00eanio \n\nSARM   \u201cSterile ?- and armadillo-motif-containing protein\u201d \n\nSFB   Soro fetal bovino \n\nSPF   \u201cSpecific pathogen free\u201d \n\nTCB   Tamp\u00e3o carbonato-bicarbonato \n\nT CD4+  Linf\u00f3cito T auxiliar \n\nT CD8+  Linf\u00f3cito T citot\u00f3xico \n\nTIR   \u201cToll/interleukin-1 receptor-like domain\u201d \n\nTGF-?   \u201cTransforming growth factor ?\u201d \n\nTh1   Linf\u00f3citos T \u201chelper\u201d classe 1 \n\nTh2   Linf\u00f3citos T \u201chelper\u201d classe 2 \n\nTh17   Linf\u00f3citos T \u201chelper\u201d classe 17 \n\nTLR   \u201cToll-Like receptor\u201d    \n\nTLR-2   \u201cToll-Like receptor 2\u201d  \n\nTLR-3   \u201cToll-Like receptor 3\u201d  \n\nTLR-4   \u201cToll-Like receptor 4\u201d  \n\nTLR-5   \u201cToll-Like receptor 5\u201d  \n\nTLR-9   \u201cToll-Like receptor 9\u201d  \n\nTNF-?   \u201cTumor necrosis factor ?\u201d \n\nTreg   C\u00e9lula T reguladora \n\nTRAM  \u201cTRIF-related adaptor molecule\u201d \n\nTRIF   \u201cTIR-domain-containing adapter-inducing interferon-?\u201d \n\nTRIS   \u201ctris(hidroximetil)aminometano\u201d \n\nUFC   Unidade formadora de col\u00f4nias \n\nWT   \u201cWild Type\u201d \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nSUM\u00c0RIO \n\n \n\n1 INTRODU\u00c7\u00c3O................................................................................................ \n\n \n\n \n\n23 \n\n2 OBJETIVOS..................................................................................................... 33 \n\n3 MATERIAL E M\u00c9TODOS............................................................................. 34 \n\n3.1 Experimentos in vitro....................................................................................   34 \n\n3.1.1 Animais....................................................................................................... 34 \n\n3.1.2 Fungo........................................................................................................... 34 \n\n3.1.3 Lavado Peritoneal para obten\u00e7\u00e3o de mcr\u00f3fagos..................................... 34 \n\n3.1.4 Lavado Peritoneal para obten\u00e7\u00e3o de PMNs............................................ 35 \n\n3.1.5 Lavado Bronco alveolar.............................................................................                                                36 \n\n3.1.6 Tratamento com IFN-? .............................................................................                                        36 \n\n3.1.7 Infec\u00e7\u00e3o dos macr\u00f3fagos e leuc\u00f3citos PMNs............................................                37 \n\n3.1.8 Determina\u00e7\u00e3o de UFC .............................................................................. 37 \n\n3.1.9 Fagocitose....................................................................................................           37 \n\n3.1.9.1 Fagocitose por microscopia.................................................................... 37 \n\n3.1.9.2 Fagocitose por citometria de fluxo........................................................ 38 \n\n3.1.10 Dosagem de NO........................................................................................ 38 \n\n3.1.11 ELISA........................................................................................................ 38 \n\n3.2 Experimentos in vivo.....................................................................................  39 \n\n3.2.1 Animais....................................................................................................... 39 \n\n3.2.2 Infec\u00e7\u00e3o intra-traqueal..............................................................................                                                           39 \n\n3.2.3 Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o...................................................................           39 \n\n3.2.4 Avalia\u00e7\u00e3o do tempo de sobrevida.............................................................  39 \n\n3.2.5 Leuc\u00f3citos Infiltrantes de Pulm\u00e3o............................................................           39 \n\n\n\n3.2.6 Citometria de fluxo.................................................................................... 40 \n\n3.2.7 Caracteriza\u00e7\u00e3o morfol\u00f3gica das suspens\u00f5es celulares por citospim ....   40 \n\n3.2.8 ELISA.........................................................................................................                                           40 \n\n3.2.9 Dosagem de NO......................................................................................... 41 \n\n3.2.10 An\u00e1lise histopatol\u00f3gica............................................................................ 41 \n\n3.2.11 Deple\u00e7\u00e3o de Granul\u00f3citos........................................................................                   41 \n\n3.2.11.1 Deple\u00e7\u00e3o................................................................................................. 41 \n\n3.2.11.2 Aavalia\u00e7\u00e3o da deple\u00e7\u00e3o......................................................................... 41 \n\n3.2.11.3 Avalia\u00e7\u00e3o do tempo de sobrevida........................................................ 42 \n\n3.2.12 Dosagem de anticorpos............................................................................ 42 \n\n3.2.13 An\u00e1lise estat\u00edstica.....................................................................................      42 \n\n4 RESULTADOS................................................................................................. 43 \n\n4.1 Estudo do TLR2 na paracoccidioidomicose pulmonar murina................                   43 \n\n4.1.1 Estudos in vitro...........................................................................................                                        43 \n\n4.1.1.1 Fagocitose.................................................................................................                                43 \n\n4.1.1.2 Avalia\u00e7\u00e3o da atividade fungicida de macr\u00f3fagos.................................                               43 \n\n4.1.1.3 Dosagem de NO.......................................................................................                                                 45 \n\n4.1.1.4 Produ\u00e7\u00e3o de citocinas............................................................................. 47 \n\n4.1.2 Estudos in vivo............................................................................................                                              49 \n\n4.1.2.1 Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o por UFC............................................... 49 \n\n4.1.2.2 Dosagem de NO.......................................................................................                               50 \n\n4.1.2.3 Avalia\u00e7\u00e3o da atividade fungicida de leuc\u00f3citos PMNs .......................   51 \n\n4.1.2.4  Caracteriza\u00e7\u00e3o morfol\u00f3gica das popula\u00e7\u00f5es celulares ...................... \n\n \n\n53 \n\n4.1.2.5 Estudo da deple\u00e7\u00e3o de leuc\u00f3citos PMNs............................................... 55 \n\n\n\n4.1.2.5.1 Avalia\u00e7\u00e3o da deple\u00e7\u00e3o.......................................................................... 55 \n\n4.1.2.5.2 Avalia\u00e7\u00e3o da carga f\u00fangica por UFC.................................................                             56 \n\n4.1.2.5.3 Tempo de sobrevida............................................................................. 58 \n\n4.1.2.6 Produ\u00e7\u00e3o de citocinas............................................................................. \n \n\n59 \n\n4.1.2.7 Produ\u00e7\u00e3o de quimiocinas........................................................................ \n \n\n63 \n\n4.1.2.8 Citometria de fluxo................................................................................. \n\n4.1.2.9 Caracteriza\u00e7\u00e3o intracelular de IL-17.................................................... \n\n65 \n\n68 \n\n4.1.2.10 An\u00e1lise das c\u00e9lulas T reguladoras........................................................                             71 \n\n4.1.2.11 Dosagem de anticorpos.........................................................................                                                   72 \n\n4.1.2.12 Sobrevida...............................................................................................                                                        73 \n\n4.1.2.13 An\u00e1lise histopatol\u00f3gica......................................................................... 74 \n\n4.2 Estudo da mol\u00e9cula adaptadora Myd88 na PCM...................................... 75 \n\n4.2.1 Estudos in vitro...........................................................................................                                        75 \n\n4.2.1.1 Fagocitose................................................................................................. 75 \n\n4.2.1.2 Avalia\u00e7\u00e3o da atividade fungicida de macr\u00f3fagos.................................                                77 \n\n4.2.1.3 Dosagem de NO....................................................................................... 78 \n\n4.2.2 Estudos in vivo............................................................................................                                    79 \n\n4.2.2.1 Estudo da fase aguda.................................................... ......................... 79 \n\n4.2.1.1.1 Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o por UFC............................................                                 79 \n\n4.2.1.1.2 Dosagem de NO.................................................................................... 79 \n\n4.2.1.1.3 Dosagem de citocinas...........................................................................                                                          81 \n\n4.2.2.2 Estudo da fase cr\u00f4nica............................................................................ 82 \n\n4.2.2.2.1 Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o por UFC............................................                                82 \n\n4.2.2.2.2 Dosagem de NO...................................................................................                                                                                       83 \n\n4.2.2.2.3 Dosagem de citocinas...........................................................................                                                          84 \n\n\n\n4.2.2.2.4 Citometria de fluxo ............................................................................. \n\n4.2.2.2.5 Caracteriza\u00e7\u00e3o morfol\u00f3gica das popula\u00e7\u00f5es celulares .................... \n\n86 \n\n88 \n\n4.2.2.2.6 An\u00e1lise das c\u00e9lulas T reguladoras.......................................................      89 \n\n4.2.2.2.7 Sobrevida..............................................................................................         90 \n\n4.2.2.2.8 An\u00e1lise histopatol\u00f3gica........................................................................ 91 \n\n5 DISCUSS\u00c3O..................................................................................................... 96 \n\n6 CONCLUS\u00d5ES................................................................................................ 114 \n\nREFER\u00caNCIAS BIBLIOGR\u00c1FICAS.............................................................. 115 \n\nANEXO A............................................................................................................ 132 \n\nANEXO B............................................................................................................ 144 \n\nANEXO C........................................................................................................... 158 \n\nANEXO D........................................................................................................... 166 \n\n \n\n \n\n\n\n 23 \n\n \n\n1 INTRODU\u00c7\u00c3O \n\n \n\n A paracoccidioidomicose (PCM), causada pelo fungo Paracoccidioides \n\nbrasiliensis, \u00e9 uma micose sist\u00eamica do homem e geograficamente est\u00e1 confinada \u00e0 \n\nAm\u00e9rica Latina e Central (M\u00e9xico). Sua \u00e1rea de endemicidade se estende da Am\u00e9rica \n\nCentral \u00e0 Argentina, afeta principalmente as comunidades rurais, sendo uma das \n\nmicoses profundas de maior preval\u00eancia destas regi\u00f5es. Foi estimado em uma regi\u00e3o \n\nend\u00eamica da Am\u00e9rica do Sul, onde vivem aproximadamente 90 milh\u00f5es de pessoas, que \n\n10 milh\u00f5es est\u00e3o em eminente risco de infec\u00e7\u00e3o. N\u00e3o s\u00f3 a incid\u00eancia \u00e9 vari\u00e1vel entre os \n\npa\u00edses, mas tamb\u00e9m entre distintas regi\u00f5es no mesmo pa\u00eds. Observa-se, por exemplo, \n\num franco contraste entre uma incid\u00eancia rara nas regi\u00f5es \u00e1ridas e semi-\u00e1ridas do \n\nNordeste do Brasil, ou ainda incomuns nas regi\u00f5es super\u00famidas da Amaz\u00f4nia, versus a \n\nalta incid\u00eancia nas regi\u00f5es Centro e Sudeste do pa\u00eds (RESTREPO, 1985; RESTREPO et \n\nal., 2001). H\u00e1 evid\u00eancias, portanto, de condi\u00e7\u00f5es ecol\u00f3gicas que favorecem a sobrevida \n\ndo fungo na natureza em regi\u00f5es end\u00eamicas. Entre essas condi\u00e7\u00f5es podemos citar: \n\ntemperatura m\u00e9dia entre 17 \u00baC e 24 \u00baC, invernos relativamente curtos e n\u00e3o muito \n\nrigorosos, pluviosidade entre 500-2500 mm/ano, altitude entre o n\u00edvel do mar e os 1500 \n\nm, solos f\u00e9rteis e com cobertura vegetal (RESTREPO, 1994). \n\nO P. brasiliensis \u00e9 um fungo com caracter\u00edsticas de dimorfismo t\u00e9rmico, que \n\ncresce como mic\u00e9lio \u00e0 temperatura de 25 \u00baC e como c\u00e9lula leveduriforme no tecido e in \n\nvitro a 37 \u00baC (RESTREPO, 1985). Segundo San Blas et al. (1980) a temperatura parece \n\nser o \u00fanico fator que interfere no dimorfismo do P. brasiliensis e este processo \u00e9 \n\nrevers\u00edvel. \n\nEstudo epidemiol\u00f3gico relata 3181 \u00f3bitos pela PCM no Brasil entre 1980 e 1995 \n\ne taxa de mortalidade m\u00e9dia anual 1,45/milh\u00e3o de habitantes. As regi\u00f5es Sul e Centro-\n\nOeste apresentam as maiores taxas de mortalidade regional. O Sudeste apresentou a taxa \n\nmais baixa e com tend\u00eancia de queda. O trabalho apresenta dados que indicam a \n\npreval\u00eancia da doen\u00e7a em \u00e1reas rurais e mortalidade predominante no sexo masculino \n\nem uma propor\u00e7\u00e3o de 562 homens/100 mulheres (COUTINHO et al., 2002). \n\n A infec\u00e7\u00e3o \u00e9 usualmente adquirida pela via respirat\u00f3ria, muito provavelmente \n\npela inala\u00e7\u00e3o de prop\u00e1gulos a\u00e9reos do fungo (con\u00eddios) que atingindo os pulm\u00f5es \n\npodem desenvolver-se em leveduras e a partir do foco prim\u00e1rio da infec\u00e7\u00e3o disseminar-\n\n\n\n 24 \n\nse pela via linfo-hematog\u00eanica para diferentes \u00f3rg\u00e3os ou sistemas (RESTREPO, 1985). \n\nO desenvolvimento da PCM depende da intera\u00e7\u00e3o entre o fungo e o hospedeiro, sendo a \n\nades\u00e3o \u00e0s c\u00e9lulas e \u00e0 superf\u00edcie de mucosas do hospedeiro importantes no \n\nestabelecimento da infec\u00e7\u00e3o. Desta forma, o P. brasiliensis pode penetrar ativamente \u00e0 \n\nsuperf\u00edcie muco cut\u00e2nea e parasitar as c\u00e9lulas epiteliais, escapando assim das defesas do \n\nhospedeiro e atingir os tecidos mais profundos pela via linfo-hematog\u00eanica (BRITO et \n\nal., 1973). \n\nA PCM apresenta-se em diferentes formas no hospedeiro. A grande maioria dos \n\nindiv\u00edduos desenvolve infec\u00e7\u00e3o pulmonar assintom\u00e1tica, enquanto que alguns \n\nindiv\u00edduos apresentam manifesta\u00e7\u00f5es cl\u00ednicas da doen\u00e7a. As formas polares da PCM \n\ns\u00e3o a hiper\u00e9rgica ou localizada e an\u00e9rgica ou disseminada (MONTENEGRO e \n\nFRANCO, 1994). O curso da infec\u00e7\u00e3o depende de diversos fatores, como a resposta do \n\nhospedeiro, via de infec\u00e7\u00e3o e a virul\u00eancia do agente infectante (BRUMMER et al., \n\n1993).  \n\nEstudos recentes t\u00eam demonstrado que a resposta imune celular tem papel \n\nprincipal na defesa dos hospedeiros contra a infec\u00e7\u00e3o pelo P. brasiliensis, enquanto que \n\nas formas mais graves da doen\u00e7a est\u00e3o associadas a n\u00edveis altos de anticorpos e ativa\u00e7\u00e3o \n\npoliclonal de linf\u00f3citos B (ARANGO et al., 1982; CASTANEDA et al., 1988; \n\nFAZIOLI, 1997). Estas caracter\u00edsticas indicam que a resposta imune relacionada com a \n\nprodu\u00e7\u00e3o de anticorpos, tais como as respostas imunes governadas por linf\u00f3citos T-\n\nhelper 2 (Th2), preferencialmente conduz para a doen\u00e7a mais grave e aquelas associadas \n\ncom a ativa\u00e7\u00e3o da imunidade celular, comandada pelos linf\u00f3citos T helper 1 (Th1), \n\nlevam a uma patologia mais branda.  \n\nTrabalhos recentes t\u00eam demonstrado claramente que pacientes com a forma \n\ngrave da PCM produzem n\u00edveis de IgE, IgG4 (regulados por IL-4) e IgA (regulada pelo \n\nTGF-?, IL-5 e IL-10) mais altos do que aqueles com a forma branda da doen\u00e7a (BAIDA \n\net al., 1999; MAMONI et al., 2002). Al\u00e9m disso, a secre\u00e7\u00e3o de n\u00edveis mais altos de \n\ncitocinas do tipo 2 (IL-4, IL-5, IL-10) e TGF-?, bem como a presen\u00e7a de eosinofilia, foi \n\ndetectada em pacientes com infec\u00e7\u00e3o mais disseminada do que aqueles com a doen\u00e7a \n\nmenos grave (OLIVEIRA et al., 2002). Em pacientes com a doen\u00e7a ativa, foi \n\nencontrada diminui\u00e7\u00e3o na secre\u00e7\u00e3o de IFN-? (KARHAWI et al., 1999) e o aumento da \n\nexpress\u00e3o de CTLA-4 em c\u00e9lulas mononucleares do sangue perif\u00e9rico, aumento este \n\nque pode estar relacionado com a anergia dos linf\u00f3citos T (CAMPANELLI et al., 2003). \n\n\n\n 25 \n\nEm conjunto, estes dados indicam um padr\u00e3o de resposta imune Th1/Th2 na PCM, isto \n\n\u00e9, as c\u00e9lulas Th2 est\u00e3o preferencialmente associadas com a doen\u00e7a progressiva e grave e \n\nas c\u00e9lulas Th1 associadas com a forma benigna da infec\u00e7\u00e3o. Alternativamente, a anergia \n\nde c\u00e9lulas T poderia ser a respons\u00e1vel pela resposta imune inadequada de pacientes com \n\na forma grave.         \n\nUtilizando um modelo de infec\u00e7\u00e3o intraperitoneal (i.p.) de PCM, Calich et al., \n\n(1985) demonstraram que havia diferen\u00e7as significantes entre resist\u00eancia e \n\nsusceptibilidade ao fungo, entre v\u00e1rias linhagens isog\u00eanicas de camundongo. Foram \n\ncaracterizadas como as mais resistentes as linhagens A/Sn e A/J, enquanto que animais \n\nB10.A mostraram-se altamente suscept\u00edveis \u00e0 infec\u00e7\u00e3o pelo P. brasiliensis.  \n\nEstudos mais recentes desenvolvidos em nosso laborat\u00f3rio t\u00eam utilizado um \n\nmodelo de PCM pulmonar empregando as mesmas linhagens de camundongos, \n\nutilizando, por\u00e9m, a via intratraqueal (i.t.) de infec\u00e7\u00e3o. Foi observado que camundongos \n\nA/Sn desenvolvem PCM cr\u00f4nica, benigna e restrita aos pulm\u00f5es. Animais B10.A \n\ndesenvolvem doen\u00e7a disseminada e progressiva. Os resultados obtidos sugeriram que a \n\nresist\u00eancia a PCM estava associada \u00e0 atividade de linf\u00f3citos T, macr\u00f3fagos e linf\u00f3citos \n\nmediados por IFN-? (CANO et al., 1995). Estudos in vivo demonstraram ainda que o \n\nIFN-? tem efeito protetor na PCM pulmonar. A deple\u00e7\u00e3o de IFN-? por anticorpos \n\nmonoclonais agravou a doen\u00e7a, tanto em animais suscept\u00edveis, como em animais \n\nresistentes ao fungo. Nesses animais depletados houve aumento da carga f\u00fangica \n\npulmonar e anergia da resposta imune celular (CANO et al., 1998). Souto et al. (2000) \n\nao estudarem o papel do IFN-? e TNF-? na resist\u00eancia \u00e0 infec\u00e7\u00e3o, demonstraram que o \n\nIFN-? atua no mecanismo de resist\u00eancia \u00e0 doen\u00e7a e induz a produ\u00e7\u00e3o de NO que \n\ndetermina anergia de c\u00e9lulas T. Outros estudos revelam que a produ\u00e7\u00e3o de quimiocinas \n\ne o recrutamento de leuc\u00f3citos para os pulm\u00f5es em camundongos infectados por P. \n\nbrasiliensis s\u00e3o modulados por IFN-?. Souto et al. (2003) evidenciaram isto ao estudar a \n\nprodu\u00e7\u00e3o de quimiocinas em camundongos C57Bl/6 comparados a animais da mesma \n\nlinhagem, por\u00e9m com o gene para IFN-? nocauteado. Estes \u00faltimos produziram baixos \n\nn\u00edveis de quimioatraentes para c\u00e9lulas mononucleares como IP-10, Mig e MCP-1, e \n\nn\u00edveis altos de quimioatraentes de neutr\u00f3filos como KC e MIP-1?. \n\n Estudos realizados com o modelo intraperitoneal (i.p.) e com o modelo \n\npulmonar da PCM demonstraram que a infec\u00e7\u00e3o pelo P. brasiliensis leva a diferentes \n\ngraus de ativa\u00e7\u00e3o macrof\u00e1gica, que dependem do padr\u00e3o gen\u00e9tico da linhagem de \n\n\n\n 26 \n\ncamundongo empregada (KASHINO et al., 1995). O \u00f3xido n\u00edtrico, um dos mais \n\nimportantes intermedi\u00e1rios reativos do nitrog\u00eanio, \u00e9 um dos principais respons\u00e1veis pela \n\natividade microbicida dos macr\u00f3fagos. A enzima \u00f3xido-n\u00edtrico-sintetase induzida (iNOS \n\nou NOS2) \u00e9 a respons\u00e1vel pela produ\u00e7\u00e3o de NO e est\u00e1 amplamente envolvida em \n\nprocessos inflamat\u00f3rios e infecciosos (MACMICKING at al., 1997). Foi demonstrada a \n\nparticipa\u00e7\u00e3o do NO em v\u00e1rias infec\u00e7\u00f5es por microrganismos, inclusive pelo P. \n\nbrasiliensis. Bocca et al. (1988) demonstraram que o tratamento in vivo com um \n\ninibidor de NO agravava a doen\u00e7a em camundongos (C57Bl/6) infectados pelo P. \n\nbrasiliensis, por\u00e9m revertia a anergia dos linf\u00f3citos T a ant\u00edgenos do fungo. \n\n Os leuc\u00f3citos polimorfonucleares (PMN) t\u00eam a\u00e7\u00e3o evidente na imunidade \n\nprotetora de camundongos suscept\u00edveis, embora protejam camundongos resistentes \n\nsomente ao in\u00edcio da infec\u00e7\u00e3o. Fato interessante observado neste trabalho foi o de que a \n\ndeple\u00e7\u00e3o de leuc\u00f3citos PMN induzia doen\u00e7a muito grave nos camundongos suscept\u00edveis \n\nem concomit\u00e2ncia com n\u00edveis elevados de citocinas proinflamat\u00f3rias. Assim, a atua\u00e7\u00e3o \n\nexcessiva do sistema imune pode ser delet\u00e9ria ao hospedeiro (PINA et al., 2006).  \n\n No nosso modelo experimental, v\u00e1rias observa\u00e7\u00f5es indicam que o paradigma \n\nTh1/Th2 de ativa\u00e7\u00e3o da resposta imune adaptativa n\u00e3o explica completamente os \n\nfen\u00f4menos de resist\u00eancia e susceptibilidade ao fungo. Assim, a IL-4 \u00e9 protetora para \n\ncamundongos suscept\u00edveis (ARRUDA et al., 2004), o tratamento com IL-12 ex\u00f3gena \n\nleva \u00e0 menor dissemina\u00e7\u00e3o do fungo, mas induz intensa patologia pulmonar associada \n\ncom exuberante influxo de c\u00e9lulas inflamat\u00f3rias (ARRUDA et al., 2002); a deple\u00e7\u00e3o de \n\nc\u00e9lulas T CD4+ n\u00e3o altera o curso da doen\u00e7a de camundongos suscept\u00edveis \n\n(CHIARELLA et al., 2007) e a produ\u00e7\u00e3o excessiva de \u00f3xido n\u00edtrico induz anergia da \n\nimunidade celular (NASCIMENTO et al., 2002). \n\nDiferentemente do que se supunham na doen\u00e7a humana, experimentos de \n\ndeple\u00e7\u00e3o in vivo e com camundongos nocaute (KO) para genes de subpopula\u00e7\u00f5es \n\nlinfocit\u00e1rias (CD4+ e CD8+) t\u00eam demonstrado que os linf\u00f3citos T CD8+ s\u00e3o \n\nfundamentais para o controle da PCM pulmonar e podem se apresentar sob os padr\u00f5es \n\ndo tipo 1 (secretor de IFN-?) ou tipo 2 (secretor de IL-4) de ativa\u00e7\u00e3o. Al\u00e9m disso, estes \n\nlinf\u00f3citos parecem ser fundamentais para o controle da carga f\u00fangica pulmonar \n\n(CALICH e BLOTTA, 2005; CHIARELLA et al., 2007; ARRUDA et al., 2007).  Os \n\nlinf\u00f3citos T CD4+ do tipo 1 s\u00e3o ativados ao in\u00edcio da resposta imune de camundongos \n\nresistentes que mais tardiamente ativam subpopula\u00e7\u00f5es Th2. Esta ativa\u00e7\u00e3o parece \n\ncontribuir para o padr\u00e3o resistente, talvez regulando negativamente processo \n\n\n\n 27 \n\ninflamat\u00f3rio lesivo para tecidos do hospedeiro. A subpopula\u00e7\u00e3o T CD4+ de \n\ncamundongos suscept\u00edveis \u00e9 completamente an\u00e9rgica e a doen\u00e7a destes animais n\u00e3o se \n\naltera pela deple\u00e7\u00e3o seletiva de linf\u00f3citos T CD4+. Assim, em camundongos \n\nsuscept\u00edveis outros mecanismos imunorregulat\u00f3rios parecem estar associados \u00e0 \n\nsusceptibilidade gen\u00e9tica da doen\u00e7a. Neste aspecto, recentes trabalhos realizados com \n\npacientes t\u00eam demonstrado que a imunossupress\u00e3o na PCM est\u00e1 associada \u00e0 express\u00e3o \n\naumentada de mol\u00e9culas CTLA-4 por linf\u00f3citos de pacientes (CAMPANELLI et al, \n\n2003), \u00e0 apoptose de c\u00e9lulas T (CACERE et al., 2002) e \u00e0 a\u00e7\u00e3o de c\u00e9lulas T reguladoras \n\nde fen\u00f3tipo T CD4+CD25+ Foxp3+ (CAVASSANI, 2006).  \n\nToll-Like Receptors (TLRs) s\u00e3o receptores recentemente descritos que \n\nreconhecem mol\u00e9culas-padr\u00e3o expressas por diversos pat\u00f3genos. Estes receptores foram \n\nencontrados inicialmente em Drosophila melanogaster e denominados \u201cToll\u201d e \n\nassociados com a defesa contra parasitas. A seguir, foram descritos receptores \n\nhom\u00f3logos em mam\u00edferos e ent\u00e3o denominados de \u201cToll-Like Receptors\u201d. Hoje, \n\nconhecemos 13 fam\u00edlias de TLRs e todos eles apresentam pequenas diferen\u00e7as nas \n\ncadeias de amino\u00e1cidos que comp\u00f5e as prote\u00ednas que os formam. Devido estas \n\ndiferen\u00e7as, cada TLR \u00e9 capaz de reconhecer classes diferentes de mol\u00e9culas biol\u00f3gicas \n\npresentes em diversos microorganismos, como por exemplo, LPS, lipoprote\u00ednas, \n\nflagelina, peptideoglicana, DNA entre outras (TAKEDA et al., 2003; AKIRA et al., \n\n2006).  \n\n Quando ativados, os TLRs desencadeiam uma sinaliza\u00e7\u00e3o intracelular que \n\nculmina com a ativa\u00e7\u00e3o do macr\u00f3fago e com a s\u00edntese de compostos que podem \n\neliminar o pat\u00f3geno; esta ativa\u00e7\u00e3o pode ocorrer atrav\u00e9s da ativa\u00e7\u00e3o do fator de \n\ntranscri\u00e7\u00e3o NFkB  ou do fator de transcri\u00e7\u00e3o AP-1, por exemplo; ambos ativam genes a \n\nproduzir citocinas que est\u00e3o ligadas \u00e0 inflama\u00e7\u00e3o, como o fator de necrose tumoral-alfa \n\n(TNF-?) e IL-1, com a prolifera\u00e7\u00e3o celular (IL-2) e a apoptose. A ativa\u00e7\u00e3o final do \n\nNFkB pode ser desencadeada por um sinal proveniente de um TLR e a via de \n\nsinaliza\u00e7\u00e3o pode ser dependente ou independente da prote\u00edna adaptadora denominada  \n\nFator 88 de diferencia\u00e7\u00e3o miel\u00f3ide (MyD88). A sinaliza\u00e7\u00e3o MyD88-dependente \u00e9 \n\ncompartilhada por todos os TLRs, exceto o TLR-9. Se a via de ativa\u00e7\u00e3o for \n\nindependente de MyD88, o sinal proveniente do TLR ativa o NFkB atrav\u00e9s de outras \n\nduas mol\u00e9culas adaptadoras como TRIF e TRAM, ou ainda MyD88 pode associar-se a \n\noutra prote\u00edna adaptadora como a MAL (ou TIRAP) para sinalizar a produ\u00e7\u00e3o de  \n\nNFkB. A TRIF \u00e9 uma prote\u00edna adaptadora contendo o dom\u00ednio TIR (dom\u00ednio de \n\n\n\n 28 \n\nhomologia ao receptor Toll/IL-1 induzindo IFN-?) e est\u00e1 ligada \u00e0 sinaliza\u00e7\u00e3o via TLR-\n\n9; a via dependente de TRIF pode atuar tamb\u00e9m via outros fatores de transcri\u00e7\u00e3o, como \n\no IRF3, IRF5 e IRF7, e estes culminam com a ativa\u00e7\u00e3o dos genes que codificam IFN-\n\n?/?; TRIF ainda pode associar-se com TRAM para desencadear a produ\u00e7\u00e3o de NFkB e \n\nIRF3, e este caso ocorre quando h\u00e1 ativa\u00e7\u00e3o do TLR-4. Outra prote\u00edna adaptadora \u00e9 a \n\nMAL, que \u00e9 requisitada pela sinaliza\u00e7\u00e3o via TLR-2 e TLR-4 e atua ligada \u00e0 prote\u00edna \n\nMyD88. Recentemente, uma quinta prote\u00edna adaptadora foi revelada, a SARM, e parece \n\natuar como reguladora negativa da sinaliza\u00e7\u00e3o via TRIF (DOYLE et al., 2006; \n\nO\u201dNEILL e BOWIE, 2007). \n\n Diversos trabalhos v\u00eaem demonstrando a import\u00e2ncia da prote\u00edna MyD88 \n\nno controle das infec\u00e7\u00f5es: Fremond et al., 2007 relataram que MyD88 \u00e9 crucial para o \n\ncontrole do crescimento do Mycobacterium tuberculosis. A produ\u00e7\u00e3o de algumas \n\ncitocinas como TNF-?, IL-6, e IL-12p40 foi observada em n\u00edveis menores em \n\nmacr\u00f3fagos provenientes de animais MyD88KO e infectados com a bact\u00e9ria, quando \n\ncomparado ao grupo controle. Al\u00e9m disso, camundongos deficientes e infectados com a \n\nbact\u00e9ria apresentaram um tempo m\u00e9dio de sobrevida consideravelmente menor que os \n\nanimais controle.  Campos et al. (2004) relataram que a prote\u00edna MyD88 \u00e9 \n\nindispens\u00e1vel no controle de infec\u00e7\u00f5es por Trypanosoma cruzi. Camundongos \n\nMyD88KO infectados com o protozo\u00e1rio apresentaram uma alta parasitemia e acelerada \n\nmortalidade quando comparados ao grupo controle. A sinaliza\u00e7\u00e3o via MyD88 tamb\u00e9m \n\nest\u00e1 envolvida no controle de infec\u00e7\u00f5es virais, WIRTZ et al. (2005) relataram que o \n\nv\u00edrus Epstein-Barr ativa a produ\u00e7\u00e3o de NF-?B atrav\u00e9s do TLR-2 dependentemente de \n\nMyD88 e esta ativa\u00e7\u00e3o \u00e9 crucial para uma eficiente imunidade frente a este v\u00edrus.  \n\n Em infec\u00e7\u00f5es f\u00fangicas Bretz et al., 2008 demonstraram que a sinaliza\u00e7\u00e3o via \n\nMyD88 \u00e9 essencial para controle do crescimento do fungo Aspergillus fumigatus. A \n\naus\u00eancia desta prote\u00edna levou a menores n\u00edveis de IFN-?, IL-1?, IL-6 e da quimiocina \n\nKC quando comparado ao grupo controle.  Trabalhando com C\u00e2ndida albicans, De \n\nLuca et al. (2007) demonstraram que a prote\u00edna MyD88 \u00e9 essencial para atividade \n\nantiinflamat\u00f3ria exercida pelas c\u00e9lulas T reguladoras (Treg) no local da infec\u00e7\u00e3o. Em \n\noutro trabalho, Biondo et al. (2005) relataram que TLR-2 e MyD88 s\u00e3o essenciais na \n\ndefesa contra o fungo Crytococcus neoformans. Animais TLR-2 e MyD88KO \n\napresentaram menores n\u00edveis de TNF-?, IL-12p40 e IFN-? comparados aos animais \n\ncontrole em resposta \u00e0 infec\u00e7\u00e3o pelo fungo. Al\u00e9m disso, animais MyD88KO \n\n\n\n 29 \n\napresentaram alta mortalidade quando comparados aos animais controle e TLR-2KO em \n\nresposta \u00e0 infec\u00e7\u00e3o pelo criptococcus.   \n\n Cada vez mais vem sendo demonstrada a import\u00e2ncia dos receptores da \n\nfam\u00edlia Toll-Like no reconhecimento de diversos pat\u00f3genos. Este reconhecimento \n\nmuitas vezes determina o curso da doen\u00e7a causada por bact\u00e9rias, fungos, protozo\u00e1rios e \n\nv\u00edrus (NETEA et al., 2006; ROPERT et al., 2008; THOMPSOM et al., 2008). Em \n\ntrabalho pioneiro, Campos et al. (2001) sugerem que grupamentos \n\nglicosilfosfatidilinositol (GPI) isolados do protozo\u00e1rio Trypanosoma cruzi ativam a \n\nprodu\u00e7\u00e3o de IL-12, TNF-? e  \u00f3xido n\u00edtrico (NO) por macr\u00f3fagos de camundongos via \n\nTLR-2. Assim, a ativa\u00e7\u00e3o do TLR-2 poderia iniciar um mecanismo de defesa inata e \n\numa resposta inflamat\u00f3ria durante o processo de infec\u00e7\u00e3o pelo protozo\u00e1rio. THOMA\u2013\n\nUSZYNSKI et al.  (2001) demonstraram que lipoprote\u00ednas da bact\u00e9ria causadora da \n\ntuberculose Mycobaterium tuberculosis ativam macr\u00f3fagos de camundongos e humanos \n\nvia TLR-2. Por outro lado, Campos et al. (2004) relatam que LPS derivado da bact\u00e9ria \n\nBrucella abortus ativa macr\u00f3fagos via TLR-4. Este fato foi facilmente demonstrado \n\nutilizando um camundongo que tem uma muta\u00e7\u00e3o no gene que codifica o TLR-4 \n\n(C3H/HeJ) e uma linhagem normal (C3H/HePas) que expressa o receptor inalterado. \n\nMacr\u00f3fagos de ambas as linhagens foram desafiados com LPS, por\u00e9m os deficientes \n\npara TLR-4 produziram n\u00edveis menores de IL-12 e TNF-?, o que sugere a participa\u00e7\u00e3o \n\ndo TLR-4 na imunomodula\u00e7\u00e3o dos macr\u00f3fagos.  \n\n Em rela\u00e7\u00e3o \u00e0s infec\u00e7\u00f5es f\u00fangicas diversos trabalhos v\u00eaem demonstrando a \n\nimport\u00e2ncia de diferentes TLRs na imunidade contra fungos, e, de modo geral TLR-2 e \n\nTLR-4 t\u00eam sido descritos como os mais importantes.  Belochio et al. (2004) \n\ndemonstraram que a resposta imune inata e adaptativa \u00e0s infec\u00e7\u00f5es por Candida \n\nalbicans e Aspergillus fumigatus \u00e9 coordenada por diferentes TLRs, particularmente por \n\nTLR-2, TLR-4 e TLR-9. Neste trabalho, as diferentes formas do fungo, hifa e con\u00eddios, \n\ns\u00e3o reconhecidas por diferentes Tolls. Estes autores demonstraram tamb\u00e9m que a \n\npresen\u00e7a do TLR-2 e do TLR-9 levou a uma doen\u00e7a mais grave, com n\u00edveis altos TNF-\n\n? e de UFC em compara\u00e7\u00e3o com os observados nos camundongos TLR-2 KO e TLR-9 \n\nKO. Em outro trabalho com Aspergillus fumigatus, demonstrou-se que macr\u00f3fagos \n\nperitoneais de camundongos deficientes para o TLR-4, quando estimulados com \n\ncon\u00eddios do fungo, produzem menores n\u00edveis de TNF-?, IL-1? e IL-1?, comparando-se \n\n\n\n 30 \n\ncom macr\u00f3fagos provenientes de animais que expressam o TLR-4 funcional, (NETEA \n\net al., 2003). \n\n  Viriyakosol et al. (2004) relataram que a ativa\u00e7\u00e3o de macr\u00f3fagos \n\nperitoneais por Coccidioides posadassi \u00e9 dependente do TLR-2 e independente do TLR-\n\n4. Ao desafiar macr\u00f3fagos de camundongos TLR-2 KO com o fungo, observaram n\u00edveis \n\nmenores de TNF-? e MIP-2 em compara\u00e7\u00e3o \u00e0queles produzidos por com macr\u00f3fagos de \n\nanimais que apresentam o receptor funcional. Contudo, o mesmo desafio n\u00e3o resultou \n\nem diferen\u00e7as na produ\u00e7\u00e3o destas citocinas quando macr\u00f3fagos de animais TLR-4 KO \n\nforam comparados a macr\u00f3fagos de animais que apresentam o TLR-4 funcional.  \n\n Trabalhando com hifas e leveduras de C\u00e2ndida albicans Gozalbo et al. \n\n(2006) demonstraram que TLR-4 e TLR-2 participam da defesa do hospedeiro frente a \n\neste fungo.  Ambas as formas dos fungos foram capazes de ativar os receptores que s\u00e3o \n\nrespons\u00e1veis pela ativa\u00e7\u00e3o de macr\u00f3fagos e produ\u00e7\u00e3o de citocinas proinflamat\u00f3rias \n\ncomo o TNF-?. Esta interpreta\u00e7\u00e3o contrasta com os achados in vivo de Belochio et al. \n\n(2004), que demonstraram que a presen\u00e7a de TLR-2 leva a candid\u00edase mais grave. Ao \n\ntrabalhar com Cryptococcus neoformans, Biondo et al. (2005), demonstraram que \n\nMyD88, TLR-2 e n\u00e3o o TLR-4 s\u00e3o essenciais para defesa contra este fungo oportunista, \n\ne isso ocorre atrav\u00e9s da indu\u00e7\u00e3o da produ\u00e7\u00e3o de TNF-?, IL-12 e IFN-?. \n\n TLRs n\u00e3o s\u00e3o exclusivos das c\u00e9lulas da imunidade inata como os \n\nmacr\u00f3fagos e as c\u00e9lulas dentr\u00edticas, est\u00e3o presentes tamb\u00e9m em c\u00e9lulas da imunidade \n\nadquirida, como os linf\u00f3citos T, contribuindo assim, na modula\u00e7\u00e3o deste tipo de \n\nimunidade adquirida. C\u00e9lulas T naive apresentam baixos n\u00edveis de mRNA e de \n\nprote\u00ednas intracelulares para TLR-2 e TLR-4, por\u00e9m c\u00e9lulas T de mem\u00f3ria e ativadas \n\nexpressam altos n\u00edveis de TLR-2 e TLR-4 expressos na membrana (LIU e ZHAO, \n\n2007). Al\u00e9m disso, trabalhos recentes evidenciam que a sinaliza\u00e7\u00e3o via TLR-2 regula a \n\nexpans\u00e3o e fun\u00e7\u00e3o das c\u00e9lulas T reguladoras (Tregs) (STUMULLER et al., 2006; LIU e \n\nZHAO, 2007).  Para exemplificar, recentes estudos teorizaram que ligantes derivados de \n\nLeishmania sp podem induzir a expans\u00e3o das Tregs contribuindo para a supress\u00e3o da \n\nresposta imune contra o pat\u00f3geno (SUFFIA et al., 2006; STUMULLER et al., 2006; \n\nSTUMULLER et al., 2007). \n\n Cada vez mais vem sendo descrito o papel dos TLRs na determina\u00e7\u00e3o da \n\ngera\u00e7\u00e3o de um padr\u00e3o de resposta imune. Dependendo do parasita e do receptor \n\n\n\n 31 \n\nenvolvido, podemos observar um padr\u00e3o de resposta Th1, Th2 e Th17. Trabalhando \n\ncom c\u00e9lulas humanas, KATTAH et al. (2008) demonstraram que a ativa\u00e7\u00e3o via TLR-4 e \n\nvia TLR-7/8 ativam a produ\u00e7\u00e3o de citocinas como IL-6, IL-23, TGF-?, e este conjunto \n\nde citocinas determinou, ent\u00e3o, a diferencia\u00e7\u00e3o de linf\u00f3citos TCD4+ naive em linf\u00f3citos \n\nTCD4+ Th17, com produ\u00e7\u00e3o majorit\u00e1ria de IL-17. Os mesmos resultados n\u00e3o foram \n\nencontrados quando o grupo trabalhou com ativa\u00e7\u00e3o via TLR-2, TLR-3 e TLR-9. \n\n A IL-17 \u00e9 uma citocina recentemente descrita e largamente produzida por \n\numa subpopula\u00e7\u00e3o de linf\u00f3citos T CD4+ ativados; entretanto, a IL-17 \u00e9 conhecida \n\ntamb\u00e9m por sua atividade reguladora da imunidade inata e na defesa contra parasitas. \n\nUma das atividades reconhecidas da IL-17 \u00e9 a mobiliza\u00e7\u00e3o de neutr\u00f3filos para s\u00edtios \n\ninflamat\u00f3rios atrav\u00e9s da indu\u00e7\u00e3o da produ\u00e7\u00e3o de quimiocinas, como as CXC, \n\nquimiocinas cujas ciste\u00ednas terminais s\u00e3o espa\u00e7adas por um amino\u00e1cido e que t\u00eam a\u00e7\u00e3o \n\npreferencialmente sobre leuc\u00f3citos PMN (KOLLS e LINDES, 2004; MIYAMOTO et \n\nal., 2003; STOCKINGER et al., 2007). A citocina IL-23, da mesma forma que a IL-12, \n\n\u00e9 membro da fam\u00edlia das citocinas proinflamat\u00f3rias. Compartilham a cadeia pept\u00eddica \n\np40, enquanto que as cadeias p35 e p19 s\u00e3o especificas da IL-12 e IL-23, \n\nrespectivamente. Enquanto que ambas as citocinas induzem a produ\u00e7\u00e3o de IFN-? em \n\nlinf\u00f3citos T CD4+, a IL-23, embora n\u00e3o envolvida na diferencia\u00e7\u00e3o Th17, tem uma \n\nimportante fun\u00e7\u00e3o na manuten\u00e7\u00e3o e na fun\u00e7\u00e3o efetora de c\u00e9lulas Th17 (BETTELLI, et \n\nal., 2006; STOCKINGER et al., 2007).  \n\n Trabalhos recentes t\u00eam demonstrado que as citocinas IL-17/IL-23 t\u00eam uma \n\nimportante fun\u00e7\u00e3o na defesa contra fungos. Zelante et al. (2007) demonstraram que \n\nestas citocinas atuam como reguladores negativos da resposta Th1 promovida por \n\nfungos, particularmente Candida albicans e Aspergilus fumigatus. Al\u00e9m disso, a IL-17 \n\npromove uma inflama\u00e7\u00e3o rica em neutr\u00f3filo, enquanto que a IL-23 regula a atividade \n\nfungicida destas c\u00e9lulas. Em adi\u00e7\u00e3o, em recente trabalho, Bozza et al. (2008) \n\ndemonstraram que a perda do Toll IL-1R8, que \u00e9 um regulador negativo da sinaliza\u00e7\u00e3o \n\nvia TLR/IL-1R, exarceba a resposta Th17 em resposta a infec\u00e7\u00f5es f\u00fangicas. \n\n Alguns trabalhos t\u00eam contribu\u00eddo para elucidar o papel dos TLRs na \n\nparacoccidioimicose. Trabalhando com animais suscept\u00edveis, Ferreira et al. (2007) \n\nverificaram um aumento da express\u00e3o de TLR-2 em resposta a infec\u00e7\u00e3o pelo P. \n\nbrasiliensis em camundongos B10.A, caracterizando a intera\u00e7\u00e3o fungo-TLR-2 como um \n\nposs\u00edvel mecanismo de susceptibilidade. Em elegante trabalho, os autores relataram que \n\n\n\n 32 \n\na administra\u00e7\u00e3o terap\u00eautica de lectinas KM+ derivadas de Artocarpus integrif\u00f3lia (jaca) \n\nem camundongos BALB/c, protege estes camundongos durante a infec\u00e7\u00e3o pelo P. \n\nbrasiliensis atrav\u00e9s da produ\u00e7\u00e3o de IL-12 via TLR-2 (COLTRI et al., 2008).  \n\n Em nosso grupo, trabalhando com animais TLR-4-deficientes, verificamos \n\nque macr\u00f3fagos provenientes de animais TLR-4 deficientes e infectados in vitro com o \n\nfungo P. brasiliensis, apresentaram uma menor carga f\u00fangica associada a menores \n\nn\u00edveis de NO, IL-12 e MCP-1 quando comparados a macr\u00f3fagos provenientes de \n\nanimais TLR-4 competentes. In vivo, a presen\u00e7a de TLR-4 levou a uma infec\u00e7\u00e3o mais \n\nsevera, com maior carga f\u00fangica pulmonar, maior afluxo de macr\u00f3fagos e linf\u00f3citos \n\nTCD4 e TCD8 ativados para o local da infec\u00e7\u00e3o. Observamos tamb\u00e9m que a presen\u00e7a \n\ndo TLR-4 modulou a s\u00edntese de algumas citocinas, as Th1 (IL-12, TNF-?) e Th17 (IL-\n\n17, IL-6, TGF-?, e IL-23) que foram secretadas em maiores n\u00edveis por animais TLR-4 \n\ncompetentes, indicando um importante papel do TLR-4 na ativa\u00e7\u00e3o e modula\u00e7\u00e3o de \n\nsubpopula\u00e7\u00f5es de linf\u00f3citos T (LOURES et al., 2010). \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 33 \n\n2 OBJETIVOS \n\n \n\nEstudar in vitro o envolvimento do TLR-2 e da prote\u00edna MYD88 na intera\u00e7\u00e3o \n\nentre macr\u00f3fagos de camundongos e o P .brasiliensis. Para tanto foram usados \n\nmacr\u00f3fagos de camundongos TLR-2/KO e MYD88/KO e controles normais da \n\nlinhagem C57Bl/6. Nestes ensaios foram caracterizadas a fagocitose, a atividade \n\nfungicida, e a secretora de NO e de citocinas.  \n\nInvestigar o papel do TLR-2 e da prote\u00edna MYD88 na infec\u00e7\u00e3o pulmonar pelo \n\nP.brasiliensis. Estudamos comparativamente o grau de infec\u00e7\u00e3o em camundongos \n\ndeficientes e normais (TLR-2/KO, MYD88/KO e C57Bl/6 normais, respectivamente). \n\nAl\u00e9m do grau de infec\u00e7\u00e3o determinado pela contagem do n\u00famero de fungos vi\u00e1veis nos \n\npulm\u00f5es, ba\u00e7o e f\u00edgado, histopatologia e tempo de sobrevida, foram tamb\u00e9m \n\ncaracterizadas a imunidade humoral (dosagem de anticorpos) e celular (caracteriza\u00e7\u00e3o \n\ndas subpopula\u00e7\u00f5es celulares infiltrantes no pulm\u00e3o). As citocinas e quimiocinas foram \n\ndosadas em homogenatos de \u00f3rg\u00e3os. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 34 \n\n3 MATERIAL E M\u00c9TODOS \n\n \n\n3.1 Experimentos in vitro: \n\n3.1.1 Animais \n\nForam utilizados camundongos nocaute para o TLR-2 e para a prote\u00edna MyD88, \n\nassim como camundongos controle, todos da linhagem C57Bl/6. Estes animais foram \n\numa gentil doa\u00e7\u00e3o do Prof. Shizuo Akira, da Universidade de Osaka, Jap\u00e3o. Todos os \n\ncamundongos tinham a condi\u00e7\u00e3o de SPF (Specific Pathogen Free) e foram criados \n\nno Biot\u00e9rio do Departamento de Imunologia do ICB-USP. Os camundongos foram \n\nutilizados ao atingirem 6 a 8 semanas de idade. Para induzir em cada camundongo o \n\nafluxo de c\u00e9lulas, foram injetados 3 mL de meio Tioglicolato Brewer (DIFCO) 72 \n\nhoras antes da lavagem do perit\u00f4nio para a obten\u00e7\u00e3o das c\u00e9lulas inflamat\u00f3rias.  \n\n \n\n3.1.2 Fungo \n\n  Foi utilizado o isolado Pb 18 (virulento) do P. brasiliensis, (KASHINO, 1985). \n\nO fungo foi mantido em meio s\u00f3lido de Fava Netto (FAVA NETTO, 1955) a 36 \u00baC, \n\npor repiques semanais. Suspens\u00f5es celulares foram obtidas na fase exponencial de \n\ncrescimento leveduriforme, ou seja, ap\u00f3s uma semana de cultivo, e lavadas tr\u00eas vezes \n\nem solu\u00e7\u00e3o salina est\u00e9ril. A concentra\u00e7\u00e3o de c\u00e9lulas f\u00fangicas foi ajustada ap\u00f3s \n\ncontagem em c\u00e2mara hemocitom\u00e9trica (Neubauer). A viabilidade da suspens\u00e3o \n\ncelular foi avaliada utilizando o corante Janus Green, e a viabilidade foi sempre \n\nsuperior a 85%.  Para obten\u00e7\u00e3o de leveduras n\u00e3o vi\u00e1veis do fungo, suspens\u00f5es \n\nf\u00fangicas foram deixadas a 56 \u00baC por 1 hora. \n\n \n\n3.1.3 Lavado peritoneal para obten\u00e7\u00e3o de macr\u00f3fagos \n\nCamundongos pr\u00e9-inoculados com tioglicolato foram submetidos a um processo \n\nde obten\u00e7\u00e3o de lavado peritoneal (LP). Para isto, os animais foram sacrificados por \n\nexcesso do anest\u00e9sico e o perit\u00f4nio foi lavado com inje\u00e7\u00e3o de 5-6 mL de PBS est\u00e9ril ou \n\nmeio de cultura n\u00e3o suplementado (DMEM-Dulbecco\u2019s Modified Eagle\u2019s Medium).  \n\nA viabilidade da suspens\u00e3o celular foi avaliada utilizando o corante Trypan \n\nBlue, e foi usada sempre que superior a 85%. As suspens\u00f5es celulares foram mantidas \n\n\n\n 35 \n\nem gelo para contagem diferencial de c\u00e9lulas e ent\u00e3o centrifugadas a 1200 rpm, a 4\u00baC \n\npor 10 minutos e ressuspensas em 1,0 mL de meio de cultura (DMEM) suplementado \n\ncom 10% de soro fetal bovino. \n\nAs c\u00e9lulas do LP foram ajustadas para 2x106 /mL e utilizadas nos ensaios de \n\natividade fungicida, produ\u00e7\u00e3o de citocinas e NO. Um volume de 500 \u00b5 L de c\u00e9lulas foi \n\ndispensado em cada po\u00e7o de placas de cultivo de 24 po\u00e7os. As culturas foram incubadas \n\na 37 \u00baC em estufa contendo 5% CO2 por duas horas. As c\u00e9lulas n\u00e3o aderentes foram \n\nremovidas por aspira\u00e7\u00e3o e a monocamada aderente foi lavada com o meio de cultura \n\nn\u00e3o suplementado. O n\u00famero de c\u00e9lulas n\u00e3o aderentes foi determinado por contagem \n\nem c\u00e2mara hemocitom\u00e9trica, sendo subtra\u00eddo do n\u00famero de c\u00e9lulas peritoneais \n\nincubadas. \n\n \n\n3.1.4 Lavado peritoneal para obten\u00e7\u00e3o de leuc\u00f3citos PMN \n\nCamundongos pr\u00e9-inoculados pela via i.p. com uma solu\u00e7\u00e3o de 500\u00b5 L de PBS \n\ncontendo 1x107 leveduras n\u00e3o vi\u00e1veis do P. brasiliensis foram submetidos a um \n\nprocesso de obten\u00e7\u00e3o de lavado peritoneal (LP) 6 horas ap\u00f3s a inocula\u00e7\u00e3o das leveduras \n\nn\u00e3o vi\u00e1veis, como descrito no item 1.3.  \n\n As c\u00e9lulas do LP foram colocadas em placas de cultura de 24 po\u00e7os e incubadas \n\npor 1 hora a 37 \u00baC em estufa contendo 5% CO2. As c\u00e9lulas n\u00e3o aderentes foram \n\najustadas para 1x106 /mL e utilizadas nos ensaios de atividade fungicida. Um volume de \n\n200 \u00b5 L (2x105) de c\u00e9lulas foi dispensado em cada po\u00e7o de placas de cultivo de 96 \n\npo\u00e7os.  \n\n \n\n3.1.5 Lavado bronco alveolar para obten\u00e7\u00e3o de macr\u00f3fagos e leuc\u00f3citos PMN \n\nUm grupo de animais foi infectado pelo fungo P. brasiliensis (1x106/animal) e \n\nap\u00f3s duas semanas de infec\u00e7\u00e3o submetido ao lavado bronco alveolar (LBA). Os animais \n\nforam sacrificados e dissecados, a cavidade tor\u00e1cica aberta e a traqu\u00e9ia cateterizada. Os \n\npulm\u00f5es foram ent\u00e3o lavados com inje\u00e7\u00f5es de 1 mL de meio DMEM. \n\nA viabilidade da suspens\u00e3o celular foi avaliada utilizando o corante Trypan \n\nBlue, e foi usada sempre que superior a 85%. As suspens\u00f5es celulares foram mantidas \n\n\n\n 36 \n\nem gelo para contagem diferencial de c\u00e9lulas e ent\u00e3o centrifugadas a 1200 rpm, a 4\u00baC \n\npor 10 minutos e ressuspensas em 1,0 mL de meio de cultura (DMEM) suplementado \n\ncom 10% de soro fetal bovino. \n\nPara obten\u00e7\u00e3o de leuc\u00f3citos PMN, as c\u00e9lulas provenientes do LBA foram \n\ndespejadas em placas de cultura de 24 po\u00e7os e incubadas a 37\u00baC em estufa contendo 5 \n\n% CO2 por uma hora.  As c\u00e9lulas n\u00e3o aderentes, contendo os leuc\u00f3citos PMNs, foram \n\najustadas para 1x106 /mL e utilizadas nos ensaios de atividade fungicida. Para tanto, um \n\nvolume de 200\u00b5 L (2x105 c\u00e9lulas) da suspens\u00e3o celular foi despejado em placas de \n\ncultura de 96 po\u00e7os.  \n\nPara obten\u00e7\u00e3o dos macr\u00f3fagos alveolares, outro grupo de c\u00e9lulas obtidas do \n\nLBA foi diretamente ajustado para 2x106 /mL e utilizadas nos ensaios de atividade \n\nfungicida, produ\u00e7\u00e3o de citocinas e NO. Neste caso, um volume de 500 \u00b5 L de c\u00e9lulas foi \n\ndispensado em cada po\u00e7o de placas de cultivo de 24 po\u00e7os. As culturas foram incubadas \n\na 37 \u00baC em estufa contendo 5% CO2 por duas horas. As c\u00e9lulas n\u00e3o aderentes foram \n\nremovidas por aspira\u00e7\u00e3o e a monocamada aderente foi lavada com o meio de cultura \n\nn\u00e3o suplementado. O n\u00famero de c\u00e9lulas n\u00e3o aderentes foi determinado por contagem \n\nem c\u00e2mara hemocitom\u00e9trica, sendo subtra\u00eddo do n\u00famero de c\u00e9lulas alveolares \n\nincubadas. \n\n \n\n3.1.6 Tratamento das culturas de macr\u00f3fagos por IFN-???? \n\n Monocamadas de macr\u00f3fagos peritoneais de camundongos foram incubadas \n\ndurante a noite a 37 \u00baC em estufa de CO2  tendo sido tratadas previamente com 500 \u00b5 L \n\nde meio de cultura suplementado contendo IFN-? (20.000 pg/mL \u2013 BD-Biosciences).  \n\n \n\n3.1.7 Infec\u00e7\u00e3o dos macr\u00f3fagos e leuc\u00f3citos PMNs \n\n As leveduras de Pb foram suspensas em 2 mL de DMEM. Os macr\u00f3fagos foram \n\ninfectados com a suspens\u00e3o de leveduras, em uma rela\u00e7\u00e3o levedura-macr\u00f3fago de 1:50 \n\n(CANO et al., 1992, 1994). Foi realizado o co-cultivo por 2 horas, as culturas foram \n\nlavadas e novamente incubadas por 48 horas. Ap\u00f3s o per\u00edodo de incuba\u00e7\u00e3o, os \n\nsobrenadantes foram retirados e armazenados a \u2013 70 \u00baC para determinar a presen\u00e7a de \n\nNO e citocinas.  \n\n\n\n 37 \n\nA cultura de leuc\u00f3citos PMNs foi infectada com o fungo em uma rela\u00e7\u00e3o \n\nlevedura-PMN de 1:2.  Foi realizado o co-cultivo por 1 hora a 37 \u00baC em estufa contendo \n\n5% CO2.  \n\n \n\n3.1.8 Determina\u00e7\u00e3o de Unidades Formadoras de Col\u00f4nias (UFC) \n\n Ap\u00f3s o co-cultivo de macr\u00f3fagos e fungos a 37 \u00baC em estufa contendo 5% CO2, \n\no sobrenadante foi retirado e as monocamadas foram tratadas por duas ou tr\u00eas vezes \n\ncom \u00e1gua destilada para lisar os macr\u00f3fagos. O material de cada lavagem foi recolhido \n\nem tubos FALCON de 25mL, um para cada po\u00e7o da placa. Este material foi \n\ncentrifugado, ressuspenso em 1mL de DMEM e a suspens\u00e3o obtida plaqueada (100 \n\n\u00b5L/placa) em meio Brain Heart Infusion (BHI) com 5% de \u201cfator de crescimento do \n\nfungo\u201d e 4% de soro eq\u00fcino, especial para recupera\u00e7\u00e3o de P. brasiliensis vi\u00e1veis \n\n(SINGERS-VERMES et al., 1992). Para a cultura de PMNs, 100\u00b5L do co-cultivo foi \n\nplaqueada em meio BHI. As placas foram incubadas a 37 \u00baC e as col\u00f4nias contadas \n\ndiariamente at\u00e9 que nenhum aumento em UFC fosse observado.  \n\n \n\n3.1.9 Fagocitose \n\n3.1.9.1 Ensaio da fagocitose por microscopia \u2013 TLR-2 \n\n Para o ensaio de fagocitose foram realizados experimentos seguindo a t\u00e9cnica \n\ndescritas nos itens 31.3, 3.1.6 e 3.1.7; contudo, o cultivo de macr\u00f3fagos foi realizado \n\nsobre lam\u00ednulas redondas em placas de cultura de 24 po\u00e7os e utilizamos uma rela\u00e7\u00e3o \n\nlevedura-macr\u00f3fago de 1:50. Ap\u00f3s de 4h de infec\u00e7\u00e3o com o fungo o sobrenadante foi \n\nremovido, incluindo as leveduras n\u00e3o aderidas ou n\u00e3o fagocitadas e as lam\u00ednulas foram \n\ncoradas com HE (Hematoxilina e Eosina - Newprov). Uma m\u00e9dia de 1000 macr\u00f3fagos \n\nfoi contada para determinar a porcentagem de c\u00e9lulas com fungos aderidos e/ou \n\nfagocitados. Usamos este crit\u00e9rio em fun\u00e7\u00e3o do tamanho e aspecto morfol\u00f3gico do \n\nfungo que muitas vezes impede a correta discrimina\u00e7\u00e3o entre fungos aderidos e aqueles \n\ninternalizados (CALICH et al., 1979). \n\n \n\n3.1.9.2 Ensaio da fagocitose por citometria de fluxo \u2013 MyD88 \n\nPara o ensaio de fagocitose por citometria de fluxo foram realizados \n\nexperimentos seguindo a t\u00e9cnica descritas nos itens 3.1.3, 3.1.6 e 3.1.7. O cultivo de \n\nmacr\u00f3fagos foi realizado placas de cultura de 24 po\u00e7os e utilizamos uma rela\u00e7\u00e3o \n\nlevedura-macr\u00f3fago de 1:1. A infec\u00e7\u00e3o foi realizada com leveduras n\u00e3o vi\u00e1veis do \n\n\n\n 38 \n\nfungo previamente marcadas com iodeto de prop\u00eddio (PI).  Para marca\u00e7\u00e3o do fungo \n\nutilizamos 100 \u00b5g de PI (Sigma) para cada 1 mL de suspens\u00e3o f\u00fangica contendo 1 x 106 \n\nleveduras de acordo com a t\u00e9cnica descrita por HATANO et al. (2009). Ap\u00f3s 2 horas de \n\ninfec\u00e7\u00e3o o sobrenadante foi removido, incluindo as leveduras n\u00e3o aderidas ou n\u00e3o \n\nfagocitadas. Ap\u00f3s este per\u00edodo as c\u00e9lulas foram recolhidas das placas de 24 po\u00e7os, \n\najustadas em 1 x 106/mL e marcadas com anti-CD11b (FITC). A leitura foi realizada \n\nimediatamente ap\u00f3s a marca\u00e7\u00e3o no FACsCalibur (BD Bioscience). \n\n \n\n3.1.10 Dosagem de NO \n\n  A concentra\u00e7\u00e3o de \u00f3xido n\u00edtrico nos sobrenadantes das culturas de macr\u00f3fagos \n\nfoi medida com o reagente de Griess (1% sulfanilamida, 0,1% diidrocloreto de \n\nnaftiletilenodiamina, 2,5% H3PO4), sendo utilizado um volume de 50 \u00b5L do \n\nsobrenadante da cultura e igual volume do reagente de Griess. Foram incubados em \n\ntemperatura ambiente por 15 minutos e ent\u00e3o determinada a absorb\u00e2ncia em \n\nequipamento Labsystems Multiskan MCC/340 (450nm). A concentra\u00e7\u00e3o de \u00f3xido \n\nn\u00edtrico foi determinada utilizando-se curva padr\u00e3o padronizada com diferentes \n\nconcentra\u00e7\u00f5es de nitrito de s\u00f3dio (DING et al., 1988). \n\n \n\n3.1.11 Dosagem de citocinas e quimiocinas por ELISA \n\nA dosagem de citocinas (TNF-?, IL-12, IL-6 e IL-10) e da quimiocina (MCP-1) \n\nfoi realizada no sobrenadante de macr\u00f3fagos peritoneais. A presen\u00e7a e concentra\u00e7\u00e3o das \n\ncitocinas foram determinadas por testes ELISA, segundo metodologia sugerida pelo \n\nfabricante (BD Biosciences). A rea\u00e7\u00e3o foi interrompida com a adi\u00e7\u00e3o de \u00e1cido sulf\u00farico \n\n2N. A leitura das densidades \u00f3pticas foi feita a 450 nm.  \n\n \n\n3.2 Experimentos in vivo \n\n3.2.1 Animais \n\n           Foram utilizados camundongos C57Bl/6 normais e animais nocaute para o TLR-\n\n2 e para prote\u00edna MyD88. Todos os camundongos tinham a condi\u00e7\u00e3o de SPF (Specific \n\nPathogen Free) e foram criados no Biot\u00e9rio do Departamento de Imunologia do ICB-\n\nUSP. Foram utilizados ao atingirem 6 a 8 semanas de idade. \n\n \n\n\n\n 39 \n\n3.2.2 Infec\u00e7\u00e3o intratraqueal (i.t.) \n\n Os animais foram infectados por administra\u00e7\u00e3o i.t. de 1x106 leveduras vi\u00e1veis de \n\nP. brasiliensis contidas em 50\u00b5l de PBS. O procedimento foi realizado com os animais \n\nsob anestesia como previamente descrito por Cano et al. (1995).  \n\n \n\n3.2.3 Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o atrav\u00e9s da determina\u00e7\u00e3o de UFC \n\n O grau da infec\u00e7\u00e3o foi avaliado em todos os animais atrav\u00e9s da recupera\u00e7\u00e3o de \n\nfungos vi\u00e1veis do pulm\u00e3o, f\u00edgado e ba\u00e7o, ap\u00f3s 48h , 2 e 11 semanas ap\u00f3s a infec\u00e7\u00e3o \n\npara os experimentos com TLR-2 e ap\u00f3s 48h e 8 semanas para o estudo da prote\u00edna \n\nMyD88. Usamos meio BHI suplementado da mesma forma que o experimento in vitro. \n\n \n\n3.2.4 Avalia\u00e7\u00e3o do tempo de sobrevida \n\n Grupos de 8-12 animais foram infectados com P. brasiliensis via i.t. e foram \n\nacompanhados quanto ao tempo de sobrevida.  \n\n \n\n3.2.5 Preparo de suspens\u00f5es de Leuc\u00f3citos Infiltrantes de Pulm\u00e3o (LIP) \n\nAs suspens\u00f5es celulares de linf\u00f3citos infiltrantes de pulm\u00e3o foram preparadas de \n\nacordo com Huffnagle et al. (1991). Os pulm\u00f5es foram removidos e digeridos por 60 \n\nminutos em tamp\u00e3o de digest\u00e3o contendo colagenase (1mg/mL) e DNAse (30\u00b5 g/mL). \n\nOs linf\u00f3citos foram isolados por centrifuga\u00e7\u00e3o em Percoll \u2013 20% (Pharmacia Biotech \n\nAB, Uppsala, Sweden). As c\u00e9lulas foram contadas e a viabilidade determinada pela \n\nmarca\u00e7\u00e3o de azul de Trypan. Os eritr\u00f3citos foram lisados com tamp\u00e3o de lise (cloreto de \n\nam\u00f4nio + TRIS) antes da marca\u00e7\u00e3o celular. \n\n \n\n3.2.6 Citometria de fluxo para caracteriza\u00e7\u00e3o de subpopula\u00e7\u00f5es celulares e \n\ncitocinas intracelulares \n\nC\u00e9lulas infiltrantes dos pulm\u00f5es (CANO et al., 2000) foram obtidas nas segunda e \n\nd\u00e9cima semanas ap\u00f3s infec\u00e7\u00e3o. A concentra\u00e7\u00e3o celular foi ajustada, e os linf\u00f3citos \n\nforam adicionados \u00e0 placas de fundo em U na quantidade de 1x106 cels/po\u00e7o. Em \n\nseguida, as c\u00e9lulas foram ressuspensas em PBS-azida (0,1%) contendo soro fetal bovino \n\n(SFB, 5%). As placas foram centrifugadas, os sobrenadantes foram dispensados e o Ac \n\n\n\n 40 \n\nmarcado (20 \u00b5L no t\u00edtulo adequado) foi adicionado. Ap\u00f3s incuba\u00e7\u00e3o por 20 minutos em \n\ngeladeira, as c\u00e9lulas foram lavadas, ressuspensas em PBS-azida e transferidas para \n\ntubos de leitura de FACS. Todas as amostras foram mantidas em banho de gelo e \n\nprotegidas da luz. As c\u00e9lulas marcadas foram analisadas em cit\u00f4metro de fluxo FACS \n\nCalibur (Becton-Dickison). Foram usados anticorpos marcados com isotiocinado de \n\nfluoresce\u00edna, ficoeritrina ou outro fluorocromo (BD Biociences) na combina\u00e7\u00e3o \n\nadequada para a popula\u00e7\u00e3o celular a ser analisada (marcadores celulares de linf\u00f3citos: \n\nanti- CD4, CD8, CD69, CD25, Foxp3, IL-17 e marcadores celulares de macr\u00f3fagos: \n\nCD11b, CD40, CD80, CD86 e MCH-II).  \n\nPara determina\u00e7\u00e3o dos n\u00edveis intracelulares de Foxp3 e de IL-17 as c\u00e9lulas foram \n\ntratadas com Perm/Wash Buffer (BD Biociences) para alterar a permeabilidade da \n\nmembrana e o anticorpo poder fazer a marca\u00e7\u00e3o intracitoplasm\u00e1tica. Para dosagem de \n\nIL-17 intracelular as c\u00e9lulas foram tratadas com meio contendo 50ng/mL de Phorbol 12-\n\nmyristate 13-acetato (PMA), 500ng/mL de Ionomicina (Sigma) e com Monensina \n\n(3mM, eBioscience) por 6 horas, antes da marca\u00e7\u00e3o.  \n\n \n\n3.2.7 Caracteriza\u00e7\u00e3o morfol\u00f3gica das popula\u00e7\u00f5es celulares por citocentrifuga\u00e7\u00e3o \n\n Para contagem diferencial, amostras da suspens\u00e3o celular obtida de acordo com \n\na t\u00e9cnica descrita no item 2.5. A concentra\u00e7\u00e3o celular foi ajustada a 1x105 c\u00e9lulas em \n\n100 \u00b5L de meio RPMI e centrifugadas em Cytospin (Shandon Cytospin, Pittsburgh, \n\nPa.). As l\u00e2minas foram coradas com corante HE e um total de 200 a 400 c\u00e9lulas foram \n\ncontadas em cada amostra.  \n\n \n\n3.2.8 Dosagem de citocinas e quimiocinas por ELISA nos homogenatos de pulm\u00e3o \n\nA dosagem de citocinas (TNF-?, IFN-?, IL-4, IL-5, IL-10, IL-17, IL-23, IL-12, \n\nIL-6 e TGF-?) foi realizada no sobrenadante dos macerados dos \u00f3rg\u00e3os utilizados na \n\ndetermina\u00e7\u00e3o de UFC dos animais, assim como a dosagem das quimiocinas MCP-1 e \n\nKC. A presen\u00e7a e concentra\u00e7\u00e3o das citocinas foram determinadas por testes de ELISA \n\nde captura, segundo metodologia sugerida pelo fabricante (BD Biosciences,  \n\neBiosciences ou IBL). A rea\u00e7\u00e3o foi interrompida com a adi\u00e7\u00e3o de \u00e1cido sulf\u00farico 2N. A \n\nleitura das densidades \u00f3pticas foi feita a 450 nm.  \n\n \n\n \n\n \n\n\n\n 41 \n\n3.2.9 Dosagem de NO \n\n         A concentra\u00e7\u00e3o de nitritos no homogenatos de \u00f3rg\u00e3os e sobrenadante foi utilizada \n\ncomo indicadora de s\u00edntese de NO atrav\u00e9s do reativo de Griess, seguindo a mesma \n\nt\u00e9cnica descrita para o experimento in vitro. \n\n \n\n3.2.10 An\u00e1lise histopatol\u00f3gica \n\nAp\u00f3s 8 ou 11 semanas de infec\u00e7\u00e3o o pulm\u00e3o esquerdo de cada camundongo foi \n\nremovido e fixado em 10% de formalina e embebido em parafina. Sec\u00e7\u00f5es (5\u00b5 m) foram \n\ncoradas com Hematoxilina e Eosina (H&amp;E) para an\u00e1lise das les\u00f5es e com a colora\u00e7\u00e3o \n\nGroccot para visualizar os fungos. A patologia foi qualitativamente avaliada em rela\u00e7\u00e3o \n\n\u00e0 forma\u00e7\u00e3o de granulomas, densidade de c\u00e9lulas inflamat\u00f3rias e organiza\u00e7\u00e3o da les\u00e3o. \n\n \n\n3. 2.11 Deple\u00e7\u00e3o de Granul\u00f3citos \n\n3.2.11.1 Deple\u00e7\u00e3o  \n\n Camundongos deficientes e normais para o TLR-2 foram depletados de \n\ngranul\u00f3citos atrav\u00e9s da inocula\u00e7\u00e3o do anticorpo monoclonal anti-PMN (clone RB6-\n\n8C5) purificado (250\u00b5 g/camundongo) gentilmente cedido pelo Dr. J\u00falio Scharfstein da \n\nUniversidade Federal do Rio de Janeiro e pela Dra. Ises de Almeida Abrahamsohn do \n\nInstituto de Ci\u00eancias Biom\u00e9dicas da Universidade de S\u00e3o Paulo. O anticorpo foi \n\ninoculado pela via i.p. 24 horas antes da inocula\u00e7\u00e3o i.t. com o fungo. A deple\u00e7\u00e3o foi \n\nrepetida nos dias 2 e 5 ap\u00f3s a infec\u00e7\u00e3o. \n\n Os animais controle foram inoculados com IgG normal de rato nos mesmo dias e \n\nna mesma concentra\u00e7\u00e3o prot\u00e9ica do anticorpo monoclonal. \n\n \n\n3.2.11.2 Avalia\u00e7\u00e3o da deple\u00e7\u00e3o de leuc\u00f3citos PMNs \n\n O n\u00famero de leuc\u00f3citos PMN foi avaliado antes do tratamento (tempo -1) e 24 \n\nhoras ap\u00f3s a inocula\u00e7\u00e3o do AcM, imediatamente antes da inocula\u00e7\u00e3o de leveduras do P. \n\nbrasiliensis (tempo zero). Foi coletado o sangue da cauda de camundongos de ambas as \n\nlinhagens, para contagem total e diferencial dos leuc\u00f3citos.  A contagem global foi \n\nrealizada em c\u00e2mara de Neubauer e a diferencial foi feita em esfrega\u00e7o corada com HE \n\n(Hematoxilina e Eosina - Newprov). \n\n \n\n \n\n \n\n\n\n 42 \n\n3.2.11.3 Avalia\u00e7\u00e3o do tempo de sobrevida \n\n Grupos de 8 animais depletados e n\u00e3o depletados de PMN foram infectados com \n\nP. brasiliensis via i.t. e foram acompanhados quanto ao tempo de sobrevida. As mortes \n\nforam registradas diariamente.  \n\n \n\n3.2.12 Determina\u00e7\u00e3o do n\u00edvel de anticorpos espec\u00edficos \n\nPara determinar a resposta imune humoral dos animais infectados \n\nintratraquealmente com leveduras vi\u00e1veis de P. brasiliensis, amostras de sangue foram \n\nobtidas nos diversos camundongos. Os anticorpos totais espec\u00edficos anti-P. brasiliensis \n\ne seus is\u00f3tipos IgM, IgA, IgG1, IgG2a, IgG2b e IgG3 foram detectados pelo m\u00e9todo \n\nimunoenzim\u00e1tico (ELISA) previamente preconizado para este sistema ant\u00edgeno-\n\nanticorpo por Mendes-Giannini et al., 1984 e modificado por Vaz et al., 1998. \n\n \n\n3.2.13 An\u00e1lise estat\u00edstica \n\n Os grupos tratados e n\u00e3o tratados foram analisados pelo teste t de Student ou \n\nan\u00e1lise de vari\u00e2ncia, dependendo do n\u00famero de grupos. A mortalidade foi avaliada pelo \n\nteste U de Mann-Whitney. O n\u00edvel de signific\u00e2ncia foi definido como p&lt;0,05. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 43 \n\n4 RESULTADOS \n\n4.1 Estudo do receptor TLR-2 na paracoccidioidomicose pulmonar murina. \n\n4.1.1 In vitro \n\n4.1.1.1 Ensaio da Fagocitose \n\n Os macr\u00f3fagos peritoneais de animais TLR-2-/- e WT foram infectados com \n\nleveduras vi\u00e1veis do fungo (rela\u00e7\u00e3o Pb/M\u00d8 de 1/25) sobre lam\u00ednulas redondas em placa \n\nde cultura de 24 po\u00e7os. Ap\u00f3s 4 horas de incuba\u00e7\u00e3o a 37 \u00baC em estufa contendo 5% de \n\nCO2 o sobrenadante foi removido e as lam\u00ednulas foram coradas e examinadas ao \n\nmicrosc\u00f3pio \u00f3ptico comum. Uma m\u00e9dia de 1000 macr\u00f3fagos foi contada em cada \n\nlam\u00ednula para determinar o n\u00famero de fungos aderidos e/ou ingeridos ap\u00f3s as 4 horas de \n\nincuba\u00e7\u00e3o.  Os resultados expressos na figura 1 mostram que macr\u00f3fagos de animais \n\nque expressam o TLR-2 normal t\u00eam maior capacidade de aderir e/ou ingerir as \n\nleveduras do P. brasiliensis comparando-se com os macr\u00f3fagos de animais TLR-2-/-. O \n\nfen\u00f4meno tamb\u00e9m ocorreu quando as culturas foram pr\u00e9-tratadas com IFN-? (20.000 \n\npg/mL), por\u00e9m, neste caso, a diferen\u00e7a n\u00e3o foi estatisticamente significante. \n\n \n\n4.1.1.2 Avalia\u00e7\u00e3o da atividade fungicida de macr\u00f3fagos peritoneais e alveolares \n\natrav\u00e9s da determina\u00e7\u00e3o de Unidades Formadoras de Col\u00f4nia (UFC) \n\n A figura 2 mostra um n\u00famero menor de fungos recuperados nas culturas de \n\nmacr\u00f3fagos peritoneais dos camundongos deficientes quanto \u00e0 express\u00e3o do TLR-2. O \n\nmesmo aconteceu quando os macr\u00f3fagos foram pr\u00e9-ativados com IFN-? (20.000 \n\npg/mL).  Resultados semelhantes foram obtidos quando utilizamos macr\u00f3fagos  \n\nalveolares (figura 03). \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 44 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 1. Avalia\u00e7\u00e3o de atividade fagoc\u00edtica de macr\u00f3fagos de animais normais e deficientes para             \no TLR-2. Os macr\u00f3fagos peritoneais de animais TLR-2-/- e WT (1x106 c\u00e9lulas/po\u00e7o) \nativados ou n\u00e3o com IFN-? (20.000 pg/mL) foram co-cultivados com leveduras \nvi\u00e1veis do P. brasiliensis em uma rela\u00e7\u00e3o fungo/M\u00d8 de 1:50 sobre lam\u00ednulas \nredondas em uma placa de cultura de 24  po\u00e7os. Ap\u00f3s 4 horas de incuba\u00e7\u00e3o o \nsobrenadante do cultivo foi desprezado e as lam\u00ednulas foram coradas e examinadas \nem microsc\u00f3pio \u00f3ptico. Uma m\u00e9dia de 1000 M\u00d8 foi contada e analisada o n\u00famero de \nM\u00d8 com leveduras aderidas e/ou ingeridas. As barras representam as m\u00e9dias \u00b1 EP de \n5 po\u00e7os por grupo ensaiado. O asterisco representa diferen\u00e7a estatisticamente \nsignificante entre os grupos ligados pela barra (*P&lt;0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 2.  Avalia\u00e7\u00e3o da atividade fungicida de macr\u00f3fagos peritoneais atrav\u00e9s da recupera\u00e7\u00e3o de \nUnidades Formadoras de Col\u00f4nia (UFC)/mL ap\u00f3s 48h de co-cultivo. As \nmonocamadas de macr\u00f3fagos de ambas as linhagens foram tratadas ou n\u00e3o com IFN-? \n(20.000pg/mL) e infectadas com o P. brasiliensis na propor\u00e7\u00e3o 1 fungo para 50 \nmacr\u00f3fagos ap\u00f3s 24h. O asterisco representa diferen\u00e7a estatisticamente significante \nentre os grupos (*P&lt;0,05). \n\n \n\n0\n\n20\n\n40\n\n60\n\n80\n\n100\n\n*\n\n M\u00d8 + Pb                 M\u00d8 + Pb + IFN-????\n\nN\nr.\n\n f\nu\n\nn\ng\n\no \nad\n\ner\nid\n\no \na \n\n1\n0\n\n0\n0\n\n m\nac\n\nr\u00f3\nfa\n\ng\nos\n\n0\n\n2000\n\n4000\n\n6000\n\n8000\n\n10000\n\n12000\n\n*\n\n*\n\nMacr\u00f3fago Peritoneal\n\nM \u00d8 + Pb         M \u00d8 +Pb + IFN-????\n\nU\nF\n\nC\n/m\n\nL\n\n       WT   \nTLR-2-/-          \n\n       WT  \nTLR-2-/- \n\n\n\n 45 \n\nMacr\u00f3fago Alveolar\n\n0\n\n1000\n\n2000\n\n3000\n\n4000\n\n5000\n\n6000\nWT\n\nTLR2-/-*\n\n*\n\nMo + Pb                Mo + Pb + IFN-?\n\nU\nF\n\nC\n/m\n\nL\n\n \n\nFigura 3. Avalia\u00e7\u00e3o da atividade fungicida de macr\u00f3fagos alveolares atrav\u00e9s da recupera\u00e7\u00e3o de \nUnidades Formadoras de Col\u00f4nia (UFC)/mL ap\u00f3s 48h de co-cultivo. As \nmonocamadas de macr\u00f3fagos de ambas as linhagens foram tratadas ou n\u00e3o com IFN-? \n(20.000pg/mL) e infectadas com o P. brasiliensis na propor\u00e7\u00e3o 1 fungo para 50 \nmacr\u00f3fagos ap\u00f3s 24h. As barras representam as m\u00e9dias \u00b1 EP de 5 po\u00e7os por grupo \nensaiado. O asterisco representa diferen\u00e7a estatisticamente significante entre os \ngrupos (*P&lt;0,05). \n\n \n\n4.1.1.3 Dosagem de NO \n\n  A figura 4 mostra que macr\u00f3fagos provenientes de camundongos deficientes \n\npara o TLR-2 produziram concentra\u00e7\u00f5es menores de NO em compara\u00e7\u00e3o com os \n\ncamundongos selvagens. Isso ocorreu tanto nos grupos de macr\u00f3fagos apenas tratados \n\ncom IFN-?, quanto nos grupos tratados com IFN-? e infectados com o fungo. Al\u00e9m \n\ndisso, a adi\u00e7\u00e3o de P. brasiliensis levou a um aumento significativo na s\u00edntese de NO \n\nquando comparamos com o grupo que n\u00e3o recebeu o fungo. Nos grupos de macr\u00f3fagos \n\nsem tratamento e nos grupos apenas infectados com o fungo, n\u00e3o houve produ\u00e7\u00e3o de \n\nNO em ambas as linhagens estudadas (dados n\u00e3o mostrados). Para ambas as linhagens a \n\nadi\u00e7\u00e3o de IFN-? levou a menor recupera\u00e7\u00e3o de fungos e maior s\u00edntese de NO.  Assim, \n\npode-se sugerir que o TLR-2 \u00e9 um dos receptores envolvidos no reconhecimento do P. \n\nbrasiliensis por parte dos macr\u00f3fagos peritoneais e \u00e9 capaz de desencadear a s\u00edntese de \n\nNO. Contudo, \u00e9 conveniente ressaltar que em animais WT, que produziram maiores \n\nconcentra\u00e7\u00f5es de NO, recuperamos um n\u00famero maior de fungos, comparando-se com \n\nos camundongos TLR-2-/-.  Mais uma vez, obtivemos resultados semelhantes quando \n\ntrabalhamos com macr\u00f3fagos alveolares (figura 05). \n\n \n\n \n\n\n\n 46 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 4. Quantifica\u00e7\u00e3o de NO no sobrenadante de cultura de macr\u00f3fagos peritoneais de animais \nTLR-2-/- e WT.  Macr\u00f3fagos foram cultivados com a adi\u00e7\u00e3o ou n\u00e3o de IFN-? \n(20.000pg/mL) durante a noite. Algumas monocamadas de macr\u00f3fagos foram \ninfectadas com o P.brasiliensis em uma propor\u00e7\u00e3o de 50 macr\u00f3fagos para 1 fungo. \nAp\u00f3s 48 horas de incuba\u00e7\u00e3o a produ\u00e7\u00e3o de NO foi avaliada no sobrenadante do \ncultivo.  O grupo controle de macr\u00f3fagos foi mantido sem tratamento, onde n\u00e3o \nhouve produ\u00e7\u00e3o de NO. O asterisco representa diferen\u00e7a estatisticamente significante \n(*P<0,05). \n\n \n\n0\n\n10\n\n20\n\n30\n\n40\n\n50\nWT\n\nTLR2 -/-\n\n*\n\n*\n\n                             M\u00d8  + IFN-????   M\u00d8 + Pb +IFN-????\n\nMacr\u00f3fago Alveolar\n\nN\nit\n\nri\nto\n\n (\n\u00b5\u00b5 \u00b5\u00b5\n\nM\n)\n\n \n\nFigura 5. Quantifica\u00e7\u00e3o de NO no sobrenadante de cultura de macr\u00f3fagos alveolares de animais \nTLR-2-/- e WT.  Macr\u00f3fagos foram cultivados com a adi\u00e7\u00e3o ou n\u00e3o de IFN-? \n(20.000pg/mL) durante a noite. Algumas monocamadas de macr\u00f3fagos foram \ninfectadas com o P.brasiliensis em uma propor\u00e7\u00e3o de 50 macr\u00f3fagos para 1 fungo. \nAp\u00f3s 48 horas de incuba\u00e7\u00e3o a produ\u00e7\u00e3o de NO foi avaliada no sobrenadante do \ncultivo.  O grupo controle de macr\u00f3fagos foi mantido sem tratamento, onde n\u00e3o \nhouve produ\u00e7\u00e3o de NO. Os dados representam a m\u00e9dia \u00b1 EP de 5 po\u00e7os por grupo. O \nasterisco representa diferen\u00e7a estatisticamente significante (*P<0,05). \n\n \n\n \n\n \n\nM a c r\u00f3 fa g o  P e rito ne a l\n\n0\n\n2 5\n\n5 0\n\n7 5\n\n1 0 0\n\n*\n\n*\n\n    M \u00d8   +  IF N - ????           M \u00d8  +  P b  + IF N - ????\n\nN\nit\n\nri\nto\n\n( \u00b5\u00b5 \u00b5\u00b5\nM\n\n)\n\n       WT  \nTLR-2-/- \n\n  \n\n\n\n 47 \n\n 4.1.1.4 Produ\u00e7\u00e3o de citocinas \n\n  A produ\u00e7\u00e3o de IL-10 foi menor nas culturas de macr\u00f3fagos provenientes de \n\nanimais que n\u00e3o expressam o TLR-2, e o mesmo fen\u00f4meno permaneceu quando os \n\nmacr\u00f3fagos destes animais foram estimulados com IFN-?, como demonstrado na figura \n\n6. A produ\u00e7\u00e3o de IL-10 foi ausente para as duas linhagens no grupo controle onde havia \n\napenas macr\u00f3fagos na cultura ou macr\u00f3fagos pr\u00e9-ativados com IFN-?. \n\n  Da mesma forma que para a citocina antinflamat\u00f3ria IL-10, a produ\u00e7\u00e3o da \n\nquimiocina MCP-1 apresentou-se em concentra\u00e7\u00f5es baixas nas culturas de macr\u00f3fagos \n\nde animais TLR-2 deficientes, comparando-se com a produ\u00e7\u00e3o de macr\u00f3fagos \n\nprovenientes de animais TLR-2 normais. A produ\u00e7\u00e3o deste mediador foi maior quando \n\nos macr\u00f3fagos foram apenas desafiados pelo fungo, comparando-se quando foram pr\u00e9-\n\nativados com IFN-? e desafiados pelo P. brasiliensis. \n\n  N\u00e3o houve diferen\u00e7a na produ\u00e7\u00e3o de IL-12 e de TNF-? nas culturas de \n\nmacr\u00f3fagos de ambos os grupos estudados. Em rela\u00e7\u00e3o \u00e0 citocina IL-6, observamos \n\nn\u00edveis maiores nas culturas de macr\u00f3fagos provenientes de animais TLR-2 normais no \n\ngrupo controle, ou seja, apenas macr\u00f3fagos na cultura (dados n\u00e3o mostrados). Quando \n\nas culturas foram infectadas com o P. brasiliensis os n\u00edveis de IL-6 foram maiores e os \n\nanimais TLR-2 normais continuaram a produzir n\u00edveis maiores desta citocinas quando \n\ncomparados aos animais TLR-2-/-. Entretanto, se a cultura foi antes primada com IFN-? \n\no mesmo fen\u00f4meno n\u00e3o ocorreu Assim, pode-se sugerir que o Toll-Like receptor 2 \u00e9 um \n\ndos receptores envolvidos no reconhecimento do P. brasiliensis por parte dos \n\nmacr\u00f3fagos peritoneais e alveolares e \u00e9 capaz de desencadear a s\u00edntese de citocinas.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 48 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n                                                 \n\nFigura 6.  Quantifica\u00e7\u00e3o de IL-10, MCP-1, IL-12, TNF-? e IL-6 na de cultura de macr\u00f3fagos \nperitoneais de animais normais e deficientes para o TLR-2. Os macr\u00f3fagos foram \ncultivados com a adi\u00e7\u00e3o ou n\u00e3o de IFN-? (20.000 pg/mL) durante a noite. Algumas \nmonocamadas de macr\u00f3fagos foram infectadas com o P.brasiliensis em uma \npropor\u00e7\u00e3o de 50 macr\u00f3fagos para 1 fungo. Ap\u00f3s 48 horas de incuba\u00e7\u00e3o a produ\u00e7\u00e3o \nde citocinas foi avaliada no sobrenadante do cultivo.  O grupo controle de \nmacr\u00f3fagos foi mantido sem tratamento. Os dados representam a m\u00e9dia \u00b1 EP de 5 \npo\u00e7os por grupo. Os asteriscos representam diferen\u00e7as estatisticamente significantes \n(* P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n  M\u00d8 + Pb             M\u00d8 + Pb + IFN-? \n\nTNF-? \n6000 \n\n4000 \n\n2000 \n\n750 \n\n500 \n\n250 \n\n0 \n\n1000 \n\nIL-10\n\n0\n\n100\n\n200\n\n300\n\n400\n\n500\n\n600\n\n700\n\n M\u00d8 + Pb          M\u00d8 + Pb + IFN-?\n\n*\n\n*\n\np\ng\n\n/m\nL\n\nIL-12\n\n0\n\n100\n\n200\n\n300\n\n400\n\n500\n\n600\n\n700\n\n M\u00d8 + Pb          M\u00d8 + Pb + IFN-?\n\np\ng/\n\nm\nL\n\nIL-6\n\n0\n\n500\n\n1000\n\n1500\n\n2000\n\n2500\n\n M\u00d8 + Pb          M\u00d8 + Pb + IFN-?\n\np\ng\n\n/m\nL\n\n*\n\nMCP-1\n\n0\n500\n\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n4500\n5000\n5500\n\n M\u00d8 + Pb   M\u00d8 + Pb + IFN-?\n\np\ng\n\n/m\nL *\n\n*\n\n       WT \nTLR-2-/- \n\n\n\n 49 \n\n4.1.2 Experimentos in vivo \n\n4.1.2.1 Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o atrav\u00e9s de UFC obtidas do macerado de \n\npulm\u00e3o \n\n A figura 7 mostra a m\u00e9dia de UFC/g de tecido (log10) no pulm\u00e3o dos animais \n\nTLR-2-/- e WT obtidos ap\u00f3s 48 horas, 2 e 11 semanas de infec\u00e7\u00e3o. Observamos que em \n\ntodos os tempos de infec\u00e7\u00e3o houve diferen\u00e7a no controle da carga f\u00fangica entre as duas \n\nlinhagens: houve um maior n\u00famero de fungos recuperados a partir do macerado do \n\npulm\u00e3o dos animais que possuem o TLR-2 funcional. N\u00e3o houve dissemina\u00e7\u00e3o para \n\nf\u00edgado e ba\u00e7o em 48 horas e em 2 semanas de infec\u00e7\u00e3o. Entretanto houve uma pequena \n\ndissemina\u00e7\u00e3o para o ba\u00e7o ap\u00f3s 11 semanas de infec\u00e7\u00e3o, por\u00e9m sem diferen\u00e7a estat\u00edstica \n\nentre os grupos estudados (dados n\u00e3o apresentados). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 7. Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o atrav\u00e9s de Unidades Formadoras de Col\u00f4nia (UFC).   \nOs camundongos TLR-2-/- e WT foram infectados com 1x106 de leveduras do P. \nbrasiliensis pela via i.t.. O grau de infec\u00e7\u00e3o foi determinado ap\u00f3s 48 horas, 2 e 11 \nsemanas de infec\u00e7\u00e3o pela contagem de UFC. Os asteriscos representam diferen\u00e7as \nestatisticamente significante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\nPulm\u00e3o\n\n4\n\n5\n\n6\n\n7\n\n8\n\n* *\n*\n\n48h          2 semanas      11 semanas\n\nU\nF\n\nC\n l\n\no\ng\n\n1\n0/\n\ng\n t\n\nec\nid\n\no\n\n       WT  \nTLR-2-/- \n\n\n\n 50 \n\n4.1.2.2 Dosagem de NO \n\n Na figura 8 temos a quantifica\u00e7\u00e3o de NO presente no macerado dos pulm\u00f5es dos \n\nanimais TLR-2-/- e WT ap\u00f3s 48 horas, 2 e 11 semanas de infec\u00e7\u00e3o. A dosagem foi feita \n\nimediatamente ap\u00f3s a coleta do sobrenadante do macerado. A concentra\u00e7\u00e3o de NO \n\nencontrada foi maior no grupo de animais que expressa o TLR-2 comparando-se com o \n\ngrupo que n\u00e3o apresenta o receptor. O fen\u00f4meno ocorreu em todos os tempos de \n\ninfec\u00e7\u00e3o. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 8. Quantifica\u00e7\u00e3o de NO no macerado do pulm\u00e3o de animais TLR-2-/- e WT.  Os animais \nforam infectados com 1x106 leveduras de P.brasiliensis inoculadas pela via i.t. e \nsacrificados ap\u00f3s 48 horas, 2 e 11 semanas de infec\u00e7\u00e3o. Os dados representam a \nm\u00e9dia \u00b1 EP de 6 animais por grupo. O asterisco representa diferen\u00e7a estatisticamente \nsignificante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nNO\n\n0\n\n10\n\n20\n\n30\n\n40\n\n50\n\n60\n\n70\n\n48h          2 semanas       11 semanas\n\n* * *\n\nN\nit\n\nri\nt ?? ??\n\n (\n\u00b5\u00b5 \u00b5\u00b5\n\nM\n)\n\n       WT  \nTLR-2-/- \n\n\n\n 51 \n\n4.1.2.3 Avalia\u00e7\u00e3o da atividade fungicida de leuc\u00f3citos Polimorfonucleares (PMNs) \n\natrav\u00e9s da determina\u00e7\u00e3o de Unidades Formadoras de Col\u00f4nia (UFC) \n\n Ap\u00f3s 15 dias de infec\u00e7\u00e3o pelo fungo P. brasilienses, animais TLR-2KO e \n\nWT sofreram o lavado bronco alveolar (LBA). Os leuc\u00f3citos PMNs obtidos do lavado \n\ndo LBA foram infectados in vitro com o fungo P. brasiliensis na propor\u00e7\u00e3o de 2 PMNs \n\npara 1 fungo.  Ap\u00f3s 1 hora de co-cultivo, 100 \u00b5 L da solu\u00e7\u00e3o foi plaqueada em meio \n\nBHI e observado o crescimento f\u00fangico atrav\u00e9s da forma\u00e7\u00e3o de UFC. A figura 9 mostra \n\num n\u00famero semelhante de fungos recuperados nas culturas de leuc\u00f3citos PMNs \n\nalveolares dos camundongos deficientes e normais quanto \u00e0 express\u00e3o do TLR-2.  \n\n O mesmo resultado aconteceu quando trabalhamos com os leuc\u00f3citos PMNs \n\nperitoneais (figura 10), neste caso, grupos de animais TLR-2 KO e WT receberam via \n\ni.p. 1x107 leveduras n\u00e3o vi\u00e1veis do P. brasiliensis e ap\u00f3s 6 horas foi realizado o LP. Os \n\nleuc\u00f3citos PMNs obtidos do LP foram infectados in vitro com o fungo P. brasiliensis na \n\npropor\u00e7\u00e3o de 2 PMNs para 1 fungo.  Ap\u00f3s 1 hora de co-cultivo, 100 \u00b5 L da suspens\u00e3o \n\nforam plaqueados em meio BHI e observado o crescimento f\u00fangico atrav\u00e9s da forma\u00e7\u00e3o \n\nde UFC. Tais resultados evidenciam que os leuc\u00f3citos PMNs de ambas as linhagens \n\npossuem a mesma habilidade em controlar a carga f\u00fangica pulmonar. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 52 \n\n \n\n \n\n \n\nPMN alveolar\n\nWT TLR2KO\n0\n\n1000\n\n2000\n\n3000\n\n4000\n\n5000\n\n6000\n\n7000\n\n8000\n\nU\nF\n\nC\n/m\n\nL\n\n \n\nFigura 9. Avalia\u00e7\u00e3o da atividade fungicida de leuc\u00f3citos PMNs alveolares atrav\u00e9s da \nrecupera\u00e7\u00e3o de Unidades Formadoras de Col\u00f4nia (UFC)/mL ap\u00f3s 1h de co-cultivo. \nPMNs recuperados do lavado bronco alveolar a partir de animais infectados pelo P. \nbrasiliensis ap\u00f3s 15 dias de infec\u00e7\u00e3o. Os PMNs foram reinfectados in vitro com o \nP. brasiliensis na propor\u00e7\u00e3o 1 fungo para 2 PMNs.  \n\n \n\n \n\n \n\n \n\n \n\n \n\nPMN peritoneal\n\nWT TLR2KO\n0\n\n1000\n\n2000\n\n3000\n\n4000\n\n5000\n\n6000\n\n7000\n\n8000\n\nU\nF\n\nC\n/m\n\nL\n\n \n\n \n\nFigura 10. Avalia\u00e7\u00e3o da atividade fungicida de leuc\u00f3citos PMNs peritoneais atrav\u00e9s da \nrecupera\u00e7\u00e3o de Unidades Formadoras de Col\u00f4nia (UFC)/mL ap\u00f3s 1h de co-cultivo. \nPMNs recuperados de camundongos 6 horas ap\u00f3s inocula\u00e7\u00e3o de suspens\u00e3o morta \ndo P. brasiliensis. C\u00e9lulas n\u00e3o aderentes foram infectadas com o P. brasiliensis na \npropor\u00e7\u00e3o 1 fungo para 2 PMNs.  \n\n \n\n\n\n 53 \n\n4.1.2.4 Caracteriza\u00e7\u00e3o morfol\u00f3gica das popula\u00e7\u00f5es celulares infiltrantes dos \n\npulm\u00f5es \n\nC\u00e9lulas infiltrantes dos pulm\u00f5es foram obtidas na segunda e na d\u00e9cima primeira \n\nsemana ap\u00f3s a infec\u00e7\u00e3o. A concentra\u00e7\u00e3o celular foi ajustada a 2 x 104 c\u00e9lulas em 150 ul  \n\nde meio RPMI e centrifugadas em Cytospin. As l\u00e2minas foram coradas e um total de \n\n200 a 400 c\u00e9lulas foram contadas em cada amostra. Como observado na figura 11A, um \n\nmenor n\u00famero de macr\u00f3fagos foi obtido a partir da suspens\u00e3o celular provenientes de \n\nanimais TLR-2-/-comparando-se com o WT. Por outro lado, animais TLR-2-/- \n\napresentaram maior n\u00famero de polimorfonucleares (PMN) e linf\u00f3citos nos pulm\u00f5es, \n\ncomparando-se com os animais controles. Ap\u00f3s a d\u00e9cima primeira semana de infec\u00e7\u00e3o, \n\ncomo observamos na figura 11B, encontramos o mesmo n\u00famero de macr\u00f3fagos e de \n\nlinf\u00f3citos no infiltrado de pulm\u00e3o entre as duas linhagens, entretanto, animais TLR-2-/- \n\napresentaram maior n\u00famero de PMN comparando-se com o valor observado nos \n\nanimais WT. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 54 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 11. Caracteriza\u00e7\u00e3o morfol\u00f3gica das popula\u00e7\u00f5es celulares de Leuc\u00f3citos Infiltrantes de \nPulm\u00e3o (LIP) ap\u00f3s 2 (A) e 11 semanas (B) de infec\u00e7\u00e3o em animais TLR-2-/- e WT. \nOs dados representam a m\u00e9dia \u00b1 EP de 6 animais por grupo. Os asteriscos \nrepresentam diferen\u00e7as estatisticamente significante (*P<0,05). \n\n \n\n \n\n \n\n \n\n0\n\n25\n\n50\n\n75\n\n100\n\n*\n\n*\n\n*\n\nA\n\nMacr\u00f3fagos      PMN            Linf\u00f3citos\n\nL\n I\n\n P\n (\n\n%\n)\n\n0\n\n25\n\n50\n\n75\n\n100\n\n*\n\nB\n\nMacr\u00f3fagos      PMN           Linf\u00f3ci tos\n\nL\n I\n\n P\n (\n\n%\n)\n\n       WT  \nTLR-2-/- \n\n\n\n 55 \n\n4.1.2.5 Estudo do efeito da deple\u00e7\u00e3o de leuc\u00f3citos PMNs em animais normais e \n\ndeficientes para o TLR-2. \n\n Com os resultados mostrados at\u00e9 agora observamos que os animais TLR-2-\n\ndeficientes apresentaram uma menor carga f\u00fangica pulmonar em rela\u00e7\u00e3o aos \n\ncamundongos normais e esta maior carga f\u00fangica estava acompanhada com um n\u00famero \n\nmaior de PMNs no infiltrado pulmonar. Para elucidar se havia alguma rela\u00e7\u00e3o entre \n\nmenor carga f\u00fangica devido ao maior afluxo de neutr\u00f3filos, prosseguimos com \n\nexperimentos de deple\u00e7\u00e3o de PMNs. Animais TLR-2 normais e deficientes foram \n\ntratados com anticorpos anti-PMN um dia antes da infec\u00e7\u00e3o pelo P. brasiliensis e nos \n\ndias 2 e 5 p\u00f3s infec\u00e7\u00e3o; foram ent\u00e3o observados em rela\u00e7\u00e3o \u00e0 carga f\u00fangica pulmonar e \n\no tempo de sobrevida. \n\n \n\n4.1.2.5.1 Avalia\u00e7\u00e3o da deple\u00e7\u00e3o \n\n O n\u00famero total de granul\u00f3citos e de leuc\u00f3citos PMN foi avaliado antes do \n\ntratamento (tempo -1) e 24 horas ap\u00f3s a inocula\u00e7\u00e3o do AcM, imediatamente antes da \n\ninocula\u00e7\u00e3o de leveduras do P. brasiliensis (tempo zero). Foi coletado o sangue da cauda \n\nde camundongos de ambas as linhagens, para contagem total e diferencial dos \n\nleuc\u00f3citos.  A contagem global foi realizada em c\u00e2mara de Neubauer e a diferencial foi \n\nfeita em extens\u00e3o sangu\u00ednea corada com Gimsa.   \n\n Antes do tratamento com o anticorpo anti-PMN, animais WT apresentaram 10,1 \n\nx106 (\u00b1 2,4 x106) c\u00e9lulas na contagem global. Destas c\u00e9lulas, 17% eram leuc\u00f3citos \n\nPMN; animais TLR-2 apresentaram neste tempo 9,96 x106 (\u00b1 1,8 x106) c\u00e9lulas totais e \n\ndestas c\u00e9lulas 22% eram leuc\u00f3citos PMN. No dia zero, ap\u00f3s a inocula\u00e7\u00e3o do anticorpo \n\nanti-PMN e imediatamente antes da infec\u00e7\u00e3o pelo fungo, o procedimento foi repetido. \n\nNeste caso, animais WT apresentaram 2,9 x106 (\u00b1 0,9 x106) c\u00e9lulas totais e destas \n\nc\u00e9lulas o total de PMN correspondia a 5% das c\u00e9lulas. Os animais TLR-2KO \n\napresentaram 3,3 x106 (\u00b1 0,8 x106) c\u00e9lulas na contagem global e destas c\u00e9lulas 3% \n\ncorrespondiam a leuc\u00f3citos PMN.  \n\n No grupo animais controle, tratado com anticorpo IgG normal de rato o mesmo \n\nprocedimento foi realizado. Neste caso, animais WT apresentaram 12,3 x106 (\u00b1 0,7 \n\nx106) c\u00e9lulas totais e destas c\u00e9lulas 17% correspondiam a leuc\u00f3citos PMN, enquanto \n\nque, para os animais TLR-2KO encontramos 9,71 x106 (\u00b1 0,7 x106) e destas c\u00e9lulas \n\n24% corresponderam a leuc\u00f3citos PMN.  \n\n\n\n 56 \n\n Para ambos os grupos, o procedimento foi repetido ap\u00f3s a terceira inocula\u00e7\u00e3o do \n\nanticorpo anti-PMN e com IgG normal de rato. Resultados semelhantes aos descritos \n\nacima foram encontrados, evidenciando a efici\u00eancia do anticorpo em depletar os \n\nleuc\u00f3citos PMN. \n\n \n\n4.1.2.5.2 Avalia\u00e7\u00e3o da carga f\u00fangica por UFC.  \n\n Grupos de animais normais e deficientes para o TLR-2 tratados com a AcM anti-\n\nPMN ou IgG normal e infectados com o fungo P. brasiliensis foram sacrificados ap\u00f3s 2 \n\ne 6 dias de infec\u00e7\u00e3o. Como observado na figura 12A, animais deficientes para o TLR-2 \n\napresentaram, ap\u00f3s dois dias de infec\u00e7\u00e3o, uma  menor carga f\u00fangica em rela\u00e7\u00e3o aos \n\nanimais normais para o TLR-2, quando ambas as linhagens foram tratadas com IgG \n\nnormal de rato. Por outro lado, quando estas linhagens sofreram deple\u00e7\u00e3o de PMNs foi \n\nobservado um aumento da carga f\u00fangica nos animais TLR-2 deficientes. N\u00e3o houve \n\naltera\u00e7\u00e3o na carga f\u00fangica pulmonar entre animais TLR-2-normais quando tratados com \n\nanticorpo IgG normal e quando depletados com anti-PMN.  Resultados equivalentes \n\nforam observados ap\u00f3s 6 dias de infec\u00e7\u00e3o, como demonstrado na figura 12B. Estes \n\nresultados evidenciam o papel dos leuc\u00f3citos PMN no controle da carga f\u00fangica \n\npulmonar nos animais TLR-2-deficientes. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 57 \n\n \n\n                  A \n\n5.0\n\n5.5\n\n6.0\n\n6.5\nWT\n\nTLR2 -/-\n\n*\n\n#\n\n2 Dias\n\nIgG                              anti -PMN\n\nU\nF\n\nC\n g\n\n/t\nec\n\nid\no\n\n (\nlo\n\ng\n1\n\n0\n)\n\n \n\n \n\n                        B \n\n4.5\n\n5.0\n\n5.5\n\n6.0\n\n6.5\nWT\n\nTLR2 -/-\n\n*\n\n6  Dias\n\nIgG                              anti -PMN\n\nU\nF\n\nC\n g\n\n/t\nec\n\nid\no\n\n (\nlo\n\ng\n1\n\n0\n)\n\n \n\nFigura 12. Efeito da deple\u00e7\u00e3o de leuc\u00f3citos PMN no grau de infec\u00e7\u00e3o de animais TLR-2 \nnormais e deficientes ap\u00f3s a infec\u00e7\u00e3o pelo P. brasiliensis. Ambas as linhagens \nforam tratadas com AcM anti-PMN nos dias -1, 2 e 5 ou IgG normal de rato. A \ninfec\u00e7\u00e3o com 1x106 do P. brasiliensis foi no dia zero e o grau de infec\u00e7\u00e3o avaliado \nno dia 2 (A) e no dia 6 (B) por determina\u00e7\u00e3o de UFC. As barras representam as \nm\u00e9dias \u00b1 EP dos grupos ensaiados. O asterisco representa diferen\u00e7a estatisticamente \nsignificante entre os grupos ligados pela barra (*/#P&lt;0,05). \n\n \n\n \n\n \n\n \n\n\n\n 58 \n\n4.1.2.5.3 Tempo do Sobrevida \n\n Grupo de 8 animais TLR-2 normais e deficientes, tratados com AcM anti-PMN e \n\ninfectados i.t. com o fungo P. brasiliensis assim como 6 animais controle, tratado com \n\nIgG normal e infectados com o fungo foram observados durante um per\u00edodo de 10 dias, \n\nsendo registrados o tempo de sobrevida para cada animal (em dias).  \n\n Como observado na figura 13, houve a morte de quatro animais TLR-2-\n\ndeficientes depletados com o anticorpo anti-PMN. N\u00e3o houve morte entre os animais \n\nWT e depletados de PMN. Nos grupos tratados com IgG, houve apenas uma morte entre \n\nos animais TLR-2- normais. Assim, ap\u00f3s 10 dias de observa\u00e7\u00e3o houve mortalidade de \n\n50% dos animais somente no grupo de TLR-2-deficientes tratados com anti-PMN. A \n\nan\u00e1lise estat\u00edstica destes dados (m\u00e9todo de compara\u00e7\u00e3o de curvas de sobrevida pelo \n\nLogrank) demonstrou que a sobrevida dos animais TLR-2-deficientes tratados foi \n\nsignificativamente menor do que dos animais WT depletados de PMN (p=0,045). Em \n\nrela\u00e7\u00e3o ao grupo de animais tratados com IgG normal foi observada apenas uma morte \n\nno per\u00edodo estudado. N\u00e3o houve assim, diferen\u00e7a no tempo de sobrevida entre animais \n\nTLR-2 normais e deficientes.  \n\n \n\n \n\n0 1 2 3 4 5 6 7 8 9 10\n0\n\n25\n\n50\n\n75\n\n100 WT IgG\nTLR2KO IgG\nWT anti-PMN\nTLR2KO anti-PMN\n\n*\n\nDias\n\n%\n d\n\ne\n S\n\no\nb\n\nre\nv\nid\n\na\n\n \n\n \n\nFigura 13. Tempo de sobrevida de camundongos TLR-2 normais e deficientes tratados com \nAcM anti-PMN e infectados com 1x106 leveduras do fungo P. brasiliensis (n=8 \ncamundongos/linhagem) e camundongos infectados e tratados com IgG de rato \ncomo controle (n=6 camundongos/linhagem). (* P<0,05). \n\n \n\n \n\n\n\n 59 \n\n4.1.2.6 Dosagem de citocinas no homogenato do pulm\u00e3o  \n\nA figura 14 mostra a produ\u00e7\u00e3o de algumas citocinas Th1 (IL2, IL-12, TNF-? e \n\nIFN-?)  no homogenato do pulm\u00e3o de camundongos ap\u00f3s 48 horas, 2 e 11 semanas de \n\ninfec\u00e7\u00e3o com o P. brasiliensis. Pode-se verificar que camundongos TLR-2-normais e \n\nTLR-2-deficientes produziram n\u00edveis semelhantes destas citocinas. Com exce\u00e7\u00e3o da \n\ncitocina IL-12, que foi encontrada em n\u00edveis menores no homogenato do pulm\u00e3o de \n\nanimais TLR-2-deficientes ap\u00f3s 11 semanas de infec\u00e7\u00e3o. Encontramos tamb\u00e9m, um \n\npadr\u00e3o semelhante de produ\u00e7\u00e3o de citocinas Th2 (IL-4, IL-5 e IL-10) no homogenato do \n\npulm\u00e3o das duas linhagens ap\u00f3s 48 horas e 2 semanas de infec\u00e7\u00e3o. Quando trabalhamos \n\ncom tempo longo de infec\u00e7\u00e3o, observamos menores n\u00edveis de IL-10 no homogenato de \n\npulm\u00e3o dos animais TLR-2-deficientes (figura 15).  \n\nEm rela\u00e7\u00e3o \u00e0s citocinas relacionadas com o padr\u00e3o de resposta Th17 (IL-17, IL-\n\n23, IL-6 e TGF-?) verificamos que ap\u00f3s 48 horas de infec\u00e7\u00e3o os animais TLR-2-\n\ndeficientes produziram maiores n\u00edveis de IL-17 e TGF-?. Na segunda semana, al\u00e9m \n\ndestas, IL-6 e IL-23 tamb\u00e9m ocorreu em n\u00edveis maiores nesta mesma linhagem. J\u00e1 na \n\nd\u00e9cima primeira semana, n\u00edveis semelhantes destas citocinas ocorreram em ambas as \n\nlinhagens, com exce\u00e7\u00e3o da IL-23, que continuou em maiores n\u00edveis em animais TLR-2-\n\ndeficientes (figura 16).  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 60 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nIL-2\n\n48 h 2 semanas 11 semanas\n0\n\n50\n\n100\n\n150\n\n200\n\n250\n\npg\n/m\n\nL\n\nIFN-????\n\n48 h 2 semanas 11 semanas\n0\n\n2500\n\n5000\n\n7500\n\np\ng\n\n/m\nL\n\n \n\n \n\n \n\nFigura 14. Quantifica\u00e7\u00e3o de IL-12, TNF-?, IL-2 e IFN-? em homogenato de pulm\u00e3o de animais \nTLR-2-KO e WT ap\u00f3s 48 horas, 2  e 11 semanas de infec\u00e7\u00e3o. As barras \nrepresentam as m\u00e9dias \u00b1 EP de 6 animais por grupo. O asterisco representa \ndiferen\u00e7a estatisticamente significante entre os grupos (*P&lt;0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\nIL-12\n\n500\n\n1000\n\n1500\n\n2000\n\n2500\n\n3000\n\n3500\n\n48 h 2 semanas 11 semanas\n0\n\n*pg\n/m\n\nL\n\nIL-12\n\n500\n\n1000\n\n1500\n\n2000\n\n2500\n\n3000\n\n3500\n\n48 h 2 semanas 11 semanas\n0\n\n*pg\n/m\n\nL\n\nTNF-?\n\n48 h 2 semanas 11 semanas\n0\n\n2500\n\n5000\n\n7500\n\n10000\n\n12500\n\npg\n/m\n\nL\n\nTNF-?\n\n48 h 2 semanas 11 semanas\n0\n\n2500\n\n5000\n\n7500\n\n10000\n\n12500\n\npg\n/m\n\nL\n\nWT TLR2 -/-WT TLR2 -/-\n\n\n\n 61 \n\n \n\n \n\n \n\n \n\n \n\nIL-4\n\n48 h 2 semanas 11 semanas\n0\n\n25\n\n50\n\n75\n\n100\n\n125\n\npg\n/m\n\nL\n\n \n\nIL-5\n\n48 h 2 semanas 11 semanas\n0\n\n100\n\n200\n\n300\n\n400\n\npg\n/m\n\nL\n\n \n\n \n\n \n\nFigura 15. Quantifica\u00e7\u00e3o de IL-4, IL-5 e IL-10 em homogenato de pulm\u00e3o de animais TLR-2-\nKO e WT ap\u00f3s 48 horas, 2  e 11 semanas de infec\u00e7\u00e3o. As barras representam as \nm\u00e9dias \u00b1 EP de 6 animais por grupo. O asterisco representa diferen\u00e7a \nestatisticamente significante entre os grupos (*P&lt;0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nIL-10\n\n48h 2 semanas 11 semanas\n0\n\n1000\n\n2000\n\n3000\n\n*\n\npg\n/m\n\nL\n\nIL-10\n\n48h 2 semanas 11 semanas\n0\n\n1000\n\n2000\n\n3000\n\n*\n\npg\n/m\n\nL\n\nWT TLR2 -/-WT TLR2 -/-\n\n\n\n 62 \n\n \n\n \n\n \n\n \n\n \n\nIL-6\n\n48 h 2 semanas 11 semanas\n0\n\n500\n1000\n1500\n2000\n2500\n3000\n3500\n4000\n4500\n5000\n5500 *\n\np\ng\n\n/m\nL\n\nTGF-????\n\n48 h 2 semanas 11 semanas\n0\n\n1000\n\n2000\n\n3000\n\n4000\n\n5000\n\n*\n*\n\np\ng\n\n/m\nL\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 16. Quantifica\u00e7\u00e3o de TGF-?, IL-6, IL-23 e IL-17 em homogenato de pulm\u00e3o de animais \nTLR-2-KO e WT ap\u00f3s 48 horas, 2  e 11 semanas de infec\u00e7\u00e3o. As barras \nrepresentam as m\u00e9dias \u00b1 EP de 6 animais por grupo. O asterisco representa \ndiferen\u00e7a estatisticamente significante entre os grupos (*P&lt;0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nIL-17\n\n48 h 2 semanas 11 semanas\n0\n\n100\n\n200\n\n300\n\n400\n\n500\n\n600\n\n*\n\np\ng/\n\nm\nL\n\n*\n\nIL-17\n\n48 h 2 semanas 11 semanas\n0\n\n100\n\n200\n\n300\n\n400\n\n500\n\n600\n\n*\n\np\ng/\n\nm\nL\n\n*\n\nIL-23\n\n48 h 2 semanas 11 semanas\n0\n\n250\n\n500\n\n750\n\n1000\n\n*\n\np\ng/\n\nm\nL\n\nIL-23\n\n48 h 2 semanas 11 semanas\n0\n\n250\n\n500\n\n750\n\n1000\n\n*\n\np\ng/\n\nm\nL\n\nWT TLR2 -/-WT TLR2 -/-\n\n\n\n 63 \n\n4.1.2.7 Dosagem da quimiocina KC e MCP-1 em homogenatos do pulm\u00e3o \n\n Em experimentos anteriores verificamos que houve um maior afluxo de \n\nneutr\u00f3filos para os pulm\u00f5es de animais deficientes para o TLR-2. Como o recrutamento \n\nde neutr\u00f3filos pode ser dependente de uma quimiocina CXC, prosseguimos com \n\npesquisa da quimiocina KC, uma quimiocina CXC, no homegenato do pulm\u00e3o de \n\nanimais normais e deficientes para o TLR-2 e infectados com o fungo P. brasiliensis. \n\nAl\u00e9m disso, houve diferen\u00e7a na migra\u00e7\u00e3o de macr\u00f3fagos para o local da infec\u00e7\u00e3o. Com \n\nmenor afluxo destas c\u00e9lulas para o pulm\u00e3o dos animais TLR-2-/- quando comparados ao \n\ngrupo controle. Assim, tamb\u00e9m dosamos os n\u00edveis de MCP-1, quimiocina relacionada \n\ncom a migra\u00e7\u00e3o de mon\u00f3citos para o s\u00edtio inflamat\u00f3rio, nos pulm\u00f5es dos grupos \n\nestudados. \n\n Como mostrado na figura 17, encontramos maiores n\u00edveis da quimiocina KC em \n\nhomogenatos do pulm\u00e3o de animais deficientes para o TLR-2, o mesmo grupo que \n\napresentou maior afluxo de neutr\u00f3filos no infiltrado celular dos pulm\u00f5es. Em rela\u00e7\u00e3o \u00e0 \n\nMCP-1, encontramos n\u00edveis menores desta quimiocina no homogenato do pulm\u00e3o de \n\nanimais TLR-2-/-, os mesmos que apresentaram menor afluxo de macr\u00f3fagos, como \n\ndemonstrado na figura 18. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 64 \n\nKC\n\n0\n\n250\n\n500\n\n750\n\n1000\n\n1250\n\n1500\n\n1750\n\n2000\n\n2250\nWT\n\nTLR2-/-\n\n*\n\n*\n\n2 semanas                   11 semanas\n\np\ng\n\n/m\nL\n\n \n\n \n\nFigura 17. Quantifica\u00e7\u00e3o da quimiocina KC em homogenato de pulm\u00e3o de animais TLR-2-KO \n\ne WT ap\u00f3s  2  e 11 semanas de infec\u00e7\u00e3o. As barras representam as m\u00e9dias \u00b1 EP de \n6 animais por grupo. O asterisco representa diferen\u00e7a estatisticamente significante \nentre os grupos (*P&lt;0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 18. Quantifica\u00e7\u00e3o da quimiocina MCP-1 em homogenato de pulm\u00e3o de animais TLR-2-\nKO e WT ap\u00f3s 2  e 11 semanas de infec\u00e7\u00e3o.  As barras representam as m\u00e9dias \u00b1 EP \nde 6 animais por grupo. O asterisco representa diferen\u00e7a estatisticamente \nsignificante entre os grupos (*P&lt;0,05). \n\n \n\n \n\n2 semanas                 11 semanas\n\nMCP-1\n\n0\n\n500\n\n1000\n\n1500\n\n2000\n\n2500\n\n3000\n\n3500\n\n*\n\n*\n\np\ng/\n\nm\nL\n\n2 semanas                 11 semanas\n\nMCP-1\n\n0\n\n500\n\n1000\n\n1500\n\n2000\n\n2500\n\n3000\n\n3500\n\n*\n\n*\n\np\ng/\n\nm\nL\n\nWT TLR2 -/-WT TLR2 -/-\n\n\n\n 65 \n\n4.1.2.8 Citometria de fluxo para caracteriza\u00e7\u00e3o de subpopula\u00e7\u00f5es celulares no \n\ninfiltrado inflamat\u00f3rio dos pulm\u00f5es \n\n        C\u00e9lulas infiltrantes dos pulm\u00f5es dos pulm\u00f5es foram obtidas na segunda e na \n\nd\u00e9cima primeira semana ap\u00f3s infec\u00e7\u00e3o. A concentra\u00e7\u00e3o celular foi ajustada a 1x106 \n\ncels/mL e marcadas com Ac no titulo previamente determinado e na combina\u00e7\u00e3o \n\nadequada para a popula\u00e7\u00e3o celular a ser estudada. Como observado na Figura 19A, ap\u00f3s \n\na segunda semana de infec\u00e7\u00e3o n\u00e3o houve diferen\u00e7a na express\u00e3o dos marcadores \n\ncelulares CD11b, CD80, CD86, CD40 e Ia (MHC-classe II). Do mesmo modo, ap\u00f3s a \n\nd\u00e9cima primeira semana de infec\u00e7\u00e3o animais TLR-2-deficientes e normais apresentaram \n\na mesma freq\u00fc\u00eancia dos marcadores estudados. \n\n            Em rela\u00e7\u00e3o \u00e0s popula\u00e7\u00f5es linfocit\u00e1rias observamos um n\u00famero semelhante de \n\nc\u00e9lulas T CD4 e TCD8 nas suspens\u00f5es celulares provenientes de animais TLR-2-/- e WT \n\nap\u00f3s a segunda semana de infec\u00e7\u00e3o (Figura 20A). No tempo longo de infec\u00e7\u00e3o \n\nobservamos maior n\u00famero de linf\u00f3citos T CD4, T CD8, de linf\u00f3citos ativados CD25+ e \n\nde linf\u00f3citos T CD8+CD69+ nos animais TLR-2-normais quando comparados as \n\npopula\u00e7\u00f5es celulares de animais TLR-2-/- (Figura 20B). \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 66 \n\nCD11b IaK CD80 CD86 CD40\n0\n\n5\n\n10\n\n15\n\n20\n\nL\n I\n\n P\n (\n\nx \n1\n\n0\n6  \n\nce\nll\n\ns)\n\n \n\nCD11b IaK CD80 CD86 CD40\n0\n\n5\n\n10\n\n15\n\n20\n\nL\n I\n\n P\n (\n\nx \n1\n\n0\n6  \n\nce\nll\n\ns)\n\n \n\n \n\n \n\nFigura 19. Caracteriza\u00e7\u00e3o da express\u00e3o de marcadores de macr\u00f3fagos presentes nos Leuc\u00f3citos \nInfiltrantes de Pulm\u00e3o (LIP) por citometria de fluxo ap\u00f3s a de animais TLR-2-/- e \nWT; A: 2 semanas;  B: 11 semanas de infec\u00e7\u00e3o . \n\nB \n\nA \n\nWT TLR2 -/-WT TLR2 -/-\n\n\n\n 67 \n\nCD4 CD25 CD4CD25 CD8 CD69 CD8CD69\n0.0\n\n2.5\n\n5.0\n\n7.5\n\n10.0\n\n12.5\n\n15.0\n\nL\n I\n\n P\n (\n\nx\n 1\n\n0\n6\n c\n\nel\nls\n\n)\n\n \n\n \n\nCD4 CD25 CD4CD25 CD8 CD69 CD8CD69\n0.0\n\n2.5\n\n5.0\n\n7.5\n\n10.0\n\n12.5\n\n15.0\n\n*\n\n*\n*\n\nL\n I\n\n P\n (\n\nx\n 1\n\n0\n6\n c\n\nel\nls\n\n)\n\n \n\n \n\n \n\n \n\nFigura 20. Caracteriza\u00e7\u00e3o da express\u00e3o de marcadores de subpopula\u00e7\u00f5es de linf\u00f3citos presentes \nnos Leuc\u00f3citos Infiltrantes de Pulm\u00e3o (LIP) por citometria de fluxo ap\u00f3s a de \nanimais TLR-2-/- e WT; A: 2 semanas;  B: 11 semanas de infec\u00e7\u00e3o.  \n\n \n\n \n\n \n\n \n\nB \n\nA \n\nWT TLR2 -/-WT TLR2 -/-\n\n\n\n 68 \n\n4.1.2.9 Caracteriza\u00e7\u00e3o intracelular da express\u00e3o da citocina IL-17. \n\nC\u00e9lulas dos pulm\u00f5es obtidas como descrito no item 3.2.6 do material e m\u00e9todos \n\nforam, ap\u00f3s 72 horas e 2 semanas de infec\u00e7\u00e3o, estimuladas com PMA, ionomicina e \n\ntratadas com monensina durante 6 horas. A seguir, as c\u00e9lulas foram marcadas com \n\nanticorpos previamente titulados para linf\u00f3citos T CD4 e CD8, assim como para \n\ncitocina IL-17.   Os dot plots indicados na figura 21 demonstram que tanto ap\u00f3s 72 \n\nhoras de infec\u00e7\u00e3o, como ap\u00f3s 2 semanas, houve uma maior porcentagem de linf\u00f3citos \n\nTCD4 produtores de IL-17 nos pulm\u00f5es de animais TLR-2-/- quando comparado ao \n\ngrupo controle. Os gr\u00e1ficos \u00e0 direita demonstram o n\u00famero absoluto de c\u00e9lulas, animais \n\nTLR-2-/- tamb\u00e9m apresentaram maior n\u00famero de c\u00e9lulas TCD4+IL-17+ em compara\u00e7\u00e3o \n\ncom os animais TLR-2-normais. \n\nA figura 22 indica que ap\u00f3s 72 horas de infec\u00e7\u00e3o a freq\u00fc\u00eancia de linf\u00f3citos \n\nTCD8+IL-17+  foi semelhante entre as duas linhagens estudadas e ap\u00f3s 2 semanas de \n\ninfec\u00e7\u00e3o houve uma maior freq\u00fc\u00eancia destas c\u00e9lulas nos animais TLR-2-/-. Contudo, \n\nquando estudamos o n\u00famero absoluto de c\u00e9lulas verificamos que n\u00e3o havia diferen\u00e7a no \n\nn\u00famero total de linf\u00f3citos TCD8+IL-17+ no local da infec\u00e7\u00e3o. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 69 \n\n \n\n                     WT                                  TLR-2-/-       \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nCD4 \n\n \n\n                               \n\n                              \n\n \n\n \n\n \n\n                                   \n\n                                                     IL-17 \n\n \n\nFigura 21. Caracteriza\u00e7\u00e3o da freq\u00fc\u00eancia da express\u00e3o da citocina intracelular IL-17 por \nlinf\u00f3citos T CD4 presentes em Leuc\u00f3citos Infiltrantes de Pulm\u00e3o (LIP) por \ncitometria de fluxo ap\u00f3s 72 horas e 2 semanas de  infec\u00e7\u00e3o pelo P. brasiliensis \nem animais TLR-2-/- e WT.  Nos gr\u00e1ficos \u00e0 direita, representa\u00e7\u00e3o do n\u00famero \nabsoluto de linf\u00f3citos T CD4 produtores de IL-17. O asterisco representa \ndiferen\u00e7a estatisticamente significante entre os grupos (*P&lt;0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nWT TLR2 -/-\n0.0\n\n0.5\n\n1.0\n\n1.5\n\n2.0\n\n2.5\n\n3.0\n\n*\n\nx\n 1\n\n0\n6\n c\n\ne\nll\n\ns\n\nWT TLR2 -/-\n0.0\n\n0.5\n\n1.0\n\n1.5\n\n2.0\n\n2.5\n\n3.0\n\n*\n\nx\n 1\n\n0\n6\n c\n\ne\nll\n\ns\n\n1,8 % 4,32% \n\n3,6% 1,24 % \n\n2 semanas \n\n72h \n\n\n\n 70 \n\n                                 WT                                   TLR-2 -/- \n\n \n\n           \n\nCD8 \n\n  \n\n                              IL-17 \n\n \n\n \n\n \n\n \n\n \n\n \n\n                                                  IL-17 \n\n \nFigura 22. Caracteriza\u00e7\u00e3o da freq\u00fc\u00eancia da express\u00e3o da citocina intracelular IL-17 em \n\nlinf\u00f3citos T CD8 presentes em popula\u00e7\u00f5es celulares de Leuc\u00f3citos Infiltrantes de \nPulm\u00e3o (LIP) por citometria de fluxo ap\u00f3s 72 horas e 2 semanas de  infec\u00e7\u00e3o pelo \nP. brasiliensis em animais TLR-2-/- e WT.  Nos gr\u00e1ficos \u00e0 direita, representa\u00e7\u00e3o \ndo n\u00famero absoluto de linf\u00f3citos T CD8 produtores de IL-17. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nWT TLR2 -/-\n0.0\n\n0.5\n\n1.0\n\n1.5\n\n2.0\n\n2.5\n\n3.0\n\nx\n 1\n\n0\n6\n c\n\ne\nll\n\ns\n\n1,74% \n\n3,75% 1,77% \n\n2,09% \n\n72h \n\n   2 semanas \n\nWT TLR2 -/-\n0.0\n\n0.5\n\n1.0\n\n1.5\n\n2.0\n\n2.5\n\n3.0\n\nx\n 1\n\n0\n6\n c\n\ne\nll\n\ns\n\n\n\n 71 \n\n4.1.2.10 Caracteriza\u00e7\u00e3o da presen\u00e7a de c\u00e9lulas T reguladoras \n\nC\u00e9lulas infiltrantes dos pulm\u00f5es foram obtidas na segunda e na d\u00e9cima primeira \n\nsemana de infec\u00e7\u00e3o. A concentra\u00e7\u00e3o celular foi ajustada a 1x106 cels/mL e marcadas \n\ncom Ac (anti-CD4, CD25 e FoxP3) na titula\u00e7\u00e3o adequada.  Para determina\u00e7\u00e3o dos \n\nn\u00edveis intracelulares de Foxp3 as c\u00e9lulas foram permeabilizadas e o anticorpo p\u00f4de fazer \n\na marca\u00e7\u00e3o intracitoplasm\u00e1tica. Como observado na figura 23, na segunda semana de \n\ninfec\u00e7\u00e3o n\u00e3o houve diferen\u00e7a entre os grupos estudados em rela\u00e7\u00e3o ao n\u00famero de \n\nc\u00e9lulas expressando FoxP3, um t\u00edpico marcador de c\u00e9lula T reguladora (Treg). Contudo, \n\nap\u00f3s 11 semanas de infec\u00e7\u00e3o animais TLR-2-/- apresentaram menor n\u00famero de c\u00e9lulas \n\nexpressando este marcador, quando comparado ao grupo controle. \n\n \n\n \n\n0\n\n2\n\n4\n\n6\n\n8\n\n10\n\n12\n\n2 semanas              11 semanas\n\n*\n\nC\nD\n\n4\n+\nC\n\nD\n2\n\n5\n+\nF\n\no\nx\n\nP\n3\n\n+\n/T\n\no\nta\n\nlC\nD\n\n4\n+\n(%\n\n)\n\n \n\nFigura 23. An\u00e1lise da express\u00e3o do fator de transcri\u00e7\u00e3o FoxP3 em exsudatos inflamat\u00f3rios de \nanimais TLR-2-/- e WT ap\u00f3s a segunda e d\u00e9cima primeira semana de infec\u00e7\u00e3o. A \nporcentagem de c\u00e9lulas que expressam FoxP3+ foi obtida a partir de um gate de \npopula\u00e7\u00f5es celulares CD4+CD25+ e calculado em rela\u00e7\u00e3o ao total de linf\u00f3citos T \nCD4+ O asterisco representa diferen\u00e7a estatisticamente significante entre os grupos \n(*P&lt;0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nWT\n\nTLR-2 -/-\n\n\n\n 72 \n\n4.1.2.11 Dosagem de anticorpos  \n\n A resposta imune humoral dos animais TLR-2-/- e WT infectados com o fungo \n\nfoi avaliada pela produ\u00e7\u00e3o de anticorpos anti P. brasiliensis (Ig total e os diferentes \n\nis\u00f3tipos). Assim, ap\u00f3s 11 semanas de infec\u00e7\u00e3o, os animais foram anestesiados, suas \n\nart\u00e9rias e veias axilares seccionadas e coletadas amostras do sangue para obten\u00e7\u00e3o do \n\nsoro; as amostras foram estocadas a -20 \u00b0C at\u00e9 o momento da detec\u00e7\u00e3o dos n\u00edveis de \n\nanticorpos por ELISA.  \n\n Como o indicado na figura 24, os animais TLR-2-/- apresentaram t\u00edtulos \n\nsemelhantes de anticorpos comparando-se com os t\u00edtulos de anticorpos encontrados no \n\nsoro de animais que expressam o TLR-2 funcional. \n\n \n\n \n\nIgG IgG1 IgG2a IgG2b IgG3 IgM IgA\n0\n\n3\n\n6\n\n9\n\n12\n\n15\n\n18\n\nT\n\u00edt\n\nu\nlo\n\n d\ne\n\n A\nn\n\nti\nc\n\no\nrp\n\no\ns\n\n (\nL\n\no\ng\n\n2\n)\n\n \n  \n\n \n\nFigura 24. Quantifica\u00e7\u00e3o de anticorpos s\u00e9ricos (IgG total, IgG1, IgG2a, IgG2b, IgG3, IgM e \nIgA) ap\u00f3s 11 semanas de infec\u00e7\u00e3o de animais TLR-2-/- e WT. Os animais foram \ninfectados com 1x106 leveduras de P.brasiliensis inoculadas pela via i.t. e \nsacrificados.  Os dados representam a m\u00e9dia \u00b1 EP de 5 animais por grupo.  \n\n  \n\n \n\n \n\n \n\n \n\n \n\nWT TLR2 -/-WT TLR2 -/-\n\n\n\n 73 \n\n4.1.2.12 Sobrevida \n\n Grupos de 12 animais TLR-2-/- e 12 animais WT foram infectados com \n\nleveduras vi\u00e1veis do P. brasiliensis e observados durante um per\u00edodo de 250 dias, sendo \n\nregistrado o tempo de sobrevida (em dias) para cada animal.  \n\n Como observado na figura 25 a mortalidade dos animais WT inicia-se no dia 77 \n\ne no dia 150 nos animais TLR-2-/- . Ap\u00f3s 250 dias, 3 animais TLR-2-/- continuavam \n\nvivos, enquanto que todos os animais WT morreram. A an\u00e1lise estat\u00edstica destes dados \n\nde sobrevida (m\u00e9todo de compara\u00e7\u00e3o de curvas de sobrevida pelo teste de Logrank) \n\ndemonstrou n\u00e3o haver diferen\u00e7as estat\u00edsticas entre os grupos estudados. O tempo m\u00e9dio \n\nde sobrevida foi de 221 dias para os animais TLR-2-/- e de 195 dias para os animais WT. \n\n \n\n \n\n \n\nFigura 25. Tempo de sobrevida de camundongos TLR-2-/- e WT infectados pela via i.t. com \n1x106 leveduras vi\u00e1veis do P. brasiliensis (n = 10-12 camundongo/linhagem). A \nsobrevida dos animais foi acompanhada por 250 dias. O experimento foi repetido \nduas vezes com resultados semelhantes. \n\n \n\n \n\n \n\n \n\n \n\ns\no\n\nb\nre\n\nv\nid\n\na \n(%\n\n)\n\nDias \n\n100 \n\n80 \n\n60 \n\n40 \n\n20 \n\n0 \n25 75 125 175 225 \n\nWT \nTLR-2-\n/- \n\n\n\n 74 \n\n4.1.2.13 An\u00e1lise histopatol\u00f3gica \n\nAp\u00f3s 11 semanas de infec\u00e7\u00e3o o pulm\u00e3o esquerdo de cada camundongo foi \n\nremovido e fixado em 10% de formalina e embebido em parafina. Sec\u00e7\u00f5es (5\u00b5 m) foram \n\ncoradas com Hematoxilina e Eosina (H&amp;E) para an\u00e1lise das les\u00f5es e com a colora\u00e7\u00e3o \n\nGroccot, para visualizar os fungos. Verificamos que, neste per\u00edodo de infec\u00e7\u00e3o, apesar \n\nda menor carga f\u00fangica encontrada nos animais TLR-2-/-, n\u00e3o houve diferen\u00e7a na \n\ngravidade das les\u00f5es entre animais TLR-2 deficientes e o grupo controle. Ambas as \n\nlinhagens apresentaram les\u00f5es extensas e confluentes ocupando quase todo o \n\npar\u00eanquima pulmonar que apresentou tamb\u00e9m um elevado n\u00famero de leveduras (figura \n\n26).  \n\n \n\nA                                                                 B       \n\n   \n\nC                                                                   D \n\n    \n\n \n\n         \nFigura 26. Fotomicrografias de les\u00f5es pulmonares de animais TLR-2-normais (A e C) e TLR-\n\n2-deficientes (B e D) ap\u00f3s 11 semanas de infec\u00e7\u00e3o com o fungo P. brasiliensis. \nH&amp;E ( A e B; 100x) e Groccot (C e D; 100x). \n\n \n \n \n \n\n\n\n 75 \n\n4.2  Influ\u00eancia da mol\u00e9cula adaptadora MyD88 na PCM \n\n4.2.1 In vitro \n\n4.2.1.1 Ensaio da Fagocitose \n\n Os macr\u00f3fagos peritoneais de animais MyD88KO e WT foram desafiados com \n\nleveduras n\u00e3o vi\u00e1veis do fungo previamente marcadas com iodeto de prop\u00eddio (PI) \n\n(rela\u00e7\u00e3o Pb/M\u00d8 de 1/1) por 2 horas. Ap\u00f3s este per\u00edodo as c\u00e9lulas foram recolhidas das \n\nplacas de 24 po\u00e7os, ajustadas em 1 x 106/mL e marcadas com anti-CD11b (FITC). A \n\nleitura foi realizada imediatamente ap\u00f3s a marca\u00e7\u00e3o no FACs Calibur.  O resultado \n\nrepresentativo de um experimento expresso na figura 27 demonstra que macr\u00f3fagos de \n\nanimais MyD88KO competentes apresentaram menor capacidade de aderir e/ou ingerir \n\nas leveduras n\u00e3o vi\u00e1veis do P. brasiliensis comparando-se com os macr\u00f3fagos de \n\nanimais MyD88 competentes. O fen\u00f4meno tamb\u00e9m ocorreu quando as culturas foram \n\npr\u00e9-tratadas com IFN-?. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 76 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 27. Avalia\u00e7\u00e3o de atividade fagoc\u00edtica de macr\u00f3fagos de animais normais e deficientes \npara a prote\u00edna MyD88. Os macr\u00f3fagos peritoneais de animais MyD88KO e WT \n(1x106 c\u00e9lulas/po\u00e7o) ativados ou n\u00e3o com IFN-? (20.000 pg/mL) foram co-\ncultivados com leveduras n\u00e3o vi\u00e1veis do P. brasiliensis marcados com PI em uma \nrela\u00e7\u00e3o fungo/M\u00d8 de 1:1. Ap\u00f3s 2 horas de incuba\u00e7\u00e3o o sobrenadante do cultivo foi \ndesprezado e as c\u00e9lulas recolhidas e marcadas com anti-CD11b (FITC). A leitura \nfoi realizada imediatamente ap\u00f3s a marca\u00e7\u00e3o no FACs Calibur. Em A temos um dot \nplot representativo de culturas n\u00e3o tratadas com IFN-?; na figura B, os macr\u00f3fagos \nforam primados com esta citocina. Na figura C temos a m\u00e9dia de macr\u00f3fagos \ncontendo Pb-PI em cada grupo. O asterisco representa diferen\u00e7a estatisticamente \nsignificante entre os grupos estudados (*P&lt;0,05). \n\n \n\nA\n\n18,9%35,9%\n\nC\nD\n\n11\nb\n -\n\nF\nit\n\nc\n\nPb - PI\n\nA\n\n18,9%35,9%\n\nC\nD\n\n11\nb\n -\n\nF\nit\n\nc\n\nPb - PI\nB\n\n21,9%39,8%\n\nC\nD\n\n11\nb\n -\n\nF\nit\n\nc\n\nPb - PI\n\nB\n\n21,9%39,8%\n\nC\nD\n\n11\nb\n -\n\nF\nit\n\nc\n\nPb - PI\n\n0\n\n20\n\n40\n\n60\n\n80\n\n* *\n\nC\n\n    M?             M? + IFN-?\n\n%\n C\n\nD\n11\n\nb+\n P\n\nb-\nP\n\nI+\n\nWT MyD88KO WT\n\nWT                             MyD88KO \n\nWT                             MyD88KO \n\n\n\n 77 \n\n4.2.1.2 Avalia\u00e7\u00e3o da atividade fungicida de macr\u00f3fagos peritoneais atrav\u00e9s da \n\ndetermina\u00e7\u00e3o de Unidades Formadoras de Col\u00f4nia (UFC) \n\n A figura 28 mostra um n\u00famero maior de fungos recuperados nas culturas de \n\nmacr\u00f3fagos peritoneais dos camundongos deficientes quanto \u00e0 express\u00e3o da prote\u00edna \n\nMyD88. O mesmo aconteceu com macr\u00f3fagos pr\u00e9-ativados com IFN-? (20.000 pg/mL), \n\npor\u00e9m neste tratamento observamos uma menor carga f\u00fangica em ambas as linhagens \n\nem compara\u00e7\u00e3o aos grupo que n\u00e3o foram tratados com esta citocina.  \n\n \n\n \n\n0\n\n2000\n\n4000\n\n6000\n\n8000\n\n10000\n\n12000\n\nMo + Pb                Mo + Pb + IFN-?\n\n*\n\n*\n\nC\nF\n\nU\n/m\n\nL\n\n \n\n \n\n \n\n \n\nFigura 28. Avalia\u00e7\u00e3o da atividade fungicida de macr\u00f3fagos peritoneais atrav\u00e9s da recupera\u00e7\u00e3o \nde Unidades Formadoras de Col\u00f4nia (UFC)/mL ap\u00f3s 48h de co-cultivo. As \nmonocamadas de macr\u00f3fagos de animais WT e MyD88KO foram tratadas ou n\u00e3o \ncom IFN-? (20.000pg/mL) e infectadas com o P. brasiliensis na propor\u00e7\u00e3o 1 fungo \npara 25 macr\u00f3fagos ap\u00f3s 24h. O asterisco representa diferen\u00e7a estatisticamente \nsignificante entre os grupos (*P&lt;0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nWT MyD88KO WT \n\n\n\n 78 \n\n4.2.1.3 Dosagem de NO \n\n  A figura 29 mostra que macr\u00f3fagos provenientes de camundongos deficientes \n\npara a prote\u00edna MyD88  produzem concentra\u00e7\u00f5es menores de NO em compara\u00e7\u00e3o com \n\nos macr\u00f3fagos de camundongos selvagens. Isso ocorreu tanto nos grupos de macr\u00f3fagos \n\napenas tratados com IFN-?, quanto nos grupos tratados com IFN-? e infectados com o \n\nfungo. Al\u00e9m disso, a adi\u00e7\u00e3o de P. brasiliensis levou a um aumento significativo na \n\ns\u00edntese de NO quando comparamos com o grupo que n\u00e3o recebeu o fungo. Nos grupos \n\nde macr\u00f3fagos sem tratamento e nos grupos apenas infectados com o fungo, n\u00e3o houve \n\nprodu\u00e7\u00e3o de NO em ambas as linhagens estudadas.  \n\n \n\nN O\n\n0\n\n1 0\n\n2 0\n\n3 0\n\n4 0\n\n5 0\n\n6 0\n\n7 0\n\n*\n\n*\n\nM ????   M ????  +  P b M ????  +  I F N -???? M ????  +  P b  +  I F N -????\n\nN\nit\n\nri\nto\n\n (\n\u00b5\u00b5 \u00b5\u00b5\n\nM\n)\n\n \n\n \n\n Figura 29.  Quantifica\u00e7\u00e3o de NO no sobrenadante de cultura de macr\u00f3fagos peritoneais de \nanimais MyD88KO e WT.  Macr\u00f3fagos foram cultivados com a adi\u00e7\u00e3o ou n\u00e3o de \nIFN-? (20.000pg/mL) durante a noite. Algumas monocamadas de macr\u00f3fagos \nforam infectadas com o P.brasiliensis em uma propor\u00e7\u00e3o de 50 macr\u00f3fagos para \n1 fungo. Ap\u00f3s 48 horas de incuba\u00e7\u00e3o a produ\u00e7\u00e3o de NO foi avaliada no \nsobrenadante do cultivo.  O grupo controle de macr\u00f3fagos foi mantido sem \ntratamento, onde n\u00e3o houve produ\u00e7\u00e3o de NO. Os dados representam a m\u00e9dia \u00b1 EP \nde 5 po\u00e7os por grupo. O asterisco representa diferen\u00e7a estatisticamente \nsignificante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\nWT MyD88KO WT \n\n\n\n 79 \n\n4.2.2 Experimentos in vivo \n\n4.2.2.1 Estudo da fase aguda \n\n4.2.2.1.1 Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o atrav\u00e9s de UFC \n\n A figura 30 mostra a m\u00e9dia de UFC/g de tecido (log10) no pulm\u00e3o dos animais \n\nMyD88KO e WT obtidos ap\u00f3s 48 horas de infec\u00e7\u00e3o. Observamos que neste tempo de \n\ninfec\u00e7\u00e3o houve maior carga f\u00fangica a partir do macerado do pulm\u00e3o dos animais \n\nMyD88KO. N\u00e3o houve dissemina\u00e7\u00e3o para f\u00edgado e ba\u00e7o neste tempo de infec\u00e7\u00e3o em \n\nambas as linhagens estudadas. \n\n \n\n4.2.2.1.2 Dosagem de NO \n\n Na figura 31 temos a quantifica\u00e7\u00e3o de NO presente no homogenato dos pulm\u00f5es \n\ndos animais MyD88KO e WT ap\u00f3s 48 horas de infec\u00e7\u00e3o. A dosagem foi feita \n\nimediatamente ap\u00f3s a coleta do homogenato. A concentra\u00e7\u00e3o de NO encontrada foi \n\nmaior no grupo de animais que apresentam a sinaliza\u00e7\u00e3o via MyD88 comparando-se \n\ncom o grupo que n\u00e3o apresenta esta prote\u00edna.  \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 80 \n\nUFC 48 Horas\n\nC57Bl/6 MyD88KO\n4\n\n5\n\n6\n\n*\n\nU\nF\n\nC\n g\n\n/t\nec\n\nid\no\n\n (\nlo\n\ng\n1\n\n0)\n\n \n\n \n\nFigura 30. Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o atrav\u00e9s de Unidades Formadoras de Col\u00f4nia (UFC). \nOs camundongos MyD88KO e WT foram infectados com 1x106 de leveduras do P. \nbrasiliensis pela via i.t.. O grau de infec\u00e7\u00e3o foi determinado ap\u00f3s 48 horas de \ninfec\u00e7\u00e3o pela contagem de UFC. O asterisco representa diferen\u00e7a estatisticamente \nsignificante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n \n \n \n \nFigura 31. Quantifica\u00e7\u00e3o de NO no homogenato dos pulm\u00f5es de animais MyD88KO e WT.  Os \n\nanimais foram infectados com 1x106 leveduras de P.brasiliensis inoculadas pela via \ni.t. e sacrificados ap\u00f3s 48 horas de infec\u00e7\u00e3o. Os dados representam a m\u00e9dia \u00b1 EP de \n6 animais por grupo. O asterisco representa diferen\u00e7a estatisticamente significante \n(*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n NO  48 Horas\n\nC57 WT MyD88KO\n0\n\n5\n\n10\n\n15\n\n20\n\n25\n\n*\n\nN\nit\n\nri\nt ?? ??\n\n (\n\u00b5\u00b5 \u00b5\u00b5\n\nM\n)\n\n\n\n 81 \n\n4.2.2.1.3 Dosagem de citocinas no homogenato do pulm\u00e3o  \n\nA figura 32 mostra a produ\u00e7\u00e3o de algumas citocinas no homogenato do pulm\u00e3o \n\nde camundongos ap\u00f3s 48 horas de infec\u00e7\u00e3o com o P. brasiliensis. Ap\u00f3s este per\u00edodo de \n\ninfec\u00e7\u00e3o, n\u00edveis semelhantes de IL-10, TGF-?, IL-6, IL-17, IL-23, IFN-? e TNF-? foram \n\nencontrados no homogenato pulmonar de animais normais e deficientes  para a prote\u00edna \n\nMyD88. Em rela\u00e7\u00e3o \u00e0 IL-12 encontramos n\u00edveis menores desta citocina nos pulm\u00f5es de \n\nanimais MyD88KO. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 32. Quantifica\u00e7\u00e3o de TNF-?, IFN-? , IL-12, IL-10, TGF-?, IL-6, IL-17 e IL-23 em \nhomogenato de pulm\u00e3o de animais MyD88KO e WT ap\u00f3s 48 horas  de infec\u00e7\u00e3o. O \nasterisco representa diferen\u00e7a estatisticamente significante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nP ul m \u00e3o  4 8  Ho r as\n\n?\nTN\n\nF-\n?\n\nIF\nN\n\n-\nIL\n\n-1\n2\n\nIL\n-1\n\n0 ?\nTG\n\nF- IL\n-6\n\nIL\n-1\n\n7\nIL\n\n-2\n3\n\n0\n\n500\n\n1000\n\n1500\n\n2000\n\nW T M yD8 8 KO\n\n*\n\np\ng/\n\nm\nL\n\n\n\n 82 \n\n4.2.2.2 Estudo da fase cr\u00f4nica \n\n4.2.2.2.1 Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o atrav\u00e9s de UFC \n\nA figura 33 mostra a m\u00e9dia de UFC/g de tecido (log10) no pulm\u00e3o, f\u00edgado e ba\u00e7o \n\ndos animais MyD88KO e WT obtidos ap\u00f3s 8 semanas de infec\u00e7\u00e3o. Observamos que \n\nneste tempo de infec\u00e7\u00e3o maior carga f\u00fangica a partir do macerado do pulm\u00e3o, f\u00edgado e \n\nba\u00e7o dos animais MyD88KO. Deve-se destacar a diferen\u00e7a do n\u00famero de fungos \n\nobservados no f\u00edgado de animais deficientes e normais; os animais MyD88KO \n\napresentaram cerca de 6 log10 (1 milh\u00e3o de vezes) mais fungos que os camundongos \n\ncontrole. N\u00e3o houve dissemina\u00e7\u00e3o para o f\u00edgado dos animais WT neste tempo de \n\ninfec\u00e7\u00e3o. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 33. Avalia\u00e7\u00e3o do grau de infec\u00e7\u00e3o atrav\u00e9s de Unidades Formadoras de Col\u00f4nia (UFC). \nOs camundongos MyD88KO e WT foram infectados com 1x106 de leveduras do P. \nbrasiliensis pela via i.t.. O grau de infec\u00e7\u00e3o foi determinado ap\u00f3s 8 semanas de \ninfec\u00e7\u00e3o pela contagem de UFC.  O asterisco representa diferen\u00e7a estatisticamente \nsignificante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n8 Semanas\n\nPulm\u00e3o F\u00edgado Ba\u00e7o\n0\n\n1\n\n2\n\n3\n\n4\n\n5\n\n6\n\n7\n\n8\n\n*\n\nND\n\nU\nF\n\nC\n l\n\no\ng\n\n1\n0/\n\ng\n t\n\nec\nid\n\no *\n\n*\n\nWT MyD88KO WT\n\n\n\n 83 \n\n4.2.2.2.2 Dosagem de NO \n\n Na figura 34 temos a quantifica\u00e7\u00e3o de NO presente no macerado dos pulm\u00f5es, \n\nf\u00edgado e ba\u00e7o dos animais MyD88KO e WT ap\u00f3s 8 semanas de infec\u00e7\u00e3o. A dosagem foi \n\nfeita imediatamente ap\u00f3s a coleta do sobrenadante do macerado. Apesar da maior carga \n\nf\u00fangica nos pulm\u00f5es de animais MyD88KO, encontramos concentra\u00e7\u00f5es semelhantes \n\nde NO nos pulm\u00f5es de ambas as linhagens estudadas. Uma maior concentra\u00e7\u00e3o de NO \n\nfoi encontrada apenas no f\u00edgado do grupo de animais MyD88KO, comparando-se com o \n\ngrupo controle. N\u00e3o houve detec\u00e7\u00e3o de NO no ba\u00e7o de ambas as linhagens. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n \n \nFigura 34. Quantifica\u00e7\u00e3o de NO no homogenato dos pulm\u00f5es, f\u00edgado e ba\u00e7o de animais \n\nMyD88KO e WT.  Os animais foram infectados com 1x106 leveduras de \nP.brasiliensis inoculadas pela via i.t. e sacrificados ap\u00f3s 48 horas de infec\u00e7\u00e3o. Os \ndados representam a m\u00e9dia \u00b1 EP de 6 animais por grupo. O asterisco representa \ndiferen\u00e7a estatisticamente significante (*P<0,05). \n\n \n \n \n \n\n \n\n \n\n \n\n \n\n 8 semanas\n\nPulm\u00e3o F\u00edgado Ba\u00e7o\n0\n\n20\n\n40\n\n60\n\nWT MyD88KO\n\n*\n\nND   ND\n\nN\nit\n\nri\nto\n\n(m\nM\n\n)\n\n\n\n 84 \n\n4.2.2.2.3 Dosagem de citocinas  \n\nA figura 35 mostra a produ\u00e7\u00e3o de algumas citocinas no homogenato do pulm\u00e3o \n\nde camundongos ap\u00f3s 8 semanas de infec\u00e7\u00e3o com o P. brasiliensis. Pode-se verificar \n\nque camundongos de ambas as linhagens produziram n\u00edveis semelhantes de TNF-?, \n\nIFN-? e IL-6. Contudo, n\u00edveis menores de IL-12, IL-4, IL-5, IL-10, TGF-?, IL-17 e IL-\n\n23 foram encontrados no homogenato de pulm\u00e3o de animais MyD88KO quando \n\ncomparado ao grupo controle. A an\u00e1lise do homogenato do f\u00edgado revelou n\u00edveis \n\nmenores de IL-12, IL-4, IL-5, IL-10, TGF-?, IL-6, IL-17, IL-23 nos animais MyD88KO \n\ncomo demonstrado na figura 36.  A an\u00e1lise do homogenato de ba\u00e7o revelou n\u00edveis \n\nmenores de TNF-? em animais MyD88KO associado com n\u00edveis maiores de IL-10, \n\nquando comparado ao grupo controle (figura 37). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 35.  Quantifica\u00e7\u00e3o de TNF-?, IFN-? , IL-12, IL-4, IL-5, IL-10, TGF-?, IL-6, IL-17 e IL-\n23 em homogenato de pulm\u00e3o de animais MyD88KO e WT ap\u00f3s 8 semanas  de \ninfec\u00e7\u00e3o. O asterisco representa diferen\u00e7a estatisticamente significante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\nPul m\u00e3o\n\n?\n\nTN\nF-\n\n?\nIF\n\nN\n-\n\nIL\n-1\n\n2\nIL\n\n-4\nIL\n\n-5\nIL\n\n-1\n0 ?\n\nTG\nF- IL\n\n-6\nIL\n\n-1\n7\n\nIL\n-2\n\n3\n0\n\n100\n200\n300\n400\n500\n500\n\n2000\n\n3500\n\n5000\n\n*\n\n*\n\n*\n\n* *\n\n*\n\n*\n\np\ng\n\n/m\nL\n\nWT MyD88KO WT\n\n\n\n 85 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 36. Quantifica\u00e7\u00e3o de TNF-?, IFN-? , IL-12, IL-4, IL-5, IL-10, TGF-?, IL-6, IL-17 e IL-\n23 em homogenato de f\u00edgado de animais MyD88KO e WT ap\u00f3s 8 semanas  de \ninfec\u00e7\u00e3o.  O asterisco representa diferen\u00e7a estatisticamente significante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n \n \n \n \n \nFigura 37. Quantifica\u00e7\u00e3o de TNF-?, IFN-? , IL-12, IL-4, IL-5, IL-10, TGF-?, IL-6, IL-17 e IL-\n\n23 em homogenato de ba\u00e7o de animais MyD88KO e WT ap\u00f3s 8 semanas  de \ninfec\u00e7\u00e3o.  O asterisco representa diferen\u00e7a estatisticamente significante (*P<0,05). \n\n \n\n \n\nF\u00ed gado\n\n?\nTN\n\nF-\n?\n\nIF\nN\n\n-\nIL\n\n-1\n2\n\nIL\n-4\n\nIL\n-5\n\nIL\n-1\n\n0 ?\nTG\n\nF- IL\n-6\n\nIL\n-1\n\n7\nIL\n\n-2\n3\n\n0\n200\n400\n600\n800\n\n1000\n1000\n\n3000\n\n5000\n\n7000\n\n*\n\n*\n\n*\n\n* *\n\n*\n*\n\n*\n\npg\n/m\n\nL\n\nBa\u00e7o\n\n?\nTN\n\nF-\n?\n\nIF\nN\n-\n\nIL\n-1\n\n2\nIL\n\n-4\nIL\n\n-5\nIL\n\n-1\n0 ?\n\nTG\nF- IL\n\n-6\nIL\n\n-1\n7\n\nIL\n-2\n\n3\n0\n\n100\n200\n300\n400\n500\n500\n\n750\n\n1000\n\n1250\n\n1500\n\nWT MyD88KO\n\n*\n\n*\n\nND ND\n\np\ng\n/m\n\nL\n\nWT MyD88KO \n\n\n\n 86 \n\n4.2.2.2.4 Citometria de fluxo para caracteriza\u00e7\u00e3o de subpopula\u00e7\u00f5es celulares  \n\n        C\u00e9lulas infiltrantes dos pulm\u00f5es foram obtidas na oitava semana ap\u00f3s infec\u00e7\u00e3o. A \n\nconcentra\u00e7\u00e3o celular foi ajustada a 1x106 cels/mL e marcadas com Ac no titulo \n\npreviamente determinado e na combina\u00e7\u00e3o adequada para a popula\u00e7\u00e3o celular a ser \n\nestudada. Como observado na Figura 38, houve menor n\u00famero de c\u00e9lulas que \n\nexpressam CD11b no infiltrado celular dos animais MyD88KO, al\u00e9m de menor n\u00famero \n\nde c\u00e9lulas duplo-positivas CD11b+Iak+ e CD11b+CD40+ . N\u00e3o observamos diferen\u00e7as \n\nno n\u00famero de c\u00e9lulas CD11b+ que expressam CD80, TLR-2, TLR-4 e Dectina-1 entre as \n\nduas linhagens estudadas. \n\n            Em rela\u00e7\u00e3o \u00e0s popula\u00e7\u00f5es linfocit\u00e1rias observamos um menor n\u00famero de c\u00e9lulas \n\nT CD4, assim como um menor n\u00famero de c\u00e9lulas que expressam o marcador de \n\nativa\u00e7\u00e3o CD25 e de linf\u00f3citos duplo-positivas T CD4+CD25+ nas suspens\u00f5es celulares \n\nprovenientes de animais MyD88KO comparando-se com animais WT (Figura 39). O \n\nn\u00famero de linf\u00f3citos T CD8 e de linf\u00f3citos T CD8 ativados (CD8+CD69+) foi \n\nencontrado em n\u00famero semelhante nas duas linhagens estudadas. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 87 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 38. Caracteriza\u00e7\u00e3o do n\u00famero e express\u00e3o de marcadores de macr\u00f3fagos em Leuc\u00f3citos \nInfiltrantes de Pulm\u00e3o (LIP) por citometria de fluxo de animais MyD88KO e WT \nap\u00f3s 8 semanas  de infec\u00e7\u00e3o.  O asterisco representa diferen\u00e7a estatisticamente \nsignificante (*P<0,05). \n\n \n\n \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 39. Caracteriza\u00e7\u00e3o do n\u00famero e express\u00e3o de marcadores de linf\u00f3citos em Leuc\u00f3citos \nInfiltrantes de Pulm\u00e3o (LIP) por citometria de fluxo de animais MyD88KO e WT \nap\u00f3s 8 semanas  de infec\u00e7\u00e3o. O asterisco representa diferen\u00e7a estatisticamente \nsignificante (*P<0,05). \n\nMacr\u00f3fagos\n\n+\n\nCD\n11\n\nb\n+\n\nCD\n80\n\n+ \n\nCD\n11\n\nb\n\n+\n\nIa\nK\n\n+ \n\nCD\n11\n\nb\n\n+\n\nCD\n86\n\n+ \n\nCD\n11\n\nb\n\n+\n\nCD\n11\n\nb+\n C\n\nD4\n0\n\n+\n\nDe\ncti\n\nn-\n1\n\n+ \n\nCD\n11\n\nb\n\n+\n\nTL\nR-\n\n2\n\n+ \n\nCD\n11\n\nb\n\n+\n\nTL\nR-\n\n4\n\n+ \n\nCD\n11\n\nb\n\n0\n\n5\n\n10\n\n15\n\n20\n\n25\n\n*\n\n*\n\n*\nL\n\n I\n P\n\n (\nx \n\n10\n6  \n\nce\nls\n\n)\n\nLinf\u00f3citos\n\n+\n\nCD\n4\n\n+\n\nCD\n25\n\n+\n\n C\nD\n\n25\n\n+\n\nCD\n4\n\n+\n\nCD\n8\n\n+\n\nCD\n69\n\n+\n\n C\nD\n\n69\n\n+\n\nCD\n8\n\n0\n\n5\n\n10\n\n15\n\nWT MyD88KO\n\n*\n\n* *\n\nL\n I\n\n P\n (\n\nx \n10\n\n6\n c\n\nel\ns)\n\nWT MyD88KO WT \n\n\n\n 88 \n\n4.2.2.2.5 Caracteriza\u00e7\u00e3o morfol\u00f3gica das popula\u00e7\u00f5es celulares  \n\nC\u00e9lulas infiltrantes dos pulm\u00f5es foram obtidas na oitava semana ap\u00f3s a infec\u00e7\u00e3o. \n\nA concentra\u00e7\u00e3o celular foi ajustada a 2 x 104 c\u00e9lulas em 150 ul  de meio RPMI e \n\ncentrifugadas em Cytospin. As l\u00e2minas foram coradas e um total de 200 a 400 c\u00e9lulas \n\nforam contadas em cada amostra. Como observado na figura 40, n\u00famero semelhante de \n\nmacr\u00f3fagos e linf\u00f3citos foram observados nas suspens\u00f5es celulares provenientes de \n\nanimais MyD88KO e as do grupo controle. Por outro lado, animais MyD88KO \n\napresentaram menor afluxo de leuc\u00f3citos polimorfonucleares para os pulm\u00f5es (PMN). \n\n \n\n \n\n0\n\n20\n\n40\n\n60\n\n80\n\nWT MyD88KO\n\n  Macr\u00f3fagos       PMN            Li nf\u00f3ci tos\n\n*\n\nL\n I\n\n P\n %\n\n \nFigura 40. Caracteriza\u00e7\u00e3o morfol\u00f3gica das popula\u00e7\u00f5es celulares de Leuc\u00f3citos Infiltrantes de \n\nPulm\u00e3o (LIP) ap\u00f3s 8 semanas de infec\u00e7\u00e3o em animais MyD88KO e WT. Os dados \nrepresentam a m\u00e9dia \u00b1 EP de 6 animais por grupo. O asterisco representa diferen\u00e7a \nestatisticamente significante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 89 \n\n4.2.2.2.6 Caracteriza\u00e7\u00e3o da presen\u00e7a de c\u00e9lulas T reguladoras \n\nC\u00e9lulas infiltrantes dos pulm\u00f5es foram obtidas na oitava semana de infec\u00e7\u00e3o. A \n\nconcentra\u00e7\u00e3o celular foi ajustada a 1x106 cels/mL e marcadas com Ac (anti-CD4, CD25 \n\ne FoxP3) na titula\u00e7\u00e3o adequada.  Para determina\u00e7\u00e3o dos n\u00edveis intracelulares de Foxp3 \n\nas c\u00e9lulas foram permeabilizadas e o anticorpo pode fazer a marca\u00e7\u00e3o \n\nintracitoplasm\u00e1tica. Como observado na figura 41, houve menor express\u00e3o do fator de \n\ntranscri\u00e7\u00e3o  FoxP3, um t\u00edpico marcador de c\u00e9lula T reguladora (Treg), no infiltrado \n\ncelular de animais MyD88KO quando comparado ao grupo controle. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 41. An\u00e1lise da express\u00e3o de FoxP3 em c\u00e9lulas do exsudato inflamat\u00f3rio pulmonar de \ncamundongos MyD88KO e WT ap\u00f3s a oitava semana de infec\u00e7\u00e3o. A porcentagem \nde c\u00e9lulas que expressam FoxP3+ foi obtida a partir de um gate de popula\u00e7\u00f5es \ncelulares CD4+CD25+ e calculado em rela\u00e7\u00e3o ao total de linf\u00f3citos T CD4+ . O \nasterisco representa diferen\u00e7a estatisticamente significante (*P<0,05).  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n WT MyD88KO\n0\n\n2\n\n4\n\n6\n\n8 *\n\n%\n  C\n\nD\n4+\n\nC\nD\n\n2\n5+\n\nF\no\n\nx\nP\n\n3+\n\n\n\n 90 \n\n4.2.2.2.7 Sobrevida \n\n Grupos de 8 animais MyD88 deficientes e 8 animais WT foram infectados com \n\nleveduras vi\u00e1veis do P. brasiliensis e observados durante um per\u00edodo de 70 dias, sendo \n\nregistrado o tempo de sobrevida (em dias) para cada animal.  \n\n Como observado na figura 42, a mortalidade dos animais MyD88KO inicia-se \n\nno dia 2 e no dia 71 todos os 8 animais j\u00e1 estavam mortos. A mortalidade do grupo \n\ncontrole inicia-se no dia 12 e ap\u00f3s 71 dias 62% deste grupo ainda permaneciam vivos. \n\nA an\u00e1lise estat\u00edstica destes dados de sobrevida (m\u00e9todo de compara\u00e7\u00e3o de curvas de \n\nsobrevida pelo teste de Logrank) demonstrou que os animais MyD88KO apresentaram \n\nmenor tempo de sobrevida em rela\u00e7\u00e3o ao grupo controle (*P<0,05). \n\n \n\n \n\n \n\n0 10 20 30 40 50 60 70 80\n0\n\n20\n\n40\n\n60\n\n80\n\n100\nMyD88 KO\nC57 - WT\n\nDias\n\nS\no\n\nb\nre\n\nv\nid\n\na\n (\n\n%\n)\n\n*\n\n \n\nFigura 42. Tempo de sobrevida de camundongos MyD88KO e WT infectados pela via i.t. com \n1x106 leveduras vi\u00e1veis do P. brasiliensis (n = 8 camundongo/linhagem). A \nsobrevida dos animais foi acompanhada por 70 dias.  O asterisco representa \ndiferen\u00e7a estatisticamente significante (*P<0,05). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 91 \n\n4.2.2.2.8 An\u00e1lise histopatol\u00f3gica \n\nUma par\u00e2metro adicional de gravidade da doen\u00e7a foi obtido atrav\u00e9s da an\u00e1lise \n\nhistopal\u00f3gica dos pulm\u00f5es, f\u00edgado e ba\u00e7o de animais MyD88KO e WT infectados pela \n\nvia i.t. com 1x106 leveduras vi\u00e1veis do P. brasiliensis. Ap\u00f3s 8 semanas de infec\u00e7\u00e3o o \n\npulm\u00e3o esquerdo, o l\u00f3bulo menor f\u00edgado e metade do ba\u00e7o de cada camundongo foram \n\nremovidos e fixado em 10% de formalina e embebido em parafina. Sec\u00e7\u00f5es (5\u00b5 m) \n\nforam coradas com Hematoxilina e Eosina (H&amp;E) para an\u00e1lise das les\u00f5es e com a \n\ncolora\u00e7\u00e3o Groccot, para visualizar os fungos. Verificamos que ap\u00f3s 8 semanas de \n\ninfec\u00e7\u00e3o a an\u00e1lise das les\u00f5es de camundongos WT revelou uma pneumonia \n\npriogranulomatosa com les\u00f5es peribronquiolares, rico infiltrado linfoplasmoc\u00edtico e \n\neventual coaslesc\u00eancia. Os granulomas em geral foram bem delimitados com presen\u00e7a \n\nmoderada de fungos e espa\u00e7os alveolares ainda preservados (figura 43 A e B). Por outro \n\nlado, animais MyD88KO apresentaram les\u00f5es piogranulomatosas extensas e confluentes  \n\nocupando quase todo o par\u00eanquima pulmonar, assim como presen\u00e7a de \u00e1reas necr\u00f3ticas. \n\nEm alguns casos observamos completa consolida\u00e7\u00e3o do par\u00eanquima pulmonar sendo \n\nsubstitu\u00eddo por extensas les\u00f5es necr\u00f3ticas com ampla coloniza\u00e7\u00e3o f\u00fangica. As estruturas \n\nbronquiolares estavam comprometidas e apresentavam debris celulares, leuc\u00f3citos e rico \n\nagregado de fungos como demonstrado nas figuras 43 C e D. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nA                                                                                B \n\n\n\n 92 \n\n           \n\n \n\nC                                                                                 D \n\n                                      \n\n \n\nFigura 43. Fotomicrografias de les\u00f5es pulmonares de animais WT (A e B) e MyD88KO (C e \nD) ap\u00f3s 8 semanas de infec\u00e7\u00e3o com o fungo P. brasiliensis. H&amp;E ( A e C; 10x) e \nGroccot (B e D; 10x). \n\n \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n  \n\n \n\n \n\n\n\n 93 \n\nA an\u00e1lise histopatol\u00f3gica revelou que a estrutura hep\u00e1tica dos animais WT \n\nestava totalmente preservada e n\u00e3o foi observada a presen\u00e7a de fungos no f\u00edgado destes \n\nanimais (figuras 44 A e B). Por outro lado, a an\u00e1lise do f\u00edgado de animais MyD88KO \n\nrevelou a presen\u00e7a de extensas les\u00f5es piogranulomatosas em par\u00eanquima hep\u00e1tico. Os \n\ngranulomas confluentes apresentaram rico agregado f\u00fangico (figura 44 C e D).   \n\nA estrutura espl\u00eanica dos animais WT estava totalmente preservada e n\u00e3o foi \n\nobservada a  presen\u00e7a de fungos nas l\u00e2minas estudadas, apesar dos experimentos de \n\nUFC indicarem a presen\u00e7a de uma pequena carga f\u00fangica nestes animais (figura 45 A e \n\nB). A an\u00e1lise histopatol\u00f3gica do ba\u00e7o de animais MyD88KO revelou a presen\u00e7a de \n\nles\u00f5es piogranulomatosas espl\u00eanicas. Os granulomas confluentes apresentaram rico \n\nagregado f\u00fangico (figura 45 C e D).   \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 94 \n\n \n\n \n\nA                                                                    B \n\n       \n\n \n\nC                                                                    D \n\n       \n\n \nFigura 44. Fotomicrografias de les\u00f5es de f\u00edgado de animais WT (A e B) e MyD88KO (C e D) \n\nap\u00f3s 8 semanas de infec\u00e7\u00e3o com o fungo P. brasiliensis. H&amp;E ( A e C; 10x) e \nGroccot (B e D; 10x). \n\n \n\n \n\n \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 95 \n\n \n\n \n\nA                                                                                  B \n\n        \n\n \n\n \n\nC                                                                      D \n\n        \n\n \n \nFigura 45. Fotomicrografias de les\u00f5es de ba\u00e7o de animais WT (A e B) e MyD88KO (C e D) \n\nap\u00f3s 8 semanas de infec\u00e7\u00e3o com o fungo P. brasiliensis. H&amp;E ( A e C; 10x) e \nGroccot (B e D; 10x). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 96 \n\n \n\n \n\n5 Discuss\u00e3o \n\n Cada vez mais vem sendo demonstrada a import\u00e2ncia dos receptores da \n\nfam\u00edlia Toll-like no reconhecimento de diversos pat\u00f3genos. Os TLRs reconhecem \n\npadr\u00f5es moleculares de componentes biol\u00f3gicos associados ou n\u00e3o \u00e0 membrana de \n\npat\u00f3genos e conferem certa especificidade \u00e0 imunidade inata (HOFFMANN, 1999; \n\nADEREM et al., 2000). Os diferentes TLRs podem ter um diferente grau de \n\nimport\u00e2ncia no curso de uma infec\u00e7\u00e3o. Em infec\u00e7\u00f5es f\u00fangicas, por exemplo, o TLR-2 \u00e9 \n\nessencial para a imunidade inata frente ao Coccidiodes posadasii (VIRIYAKOSOL et \n\nal., 2004), por induzir a s\u00edntese de citocinas proinflamat\u00f3rias como IL-12, IL-6 e TNF-? \n\npor macr\u00f3fagos peritoneais. Trabalhando com Aspergillus fumigatus, Netea et al. (2003) \n\ndemonstraram que macr\u00f3fagos peritoneais de camundongos deficientes para o TLR-4 \n\nproduziram menores n\u00edveis de TNF-?, IL-1? e IL-1?, comparando-se com macr\u00f3fagos \n\nprovenientes de animais que expressam o TLR-4 funcional, quando estimulados com \n\ncon\u00eddios do fungo. Em outro trabalho, desta vez com Candida albicans, os mesmos \n\nautores demonstraram que o TLR-2 suprime a imunidade contra o fungo atrav\u00e9s da \n\nindu\u00e7\u00e3o de IL-10 e da expans\u00e3o de c\u00e9lulas T reguladoras (NETEA et al., 2004). \n\n  Trabalhando com camundongos TLR-2-/- e com seus controles WT \n\nobtivemos resultados que sugerem a participa\u00e7\u00e3o do TLR-2 no reconhecimento e \n\nativa\u00e7\u00e3o de macr\u00f3fagos perante o P. brasiliensis. A s\u00edntese de NO foi \n\nconsideravelmente menor nas culturas de macr\u00f3fagos peritoneais e alveolares de \n\ncamundongos da linhagem TLR-2-/- se comparado com a s\u00edntese de NO por macr\u00f3fagos \n\nprovenientes de camundongos WT. Este comportamento repetiu-se tanto nas culturas \n\ntratadas somente com IFN-? quanto nas culturas tratadas com a citocina e infectadas \n\ncom o fungo. \u00c9 conveniente ressaltar que nas culturas tratadas com o fungo a \n\nquantidade de NO foi maior, conforme esperado. \n\n Se macr\u00f3fagos de camundongos deficientes para TLR-2 t\u00eam menor \n\nquantidade de receptores para o fungo em sua membrana e os mesmos produziram \n\nn\u00edveis menores de NO em rela\u00e7\u00e3o aos macr\u00f3fagos de camundongos normais, pode-se \n\nsugerir que houve, no primeiro grupo, uma menor intera\u00e7\u00e3o receptor-fungo e \n\nconseq\u00fcentemente, est\u00edmulos menos eficientes para induzir a s\u00edntese de NO. Hoje \n\nsabemos que os TLRs n\u00e3o est\u00e3o ligados diretamente com a s\u00edntese de NO, contudo, \u00e9 \n\n\n\n 97 \n\nconhecida uma coopera\u00e7\u00e3o entre receptores de membrana de v\u00e1rias fam\u00edlias, entre eles \n\nos TLRs. Esta coopera\u00e7\u00e3o poderia ativar a atividade microbicida dos macr\u00f3fagos, assim \n\ncomo a s\u00edntese de NO. Realmente, rabalhos recentes relatam a coopera\u00e7\u00e3o entre TLRs e \n\noutros receptores de imunidade inata. O contato de pat\u00f3genos com o hospedeiro envolve \n\nm\u00faltiplos PAMPs e seus cognatos receptores de reconhecimento padr\u00e3o (PRRs). \u00c9 a \n\nintera\u00e7\u00e3o complexa das respostas mediadas por estes receptores, que dirige a resposta \n\ninata resultante e, finalmente, o desenvolvimento da imunidade adaptativa especifica \n\npara este pat\u00f3geno (TRINCHIERI e SHER, 2007). Nos macr\u00f3fagos, a sinaliza\u00e7\u00e3o \n\ncooperativa entre dectina-1 e TLR-2 mostrou-se necess\u00e1ria para a indu\u00e7\u00e3o de TNF-? em \n\nresposta a infec\u00e7\u00f5es f\u00fangicas. Este foi o primeiro trabalho a demonstrar a intera\u00e7\u00e3o \n\nentre um TLR e receptores n\u00e3o-TLR (BROWN, 2006; GANTNER et al., 2003). \n\nEmbora dectina-1 apresente uma habilidade espec\u00edfica direta na indu\u00e7\u00e3o da produ\u00e7\u00e3o de \n\ncitocinas em macr\u00f3fagos e DCs, como descrito acima, dectina-1 pode tamb\u00e9m interagir \n\ncom outros TLRs-MyD88 acoplados (TLR-2, TLR-4, TLR - 5, TLR7, TLR-9), \n\nresultando na indu\u00e7\u00e3o sin\u00e9rgica de v\u00e1rias citocinas, incluindo TNF-?, IL-10, IL-6 e IL-\n\n23 (DENNEHY et al., 2008; FERWERDA et al., 2008).   \n\n \n\n Os dados de UFC e ensaio de fagocitose ap\u00f3iam a hip\u00f3tese de menor \n\nativa\u00e7\u00e3o em macr\u00f3fagos de animais TLR-2-/-. O n\u00famero de fungos recuperados foi \n\nconsideravelmente menor nas culturas de macr\u00f3fagos de camundongos deficientes, \n\nassim como foi menor o n\u00famero de macr\u00f3fagos com fungos fagocitados e/ou aderidos. \n\nMais uma vez, pode-se sugerir que houve uma menor intera\u00e7\u00e3o hospedeiro-fungo \n\ndevido \u00e0 menor oferta de receptores do tipo Toll na membrana dos fag\u00f3citos e, \n\nconseq\u00fcentemente, menor foi o n\u00famero de fungos reconhecidos e fagocitados. Nas \n\nculturas pr\u00e9-ativadas com IFN-? e infectadas com o fungo, o n\u00famero de fungos \n\nrecuperados foi significativamente menor em rela\u00e7\u00e3o \u00e0s culturas somente infectadas. \n\nEstes dados sugerem que o IFN-? adicionado levou a um aumento da atividade \n\nfungicida por parte dos macr\u00f3fagos, que pode ser explicada pela maior concentra\u00e7\u00e3o de \n\nNO e eventualmente alguma outra subst\u00e2ncia fungicida produzida pelos macr\u00f3fagos. \n\nEste n\u00famero menor de fungos era esperado, pois os macr\u00f3fagos estavam estimulados \n\ncom os dois sinais necess\u00e1rios para sua ativa\u00e7\u00e3o (TUEHR e MARLETTA, 1987).  \n\n  Na PCM h\u00e1 trabalhos (CANO et al., 1998; GONZALEZ, et al., 2000) \n\nque demonstram que o NO \u00e9 mol\u00e9cula essencial e importante para a atividade fungicida \n\n\n\n 98 \n\nde macr\u00f3fagos de camundongos. Nossos resultados parecem estar de acordo com estes \n\nestudos. Por\u00e9m, os n\u00edveis mais elevados de NO produzidos por macr\u00f3fagos TLR-2 \n\nnormais n\u00e3o foram suficientes para conter o fungo, comparando-se aos macr\u00f3fagos \n\ndeficientes, que produzem menos NO, mas apresentam um n\u00famero de menor de fungos \n\nrecuperados. Este dado fala a favor da hip\u00f3tese de que os macr\u00f3fagos deficientes s\u00e3o \n\nmenos ativados e por isso fagocitam n\u00fameros menores de leveduras. \n\n Como maiores n\u00edveis de NO n\u00e3o foram suficientes para conter o fungo, em \n\nfuturos experimentos, inibiremos a s\u00edntese deste g\u00e1s e avaliaremos o comportamento \n\ndos macr\u00f3fagos de ambas as linhagens em rela\u00e7\u00e3o ao n\u00famero de UFC. Mais uma vez \n\nfica evidenciado que mecanismos independentes de NO s\u00e3o capazes de controlar o \n\ncrescimento do P. brasiliensis. Em trabalho realizado em nosso laborat\u00f3rio \n\nBERNARDINO (2005) demonstra que camundongos iNOS-KO apresentam doen\u00e7a \n\nmenos grave  na segunda semana de infec\u00e7\u00e3o, comparando-se com camundongos que \n\nexpressam iNOS funcional. Temos ent\u00e3o, outro trabalho que sugere outros mecanismos \n\ncapazes de controlar o fungo. Vale lembrar tamb\u00e9m que os dados obtidos com rela\u00e7\u00e3o \n\nao ensaio de fagocitose, UFC e produ\u00e7\u00e3o de NO com animais TLR-2-/- e WT s\u00e3o \n\nbastante semelhantes \u00e0queles que encontramos quando trabalhamos com animais \n\ndeficientes para o TLR-4 (CALICH et al., 2008; LOURES et al., 2010). \n\n Os n\u00edveis de algumas das citocinas analisadas foram diferentes entre as duas \n\nlinhagens estudadas. A produ\u00e7\u00e3o de IL-10 e MCP-1 foi menor no sobrenadante das \n\nculturas de macr\u00f3fagos de animais deficientes para o TLR-2, comparada \u00e0 produ\u00e7\u00e3o das \n\nculturas de macr\u00f3fagos que expressam o TLR-2 funcional. N\u00e3o houve diferen\u00e7a na \n\nprodu\u00e7\u00e3o de IL-12 entre as duas linhagens e, em rela\u00e7\u00e3o \u00e0 produ\u00e7\u00e3o de IL-6, \n\nobservamos que animais TLR-2-/- produziram menores n\u00edveis desta citocina, por\u00e9m a \n\nprodu\u00e7\u00e3o j\u00e1 era menor em animais deficiente no grupo controle, ou seja, em macr\u00f3fagos \n\nque n\u00e3o foram infectados com o fungo. \n\n A menor produ\u00e7\u00e3o de IL-6 e de MCP-1 (quimiocina envolvida no \n\nrecrutamento de c\u00e9lulas mononucleadas para o local da infec\u00e7\u00e3o) por animais TLR-2 \n\ndeficientes leva a supor que talvez a presen\u00e7a destas citocinas pudesse ser associada a \n\numa doen\u00e7a mais grave. Entretanto, verificamos que houve maior recupera\u00e7\u00e3o de UFC \n\nde macr\u00f3fagos TLR-2 normais, sugerindo que a ativa\u00e7\u00e3o por estas citocinas e a maior \n\nprodu\u00e7\u00e3o de NO n\u00e3o foi suficiente para matar os fungos em co-cultivo com macr\u00f3fagos \n\nin vitro. \u00c9 bem poss\u00edvel que existam outros mecanismos que controlem o n\u00famero de \n\n\n\n 99 \n\nfungos ou outra hip\u00f3tese \u00e9 que a presen\u00e7a do TLR-2 possa culminar em ingest\u00e3o de \n\ngrande n\u00famero de fungos, comparado com a ingest\u00e3o de fungos por macr\u00f3fagos TLR-2 \n\ndeficientes, hip\u00f3tese esta corroborada pelo ensaio de fagocitose. Deste modo, mesmo \n\nproduzindo maiores quantidades de citocinas ativadoras e de NO, o macr\u00f3fago do \n\nanimal TLR-2 normal n\u00e3o foi capaz de controlar o n\u00famero de fungos ingeridos. \n\n Os experimentos de UFC feitos a partir do macerado do pulm\u00e3o em tempo \n\ncurto de infec\u00e7\u00e3o (48 horas) est\u00e3o de acordo com os dados obtidos in vitro, uma vez que \n\no n\u00famero de fungos recuperados foi maior nos pulm\u00f5es dos animais WT, confirmando \n\nassim os experimentos in vitro. Os dados de produ\u00e7\u00e3o de NO tamb\u00e9m est\u00e3o de acordo \n\ncom os experimentos in vitro, uma vez que foram observados maiores n\u00edveis de NO no \n\nhomogenato de pulm\u00e3o de animais normais para o TLR-2. Tal comportamento tamb\u00e9m \n\nfoi observado quando trabalhamos com animais deficientes para o TLR-4 (CALICH et \n\nal., 2008; LOURES et al., 2010). \n\n Em rela\u00e7\u00e3o \u00e0 s\u00edntese de citocinas, ainda observando o tempo curto de \n\ninfec\u00e7\u00e3o, verificamos que animais TLR-2 deficientes e normais produziram n\u00edveis \n\nsemelhantes das citocinas Th1 (IL-12, IFN-?, IL-2 e TNF-?) e Th2 (IL-10, IL-4 e IL-5). \n\nContudo, em rela\u00e7\u00e3o \u00e0s citocinas associadas ao padr\u00e3o de resposta imune Th17 (IL-6, \n\nIL-17, IL-23 e TGF-?) encontramos n\u00edveis maiores de IL-23, IL-17 e TGB-? no \n\nhomogenato de pulm\u00e3o de animais TLR-2-/-. \n\n Ao trabalhar com tempo longo de infec\u00e7\u00e3o (2 e 11 semanas), encontramos \n\numa doen\u00e7a menos grave nos animais deficientes para o TLR-2, que apresentaram uma \n\ncarga f\u00fangica pulmonar consideravelmente menor que os animais TLR-2 normais. Estes \n\ndados reproduzem os resultados de UFC obtidos em experimentos in vitro e em tempo \n\ncurto de infec\u00e7\u00e3o: um n\u00famero menor de fungos foi recuperado de macr\u00f3fagos de \n\nanimais TLR-2 deficientes.  Em rela\u00e7\u00e3o \u00e0 s\u00edntese citocinas verificamos que os animais  \n\nTLR-2-/- e normais produziram n\u00edveis semelhantes de citocinas Th1 e Th2 na segunda \n\nsemana de infec\u00e7\u00e3o. Contudo, n\u00edveis menores de IL-10 e IL-12 foram observados no \n\nhomogenato do pulm\u00e3o de animais TLR-2-/- ap\u00f3s 11 semanas de infec\u00e7\u00e3o. Em rela\u00e7\u00e3o \n\n\u00e0s citocinas Th17, observamos mais uma vez, n\u00edveis maiores nos animais TLR-2-/-. Isso \n\nocorreu com todas as citocinas estudas na segunda semana e com a citocina IL-23, ap\u00f3s \n\n11 semanas de infec\u00e7\u00e3o. \n\n\n\n 100 \n\nObservamos ent\u00e3o, in vitro e in vivo, que o TLR-2 est\u00e1 relacionado com a \n\ns\u00edntese de IL-10. Outros autores j\u00e1 haviam demonstrado esta rela\u00e7\u00e3o, Ferreira et al. \n\n(2008), por exemplo, relataram que a intera\u00e7\u00e3o entre o P. brasiliensis e c\u00e9lulas \n\ndendr\u00edticas de camundongos resultou no aumento da express\u00e3o de TLR-2 concomitante \n\ncom maiores n\u00edveis de IL-10. Em outro trabalho, os autores relataram que em \n\ncamundongos deficientes para galactina 3 e infectados com o P. brasiliensis foi \n\nobservado um aumento nos transcritos para o TLR-2 e aumento nos n\u00edveis de IL-10 em \n\nmacr\u00f3fagos (RUAS et al., 2009).  \n\nAl\u00e9m disso, o estudo das citocinas em resposta a infec\u00e7\u00e3o pelo fungo P. \n\nbrasiliensis nos revelou que os animais TLR-2-/- apresentaram maiores n\u00edveis de \n\ncitocinas que est\u00e3o relacionadas com o padr\u00e3o de resposta imune Th17 quando \n\ncomparados \u00e0 produ\u00e7\u00e3o destas citocinas no pulm\u00e3o dos animais TLR-2-normais.  \n\n A IL-17 \u00e9 uma citocina recentemente descrita e largamente produzida por \n\numa subpopula\u00e7\u00e3o de linf\u00f3citos T CD4+ ativados; entretanto a IL-17 \u00e9 conhecida \n\ntamb\u00e9m a sua atividade reguladora da imunidade inata e na defesa contra parasitas. Uma \n\ndas atividades reconhecidas \u00e9 a mobiliza\u00e7\u00e3o de neutr\u00f3filos para s\u00edtios inflamat\u00f3rios \n\natrav\u00e9s da indu\u00e7\u00e3o da produ\u00e7\u00e3o de quimiocinas, como as CXC, quimiocinas cujas \n\nciste\u00ednas terminais s\u00e3o espa\u00e7adas por um amino\u00e1cido e que t\u00eam a\u00e7\u00e3o preferencialmente \n\nsobre leuc\u00f3citos PMN (KOLLS &amp; LINDES, 2004; MIYAMOTO et al., 2003; \n\nSTOCKINGER et al., 2007). A citocina IL-23, da mesma forma que a IL-12, \u00e9 membro \n\nda fam\u00edlia das citocinas proinflamat\u00f3rias. Compartilham a cadeia pept\u00eddica p40, \n\nenquanto que as cadeias p35 e p19 s\u00e3o especificamente da IL-12 e IL-23, \n\nrespectivamente. Enquanto que ambas as citocinas induzem a produ\u00e7\u00e3o de IFN-? em \n\nlinf\u00f3citos T CD4+, a IL-23, embora n\u00e3o envolvida na expans\u00e3o de c\u00e9lulas Th17, tem \n\numa importante fun\u00e7\u00e3o na manuten\u00e7\u00e3o na fun\u00e7\u00e3o efetora Th17 (BETTELLI, et al., \n\n2006; STOCKINGER et al., 2007). Trabalhos recentes t\u00eam demonstrado que as \n\ncitocinas IL-17/IL-23 t\u00eam uma importante fun\u00e7\u00e3o na defesa contra fungos. Zelante et al. \n\n(2007) demonstraram que estas citocinas atuam como reguladores negativos da resposta \n\nTh1 promovida por fungos, particularmente Candida albicans e Aspergilus fumigatus. \n\nAl\u00e9m disso, promove uma inflama\u00e7\u00e3o rica em neutr\u00f3filo (IL-17) e regula a atividade \n\nmicrobicida destas c\u00e9lulas (IL-23). Em adi\u00e7\u00e3o, em recente trabalho, Bozza et al., (2008) \n\ndemonstraram que a perda do Toll IL-1R8 exarceba a resposta Th17 em resposta a \n\ninfec\u00e7\u00f5es f\u00fangicas. \n\n\n\n 101 \n\nEm revis\u00e3o publicada por Cua e Kastelein, 2006, os autores relataram que na \n\ninfec\u00e7\u00e3o em mucosa de roedores por Citrobacter rodentium (MANGAN et al., 2006) ou \n\nna infec\u00e7\u00e3o pulmonar por Klebisiela pneumoniae (HAPPEL et al., 2003), o \n\ndesenvolvimento da resposta imune Th17 acontece prevalentemente no in\u00edcio da \n\ninfec\u00e7\u00e3o. Em tempos tardios, os animais foram deixando de ter uma resposta \n\npredominantemente Th17 e passaram a ter uma reposta Th1 ou Th2. Durante a \n\nhomeostase, altos n\u00edveis de TGF-? aliados a baixos n\u00edveis de IL-6 e IL-23 promovem o \n\npredom\u00ednio de c\u00e9lulas Treg que, por sua vez, suprimem a resposta Th1 e Th2. Em \n\nest\u00e1gios iniciais da infec\u00e7\u00e3o, c\u00e9lulas dendr\u00edticas produzem altos n\u00edveis de IL-6 e IL-23 \n\nvia ativa\u00e7\u00e3o por TLRs. Nesta etapa, a IL-6 inibe a diferencia\u00e7\u00e3o e atividade das c\u00e9lulas \n\nTreg; em a\u00e7\u00e3o concomitante, altas concentra\u00e7\u00f5es de IL-6 e TGF-? estimulam a \n\ndiferencia\u00e7\u00e3o de linf\u00f3citos TCD4 em c\u00e9lulas Th17. Al\u00e9m disso, a IL-23 promove a \n\nprolifera\u00e7\u00e3o das c\u00e9lulas Th17 e contribui com a manuten\u00e7\u00e3o das fun\u00e7\u00f5es inflamat\u00f3rias \n\ndesta resposta. Contudo, em fases tardias das infec\u00e7\u00f5es, c\u00e9lulas Th1 e Th2, provenientes \n\ndo ba\u00e7o e linfonodo, comandam o clearance final da infec\u00e7\u00e3o. Produzem IFN-? e IL-4, \n\nrespectivamente, citocinas que inibem a diferencia\u00e7\u00e3o e fun\u00e7\u00e3o Th17.  \n\nO mesmo fen\u00f4meno parece ter ocorrido em nosso modelo experimental; ap\u00f3s 11 \n\nsemanas de infec\u00e7\u00e3o n\u00e3o observamos mais o padr\u00e3o Th17 nos animais TLR-2KO. \n\nAmbas as linhagens produziram semelhantes n\u00edveis de citocinas Th1, Th2 e Th17 neste \n\ntempo de infec\u00e7\u00e3o. Com exce\u00e7\u00e3o da citocina IL-23, que continua em n\u00edveis maiores nos \n\nanimais TLR-2KO ap\u00f3s 11 semanas de infec\u00e7\u00e3o e da citocina IL-12, que aparece em \n\nn\u00edveis reduzidos nestes animais. Neste tempo de infec\u00e7\u00e3o n\u00e3o observamos um padr\u00e3o \n\ndefinido de resposta imune. Assim, de modo geral, podemos concluir que na aus\u00eancia \n\ndo receptor TLR-2 observamos um padr\u00e3o de resposta Th17 e podemos sugerir ent\u00e3o \n\nque a presen\u00e7a do TLR-2 inibe a resposta Th17. \n\n Embora a produ\u00e7\u00e3o de IL-17 seja usualmente associada com uma subpopula\u00e7\u00e3o \n\nTh17 de linf\u00f3citos T CD4+ (YAO et al., 1995; ZELANTE et al., 2007; KORN et al, \n\n2009; MILLS, 2008) ou TCD8+ (SUTTON et al., 2006; HAPPEL et al., 2003; MILLS, \n\n2008), alguns trabalhos v\u00eam descrevendo a produ\u00e7\u00e3o desta citocina por outras c\u00e9lulas \n\ndo sistema imune inato como linf\u00f3citos  ? ?? (ROMANI et al., 2008), c\u00e9lulas \n\ndendr\u00edticas (DE LUCA et al., 2007; ZELANTE et al., 2007; BOZA et al., 2008) \n\nleuc\u00f3citos PMNs (FERRETI et al., 2003; ROMANI et al., 2008) e at\u00e9 linf\u00f3citos NKT \n\n(MICHEL et al., 2007; MICHEL et al., 2008). Com estas informa\u00e7\u00f5es, caracterizamos \n\n\n\n 102 \n\npor citometria de fluxo quais subpopula\u00e7\u00f5es celulares foram respons\u00e1veis pela produ\u00e7\u00e3o \n\nde IL-17 na infec\u00e7\u00e3o pelo P. brasiliensis. Nossos resultados indicaram que a produ\u00e7\u00e3o \n\nde IL-17 foi predominante por linf\u00f3citos TCD4. Foi observada uma maior porcentagem \n\nde c\u00e9lulas TCD4 produtoras de IL-17 nos animais TLR-2-/- quando comparadas \u00e0 \n\nprodu\u00e7\u00e3o dos linf\u00f3citos de animais TLR-2-normais. Quando determinamos o n\u00famero \n\nabsoluto de c\u00e9lulas, verificamos que tamb\u00e9m nos animais TLR-2-/- linf\u00f3citos TCD4+IL-\n\n17+ ocorreram em maior n\u00famero. Observamos tamb\u00e9m nos camundongos TLR-2-/- uma \n\nmaior porcentagem de linf\u00f3citos TCD8+IL-17+, por\u00e9m quando analisamos o n\u00famero \n\nabsoluto de c\u00e9lulas que migraram para o pulm\u00e3o, verificamos que ambas as linhagens \n\napresentaram n\u00fameros semelhantes destas c\u00e9lulas. Assim, podemos concluir que na \n\naus\u00eancia do TLR-2 houve uma predomin\u00e2ncia da resposta imune Th17. \n\n  Diversos trabalhos v\u00eaem relacionando o afluxo de neutr\u00f3filos para o s\u00edtio \n\ninflamat\u00f3rio de infec\u00e7\u00f5es que desenvolveram um padr\u00e3o de resposta imune Th17 (LEY \n\net al., 2006; WU et al., 2007; LIANG et al., 2007). Muitas vezes este afluxo est\u00e1 \n\nrelacionado com produ\u00e7\u00e3o de altos n\u00edveis de KC, uma quimiocina CXC envolvida na \n\nquimiotaxia de neutr\u00f3filos (CARLSON et al., 2008; KOBAYASHI, 2008). A \n\nassocia\u00e7\u00e3o da produ\u00e7\u00e3o de IL-17 e afluxo de PMN para o local da infec\u00e7\u00e3o vem sendo \n\ndescrita em diversas infec\u00e7\u00f5es como, por exemplo, pneumonia bacteriana (YE et al., \n\n2001), inflama\u00e7\u00e3o cr\u00f4nica dos pulm\u00f5es (LINDEN et al., 2005) e infec\u00e7\u00f5es f\u00fangicas \n\n(COOPER, 2007; ZELANTE et al., 2007).  \n\n Estes dados est\u00e3o de acordo com o encontrado em nosso modelo, os animais \n\nTLR-2-/- que desenvolveram uma resposta Th17 concomitante com afluxo de neutr\u00f3filo \n\npara os pulm\u00f5es, tamb\u00e9m apresentaram maiores concentra\u00e7\u00f5es da quimiocina KC no \n\nhomogenato do pulm\u00e3o ap\u00f3s 2 e 11 semanas de infec\u00e7\u00e3o com o P. brasiliensis.  \n\n Os resultados de afluxo de c\u00e9lulas para os pulm\u00f5es indicaram que a menor carga \n\nf\u00fangica nos pulm\u00f5es destes animais estava associada com um maior afluxo de \n\nneutr\u00f3filos para o local da infec\u00e7\u00e3o nos animais KO. Tais resultados indicaram a \n\npossibilidade dos neutr\u00f3filos serem os respons\u00e1veis, ao menos parcialmente, pelo \n\ncontrole da carga f\u00fangica pulmonar nos animais TLR-2-/-. Os experimentos com \n\ndeple\u00e7\u00e3o de neutr\u00f3filos elucidaram esta quest\u00e3o. Quando animais TLR-2-normais e \n\ndeficientes foram tratados com AcM anti-PMN houve aumento da carga f\u00fangica \n\npulmonar somente nos animais TLR-2-/-, ou seja, somente neste grupo de animais a \n\npresen\u00e7a dos neutr\u00f3filos foi importante, parcialmente, para o controle da carga f\u00fangica. \n\n\n\n 103 \n\nAcreditamos ainda, que somente o n\u00famero e n\u00e3o o estado intr\u00ednseco de ativa\u00e7\u00e3o dos \n\nneutr\u00f3filos esteja contribuindo para o controle da carga f\u00fangica. Experimentos em que \n\navaliamos a atividade fungicida dos neutr\u00f3filos peritoneais e alveolares revelaram que \n\nneutr\u00f3filos de ambas as linhagens estudadas possuem a mesma habilidade em matar o \n\nfungo. Assim, o efeito dos leuc\u00f3citos PMN pode ser atribu\u00eddo \u00e0 sua presen\u00e7a em maior \n\nn\u00famero no s\u00edtio da infec\u00e7\u00e3o e n\u00e3o a uma maior habilidade intr\u00ednseca de matar o P. \n\nbrasiliensis. Estes dados est\u00e3o de acordo com os encontrados na literatura. Como \n\nexemplo, trabalhando com Candida albicans, Huang et al. (2004) verificaram que \n\ncamundongos desenvolveram uma candidiase sist\u00eamica grave associada com a \n\nprodu\u00e7\u00e3o deficiente de IL-17 e menor afluxo de neutr\u00f3filos para os \u00f3rg\u00e3os infectados, \n\nou seja, evidenciaram o papel protetor dos neutr\u00f3filos e a sua contribui\u00e7\u00e3o no controle \n\nda carga f\u00fangica.  \n\nComo vem sendo descrito em outros modelos em que predomina a imunidade \n\nTh17, acreditamos que os leuc\u00f3citos PMNs exer\u00e7am um duplo efeito na \n\nparacoccidioidomicose.  A prote\u00e7\u00e3o garantida pelo maior afluxo neutr\u00f3filos e a eficiente \n\nhabilidade em controlar a carga f\u00fangica pulmonar pode estar provavelmente \n\nacompanhada por danos do tecido pulmonar causado pela a\u00e7\u00e3o de enzimas produzidas \n\npelos neutr\u00f3filos como elastases, metaloproteinases e mieloperoxidases (ZELANTE et \n\nal., 2007; ROMANI et al., 2008; LINDEN et al., 2005; IVANOV et al., 2007). \n\nApesar da menor carga f\u00fangica pulmonar, nossos dados em conjunto sugerem \n\nque a resposta Th17 e os leuc\u00f3citos PMN possam exercer um efeito delet\u00e9rio nos \n\npulm\u00f5es dos animais TLR-2-/-. A menor carga f\u00fangica nesses animais estava \n\nacompanhada por les\u00f5es t\u00e3o graves quanto aquelas apresentadas pelos animais controle. \n\nEm ambos as linhagens, rea\u00e7\u00f5es inflamat\u00f3rias n\u00e3o organizadas foram observadas por \n\ntodo par\u00eanquima pulmonar sugerindo que a alta carga f\u00fangica (desenvolvida pelos \n\nanimais WT) ou a prevalente imunidade Th17 (desenvolvida pelos animais TLR-2-/-) \n\nprovocaram efeitos delet\u00e9rios similares nos pulm\u00f5es dos animais quando infectados \n\npelo P. brasiliensis. Deste modo, na aus\u00eancia do TLR-2, os animais desenvolveram uma \n\nresposta Th17, que apesar de induzir uma carga f\u00fangica menor, apresentou les\u00f5es \n\npulmonares graves. Assim, uma menor carga f\u00fangica provocou efeitos delet\u00e9rios t\u00e3o \n\ngraves quanto aqueles provocados por uma carga f\u00fangica maior nos animais TLR-2 \n\nnormais. Podemos concluir, ent\u00e3o, que o receptor TLR-2, al\u00e9m de inibir a resposta \n\nTh17, regula negativamente a patologia pulmonar. \n\n\n\n 104 \n\nO desenvolvimento de uma resposta imune Th17 na aus\u00eancia do TLR-2 sugere \n\nque o fungo P. brasilienses, assim como outros pat\u00f3genos, pode interagir como uma \n\ngama de outros receptores. Outros TLRs (CALICH et al., 2008; LOURES et al., 2010), \n\nreceptores de manose (JIMENEZ et al., 2006) ou at\u00e9 mesmo o dectina-1 (DINIZ et al., \n\n2004) podem associar-se ao fungo, ativar macr\u00f3fagos e induzir uma resposta imune que \n\nelimine o pat\u00f3geno. Para exemplificar, trabalhos recentes t\u00eam demonstrado que o \n\nreceptor det\u00e9m-1 ao ser ativado pelo agonista curdlan culmina com uma cascata de \n\nsinaliza\u00e7\u00e3o dependente da mol\u00e9cula adaptadora CARD9 e \u00e9 MyD88 independente, ou \n\nseja, n\u00e3o h\u00e1 participa\u00e7\u00e3o de TLRs na ativa\u00e7\u00e3o celular; esta ativa\u00e7\u00e3o culmina com a \n\nprodu\u00e7\u00e3o de IL-23 e indu\u00e7\u00e3o, portanto, de um padr\u00e3o de resposta Th17 \n\n(LEIBUNDGUT-LANDMANN et al., 2007; PALM e MEDHITOV, 2007).  \n\nA despeito da diferen\u00e7a da carga f\u00fangica pulmonar encontrada entre as duas \n\nlinhagens estudadas, analisamos as sub-popula\u00e7\u00f5es de linf\u00f3citos infiltrantes de pulm\u00e3o \n\nde animais TLR-2-/- e WT, assim como o perfil fenot\u00edpico de macr\u00f3fagos alveolares, \n\ntanto na fase aguda como na fase cr\u00f4nica da infec\u00e7\u00e3o. Na segunda semana de infec\u00e7\u00e3o \n\nn\u00e3o observamos diferen\u00e7as na popula\u00e7\u00e3o leucocit\u00e1ria infiltrante nos pulm\u00f5es em ambas \n\nas linhagens estudadas. Na d\u00e9cima primeira semana de infec\u00e7\u00e3o, houve menor n\u00famero \n\nde linf\u00f3citos CD4+ e CD8+ nos animais TLR-2-/-, assim como, menor express\u00e3o de \n\nmarcadores de ativa\u00e7\u00e3o CD25+ e CD69+. Assim, verificamos que a presen\u00e7a do TLR-2 \n\nparticipa na determina\u00e7\u00e3o do infiltrado pulmonar rico em linf\u00f3citos T ativados; \n\nentretanto, a maior afluxo e ativa\u00e7\u00e3o de linf\u00f3citos est\u00e1 associado com maior carga \n\nf\u00fangica. Em recente trabalho, nosso laborat\u00f3rio caracterizou o papel dos linf\u00f3citos \n\nTCD4+ no padr\u00e3o de susceptibilidade e resist\u00eancia \u00e0 infec\u00e7\u00e3o pelo P. brasiliensis. Em \n\nanimais resistentes (A/J) a deple\u00e7\u00e3o dessas c\u00e9lulas gerava resposta suprimida de HTT \n\n(hipersensibilidade do tipo tardio) nas 4\u00ba e 8\u00ba semana de infec\u00e7\u00e3o, diminui\u00e7\u00e3o da \n\nprodu\u00e7\u00e3o de anticorpos IgG2a, IgG1 e IgG2b e dos n\u00edveis de IL-2. Entretanto, a \n\naus\u00eancia destes linf\u00f3citos pouco alterava a carga f\u00fangica pulmonar e n\u00e3o diminu\u00eda a \n\nsobrevida desses animais. Nos animais suscept\u00edveis, entretanto, a deple\u00e7\u00e3o de linf\u00f3citos \n\nT CD4+ n\u00e3o alterou o curso da doen\u00e7a (CHIARELLA et al., 2007). \n\nA avalia\u00e7\u00e3o de c\u00e9lulas TCD8 (linf\u00f3citos T citot\u00f3xicos) durante a d\u00e9cima \n\nprimeira semana de infec\u00e7\u00e3o comportou-se de modo semelhante \u00e0quela dos linf\u00f3citos \n\nTCD4; obtivemos expressiva diminui\u00e7\u00e3o dessas c\u00e9lulas no animais TLR-2-/- e, ainda \n\nmais, os linf\u00f3citos nesses animais estavam menos ativados (TCD8+CD69+). Podemos \n\n\n\n 105 \n\nent\u00e3o supor que a maior freq\u00fc\u00eancia  e ativa\u00e7\u00e3o de linf\u00f3citos TCD8 nos animais WT, n\u00e3o \n\nfoi capaz, assim como os linf\u00f3citos TCD4, de controlar a carga f\u00fangica pulmonar \n\npresente no pulm\u00e3o destes animais. Assim, a presen\u00e7a do TLR-2 determina o maior \n\nafluxo e ativa\u00e7\u00e3o de linf\u00f3citos TCD8, contudo, isso n\u00e3o foi capaz de conter a carga \n\nf\u00fangica pulmonar. O papel dessas c\u00e9lulas citot\u00f3xicas efetoras baseia-se na produ\u00e7\u00e3o de \n\nsubst\u00e2ncias citot\u00f3xicas como as perforinas e granzimas que atuam destruindo c\u00e9lulas \n\ninfectadas, reduzindo o foco infeccioso (WHERRY et al., 2003). Trabalho recente \n\ndesenvolvido em nosso laborat\u00f3rio mostrou que a deple\u00e7\u00e3o de linf\u00f3citos TCD8 gerou \n\naumento da carga f\u00fangica pulmonar, tanto em animais resistentes, quanto em animais \n\nsuscept\u00edveis (CHIARELLA et al., 2007). Entretanto, em nosso trabalho, maior n\u00famero \n\nde linf\u00f3citos TCD8 foi encontrado no pulm\u00e3o de camundongos WT, associado a uma \n\nmaior carga f\u00fangica. Deste modo, o maior afluxo de linf\u00f3citos T CD8 nestes animais \n\nn\u00e3o foi capaz de controlar a carga f\u00fangica.  \n\nA seguir, caracterizamos a presen\u00e7a de c\u00e9lulas T reguladoras (Treg) nos \n\ninfiltrados inflamat\u00f3rios de pulm\u00e3o. As c\u00e9lulas Treg apresentam o fen\u00f3tipo \n\nTCD4+CD25+, expressam constitutivamente o marcador CD25 (cadeia alfa do receptor \n\nde IL-2), CTLA-4 (cytotoxic T lymphocyte-associated antigen- inibidor da ativa\u00e7\u00e3o \n\nprolongada de linf\u00f3citos T) (BELKAID et al., 2007), CD45RO (DIECKMAN et al., \n\n2001), TGF-?1 de membrana (NAKAMURA et al., 2004) e o fator de transcri\u00e7\u00e3o \n\nnuclear FoxP3+ , fundamental para sua diferencia\u00e7\u00e3o e atividade supressora \n\n(FONTENOT et al., 2003; HORI et al., 2003). As c\u00e9lulas Treg atuam atrav\u00e9s da \n\ninibi\u00e7\u00e3o da produ\u00e7\u00e3o de citocinas, como a IL-2, bloqueando o ciclo celular de linf\u00f3citos \n\nTCD4+ e TCD8+; al\u00e9m disso, podem suprimir a atividade proliferativa de linf\u00f3citos T \n\nativados CD4+CD25+ (NAKAMURA et al., 2004). Outro poss\u00edvel mecanismo da a\u00e7\u00e3o \n\nsupressora das c\u00e9lulas Treg se d\u00e1 pela produ\u00e7\u00e3o das citocinas antinflamat\u00f3ria IL-10 e \n\nTGF-? (ASSEMAN et al., 1999; BELKAID, 2007). \n\nTem sido descrita a import\u00e2ncia das c\u00e9lulas reguladoras em casos cr\u00f4nicos de \n\ninfec\u00e7\u00e3o onde, devido \u00e0 persist\u00eancia do pat\u00f3geno, essas c\u00e9lulas estariam controlando as \n\nrespostas imunes que poderiam causar quadros inflamat\u00f3rios exarcebados na tentativa \n\nde erradicar o agente infeccioso. Al\u00e9m disso, a presen\u00e7a de c\u00e9lulas T reguladoras tem \n\num papel importante na manuten\u00e7\u00e3o da mem\u00f3ria imunol\u00f3gica, uma vez que impedem a \n\nelimina\u00e7\u00e3o total dos pat\u00f3genos (ZHOU et al., 2009).  \n\nOs TLRs foram inicialmente associados com a ativa\u00e7\u00e3o do sistema imune inato; \n\nentretanto, a literatura tem demonstrado que TLRs est\u00e3o expressos em c\u00e9lulas T efetoras \n\n\n\n 106 \n\ne reguladoras. C\u00e9lulas T efetoras e reguladoras expressam TLR1, TLR-2 e TLR6. \n\nEntretanto, as c\u00e9lulas Treg expressam mais TLR-4, TLR5, TLR7 e TLR8 do que os \n\nlinf\u00f3citos efetores (SUTMULLER et al., 2007). Alem disso, a adi\u00e7\u00e3o de ligantes do \n\nTLR-2 podem regular positiva ou negativamente a a\u00e7\u00e3o supressora das c\u00e9lulas Treg \n\n(SUTMULLER et al, 2007; ZANIN-ZHOROV et al., 2006). \n\nEm elegante trabalho, Belkaid et al. (2002) mostraram que na infec\u00e7\u00e3o cr\u00f4nica \n\npor Leishmania major a presen\u00e7a de linf\u00f3citos Treg al\u00e9m de suprimir a resposta de \n\nlinf\u00f3citos TCD4+ , inibindo a s\u00edntese de IFN-?, produziram IL-10 que foi importante \n\npara a perman\u00eancia do pat\u00f3geno. Assim, al\u00e9m de atenuar a produ\u00e7\u00e3o de citocinas \n\nproinflamat\u00f3rias do perfil Th1, ainda interferiria na atividade microbicida de \n\nmacr\u00f3fagos. A presen\u00e7a dessas c\u00e9lulas parece proporcionar um equil\u00edbrio na atividade \n\nefetora das c\u00e9lulas TCD4+ que, na tentativa de eliminar o pat\u00f3geno, poderiam causar \n\ndanos teciduais ao hospedeiro.  \n\nNossos resultados na segunda semana de infec\u00e7\u00e3o, ao contr\u00e1rio do trabalho \n\nacima citado, e apesar dos animais WT apresentarem maior carga f\u00fangica no pulm\u00e3o, \n\nmostraram n\u00famero equivalente de c\u00e9lulas T reguladoras no infiltrado pulmonar de \n\nanimais TLR-2-/- e WT. Por outro lado, ap\u00f3s a d\u00e9cima primeira semana de infec\u00e7\u00e3o \n\nobservamos menor n\u00famero de Treg nos animais TLR-2-/-, os mesmos que apresentaram \n\numa menor carga f\u00fangica pulmonar. \u00c9 importante ressaltar que o maior n\u00famero de \n\nc\u00e9lulas Treg nos animais TLR-2 normais esteve associado tamb\u00e9m com maiores n\u00edveis \n\nde IL-10 pulmonar. Deste modo, um maior n\u00famero de Treg nos animais WT estava \n\nassociado a uma maior carga f\u00fangica. Entretanto, estes mesmo animais apresentaram \n\ntamb\u00e9m maior n\u00famero de linf\u00f3citos T CD4+ e CD8+ ativados. Assim, pode-se supor que \n\na presen\u00e7a do TLR-2 levou a infec\u00e7\u00f5es mais grave e maior ativa\u00e7\u00e3o do sistema imune, \n\ncom concomitante aumento da express\u00e3o de c\u00e9lulas Treg que controlaria parcialmente a \n\ninflama\u00e7\u00e3o mas causaria a manuten\u00e7\u00e3o do processo infeccioso. Desta forma, nossos \n\ndados parecem estar em desacordo com os resultados obtidos por NETEA et al. (2004), \n\nonde a presen\u00e7a do TLR-2 suprimiu a imunidade contra o fungo Candida albicans \n\natrav\u00e9s da indu\u00e7\u00e3o de IL-10 e de c\u00e9lulas T reguladoras. \n\nEstudos realizados por KASHINO et al. (1995) demonstraram que a resist\u00eancia \n\nao P. brasiliensis estava relacionada a n\u00edveis elevados de IFN-? e IgG2a, e a \n\nsusceptibilidade associada a n\u00edveis elevados de IL-5, IgG2b e IgA. Trabalhando com \n\nTLR-4, observamos que a presen\u00e7a deste receptor leva a uma maior produ\u00e7\u00e3o de IgG1, \n\nIgG2b e IgM na d\u00e9cima primeira semana de infec\u00e7\u00e3o (CALICH et al., 2008; LOURES \n\n\n\n 107 \n\net al., 2010), entretanto, resultados obtidos com animais deficientes para o TLR-2 \n\ndemonstraram  que este receptor n\u00e3o influencia a s\u00edntese de anticorpos.  \n\nEm conjunto, nossos dados parecem demonstrar que o TLR-2 \u00e9 usado pelo P. \n\nbrasiliensis para infectar os fag\u00f3citos dos hospedeiros. Esta intera\u00e7\u00e3o \u00e9 importante \n\nporque mesmo a maior ativa\u00e7\u00e3o do sistema imune inato (NO, citocinas) e adaptativo \n\n(maior n\u00famero de linf\u00f3citos TCD4+ e TCD8+ ativados) n\u00e3o consegue sobrepujar a \n\nmaior carga f\u00fangica conferida pela presen\u00e7a do TLR-2. A presen\u00e7a de c\u00e9lulas T \n\nreguladoras nos animais TLR-2-normais parece colaborar com a manuten\u00e7\u00e3o dos fungos \n\nem alto n\u00famero.  \n\nObservamos nos animais TLR-2-/- uma maior presen\u00e7a de leuc\u00f3citos PMN no \n\ninfiltrado inflamat\u00f3rio dos pulm\u00f5es e uma imunidade do tipo Th17. Esta imunidade \n\nparece estar associada \u00e0 prote\u00e7\u00e3o, uma vez que a carga f\u00fangica pulmonar permaneceu \n\nmenor do que a observada nos animais TLR-2-normais. Como, entretanto, express\u00e3o da \n\nimunidade Th17 pode levar a patologia tecidual por excesso de atividade inflamat\u00f3ria \n\natrav\u00e9s da secre\u00e7\u00e3o de metaloprote\u00ednase e mieloperoxidase por leuc\u00f3citos PMN \n\n(ROMANI et al., 2008), a an\u00e1lise da histologia pulmonar corrobora esta hip\u00f3tese. Como \n\na mortalidade dos animais TLR-2-/- e TLR-2-normais foi equivalente, \u00e9 poss\u00edvel que, \n\napesar de proteger contra o crescimento f\u00fangico, a imunidade Th17 possa ter levado a \n\npatologia pulmonar e menor tempo de sobrevida.  \n\nSurpreendentemente, estes dados n\u00e3o est\u00e3o de acordo com as informa\u00e7\u00f5es \n\nencontradas na literatura, onde a presen\u00e7a dos TLRs leva a uma doen\u00e7a menos grave, \n\ngeralmente pela produ\u00e7\u00e3o de citocinas proinflamat\u00f3rias que culminam com o aumento \n\nde imunidade celular e produ\u00e7\u00e3o de compostos que venham eliminar ou conter o \n\nparasita (CAMPOS et al., 2004; BELOCCHIO et al., 2004; VIRIYAKOSOL et al., \n\n2005;  OLIVEIRA et al., 2004). A presen\u00e7a de TLRs associada a uma doen\u00e7a mais \n\ngrave, entretanto, foi demonstrado por Belochio et al. (2004). Ao trabalhar com \n\nleveduras e hifas de C\u00e2ndida albicans, estes autores demonstraram que a presen\u00e7a do \n\nTLR-2 e do TLR-9 levou a uma doen\u00e7a mais grave, com n\u00edveis altos TNF-? e de UFC \n\nnos animais que possuem os receptores funcionais, comprando-se com os camundongos \n\nTLR-2 KO e TLR-9 KO. Al\u00e9m disso, Netea et al. (2004), demonstraram que a presen\u00e7a \n\ndo TLR-2 leva a supress\u00e3o da imunidade contra Candida albicans atrav\u00e9s da produ\u00e7\u00e3o \n\nde IL-10 e aumento de c\u00e9lulas T reguladoras. \n\n Este conjunto de informa\u00e7\u00f5es caracterizando o TLR-2 na PCM foi reunido e \n\npublicado recentemente (LOURES et al., 2009). Os achados sobre a defici\u00eancia de \n\n\n\n 108 \n\nTLR-2 levando a uma resposta Th17 foi tamb\u00e9m relatada simultaneamente por outros \n\ngrupos. Trabalhando com a bact\u00e9ria Staphylococcus aureus os autores relataram que \n\nmacr\u00f3fagos, astr\u00f3citos e micr\u00f3glia de animais TLR-2-/-produziram n\u00edveis maiores de IL-\n\n17 no abscesso cerebral ap\u00f3s infec\u00e7\u00e3o com a bact\u00e9ria quando comparado ao grupo \n\ncontrole (NICHOLS et al., 2009). Ao mesmo tempo o grupo da Dra. Bali Pulendram \n\nrelata que o metabolismo do \u00e1cido retin\u00f3ico est\u00e1 ligado \u00e0 supress\u00e3o da resposta Th17 \n\nquando h\u00e1 ativa\u00e7\u00e3o via TLR-2. Neste trabalho os autores demonstraram que o TLR-2 \n\ninduziu em c\u00e9lulas dendr\u00edticas a enzima metabolizadora do \u00e1cido retin\u00f3ico, a \n\nretinalde\u00eddo desidrogenase. Induziu tamb\u00e9m a produ\u00e7\u00e3o de IL-10 e a expans\u00e3o de \n\nc\u00e9lulas T regulat\u00f3rias FoxP3+. O \u00e1cido retin\u00f3ico atuou nas c\u00e9lulas dendr\u00edticas ativando \n\nSOCS3 (fator de supress\u00e3o da s\u00edntese de citocinas 3) que,  suprimindo a ativa\u00e7\u00e3o da \n\nprote\u00edna quinase p38 , levou \u00e0 produ\u00e7\u00e3o diminu\u00edda de algumas citocinas \n\nproinflamat\u00f3rias e as citocinas Th17. Assim como em nosso trabalho, eles demonstram \n\nque a sinaliza\u00e7\u00e3o via TLR-2 induzia as c\u00e9lulas Treg e suprimia a imunidade Th17 \n\n(MANICASSAMY et al., 2009). \n\n Na segunda etapa do nosso trabalho estudamos o envolvimento in vitro e in \n\nvivo da prote\u00edna adaptadora MyD88. Verificamos nos experimentos de fagocitose que a \n\naus\u00eancia desta prote\u00edna resultou numa menor capacidade em aderir e/ou fagocitar as \n\nleveduras n\u00e3o vi\u00e1veis do fungo por parte dos macr\u00f3fagos peritoneais. Tal \n\ncomportamento sugere que os mecanismos de ativa\u00e7\u00e3o celular que propiciam a \n\nfagocitose seriam dependente da sinaliza\u00e7\u00e3o via MyD88. A menor ativa\u00e7\u00e3o macr\u00f3fagica \n\nse confirmou nos demais experimentos in vitro; a cultura de macr\u00f3fagos peritoneais de \n\nanimais MyD88KO apresentou um maior n\u00famero de fungos recuperados nos \n\nexperimentos de UFC quando comparada \u00e0 do grupo controle. Estes mesmos \n\nmacr\u00f3fagos apresentaram pequena habilidade de produ\u00e7\u00e3o de NO. Assim, os baixos \n\nn\u00edveis de NO produzidos pelos animais MyD88KO n\u00e3o foram suficientes para controlar \n\na carga f\u00fangica na cultura. A aus\u00eancia de sinaliza\u00e7\u00e3o via mol\u00e9cula MyD88 pode \n\ntamb\u00e9m ter afetado a ativa\u00e7\u00e3o de outros genes tamb\u00e9m envolvidos nos mecanismos \n\nfungicidas. Deve-se lembrar que a mol\u00e9cula MyD88 tamb\u00e9m atua na ativa\u00e7\u00e3o de \n\nmacr\u00f3fagos estimulados atrav\u00e9s do IL-1R (receptor de IL-1) (O\u2019NEILL e BOWIE, \n\n2007). A menor capacidade de fagocitar, a pouca habilidade em matar leveduras do \n\nfungo, assim como, a menor produ\u00e7\u00e3o de NO, confirmou que a sinaliza\u00e7\u00e3o via MyD88 \n\n\n\n 109 \n\n\u00e9 indispens\u00e1vel para a ativa\u00e7\u00e3o macrof\u00e1gica e, conseq\u00fcentemente, para o controle do \n\nparasita.  \n\n Diversos trabalhos t\u00eam relatado a import\u00e2ncia da sinaliza\u00e7\u00e3o via MyD88 na \nativa\u00e7\u00e3o de macr\u00f3fagos ou de c\u00e9lulas dendr\u00edticas. Raoust et al. (2009) relataram que \n\nLPS ou flagelina derivados de Pseudomonas aeruginosa s\u00e3o capazes de ativar a \n\nprodu\u00e7\u00e3o de KC, TNF-?, IL-6 e G-CSF por macr\u00f3fagos alveolares murinos via TLRs \n\ndependentemente de MyD88. Em outro trabalho, Belochio et al. (2004) relataram que as \n\nimunidades inata e adaptativa para C. albicans e A. fumigatus exigem a a\u00e7\u00e3o \n\ncoordenada dos membros distintos da superfam\u00edlia IL-1R/TLR agindo atrav\u00e9s da \n\nsinaliza\u00e7\u00e3o via MyD88 com uma eficiente produ\u00e7\u00e3o de citocinas e mecanismos \n\nfungicidas. \n\n Os experimentos de UFC feitos a partir do macerado do pulm\u00e3o em tempo \n\ncurto de infec\u00e7\u00e3o (48 horas) est\u00e3o de acordo com os dados obtidos in vitro, uma vez que \n\no n\u00famero de fungos recuperados foi maior nos pulm\u00f5es dos animais MyD88KO, \n\nconfirmando assim os experimentos in vitro. Os dados de produ\u00e7\u00e3o de NO tamb\u00e9m \n\nest\u00e3o de acordo com os experimentos in vitro, uma vez que foram observados menores \n\nn\u00edveis de NO no homogenato de pulm\u00e3o de animais MyD88KO. \n\n Em rela\u00e7\u00e3o \u00e0 s\u00edntese de citocinas, ainda observando o tempo curto de \n\ninfec\u00e7\u00e3o (48 horas), verificamos que animais MyD88 deficientes e normais produziram \n\nn\u00edveis semelhantes das citocinas IFN-?, TNF-?, IL-10, IL-6, IL-17, IL-23 e TGF-?. \n\nContudo, o macerado de pulm\u00e3o de animais MyD88KO apresentou n\u00edveis menores de \n\nIL-12 quando comparado ao grupo controle. \n\n Ao trabalhar com tempo longo de infec\u00e7\u00e3o (8 semanas), encontramos \n\nresultados semelhantes ao da fase aguda da infec\u00e7\u00e3o, ou seja, uma doen\u00e7a mais grave \n\nnos animais deficientes para MyD88, que apresentaram uma carga f\u00fangica pulmonar, \n\nhep\u00e1tica e espl\u00eanica consideravelmente maior que os animais do grupo controle. Vale \n\nchamar a aten\u00e7\u00e3o que n\u00e3o houve dissemina\u00e7\u00e3o de fungo para o f\u00edgado dos animais \n\nMyD88 competentes, uma rica dissemina\u00e7\u00e3o foi observada apenas nos animais \n\ndeficientes. Estes dados reproduzem os resultados de UFC obtidos em experimentos in \n\nvitro e em tempo curto de infec\u00e7\u00e3o.  Contudo, apesar da diferen\u00e7a da carga f\u00fangica \n\nobservada nos pulm\u00f5es entre as duas linhagens estudadas, verificamos que a produ\u00e7\u00e3o \n\nde NO foi semelhante no homogenato do pulm\u00e3o de ambas as linhagens. Assim, fica \n\n\n\n 110 \n\nsugerido que outros mecanismos fungicidas estariam agindo nos animais MyD88 \n\ncompetentes e contribuindo para o controle da carga f\u00fangica neste grupo de animais. Ou \n\nainda, podemos supor que mesmo com altos n\u00edveis de NO nos animais MyD88KO, \n\nsemelhantes aos n\u00edveis dos animais do grupo controle, a defici\u00eancia de outros \n\nmecanismos fungicidas dependentes da sinaliza\u00e7\u00e3o via MyD88 poderia contribuir para a \n\nmaior carga f\u00fangica nos pulm\u00f5es destes animais. Por outro lado, os n\u00edveis de NO \n\npoderiam estar sendo influenciado pela carga f\u00fangica. O estudo do f\u00edgado revelou que \n\ntal hip\u00f3tese \u00e9 relevante e nem sempre maiores n\u00edveis de NO est\u00e3o associados a uma \n\nmenor carga f\u00fangica. Neste caso, a dissemina\u00e7\u00e3o de fungo para o f\u00edgado provocou uma \n\ngrande produ\u00e7\u00e3o de NO, por\u00e9m estes altos n\u00edveis de NO n\u00e3o foram capazes de controlar \n\no crescimento f\u00fangico neste \u00f3rg\u00e3o. Podemos ainda argumentar, que como n\u00e3o houve \n\ndissemina\u00e7\u00e3o do fungo para o f\u00edgado dos animais do grupo controle, n\u00e3o houve \n\nest\u00edmulos suficientes para a produ\u00e7\u00e3o de NO neste \u00f3rg\u00e3o. Esta seria tamb\u00e9m a raz\u00e3o de  \n\nencontrarmos n\u00edveis de NO n\u00e3o muito elevados no pulm\u00e3o de animais MyD88 normais. \n\nEm rela\u00e7\u00e3o \u00e0 s\u00edntese citocinas nos pulm\u00f5es verificamos que os animais  \n\nMyD88KO e WT produziram n\u00edveis semelhantes de TNF-? , IFN-? e IL-6. Contudo, \n\nn\u00edveis menores de IL-12, IL-4, IL-5, IL-10, TGF-?, IL-17 e IL-23 foram observados no \n\nhomogenato do pulm\u00e3o de animais MyD88KO ap\u00f3s 8 semanas de infec\u00e7\u00e3o. No f\u00edgado, \n\nal\u00e9m destas citocinas, a IL-6 tamb\u00e9m apresentou-se em menores n\u00edveis no homogenato \n\ndos animais MyD88KO. Por outro lado, a an\u00e1lise do homogenato de ba\u00e7o revelou que \n\napenas o TNF-? apresentou-se em n\u00edveis menores nos animais MyD88KO associado a \n\numa maior produ\u00e7\u00e3o de IL-10.  Em conjunto, os resultados de dosagem de citocinas \n\ndemonstram que a sinaliza\u00e7\u00e3o via MyD88 \u00e9 indispens\u00e1vel para a s\u00edntese de citocinas do \n\ntipo Th17, Th2 e Th17 na PCM.  \n\nAs citocinas TGF-?, IL-17 e IL-23, ligadas ao padr\u00e3o de resposta imune Th17, \n\nencontravam-se em menores n\u00edveis nos animais MyD88KO. Como o padr\u00e3o Th17 de \n\nativa\u00e7\u00e3o da resposta imune vem sendo descrito associado a um afluxo de neutr\u00f3filos \n\npara o s\u00edtio inflamat\u00f3rio, decidimos ent\u00e3o verificar a morfologia das c\u00e9lulas que \n\ninfiltravam nos pulm\u00f5es dos animais MyD88KO. Verificamos que os animais \n\nMyD88KO apresentavam um menor n\u00famero de leuc\u00f3citos PMNs quando comparado ao \n\ngrupo controle. Assim, mais uma vez verificamos que o padr\u00e3o Th17 estava ligado ao \n\nafluxo destas c\u00e9lulas ao s\u00edtio inflamat\u00f3rio na PCM. A depend\u00eancia de MyD88 para o \n\nafluxo de neutr\u00f3filos para o s\u00edtio inflamat\u00f3rio tem sido descrito em diversas infec\u00e7\u00f5es. \n\n\n\n 111 \n\nCai et al. (2009) relataram que a aus\u00eancia de MyD88 culmina com a sobreviv\u00eancia \n\ncomprometida, baixos n\u00edveis de TNF-?, IL-6 e KC e reduzido n\u00famero de neutr\u00f3filos \n\nnos pulm\u00f5es de camundongos infectados com a bact\u00e9ria Klebsiella pneumoniae. Em \n\noutro trabalho, a inabilidade de combater a infec\u00e7\u00e3o pela bact\u00e9ria Gran-negativa \n\nBurkholderia pseudomallei foi acompanhada pelo reduzido n\u00famero de neutr\u00f3filos em \n\ncamundongos MyD88KO infectados pela bact\u00e9ria (WIERSINGA et al., 2008).  \n\nA despeito da diferen\u00e7a da carga f\u00fangica pulmonar encontrada entre as duas \n\nlinhagens estudadas, analisamos as sub-popula\u00e7\u00f5es de leuc\u00f3citos infiltrantes de pulm\u00e3o \n\nde animais MyD88KO e WT, assim como o perfil fenot\u00edpico de macr\u00f3fagos alveolares, \n\nna fase cr\u00f4nica da infec\u00e7\u00e3o (oitava semana). Observamos um menor n\u00famero de \n\nmacr\u00f3fagos nos pulm\u00f5es dos animais MyD88KO caracterizado pelo menor n\u00famero de \n\nc\u00e9lulas CD11b+. Verificamos tamb\u00e9m que o infiltrado celular  presentava menor \n\nn\u00famero de c\u00e9lulas miel\u00f3ides ativadas CD11b+IaK+ e CD11b+CD40+. Ao estudar a \n\npopula\u00e7\u00e3o linfocit\u00e1ria na oitava semana de infec\u00e7\u00e3o observamos que os linf\u00f3citos T \n\nCD4 dos animais MyD88KO apareciam em menor n\u00famero e estavam menos ativados, \n\ncom menor express\u00e3o de CD25+; de acordo, observamos uma menor popula\u00e7\u00e3o de \n\nlinf\u00f3citos CD4+CD25+. Contudo, n\u00e3o observamos diferen\u00e7as no n\u00famero de linf\u00f3citos T \n\nCD8, como tamb\u00e9m n\u00e3o houve diferen\u00e7a na ativa\u00e7\u00e3o destas c\u00e9lulas entre animais \n\nMyD88 deficientes e normais. \n\n Assim, verificamos que a sinaliza\u00e7\u00e3o via MyD88 participa na determina\u00e7\u00e3o do \n\ninfiltrado pulmonar rico em macr\u00f3fagos e linf\u00f3citos T CD4 ativados. Desta forma, o \n\nmaior afluxo e ativa\u00e7\u00e3o de macr\u00f3fagos e linf\u00f3citos est\u00e1 associado com uma menor carga \n\nf\u00fangica, indicando a import\u00e2ncia da sinaliza\u00e7\u00e3o MyD88 na constru\u00e7\u00e3o de uma resposta \n\nimune eficiente capaz de controlar a carga f\u00fangica.  Como j\u00e1 mencionado \n\nanteriormente, macr\u00f3fagos alveolares s\u00e3o essenciais no controle da carga f\u00fangica de \n\nanimais suscept\u00edveis e resistentes na PCM (PINA et al., 2007). Al\u00e9m disso, em outro \n\ntrabalho do nosso grupo, demonstrou-se que os linf\u00f3citos T CD4+ s\u00e3o indispens\u00e1veis \n\npara o controle da doen\u00e7a em animais resistentes, mas n\u00e3o nos suscept\u00edveis; a deple\u00e7\u00e3o \n\nde linf\u00f3citos T CD4 gerava resposta suprimida de HTT (hipersensibilidade do tipo \n\ntardio) nas 4\u00ba e 8\u00ba semana de infec\u00e7\u00e3o, diminui\u00e7\u00e3o da produ\u00e7\u00e3o de anticorpos IgG2a, \n\nIgG1 e IgG2b e dos n\u00edveis de IL-2 (CHIARELLA et al., 2007). \n\nComo a adi\u00e7\u00e3o de ligantes a TLRs pode regular positiva ou negativamente a \n\na\u00e7\u00e3o supressora das c\u00e9lulas Treg (SUTMULLER et al., 2006; ZANIN-ZHOROV et al., \n\n\n\n 112 \n\n2006) e a sinaliza\u00e7\u00e3o via MyD88 pode ser dependente dos TLRs, decidimos analisar as \n\npopula\u00e7\u00f5es de c\u00e9lulas T reguladoras na aus\u00eancia de MyD88. Ap\u00f3s 8 semanas de \n\ninfec\u00e7\u00e3o verificamos que houve um menor afluxo de c\u00e9lulas CD4+CD25+FoxP3+ no \n\ninfiltrado c\u00e9lulas dos pulm\u00f5es dos animais MyD88KO. Este resultado sugere que a \n\nexpans\u00e3o das c\u00e9lulas Treg \u00e9 dependente da sinaliza\u00e7\u00e3o via MyD88 como j\u00e1 havia sido \n\ndescrito por Sutmuller et al. (2006). Neste trabalho, um ligante do TLR-2, o Pam3Cys, \n\natuou diretamente na prolifera\u00e7\u00e3o in vitro e in vivo de Tregs durante infec\u00e7\u00e3o por \n\nC\u00e2ndida albicans e esta prolifera\u00e7\u00e3o foi dependente de MyD88. \n\nVerificamos at\u00e9 agora que a aus\u00eancia de MyD88 resultou numa deficiente \n\nprodu\u00e7\u00e3o de compostos fungicidas por macr\u00f3fagos, como o NO, al\u00e9m de uma deficiente \n\nprodu\u00e7\u00e3o de algumas citocinas. Esta deficiente produ\u00e7\u00e3o de citocinas durante a \n\nimunidade inata deve ter ocasionado uma menor ativa\u00e7\u00e3o da resposta imune adaptativa. \n\nIsto fica evidenciado pela menor ativa\u00e7\u00e3o de macr\u00f3fagos, assim como, pelo afluxo de \n\nmenor n\u00famero de c\u00e9lulas T CD4 ativadas para o pulm\u00e3o. Este quadro culminou com \n\numa carga f\u00fangica maior nos pulm\u00f5es dos animais MyD88 deficientes, assim como, \n\npermitiu a dissemina\u00e7\u00e3o do fungo para outros \u00f3rg\u00e3os, como f\u00edgado e ba\u00e7o. Pulm\u00f5es e \n\nf\u00edgado, principalmente, apresentaram graves les\u00f5es com a presen\u00e7a de granulomas \n\ncoalescentes e ricos de agregados f\u00fangicos. Assim, camundongos MyD88 deficientes \n\nn\u00e3o foram eficientes no controle da doen\u00e7a e morreram em um tempo mais curto que os \n\nanimais MyD88 competentes, como mostrado atrav\u00e9s dos experimentos de sobrevida. \n\n Em conjunto, nossos achados demonstram que a prote\u00edna MyD88 \u00e9 \n\nimportante para a ativa\u00e7\u00e3o nos mecanismos fungicidas contra o P. brasiliensis e, \n\nconseq\u00fcentemente, para o controle da doen\u00e7a. Estes dados est\u00e3o de acordo com os \n\nencontrados na literatura. Bretz et al. (2008) ao trabalharem com Criptococcus \n\nneoformans, evidenciaram que a prote\u00edna MyD88 \u00e9 indispens\u00e1vel para o controle da \n\ncarga f\u00fangica pulmonar de camundongos infectados, al\u00e9m de ser respons\u00e1vel pela \n\norganiza\u00e7\u00e3o da inflama\u00e7\u00e3o e les\u00f5es pulmonares na fase inicial da infec\u00e7\u00e3o.  \n\nTrabalhando com C\u00e2ndida albicans, Gow et al. (2007) relataram que a prote\u00edna MyD88 \n\n\u00e9 indispens\u00e1vel para o controle da infec\u00e7\u00e3o, sendo respons\u00e1vel pela sinaliza\u00e7\u00e3o na \n\nprodu\u00e7\u00e3o de citocinas como IL-10 e TNF-?. Entretanto, em trabalho recente com o P. \n\nbrasiliensis, Gonzalez et al. (2008) relataram que a prote\u00edna MyD88 n\u00e3o \u00e9 essencial \n\npara uma defesa eficiente frente ao fungo, com equivalente crescimento f\u00fangico e \n\nprodu\u00e7\u00e3o de citocinas entre animais MyD88KO e WT. Este resultado oposto \u00e9 dif\u00edcil de \n\nexplicar, por\u00e9m o grupo utilizou-se de uma via de infec\u00e7\u00e3o diferente do nosso modelo, a \n\n\n\n 113 \n\nvia endovenosa.  Deve-se, entretanto, argumentar que em trabalhos anteriores \n\n(LOURES et al. 2009; 2010) verificamos que o TLR-2 e o TLR-4 influenciam a PCM e \n\nambos os receptores sinalizam utilizando a mol\u00e9cula adaptadora MyD88.  \n\n Gostar\u00edamos de terminar a nossa discuss\u00e3o apresentando uma vis\u00e3o geral e \n\nintegrada sobre a participa\u00e7\u00e3o dos TLRs (TLR-2 e TLR-4) e da mol\u00e9cula MyD88 na \n\nPCM murina.  A aus\u00eancia do receptor TLR-2 levou a uma infec\u00e7\u00e3o menos grave \n\nassociada com maior afluxo de PMNs para o foco da doen\u00e7a e de maiores n\u00edveis de \n\ncitocinas Th17. Contudo, animais TLR-2-deficientes apresentaram mortalidade \n\nequivalente e les\u00f5es pulmonares t\u00e3o graves quanto aquelas apresentadas pelos animais \n\ndo grupo controle.  A aus\u00eancia do receptor TLR-4 tamb\u00e9m esteve associada a uma \n\ndoen\u00e7a menos grave, com menor produ\u00e7\u00e3o de IL-12 e citocinas do tipo Th17; a \n\ndefici\u00eancia de imunidade T CD4 encontrava-se associada \u00e0 expans\u00e3o de maior n\u00famero \n\nde c\u00e9lulas T regulat\u00f3rias. Por fim, a aus\u00eancia da sinaliza\u00e7\u00e3o via MyD88 resultou numa \n\ninfec\u00e7\u00e3o mais grave, e menor produ\u00e7\u00e3o de citocinas Th1, Th2, Th17, assim como, \n\nmenor expans\u00e3o de c\u00e9lulas T efetoras e c\u00e9lulas T regulat\u00f3rias. Esta vis\u00e3o geral est\u00e1 \n\nesquematizada na figura a seguir: \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nNossos dados, portanto, demonstram que na PCM pulmonar as fun\u00e7\u00f5es \n\nexercidas pelos receptores TLR-2 e TLR-4 assim como a sinaliza\u00e7\u00e3o celular mediada \n\npela prote\u00edna adaptadora MyD88 s\u00e3o importantes para um resposta equilibrada contra o \n\nP. brasiliensis. A aus\u00eancia de cada uma destas mol\u00e9culas leva a altera\u00e7\u00f5es distintas da \n\nTLR2 \n\nAPC \n\nTLR4 \n\nMyD88 \n\nTh1 \n\nTh1 Th2 Th17 \n\nTh17 \n\nTh17 \n\nTreg \n\nTreg \n\nTreg  \n\nAumentadaMuito graves \ne com muito \n\nfungos\n\nN\u00e3o \nalterada\n\nMenos graves\ncom poucos\n\nfungos\n\nN\u00e3o \nalterada\n\nGraves com \npoucos \nfungos\n\n(   PMN)\n\nDestino da \ndoen\u00e7 a\n\n(mortalidade)\n\nGravidade \ndas \n\nles\u00f5es\n\nImuno - \nregula \u00e7 \u00e3o \n\nImunidade\nPrevalente \n\nGravidade \nda \n\nInfec\u00e7 \u00e3o\n\nAumentadaMuito graves \ne com muito \n\nfungos\n\nN\u00e3o \nalterada\n\nMenos graves\ncom poucos\n\nfungos\n\nN\u00e3o \nalterada\n\nGraves com \npoucos \nfungos\n\n(   PMN)\n\nDestino da \ndoen\u00e7 a\n\n(mortalidade)\n\nGravidade \ndas \n\nles\u00f5es\n\nImuno - \nregula \u00e7 \u00e3o \n\nImunidade\nPrevalente \n\nGravidade \nda \n\nInfec\u00e7 \u00e3o\n\n\n\n 114 \n\nresposta imune e o conhecimento da sua fun\u00e7\u00e3o proporcionou um maior entendimento \n\nda imunopatologia na paracoccidioidomicose. \n\n \n\n6 CONCLUS\u00d5ES \n\n1. Os estudos sobre a fun\u00e7\u00e3o do TLR-2 na paracoccidioidomicose sugerem que \n\neste receptor ao interagir com o P. brasiliensis leva \u00e0 ativa\u00e7\u00e3o do macr\u00f3fago, maior \n\nfagocitose e maior produ\u00e7\u00e3o de citocinas e NO. Contudo, estes mecanismos n\u00e3o foram \n\nsuficientes para controlar o crescimento f\u00fangico. A infec\u00e7\u00e3o in vivo de camundongos \n\nnormais e deficientes para o TLR-2 indicou que a presen\u00e7a do TLR-2 funcional levou a \n\numa infec\u00e7\u00e3o mais grave associada com maior produ\u00e7\u00e3o de IL-10 e expans\u00e3o de c\u00e9lulas \n\nT regulat\u00f3rias. Em contrapartida, animais TLR-2 deficientes apresentaram um infiltrado \n\nrico em PMN associado com uma produ\u00e7\u00e3o de citocinas Th17 e, apesar de uma menor \n\ncarga f\u00fangica, apresentaram les\u00f5es t\u00e3o graves quanto aquelas dos animais TLR-2 \n\nnormais. Pudemos concluir, ent\u00e3o, que o receptor TLR-2, al\u00e9m de inibir a resposta \n\nTh17, regula negativamente a patologia pulmonar. \n\n2. A aus\u00eancia da m\u00f3lecula MyD88 resultou numa produ\u00e7\u00e3o deficiente de \n\ncompostos fungicidas, como o NO, al\u00e9m de uma produ\u00e7\u00e3o diminu\u00edda de algumas \n\ncitocinas. Esta intera\u00e7\u00e3o deficiente com o fungo resultou em respostas imunes inata e \n\nadaptativa ineficientes, evidenciadas pela menor ativa\u00e7\u00e3o de macr\u00f3fagos, assim como,  \n\npelo afluxo de menor n\u00famero de c\u00e9lulas T CD4 ativadas para o foco da doen\u00e7a. Este \n\nquadro resultou em maior carga f\u00fangica nos pulm\u00f5es, assim como permitiu a \n\ndissemina\u00e7\u00e3o do fungo para outros \u00f3rg\u00e3os, como f\u00edgado e ba\u00e7o. Assim, camundongos \n\nMyD88 deficientes n\u00e3o foram capazes de controlar a doen\u00e7a  o que ocasionou a sua \n\nmortalidade precoce. Pudemos ent\u00e3o concluir que a prote\u00edna MyD88 \u00e9 importante para \n\na ativa\u00e7\u00e3o dos mecanismos de imunidade inata e adaptativa contra o P. brasiliensis e, \n\nconseq\u00fcentemente, para o controle da doen\u00e7a. \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n 115 \n\nREFER\u00caNCIAS BIBLIOGR\u00c1FICAS* \n \n\nADEREM, A.; ULEVITH, R. J. Toll-Like receptors in the induction of the innate \nimmune response. Nature, v. 406, p. 782-785, 2000. \n \n \nAKIRA, S.; UEMATSU, S. Toll-like receptors and innate immunity. J. Mol. Med., v. \n84, p. 712-725, 2006. \n \n \nASSEMAN, C.; MAUZE, S.; LEACH, M. W.; COFFMAN, R. L.; POWRIE, F. An \nessential role for interleukin 10 in the function of regulatory T cells that inhibit \nintestinal inflammation. J. Exp. Med., v. 190, p. 995-1004, 1999. \n \n \nARANGO, M.; YARZABAL, L. T-cell dysfunction and hyperimmuno-globulinemia E \nin paracoccidioidomycosis. Mycopathol., v. 79, p.115-123, 1982. \n \n \nARRUDA, C.; KASHINO, S. S.; FAZIOLI, R. A.; CALICH, V. L. A primary \nsubcutaneous infection with Paracoccidioides brasiliensis leads to immunoprotection or \nexacerbated disease depending on the route of challenge. Microbes Infect., v. 9, p. 308-\n316, 2007. \n \n \nARRUDA, C.; VALENTE-FERREIRA, R. C.; PINA, A.; KASHINO, S. S.; FAZIOLI, \nR. A.; VAZ, C. A. C.; FRANCO, M. F.; CALICH, V. L. G. Dual role of IL-4 in \npulmonary paracoccidioidomycosis: Endogenous IL-4 can induce protection or \nexacerbation of disease depending on the host genetic pattern. Infect. Immun., v. 72, p. \n3932\u20133940, 2004. \n \n \nARRUDA, C.; FRANCO, M. F.; KASHINO, S.; NASCIMENTO, F. R. F.; FAZIOLI, \nR. A.; VAZ, C. A. C.; RUSSO, M.; CALICH, V. L. G. Interleukin-12 protects mice \nagainst disseminated infection caused by Paracoccidioides brasiliensis but enhances \npulmonary inflammation. Clinical Immunology, v. 103, p. 185-195, 2002. \n \n \nBAIDA, H.; BISELLI, P. J. C.; JUVENALE, M.; DELNEGRO, G. M. B.; MENDES, \nR. P.; GIANNINI, M. J. S.; DUARTE, A. J. S.; BENARD, G. Differential antibody \nisotype expression to the major Paracoccidioides brasiliensis antigen in juvenile and \nadult form paracoccidioidomycosis. Microbes Infec., v. 1, p. 273-278, 1999. \n \n \nBELKAID, Y. Regulatory T cells and infection: a dangerous necessity. Nat. Ver. \nImmunol., v. 7, p. 875-888, 2007. \n \n*De acordo com: \nASSOCIA\u00c7\u00c3O BRASILEIRA DE NORMAS T\u00c9CNICAS. NBR 6023: Informa\u00e7\u00e3o e documenta\u00e7\u00e3o: \nrefer\u00eancias: elabora\u00e7\u00e3o. Rio de Janeiro, 2002. \n\n\n\n 116 \n\nBELKAID, Y.; PICCIRILLO, C. A.; MENDEZ, S.; SHEVACH, E. M.; SACKS, D. L. \nCD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. \nNature, v. 420, p. 502-507, 2002. \n \n \nBELLOCCHIO, S.; MONTAGNOLI, C.; BOZZA, S.; GAZIANO, R.; ROSSI, G.; \nMAMBULA, S. S.; VECCHI, A.; MANTOVANI, A.; LEVITZ, S. M.; ROMANI, L. \nThe Contribution of the Toll-Like/IL-1 receptor superfamily to innate and adaptive \nimmunity to fungal pathogens in vivo.  J. Immunol., v. 172, p. 3059-3069, 2004. \n \n \nBERNARDINO, S. Paracoccidioidomicose pulmonar em camundongos \ngeneticamente deficientes da enzima iNOS. 2005. Disserta\u00e7\u00e3o (Mestrado em \nImunologia) - Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, \n2005. \n \n \nBETTELLI, E.; CARRIER, Y.; GAO, W.; KORN, T.; STROM, T.B.; OUKKA, M.; \nWEINER, H.L.; KUCHROO, V.K. Reciprocal developmental pathways for the \ngeneration of pathogenic effector TH17 and regulatory T cells. Nature, v. 11, p. 235-\n238, 2006. \n \n \nBIONDO, C.; MIDIRI, A.; MESSINA, L.; TOMASELLO, F.; GARUFI, G.; \nCATANIA, M. R.; BOMBACI, M.; BENINATI, C.; TETI, G.; MANCUSO, G. MyD88 \nand TLR-2, but not TLR-4, are required for host defense against Cryptococcus \nneoformans. Eur. J. Immunol., v. 35, p. 870-878, 2005. \n \n \nBOCCA, A. L.; HAYASSHI, E. E.; PINHEIRO, A. G.; FURIANETTO, A. B.; \nCAMPANELLI, A. P.; CUNHA, F. Q.; FIGUEIREDO, F. Treatment of \nParacoccidioides brasiliensis infected mice with a nitric oxide inhibitor prevents the \nfailure of cell-mediated immune response. J. Immunol., v. 161, p. 3056-3063, 1988. \n \n \nBOZZA, S.; ZELANTE, T.; MORETTI, S.; BONIFAZI, P.; DELUCA, A.; \nD'ANGELO, C.; GIOVANNINI, G.; GARLANDA, C.; BOON, L.; BISTONI, F.; \nPUCCETTI, P.; MANTOVANI, A.; ROMANI, L. Lack of Toll IL-1R8 exacerbates \nTh17 cell responses in fungal infection. J. Immunol., v. 180, p. 4022-4031, 2008. \n \n \n\nBRETZ, C.; GERSUK, G.; KNOBLAUGH, S.; CHAUDHARY, N.; RANDOLPH-\nHABECKER, J.; HACKMAN, R.C.; STAAB, J.; MARR, K.A. MyD88 signaling \ncontributes to early pulmonary responses to Aspergillus fumigatus. Infect. Immun., v. \n76, p. 952-958, 2008. \n\n \n \n\n\n\n 117 \n\nBRITO, T. FURTADO, J.S.; CASTRO, R.M.; MANINI, M. Intraepithelial parasitism \nas an infection mechanism in human paracoccidioidomycosis (South American \nblastomycosis). Virchows Arch. A. Pathol. Anat., v. 361, p. 129-38. 1973. \n \n \nBRUMMER, E.; CASTANEDA, E.; RESTREPO, A. Paracoccidioidomycosis an \nupdate. Clin. Microbiol., v. 6, p. 89-98, 1993. Review. \n \n \nBROWN, G.D. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. \nImmunol., v. 6, p. 33-43, 2006. \n \n \nCACERE, C. R.; ROMANO, C. C.; MENDES-GIANNINI, M. J. S.; DUARTE, A. J.; \nBENARD, G. The role of apoptosis in the antigen-specific T cell hyporesponsiveness of \nparacoccidioidomycosis patients. Clin. Immunol., v. 105, p. 215-222, 2002. \n \n \nCAI, S.; BATRA. S.; SHEN. L.; WAKAMATSU, N.; JEYASEELAN. S. Both TRIF- \nand MyD88-dependent signaling contribute to host defense against pulmonary \nKlebsiella infection. J. Immunol., v. 183, p. 6629-6638, 2009. \n \n \nCALICH, V. L. G.; BLOTTA, M. H. S. L. Pulmonary paracoccidioidomycosis. In \nFidel, P. L.; Huffnagle, G. B.  Fungal Immunology: From an Organ Perspective. New \nYork: Springer, 2005. p. 201-228. \n \n \nCALICH, V.L.G.; PINA, A.; FELONOTO, M.; BERNARDINO, S.; COSTA, T.A. ; \nLOURES, F.V. Toll-like receptors and fungal infection: the role of TLR-2, TLR-4 and \nMyD88 in paracoccidioidomycosis. FEMS Immunol. Med. Microbiol., v. 53, p. 1-7,  \n2008. Review. \n \n \nCALICH, V. L. G.; KIPNIS, T. L.; MARIANO, M.; FAVA NETO, C.; DIAS, W. D. \nThe activation of complement system by Paracoccidioides brasiliensis \u201cin vitro\u201d: its \nopsonic effect and possible significance for an in vivo model of infection. Clin. \nImmunol. Immunopathol., v. 12, p. 20-30, 1979. \n \n \nCALICH, V. L. G.; SINGER-VERMES, L. M.; SIQUEIRA, A. M.; BURGER, E. \nSusceptibility and resistance of inbred mice to Paracoccidioides brasiliensis. Br. J. \nExp. Pathol., v. 66, p. 585-594, 1985. \n \n \nCAMPANELLI, A. P.; GISLAINE, A. M.; SOUTO, J. T.; PEREIRA, M. S. F.; \nLIVONESI, R. M.; SILVA, J. S.. Fas-Fas ligand (CD95-CD95L) and cytotoxic T \nlymphocyte antigen-4 engagement mediate T cell unresponsivess in patients with \nparacoccidioidomycosis. J. Infec. Dis., v. 187, p. 1496-1505, 2003. \n\n\n\n 118 \n\nCAMPOS, M. A. S.; ALMEIDA, I. C.; TAKEUCHI, O.; AKIRA, S.; VALENTE, E. P.; \nPROC\u00d3PIO, D. O.; TRAVASSOS, L. R.; SMITH, J. A.; GOLENBOCK, D. T.; \nGAZZINELLI, R. T. Activation of Toll-like receptor-2 by glycosylphosphatidyllinositol \nanchors from a protozoan parasite. J. Immunol., v. 167, p.  416-426, 2001. \n \n \nCAMPOS, M. A., CLOSEL, M.; VALENTE, E.P.; CARDOSO, J. E.; AKIRA, S.; \nALVAREZ-LEITE, J. I.; ROPERT, C.; GAZZINELLI, R. T. Impaired production of \nproinflammatory cytokines and host resistance to acute infection with Trypanosoma \ncruzi in mice lacking functional myeloid differentiation factor 88. J. Immunol., v. 172, \np. 1711-1718, 2004. \n \n \nCAMPOS, M. A.; ROSINHA, G. M. S.; ALMEIDA, I. C.; SALGUEIRO, X. S.; \nJARVIS, B. W.; SPLITTER, G. A.; QURESHI, N.; BRUNA-ROMERO, O.; \nGAZZINELLI, R. T.; OLIVEIRA, S. C. Role of Toll-like receptor 4 in induction of \ncell-mediated immunity and resistance to Brucella abortus infection in mice. Infec. \nImmun., v. 72, p. 176-186, 2004. \n\n \n \n\nCANO, L. E.; BRUMMER, E.; STEVENS, D. A.; RESTREPO, A. Fate of conidia from \nParacoccidioides brasiliensis after ingestion by resident macrophages or cytokine-\ntreated macrophages. Infect. Immun., v. 60, p. 2096-2100, 1992. \n \n \nCANO, L. E.; GOMEZ, V.; BRUMMER, E.; RESTREPO, A.; STEVENS, D. A. \nInhibitory effect of deferoxamine or macrophage activation on transformation of \nParacoccidioides brasiliensis conidia ingested by macrophages: reversal by \nholotrasnferrin. Infect. Immun., v. 60, p. 1494-1496, 1994. \n\n \n \n\nCANO, L. E.; SINGER-VERMES, L. M.; VAZ, C. A. C.; RUSSO, M.; CALICH, V. L. \nG. Pulmonary paracoccidioidomycosis in resistant and susceptible mice: relationship \namong progression of infection, bronchoalveolar cell activation, cellular immune \nresponse, and specific isotype patterns. Infect. Immun., v. 63, p. 1777-1783, 1995. \n \n \nCANO, L. E.; SINGER-VERMES, L. M.; COSTA, T. A.; MENGEL, J. O.; XIDIEH, C. \nF.; ARRUDA, C.; ANDR\u00c9, D. C.; VAZ, C. A.; BURGER, E.; CALICH, V. L. \nDepletion of CD8(+) T cells in vivo impairs host defense of mice resistant and \nsusceptible to pulmonary paracoccidioidomycosis. Infect. Immun., v. 68, p. 352-359, \n2000. \n \n \nCANO, L. E.; KASHINO, S. S.; ARRUDA, C.; ANDR\u00c9, D.; XIDIEH, C. F.; SINGER-\nVERMES, L. M.; VAZ, C. A. C.; BURGER, E.; CALICH, V. L. G. Protective role of \ngamma interferon in experimental pulmonary paracoccidioidomycosis. Infect. Immun., \nv. 66, p. 800-806, 1998. \n \n \n\n\n\n 119 \n\nCARLSON, T., KROENKE, M.; RAO, P.; LANE, T. E.; SEGAL, B. The Th17-ELR+ \nCXC chemokine pathway is essential for the development of central nervous system \nautoimmune disease. J. Exp. Med., v. 205, p. 811-823, 2008. \n \n \nCASTANEDA, E.; BRUMMER, E.; PAPPAGIANIS, D.; STEVENS, D. A. \nImpairment of cellular but not humoral immune response in chronic pulmonary and \ndisseminated paracoccidioidomycosis in mice. Infect. Immun., v. 56, p. 1771-1777, \n1988. \n \n \nCAVASSANI, K. A. Participa\u00e7\u00e3o de c\u00e9lulas T-reguladoras no controle da resposta \nimune durante a paracoccidioidomicose humana. 2006.  (Tese de doutorado) \u2013 \nFaculdade de Medicina, Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, 2006. \n \n \nCHIARELLA, A. P.; ARRUDA, C.; PINA, A.; COSTA, T. A.; FERREIRA, R. C.; \nCALICH, V. L. The relative importance of CD4+ and CD8+T cells in immunity to \npulmonary paracoccidioidomycosis. Microbes Infect., v. 9, p. 1078-1088, 2007. \n \n \nCOLTRI, K. C.; OLIVEIRA, L. L.; PINZAN, C. F.; VENDRUSCOLO, P. E.; \nMARTINEZ, R.; GOLDMAN, M. H.; PANUNTO-CASTELO, A.; ROQUE-\nBARREIRA, M. C. Therapeutic administration of KM+ lectin protects mice against \nParacoccidioides brasiliensis infection via interleukin-12 production in a toll-like \nreceptor 2-dependent mechanism. Am. J. Pathol., v. 173, p. 423-432, 2008. \n \n \nCOOPER, A. M. IL-23 and IL-17 have a multi-faceted largely negative role in fungal \ninfection. Eur. J. Immunol.,v. 37, p. 2680-2682, 2007.  \n\n \n \n\nCOUTINHO, Z. F.; SILVA, D.; LAZERA, M.; PETRI, V.; OLIVEIRA, R. M.; \nSABROZA, P. C.; WANKE, B. Paracoccidioidomycosis mortality in Brasil. Cad. \nSa\u00fade P\u00fablica, v. 18, p. 1441-1454, 2002. \n \n \nCUA, D.J.; KASTELEIN, R.A. TGF-?, a \u201cdouble agent\u201d in the immune pathology war. \nNat. Immunol., v. 7, p. 557-559, 2006. \n \n \nDE LUCA, A.; MONTAGNOLI, C.; ZELANTE, T.; BONIFAZI, P.; BOZZA, S.; \nMORETTI, S.; D'ANGELO, C.; VACCA, C.; BOON, L.; BISTONI, F.; PUCCETTI, \nP.; FALLARINO, F.; ROMANI, L. Functional yet balanced reactivity to Candida \nalbicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol., \nv. 179, p. 5999-6008,  2007. \n \n \n \n\n\n\n 120 \n\nDENNEHY, K.M.; FERWERDA, G.; FARO-TRINDADE, I.; PYZ, E.; WILLMENT, \nJ.A.; TAYLOR, P.R.; KERRIGAN, A.; TSONI S.V.; GORDON S.; MEYER-\nWENTRUP, F. Syk kinase is required for collaborative cytokine production induced \nthrough Dectin-1 and Toll-like receptors. Eur. J. Immunol., v. 38, p.500\u2013506, 2008. \n \n \nDIECKMANN, D.; PLOTTNER, H.; BERCHTOLD, S.; BERGER, T.; SCHULER, G.. \nEx vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory \nproperties from human blood. J. Exp. Med., v. 193, p. 1303-1310, 2001. \n \n \nDING, A. H.; NATHAN, C. F.; STUEHR, D. J. Release of reactive nitrogen \nintermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. \nImunol., v. 141, p. 2407-2412, 1988. \n \n \nDINIZ, S.N.; NOMIZO, R.; CISALPINO, P.S.; TEIXEIRA, M.M.; BROWN, G.D.; \nMANTOVANI, A.; GORDON, S.; REIS, L.F.; DIAS, A.A. PTX3 function as an \nopsonin for the dectin-1-dependent internalization of zymosan by macrophages. J. \nLeukoc. Biol., v. 75, p. 649-656, 2004. \n \n \nDOYLE, S. L.; O\u201dNEILL, L. A. J. Toll-like receptors: From the discovery of NFkB to \nnew insights into transcriptional regulation in innate immnunity. Biochem. Pharmacol., \nv. 72, p. 1102-1113, 2006. \n \n \nFAZIOLI, R. A. Paracoccidioidomicose experimental murina. Estudo da \nprolifera\u00e7\u00e3o e da contribui\u00e7\u00e3o de c\u00e9lulas T CD4\n\n+ \ne T CD8\n\n+ \nna resposta imune de \n\ncamundongos resistentes e suscept\u00edveis. 1997. (Tese de Doutorado) \u2013 Instituto de \nCi\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, 1977. \n \n \nFAVA NETTO, C. Estudos quantitativos sobre a fixa\u00e7\u00e3o do complemento na \nblastomicose sul-americana, com ant\u00edgeno polissacar\u00eddeo. Arq. Cir. Clin. Exp. S\u00e3o \nPaulo, v. 18, p. 197-254, 1955. \n  \n \nFERREIRA, K.S.; BASTOS, K.R.; RUSSO, M.; ALMEIDA, S.R. Interaction between \nParacoccidioides brasiliensis and pulmonary dendritic cells induces interleukin-10 \nproduction and toll-like receptor-2 expression: possible mechanisms of susceptibility. J. \nInfect. Dis., v. 196, p. 1108-1115, 2007. \n\n \n \n\nFERRETTI, S.; BONNEAU, O.; DUBOIS, G. R.; JONES, C. E.; TRIFILIEFF, A., IL-\n17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-\ninduced airway neutrophilia: IL-15 as a possible trigger. J. Immunol., v. 170, p. 2106-\n2112, 2003. \n \n\n\n\n 121 \n\nFERWERDA, G.. MEYER-WENTRUP, F.; KULLBERG, B.J.; NETEA. M.G.; \nADEMA. G.J. Dectin-1 synergizes with TLR-2 and TLR-4 for cytokine production in \nhuman primary monocytes and macrophages. Cell Microbiol., v. 10, p. 2058-2066, \n2008. \n \n \nFONTENOT, J.D.; RUDENSKY, A.Y. A well adapted regulatory contrivance: \nregulatory T cell development and the forkhead family transcription factor Foxp3. Nat. \nImmunol., v. 6, p. 331-337, 2005. \n\n \n \n\nFREMOND, C.M.; TOGBE, D.; DOZ, E.; ROSE, S.; VASSEUR, V.; MAILLET, I.; \nJACOBS, M.; RYFFEL. B.; QUESNIAUX, V.F. IL-1 receptor-mediated signal is an \nessential component of MyD88-dependent innate response to Mycobacterium \ntuberculosis infection. J. Immunol., v. 179, p. 1178-1189, 2007. \n \n \nGANTNER, B.N.; SIMMONS, R.M.; CANAVERA, S.J.; AKIRA, S.; UNDERHILL, \nD.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like \nreceptor 2. J. Exp. Med., v. 197, p. 1107-1117, 2003. \n \n \nGONZ\u00c1LEZ, A.; Y\u00c1\u00d1EZ, A.; GOZALBO, D.; GIL, M.L. MyD88 is dispensable for \nresistance to Paracoccidioides brasiliensis in a murine model of blood-borne \ndisseminated infection. FEMS Immunol. Med. Microbiol., v. 54, p. 365-374, 2008. \n \n \nGONZALEZ, A.; GREGORI, W.; VELEZ, D.; RESTREPO, A.; CANO, L. E. Nitric \noxide participation in the fungicidal mechanism of gamma interferon-activated murine \nmacrophages against Paracocciodioides brasiliensis conidia. Infect. Immun., v. 68, p. \n2456-2452, 2000. \n \n \nGOW, N.A.; NETEA, M.G.; MUNRO, C.A.; FERWERDA, G.; BATES, S.; MORA-\nMONTES, H.M.; WALKER, L.; JANSEN, T.; JACOBS, L.; TSONI, V.; BROWN, \nG.D.; ODDS, F.C.; VAN DER MEER, J.W.; BROWN, A.J.; KULLBERG, B.J. \nImmune recognition of Candida albicans beta-glucan by dectin-1. J. Infect. Dis., v. \n196, p. 1565-1571, 2007. \n \n \nGOZALBO, D.; GIL, M. L. TLR-2, but not TLR-4, triggers cytokine production by \nmurine cells in response of Candida albicans yest and hyphae.  Microbes and Infect., \nv. 8, p. 2299-2304, 2006. \n\n \n \n\nHAPPEL, K. I.; ZHENG, M.; YOUNG, E.; QUINTON, L. J.; LOCKHART, E.; \nRAMSAY, A. J.; SHELLITO, J. E. Cutting edge: roles of Toll-like receptor 4 and IL-23 \nin IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol., v. \n170, p. 4432-4436, 2003. \n \n\n\n\n 122 \n\nHATANO, Y.; TANIUCHI, S.; MASUDA, M.; TSUJI. S.; ITO, T.; HASUI. M.; \nKOBAYASHI. Y.; KANEKO, K. Phagocytosis of heat-killed Staphylococcus aureus by \neosinophils: comparison with neutrophils. APMIS, v. 117, p. 115-23, 2009. \n \n \nHORI, S.; NOMURA, T.; SAKAGUCHI, S. Control of regulatory T cell development \nby the transcription factor Foxp3. Science., v. 299, p.1057-1061, 2003. \n \n \nHOFFMANN, J. A.; KAFATOS, F.C.; JANEWAY, C. A.; EZEKOWITZ, R. A. \nPhylogenetic perspective in innate immunity. Science, v. 284, p. 1313-1316, 1999. \n \n\n \n\nHUANG, W.; NA, L.; FIDEL, P.L.; SCHWARZENBERGER, P. Requirement of \ninterleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. \nDis., v. 190, p. 624-631, 2004. \n \n \n HUFFNAGLE, G.B.; YATES, J.L.; LIPSCOMB, M. Immunity to a pulmonary \nCryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. \nMed., v. 173, p. 793-800, 1991. \n \n \nIVANOV, S.; BOZINOVSKI, S.; BOSSIOS, A.; VALADI, H.; VLAHOS, R.; \nMALMH\u00c4LL, C.; SJ\u00d6STRAND, M.; KOLLS, J.K.; ANDERSON, G.P.; LIND\u00c9N, A. \nFunctional relevance of the IL-23-IL-17 axis in lungs in vivo.  Am. J. Respir. Cell. \nMol. Biol., v. 36, p. 442-451, 2007. \n \n \nJIMENEZ, M. P.; RESTREPO, A.; RADZIOCH, D.; CANO, L.E.; GARCIA, L. F. \nImportance of complement 3 and mannose receptors in phagocytosis of \nParacoccidioides brasiliensis conidia by Nramp1 congenic macrophages lines. \nImmunol. Med. Micobiol., v. 47, p. 56-66, 2006. \n\n \n \n\nKARHAWI, A. S. K.; COLOMBO, A. L.; SALOM\u00c3O, R. Production of IFN-? is \nimpaired in patients with paracoccidioidomycosis during active disease and is restored \nafter clinical remission. Med. Mycol., v. 38, p. 225-229, 1999.    \n  \n \nKASHINO, S. S.; CALICH, V. L. G.; BURGER, E.; SINGERS-VERMES, L. M. In \nvivo and in vitro characteristics of six Paracoccidioides brasiliensis strains. \nMycopathol., v. 92, p. 173-178, 1985. \n \n \nKASHINO, S. S.; FAZIOLI, R. A.; MOSCARDI-BACCHI, M.; FRANCO, M.; \nSINGER-VERMES, L. M.; BURGER, E.; CALICH, V. L. G. Effect of macrophage \nblockade on the resistance of inbred mice to Paracoccidioides brasiliensis infection. \nMycopathol., v. 130, p. 131-140, 1995. \n\n\n\n 123 \n\nKATTAH, M.G.; WONG, M.T.; YOCUM, M.D.; UTZ, P.J. Cytokines secreted in \nresponse to Toll-like receptor ligand stimulation modulate differentiation of human \nTh17 cells. Arthritis Rheum., v. 58, p.1619-1629, 2008. \n \n \nKOBAYASHI, Y. The role of chemokines in neutrophil biology. Front. Biosci., v. 13, \np. 2400-2407, 2008. \n \n \nKOLLS, J.K.; LINDEN, A. Interleukin-17 family members and inflammation. \nImmunity, v. 21, p. 467-476, 2004. \n \n \nKORN, T.; BETTELLI, E.; OUKKA, M.; KUCHROO, V.K. IL-17 and Th17 Cells. \nAnnu. Rev. Immunol., v. 27, p. 485-517, 2009, Review. \n \n \nLEIBUNDGUT-LANDMANN, S.; GROSS, O.; ROBINSON, M.J.; OSORIO, F.; \nSLACK, E.C.; TSONI, S.V.; SCHWEIGHOFFER, E.; TYBULEWICZ, V.; BROWN, \nG.D.; RULAND, J.; REIS E SOUSA, C. Syk- and CARD9-dependent coupling of \ninnate immunity to the induction of T helper cells that produce interleukin 17. Nat. \nImmunol., v. 8, p. 630-638, 2007. \n\n \n \n\nLEY, K.; SMITH, E.; STARK, M.A. IL-17A-producing neutrophil-regulatory T \nlymphocytes. Immunol. Res., v. 34, p. 229-242, 2006. \n\n  \n  \n\nLIANG, S.C.; LONG, A.J.; BENNETT, F.,  WHITTERS, M.J.; KARIM, R.;  \nCOLLINS, M.; GOLDMAN, S.J.; DUNUSSI-JOANNOPOULOS, K. WILLIAMS, \nC.M.; WRIGHT, J.F.; FOUSER, L.A. An IL-17F/A heterodimer protein is produced by \nmouse Th17 cells and induces airway neutrophil recruitment. J. Immunol., v. 179, p. \n7791-7799, 2007. \n\n \n \n\nLIND\u00c9N, A.; LAAN, M., ANDERSON, J.P. Neutrophils, interleukin-17A and lung \ndisease. Eur. Respir. J., v. 25, p. 159-172, 2005. \n \n \nLIU, G.; ZHAO, Y. 2007. Toll-like receptors and immune regulation: their direct and \nindirect modulation on regulatory CD4+ CD25+ T cells. Immunology, v. 122, p.149-\n156, 2007. \n \n \nLOURES, F.V.; PINA, A.; FELONATO, M.; ARA\u00daJO, E.F.; LEITE, K.R.; CALICH, \nV.L. TLR-4 signaling leads to a more severe fungal infection associated with enhanced \nproinflammatory immunity and impaired expansion of regulatory T cells. Infect. \nImmun. 2010.  \n \n \n\n\n\n 124 \n\nLOURES, F.V.; PINA, A.; FELONATO. M.; CALICH, V.L. TLR-2 is a negative \nregulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. \nJ. Immunol., v. 183, p. 1279-1290, 2009. \n \n \nMACMICKING, J.; XIE, Q.W.; NATHAN, C. Nitric oxide and macrophage function. \nAnnu. Rev. Immunol., v. 15, p. 323-350, 1997. \n \n \nMAMONI, R. L.; NOUER, A. S. A.; OLIVEIRA, S. A.; MUSATTI, C. C.; ROSSI, C. \nL.; CAMARGO, Z. P.; BLOTTA, M. H. S. Enhanced production of specific IgG4, IgE, \nIgA e TGF-? in sera from patients with the juvenile form of paracoccidioidomycosis. \nMed. Mycology, v. 40, p. 1-7, 2002. \n \n \nMANGAN, P.R.; HARRINGTON, L.E.; O'QUINN. D.B.; HELMS, W.S.; BULLARD, \nD.C.; ELSON, C.O.; HATTON, R.D.; WAHL, S.M.; SCHOEB, T.R.; WEAVER, C.T. \nTransforming growth factor-beta induces development of the T(H)17 lineage. Nature., \nv. 441, p. 231-234, 2006. \n \n\n \nMANICASSAMY, S.; RAVINDRAN, R.; DENG, J.; OLUOCH. H.; DENNING, T.; \nKASTURI, S.P.; ROSENTHAL, K.M.; EVAVOLD, B.D.; PULENDRAN, B. Toll-like \nreceptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells \npromotes T regulatory responses and inhibits autoimmunity. Nat. Med., v. 15, p. 401-\n409, 2009. \n \n \nMENDES-GIANNINI, M. J. S.; DEL NEGRO, G. B.; SIQUEIRA, A. M. Serodiagnosis \nIn: M. Franco, C. da Silva Lacaz, A. Restrepo, and G. del Negro (ed.), \nParacoccidioidomycosis. CRC Press, Inc., Boca Raton. 345-363, 1984.. \n \n \nMICHEL, M.L.; KELLER, A.C.; PAGET, C.; FUJIO, M.; TROTTEIN, F.; SAVAGE, \nP.B.; WONG, C.H.; SCHNEIDER, E.; DY, M.;  LEITE-DE-MORAES, M.C. \nIdentification of an IL-17-producing NK1.1(neg) iNKT cell population involved in \nairway neutrophilia. J. Exp. Med., v. 204, p. 995-1001, 2007. \n \n \nMICHEL, M.L.; MENDES-DA-CRUZ, D.; KELLER, A.C.; LOCHNER, M.; \nSCHNEIDER, E.; DY, M.; EBERL, G.; LEITE-DE-MORAES, M.C. Critical role of \nROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell \ndifferentiation. Proc. Natl. Acad. Sci. U S A., v. 105, p. 19845-19850, 2008. \n \n \nMILLS, K.H. Induction, function and regulation of IL-17-producing T cells. Eur. J. \nImmunol., v. 38, p. 2636-2649, 2008. \n \n \n\n\n\n 125 \n\nMIYAMOTO, M.; PRAUSE, O.; SJ\u00d6STRAND, M.; LAAN, M.; L\u00d6TVALL, J.; \nLIND\u00c9N, A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by \nendotoxin exposure in mouse airways. J. Immunol., v. 170, p. 4665-4672, 2003. \n \n \nMONTENEGRO, M. R.; FRANCO, M. Pathology. In: Franco, M., Lacaz, C. S., \nRestrepo-Moreno, A. and Del Negro, G. (Ed.), Paracoccidioidomycosis. CRC Press, \nInc., Boca Raton, Fla. 131-147, 1994. \n \n \nNAKAMURA, K.; KITANI, A.; FUSS, I.; PEDERSEN, A.; HARADA, N.; NAWATA, \nH.; STROBER, W. TGF-beta 1 plays an important role in the mechanism of \nCD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol., v. 172, \np. 834-842, 2004. \n \n \nNASCIMENTO, F. R.; CALICH, V. L. G.; RODRIGUEZ, D.; RUSSO, M. Dual role \nfor nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction \nassociated with susceptibility. J. Immunol., v. 168, p. 4593-4600, 2002. \n \n \nNETEA, M.G.; FERWERDA. G.; VAN DER GRAAF. C.A.; VAN DER MEER. J.W.; \nKULLBERG. B.J. Recognition of fungal by tool-like receptors. Curr. Pharm. Des., v. \n12, p. 4195-4201, 2006. \n \n \nNETEA, M.G.; SUTMULLER, R.; HERMANN, C.; VAN DER GRAAF, C.A.; VAN \nDER MEER, J.W.; VAN KRIEKEN, J.H.; HARTUNG, T.; ADEMA, G.; KULLBERG, \nB.J. Toll-like receptor 2 suppresses immunity against Candida albicans through \ninduction of IL-10 and regulatory T cells. J. Immunol., v. 72, p. 3712-3718, 2004. \n \n \nNETEA, M. G.; WARRIS, A.; VAN DE MEER, J. W. M.; FENTON, M. J.;    \nVERVER-JANSSEN, T. J.G.; JACOBS., L. E. H.; ANDRESEN, T.; VERWEIJ, P.  E.; \nKULLBERG, B. J. Aspergillus fumigatus evades immune recognition during \ngermination through loss of Toll-Like Receptor-4-mediated signal transduction. J. \nInfect. Dis., v. 188, p. 320-326, 2003. \n \n \nNICHOLS, J.R.; ALDRICH, A.L.; MARIANI, M.M.; VIDLAK, D.; ESEN, N.; \nKIELIAN, T. TLR-2 deficiency leads to increased Th17 infiltrates in experimental brain \nabscesses. J. Immunol., v. 182, p. 7119-7130, 2009. \n \n \nOLIVEIRA, A. C.; PEIXOTO, J. R.; ARRUDA, L. B.; CAMPOS, M. A.; \nGAZZINELLI, R. T.; GOLENBOCK, D. T.; AKIRA, S.; PREVIATO, J. O.; \nPREVIATO, L. M.; NOBREGA, A.; BELLIO, M. Expression of functional TLR-4 \nconfers proinflammatory responsives to Trypanossoma cruzi and higher resistence to \ninfection with T. Cruzi. J. Immunol., v. 173, p. 5688-5696, 2004. \n \n\n\n\n 126 \n\nOLIVEIRA, S.J.; MAMONI, R.L.; MUSATTI, C.C.; PAPAIORDANOU, P.M.; \nBLOTTA, M.H. Cytokines and lymphocyte proliferation in juvenile and adult forms of \nparacoccidioidomycosis: comparison with infected and non-infected controls. Microbes \nInfect., v. 4, p. 139-144, 2002. \n \n \nO'NEILL, L.A.; BOWIE, A.G. The family of five: TIR-domain-containing adaptors in \nToll-like receptor signalling. Nat. Rev. Immunol., v. 7, p. 353-364. 2007, Review. \n \n \nPALM, N.W.; MEDZHITOV, R. ANTIFUNGAL DEFENSE TURNS 17. Nat. \nImmunol., v. 8, p. 549-551, 2007. \n \n \nPINA, A.; BERNARDINO, S.; CALICH, V.L. Alveolar macrophages from susceptible \nmice are more competent than those of resistant mice to control initial Paracoccidioides \nbrasiliensis infection. J Leukoc Biol., v. 83, p. 1088-1099, 2008.  \n \n \nPINA, A.; SALDIVA, P.H.N.; RESTREPO, L.E.C; CALICH V. L. G.  Neutrophil role \nin pulmonary paracoccidioidomycosis depends on the resistance pattern of hosts. J. \nLeukoc. Biol., v. 79, p. 1202-1213, 2006. \n \n \nRAOUST, E.; BALLOY, V.; GARCIA-VERDUGO, I.; TOUQUI, L.; RAMPHAL, R.; \nCHIGNARD, M. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate \nTLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. \nPLoS One, v. 4, p. 7259-7266, 2009. \n \n \nRESTREPO, A. The ecology of Paracoccidioides brasiliensis: a puzzle still unsolved. \nJ. Med. Vet. Mycol., v. 23, p. 323-334, 1985. \n \n \nRESTREPO, A.; MCEWEN, J. G.; CASTANEDA, E. The habitat of Paracoccidioides \nbrasiliensis: how far from solving the riddle? Med. Mycol., v. 39, p. 232-241, 2001. \n \n \nRESTREPO, A. Immune responses to Paracoccidioides brasiliensis in human and \nanimal hosts. In: McGinnis, M. R. (ed.), Current Topics in Medical Mycology. Springer \nVerlag, New York. 239-275, 1988. \n \n \nRESTREPO-MORENO, A. Ecology of Paracoccidioides brasiliensis. In: FRANCO, \nM.; LACAZ, C.S.; RESTREPO-MORENO, A.; DEL NEGRO G. (Ed.). \nParacoccidioidomycosis. Boca Ratton: CRC Press, cap. 8, 1994. \n \n \n\n\n\n 127 \n\nRESTREPO-MORENO, A. Ecology of Paracoccidioides brasiliensis. In: FRANCO, \nM.; LACAZ, C.S.; RESTREPO-MORENO, A.; DEL NEGRO G. (Ed.). \nParacoccidioidomycosis. Boca Ratton: CRC Press, cap. 8, 1994. \n \n \nROPERT, C.; FRANKLIN, B.S.; GAZZINELLI, R.T. Role of TLRs/MyD88 in host \nresistance and pathogenesis during protozoan infection: lessons from malaria. Semin. \nImmunopathol., v. 30, p. 41-51, 2008.       \n \n \nROMANI, L.; FALLARINO,  F.; DE LUCA, A.; MONTAGNOLI, C.;  D\u2019ANGELO, \nC.; ZELANTE, T.; VACCA, C.;BISTONI, F.; FIORETTI, M.C.; GROHMANN, U.; \nSEGAL, B.H.; PUCCETI, P. Defective tryptophan catabolism underlies inflammation \nin mouse chronic granulomatous disease. Nature, v. 451, p. 211-215, 2008. \n \n \nROMANI, L.; ZELANTE, T.; DE LUCA, A.; FALLARINO, F.; PUCCETTI, P. IL-17 \nand therapeutic kynurenines in pathogenic inflammation to fungi. J. Immunol., v. 180, \np. 5157-5162 , 2008. \n \n \nRUAS, L.P.; BERNARDES, E.S.; FERMINO,  M.L.; DE OLIVEIRA, L.L.; HSU. \nD.K.; LIU, F.T.; CHAMMAS, R.; ROQUE-BARREIRA, M.C. Lack of galectin-3 \ndrives response to Paracoccidioides brasiliensis toward a Th2-biased immunity. PLoS \nOne., v. 4, p. 4519-4524, 2009. \n \n \nSAN-BLAS, F.; SAN-BLAS, G.; INLOW, D. Dimorphism in Paracoccidioides \nbrasiliensis. Zentralbl. Bakteriol., v. 8, p. 23-28, 1980. \n \n \nSINGER-VERMES, L.M.; CIAVAGLIA, M. C.; KASHINO, S. S.; BURGER, E.; \nCALICH, V. L. G. The source of the growth-promoting factor (s) affects the plating \neficiency of Paracoccidioides brasiliensis. J. Med.Vet. Mycol., v. 30, p. 261-264, \n1992. \n \n \nSOUTO, J. T.; FIGUEIREDO, F.; FURLANETTO, A.; PFEFFER, K.; ROSSI, M. A.; \nSILVA, J. S. Interferon-gamma and tumor necrosis factor-alpha determine resistance to \nParacoccidioides brasiliensis infection in mice. Am. J. Pathol., v. 156, p. 1811-1820, \n2000. \n \n \nSOUTO, J. T.; ALIBERT, J. C.; CAMPANELLI, A. P.; LIVONESI, M. C.; MAFFEI, \nC. M. L.; FERREIRA, B. R.; TRAVASSOS, L. R.; MARTINEZ, R.; ROSSI, M. \u00aa; \nSILVA, J. S. Chemokine production and leukocyte recruitment to the lungs of \nParacoccidioides brasiliensis-infected mice is modulated by IFN-?. Am. J. Pathol., v. \n163, p. 583-590, 2003 \n \n \n\n\n\n 128 \n\nSTOCKINGER, B.; VELDHOEN, M.  Diffrentiation and function of Th17 T cells. \nCurr. Opin. Immunol., v. 19, p. 281-286, 2007. \n\n \n       \n\nSUFFIA, I.J.; RECKLING, S.K.; PICCIRILLO, C.A.; GOLDSZMID, R.S.; BELKAID, \nY. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial \nantigens. J. Exp. Med., v. 203, p.777-788, 2006. \n \n \nSUTMULLER, R.P.; MORGAN, M.E.; NETEA, M.G.; GRAUER, O.; ADEMA, G.J. \nToll-like receptors on regulatory T cells: expanding immune regulation. Trends \nImmunol., v. 27, p. 387-393, 2006. \n \n \nSUTMULLER, R.; GARRISTEN, A.; ADEMA, G.J. Regulatory T cells and toll-like \nreceptors: regulanting the regulators. Ann. Rheum. Dis., v. 66, p. 91-95, 2007. \n \n \nSUTTON, C.; BRERETON, C.; KEOGH, B.; MILLS, K. H. G.; LAVELLE, C. A \ncrucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that \nmediate autoimmune encephalomyelitis. J. Exp. Med., v. 203, p. 1685-1691, 2006. \n \n \nTAKEDA, K.; KAISHO, T.; AKIRA, S. Toll-like receptors. Annu. Rev. Immunol., v, \n21, p. 335-343, 2003. \n \n \nTHOMA-USZYNSKI, S.; STENGER, S.; TAKEUCHI, O.; OCHOA, M. T.; ENGELE, \nM.; SIELING, P. A.; BARNES, P. F.; ROLLINGHOFF, M.; BOLCSKEI, P. L.; \nWAGNER, M.; AKIRA, S.; NORGARD, M. V.; BELISLE, J. T.; GODOWSKI, P. J.; \nBLOOM, B. R.; MODLIN, R. L.. Induction of direct antimicrobial activity through \nmammalian toll-like receptors. Science, v. 21, p. 1544-1547, 2001. \n \n \n\nTHOMPSON, J. M.; IWASAKI, A. Toll-like receptors regulation of viral infection and \ndisease.  Adv. Drug. Deliv. Rev., v. 60, p. 786-794, 2008, Review. \n \n \nTRINCHIERI, G.; SHER, A. Cooperation of Toll-like receptor signals in innate \nimmune defence. Nat. Rev. Immunol., v. 7, p. 179-190, 2007. \n \n \nTUEHR, D. J.; MARLETTA, M. A. Induction of nitrite/nitrate synthesis in murine \nmacrophages by BCG infection, lymphokines, IFN-?. J. Immunol., v. 139, p. 518-526, \n1987.  \n \n \n \n \n\n\n\n 129 \n\nVAZ, C. A.; SINGER-VERMES, L. M.; CALICH, V. L. G. Comparative studies on the \nantibody repertoire produced by susceptible and resistent mice to virulent and \nnonvirulent Paracaccidioides brasiliensis isolates. Am. J. Trop. Med. Hyg., v. 59, p. \n971-977, 1998. \n \n \nVIRIYAKOSOL, S.; FIERER, J.; BROWN, G. D.; KIRKLAND, T. N. Innate immunity \nto the pathogenic fungus Coccidioides posadasii is dependent on Toll-Like Receptor 2 \nand Dectin-1. Infect. Immun., v. 73, p.1553-1560, 2004. \n \n \nWHERRY, E.J.; TEICHGR\u00c4BER, V.; BECKER, T.C.; MASOPUST, D.; KAECH, \nS.M.; ANTIA, R.; VON ANDRIAN, U.H.; AHMED, R.. Lineage relationship and \nprotective immunity of memory CD8 T cell subsets. Nat. Immunol., v. 4, p. 225-234, \n2003. \n \n \nWIERSINGA, W.J.; WIELAND, C.W.; ROELOFS, J.J.; VAN DER POLL, T. MyD88 \ndependent signaling contributes to protective host defense against Burkholderia \npseudomallei. PLoS One, v. 3, p. 3494-3499, 2008. \n \n \nWIRTZ, S.; BECKER, C.; FANTINI, M.C.; NIEUWENHUIS, E.E.; TUBBE, I.; \nGALLE, P.R.; SCHILD, H.J.; BIRKENBACH, M., BLUMBERG, R.S.; NEURATH, \nM.F. EBV-induced gene 3 transcription is induced by TLR signaling in primary \ndendritic cells via NF-kappa B activation. J. Immunol., v. 174, p. 2814-24, 2005. \n \n \nWU, Q.; MARTIN, R.J.; RINO, J.G.; BREED, R.; TORRES, R.M.; CHU, H.W. IL-23-\ndependent IL-17 production is essential in neutrophil recruitment and activity in mouse \nlung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect., \nv. 9, p. 78-86, 2007. \n \n \nYAO, Z.; PAINTER, S. L.; FANSLOW, W. C.; ULRICH, D.; MACDUFF, B. M.; \nSPRIGGS, M. K.; ARMITAGE, R. J., Human IL-17: a novel cytokine derived from T \ncells. J. Immunol., v. 155, p. 5483-5486, 1995. \n \n \nYE, P.; RODRIGUEZ, F.H.; KANALY, S.; STOCKING, H.L.; SCHURR, J.; \nSCHWARZENBERGER, P.;  OLIVER, P.; HUANG, W.; ZHANG, P.; SHELLITO, \nJ.E.; BAGBY, G.J.; NELSON, S.; CHARRIER, K.; PESCHON, J.J.; KOLLS, J.K. \nRequirement of interleukin 17 receptor signaling for lung CXC chemokine and \ngranulocyte colony-stimulating factor expression, neutrophil recruitment, and host \ndefense. J. Exp. Med., v. 194, p. 519-527, 2001. \n \n \nZANIN-ZHOROV, A,; CAHALON, L.; TAL, G.; MARGALIT, R.; LIDER, O.; \nCOHEN, I.R. Heat shock protein 60 enhances CD4CD25 regulatory T cell function via \ninnate TLR-2 signaling. J. Clin. Invest., v. 116, p. 2022-2032, 2006. \n\n\n\n 130 \n\nZELANTE, T.; DE LUCA, A.; BONIFAZI, P.; MONTAGNOLI, C.; BOZZA, S.; \nMORETTI, S.; BELLADONNA, M.L.; VACCA, C.; CONTE, C.; MOSCI, P.; \nBISTONI, F.; PUCCETTI, P.; KASTELEIN, R.A.; KOPF, M.; ROMANI, L. IL-23 and \nthe Th17 pathway promote inflammation and impair antifungal immune resistance. \nEur. J. Immunol., v. 37, p. 2695-2706, 2007. \n \n \nZHOU, X.; BAILEY-BUCKTROUT. S.; JEKER, L.T.; BLUESTONE, J.A. Plasticity \nof CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol., v. 21, p. 281-285, 2009, Review. \n\n\n\nInnate immunity to Paracoccidioides brasiliensis infection\n\nVera Lu?cia Garcia Calich \u00c6 Ta?nia Alves da Costa \u00c6\nMa??ra Felonato \u00c6 Celina Arruda \u00c6 Simone Bernardino \u00c6\nFla?vio Vieira Loures \u00c6 Laura Raquel Rios Ribeiro \u00c6\nRita de Ca?ssia Valente-Ferreira \u00c6 Adriana Pina\n\nReceived: 8 May 2007 / Accepted: 7 August 2007\n\n? Springer Science+Business Media B.V. 2007\n\nAbstract Innate immunity is based in pre-existing\n\nelements of the immune system that directly interact\n\nwith all types of microbes leading to their destruction\n\nor growth inhibition. Several elements of this early\n\ndefense mechanism act in concert to control initial\n\npathogen growth and have profound effect on the\n\nadaptative immune response that further develops.\n\nAlthough most studies in paracoccidioidomycosis\n\nhave been dedicated to understand cellular and\n\nhumoral immune responses, innate immunity remains\n\npoorly defined. Hence, the main purpose of this\n\nreview is to present and discuss some mechanisms of\n\ninnate immunity developed by resistant and suscep-\n\ntible mice to Paracoccidioides brasiliensis infection,\n\ntrying to understand how this initial host-pathogen\n\ninterface interferes with the protective or deleterious\n\nadaptative immune response that will dictate disease\n\noutcome. An analysis of some mechanisms and\n\nmediators of innate immunity such as the activation\n\nof complement proteins, the microbicidal activity of\n\nnatural killer cells and phagocytes, the production of\n\ninflammatory eicosanoids, cytokines, and chemokines\n\namong others, is presented trying to show the\n\nimportant role played by innate immunity in the host\n\nresponse to P. brasiliensis infection.\n\nKeywords Cytokines ? Dendritic cells ?\nInnate immunity ? Macrophages ?\nNK and PMN Cells ?\nParacoccidioides brasiliensis infection\n\nIntroduction\n\nInnate immunity has been defined as the first phase of\n\nimmune response and is based in pre-existing\n\nelements of the immune system that directly interact\n\nwith all types of microbes leading to their destruction\n\nor growth inhibition. Innate immunity, which is not\n\nclonally specific for a particular pathogen and does\n\nnot generate specific memory, is mediated by phys-\n\nical barriers, chemical elements, and cell components\n\nof the immune system. The adaptative immunity,\n\ninvolving more slowly developing, long-lived, and\n\nhighly antigen-specific responses are mediated by\n\ncell-mediated immunity and antibody production.\n\nSeveral elements of innate immunity act in concert to\n\ncontrol initial pathogen growth and have profound\n\neffect on the adaptative immune response that further\n\ndevelops. Furthermore, most effector mechanisms of\n\ninnate immunity are identical to those of adaptative\n\nimmunity that are activated at later phases of immune\n\nresponse.\n\nV. L. G. Calich (&amp;) ? T. A. da Costa ?\nM. Felonato ? C. Arruda ? S. Bernardino ?\nF. V. Loures ? L. R. R. Ribeiro ?\nR. de Ca?ssia Valente-Ferreira ? A. Pina\nDepartamento de Imunologia, Instituto de Cie?ncias\n\nBiome?dicas da Universidade de Sa?o Paulo (USP),\n\nAv. Prof. Lineu Prestes 1730, CEP 05508-900, Sao Paulo,\n\nSP, Brazil\n\ne-mail: vlcalich@icb.usp.br\n\n123\n\nMycopathologia (2008) 165:223\u2013236\n\nDOI 10.1007/s11046-007-9048-1\n\n\n\nSeveral mechanisms of innate immunity such as\n\nthe activation of complement proteins, the microbi-\n\ncidal activity of natural killer (NK) cells and\n\nphagocytes, the production of inflammatory cytokines\n\nand chemokines among others, have been shown to\n\nplay an important role in the early host response to\n\npathogens [1]. Besides their intrinsic complexities,\n\ninnate immunity mechanisms present important\n\npeculiarities which depend on the site they take\n\nplace [2]. The innate immune response against\n\nParacoccidioides brasiliensis, Coccidioides immitis,\n\nBlastomyces dermatitides, and Histoplasma capsula-\n\ntum, primary fungal pathogens which infect hosts\n\nthrough the respiratory tract, occurs in the lungs. The\n\nlung response to infection is initiated by the secretion\n\nof several antimicrobial proteins by the pulmonary\n\nepithelium and the phagocytic activity of resident\n\nalveolar macrophages. The cell-wall-degrading\n\nenzyme lyzozyme, the iron-chelating protein lacto-\n\nferrin and the membrane-permeabilizing members of\n\nthe defensin, cathelicidin, and pentraxin families are\n\nthe initial antimicrobial proteins secreted in the\n\nalveolar lining layer of the pulmonary epithelium.\n\nInnate immunity recognition of microorganism is\n\nmediated by germ-line encoded receptors (\u2018\u2018pattern\n\nrecognition receptors, PRR\u2019\u2019) which interact with\n\nconserved pathogen structures, the so-called \u2018\u2018patho-\n\ngen associated molecular patterns\u2019\u2019 or \u2018\u2018PAMP\u2019\u2019\n\n[3\u20135]. The initial macrophage-pathogen interaction\n\nresults in internalization by the activated cell which\n\ncan kill the organism through the action of reactive\n\noxygen species and lytic enzymes or extracellular\n\nmicrobial containment. In addition, the secretion of\n\nchemokines and cytokines orchestrates the expression\n\nof cell adhesion and chemotactic molecules which\n\nfurther control the influx and activation of inflamma-\n\ntory cells to the site of infection [1\u20135].\n\nAlthough most studies in human PCM have been\n\ndedicated to understand cellular and humoral immune\n\nresponses, innate immunity remains poorly defined.\n\nThis is easily understood when one reminds that PCM\n\ninfection and disease in human beings are recognized\n\nat a later and undefined period after initial infection,\n\nmaking difficult to evoke the early events which\n\nresulted in controlled infection or overt disease. In\n\nthis aspect, experimental models are powerful tools to\n\nstudy the initial events that govern hosts-P. brasili-\n\nensis interactions. Thus, the main purpose of this\n\nreview is to present and discuss some mechanisms of\n\ninnate immunity to P. brasiliensis infection, trying to\n\nunderstand how this initial host-pathogen interface\n\ninterferes with the protective or deleterious adapta-\n\ntive immune response that will dictate disease\n\noutcome. This review does not intend to be a\n\ncomprehensive revision of the PCM literature that\n\nhas been reported elsewhere [6\u201310], but to present a\n\npersonal view, mainly based in the murine model of\n\ngenetic resistance and susceptibility to P. brasiliensis,\n\nof how innate immunity can influence PCM severity\n\nand the adaptative immune response to this pathogen.\n\nThe isogenic murine model of resistance/\n\nsusceptibility of paracoccidioidomycosis mimics\n\nthe human disease\n\nOur laboratory established a genetically controlled\n\nmurine model of paracoccidioidomycosis (PCM),\n\nwhich allowed us to investigate several parameters of\n\nhost-parasite interactions. Most of these studies were\n\nrecently reviewed [10\u201313] and clearly showed the\n\ndiverging immune responses mounted by genetically\n\nsusceptible (B10.A) and resistant (A/Sn or A/J) mice to\n\nP. brasiliensis infection. One important characteristic of\n\nour model is the similarity with the human disease,\n\nB10.A mice mimicking the progressive, severe forms of\n\nthe disease and A/Sn mice showing similar features of\n\nthe regressive or localized forms of the infection\n\n(Fig. 1). As in the human disease, our experimental\n\nmodel demonstrated that resistance is associated with\n\nimmune responses that favor cellular immunity and\n\nactivation of phagocytes, whereas susceptibility is\n\nassociated with impairment of cellular immune\n\nresponses and preferential activation of B cells [10\u201312].\n\nAfter an intra-tracheal (i.t.) infection, the suscep-\n\ntibility and resistance patterns observed following i.p.\n\ninfection were maintained, as reflected by the high\n\nmortality rates of B10.A mice and the regressive\n\ndisease developed by the A/J strain. The susceptible\n\nmice were not able to restrain the infection to the\n\nlungs and, 2 months after infection, dissemination to\n\nliver and spleen was seen, characterizing a chronic,\n\nprogressive and disseminated form of the disease; in\n\nthe resistant mice, on the other hand, no organ\n\n224 Mycopathologia (2008) 165:223\u2013236\n\n123\n\n\n\ndissemination occurred and a pulmonary-restricted\n\nchronic disease was observed. Unexpectedly, early in\n\nthe i.t. infection (2nd and 4th weeks), A/J mice\n\npresented higher pulmonary CFU counts than B10.A\n\nmice suggesting that susceptible mice developed a\n\nmore efficient innate immunity than resistant animals.\n\nThe adaptative immunity of resistant mice appears to\n\ncompensate their ineffective innate immunity\n\n(Fig. 2). Accordingly, from week 8 of infection\n\nonward, positive DTH responses, marked control of\n\nfungal burdens, secretion of pulmonary type 1 and\n\ntype 2 cytokines and preferential production of IgG2a\n\nantibodies were seen, leading to a regressive pattern\n\nof disease. On the contrary, the anergy of DTH\n\nreactions, the preferential synthesis of IgG1 and\n\nIgG2b antibodies and the progressively increased\n\nfungal burdens of susceptible mice resulted in severe\n\ndisseminated disease leading to decreased survival\n\ntimes [14, 15].\n\nInnate immunity\n\nGenetic control of susceptibility\n\nClinical studies suggested that susceptibility to P.\n\nbrasiliensis is dependent on several factors, including\n\ngenetic background, and host\u2019s hormonal function\n\n[4\u20137]. A fungal receptor for estrogen was identified\n\nand appears to block the conversion of conidia or\n\nmycelium to the infecting yeast form [16]. This\n\nfinding was further explored in an animal model of\n\ninfection demonstrating the enhanced resistance of\n\nfemale animals [17, 18] and may explain the unusual\n\nsusceptibility of male individuals of endemic areas\n\n[6, 8, 19].\n\nGenetic studies performed by our group have\n\nshown the existence of an autosomal dominant gene\n\n(Pbr gene), which control P. brasiliensis resistance\n\n[20] and appears to be similar to the Nramp gene, that\n\ncontrol resistance to Mycobacterium sp, Leishmania\n\nsp, and Salmonella sp infection [21]. Further studies\n\nwith Nramp1 congenic macrophages (B10R and\n\nB10S expressing or not the Nramp1 protein, respec-\n\ntively) showed that B10R macrophages, in\n\ncomparison with B10S cells, expressed higher levels\n\nof mannose receptors, presented higher phagocytic\n\nability and increased inhibitory effect on the conidia\n\nto yeast conversion [22].\n\nComplement system and chemokines\n\nP. brasiliensis cells are able to activate the alternative\n\npathway of complement and yeast cells-adherent C3b\n\nFig. 1 Main features of the isogenic murine model of\nresistance and susceptibility to Paracoccidioides brasiliensis\ninfection\n\nFig. 2 At the onset of infection, susceptible (B10.A) mice\nshow a better control of pulmonary fungal loads than resistant\n\n(A/J) mice. A/J and B10.A mice were i.t. infected with one\n\nmillion P. brasiliensis yeast cells. The graph on the left shows\n\nthe recovery of viable fungal cell from lungs (colony forming\n\nunit counts, CFU), and the graph on the right the delayed\n\nhypersensitivity (DTH) responses measured during 16 weeks\n\nof infection\n\nMycopathologia (2008) 165:223\u2013236 225\n\n123\n\n\n\nmolecules can contribute to fungi phagocytosis by\n\nmacrophages [23\u201325]. On the other hand, chemokin-\n\nes which play a major role in regulating the migration\n\nof specific leukocytes subsets in both the acute and\n\nchronic inflammatory processes [26], were shown to\n\ncontrol mononuclear cell recruitment to the lungs of\n\nP. brasiliensis-infected C57BL/6 mice [27]. Unpub-\n\nlished results from our laboratory suggest that\n\nincreased and sustained expression of IP-10, RAN-\n\nTES and the chemokine receptor CXCR3 is\n\nassociated with the resistant behavior of A/Sn mice\n\n(C. Arruda and V. L. G. Calich, unpublished obser-\n\nvations). This is in accordance with the sustained T\n\ncell response mounted by resistant mice at the\n\nacquired phase of the immune response [14, 15].\n\nLipid mediators (Eicosanoids) and P. brasiliensis\n\nlipids\n\nDuring an inflammatory reaction, the enzymatic\n\noxidation of aracdonic acid (AA) by cyclooxigenase\n\nproduces prostaglandins, thromboxanes, and prosta-\n\ncyclins, whereas the 5-LO is an enzyme that catalyzes\n\nthe oxidation of AA for the synthesis of leukotrienes\n\n(LT). The importance of LT as cellular activators and\n\nchemotactic factors for neutrophils and eosinophils is\n\nvery well established, however, little is known about\n\nthe function of these lipid mediators in the host\n\ndefense against infectious agents [28, 29].\n\nAs the role of LT in pulmonary PCM was never\n\ninvestigated, we asked whether they would have a\n\nregulatory function in the severity of PCM of\n\nresistant (A/J) and susceptible (B10.A) mice and in\n\nthe fungicidal and secretory ability of their macro-\n\nphages. Our results showed that in vivo and in vitro\n\nP. brasiliensis infection induces LT synthesis. Com-\n\npared with A/J mice, levels of pulmonary LT were\n\nhigher in B10.A animals and increases in the course\n\nof infection. To evaluate the importance of LT in\n\nPCM, an inhibitor of LT synthesis (MK-0591) and an\n\nantagonist of LT receptor (montelukast) were studied\n\nin P. brasiliensis infection. In vitro, LT inhibitors\n\nsignificantly reduced the recovery of P. brasiliensis\n\nyeasts from normal and IFN-c primed macrophages.\nAt 48 h of in vivo infection, montelukast treatment of\n\nB10.A mice induced diminished fungal loads,\n\nimpaired influx of PMN leukocytes, and increased\n\nnumber of monocytes in the lungs of P. brasiliensis-\n\ninfected mice. Furthermore, in susceptible mice\n\nmontelukast treatment led to increased levels of\n\npulmonary IL-10 concomitant with diminished\n\namounts of IL-12, TNF-a, and GM-CSF. In contrast,\nat the chronic phase of the disease, LT inhibition did\n\nnot alter the fungal loads of B10.A and A/J mice. In\n\nconclusion, our results showed for the first time that\n\nLT are important mediators of the acute inflammatory\n\nreaction induced by P. brasiliensis infection affecting\n\nfungal recovery, cellular influx, and cytokines syn-\n\nthesis by susceptible mice [30, L. R. R. Ribeiro and\n\nV. L. G. Calich, unpublished observations]. Impor-\n\ntantly, our findings with LT inhibition appear to\n\ndemonstrate that the activation of innate immunity\n\ncan result in increased ingestion and survival of\n\nP. brasiliensis yeasts which can evolve to a more\n\nsevere disease.\n\nSeveral lines of evidence suggest that prostag-\n\nlandins production has a deleterious role for\n\nP. brasiliensis-infected hosts. In murine PCM, at\n\nearly steps of infection, secretion of PGE2 was shown\n\nto have an immunossupressive activity by inhibiting\n\nIL-12 production and up-regulating IL-4 and IL-10\n\nsynthesis [31]. In addition, studies with normal and\n\nIFN-c activated human macrophages demonstrated\nthat prostaglandins secretion inhibited their fungi-\n\ncidal ability which depends on the levels of hydrogen\n\nperoxide produced [32, 33]. Interestingly, recent\n\nstudies showed that virulent and low virulence strains\n\nof P. brasiliensis are able to synthesize prostaglan-\n\ndins by a cyclooxigenase-dependent pathway and that\n\nthese lipid mediators are required for P. brasiliensis\n\nsurvival [33].\n\nBesides the importance of hosts lipid mediators\n\nsuch as the eicosanoids in innate immunity, other\n\nlipid components of pathogen membranes or walls\n\nhave also been shown to play a role in the host-\n\nparasite interaction [34, 35]. Studies on the influence\n\nof P. brasiliensis lipid fractions in the fungicidal and\n\nsecretory activities of B10.A macrophages were\n\ndeveloped in our laboratories. Although all P. brasil-\n\niensis lipid fractions are potent inducers of NO\n\nsynthesis, they can inhibit or enhance the fungicidal\n\nability of macrophages. The previous in vitro treat-\n\nment of macrophages by F1 (phospholipids + neutral\n\nlipids) and F2 (short chain glycolipids) fractions\n\nresulted in increased phagocytic activity of cells, and\n\nrecovery of higher numbers of viable yeasts from\n\ninfected macrophages, despite the presence of high\n\n226 Mycopathologia (2008) 165:223\u2013236\n\n123\n\n\n\nNO levels. On the other hand, fractions 3a (glyco-\n\nsylphosphatidylinositol-anchored glycoproteins) and\n\nF3b (long chain glycolipids) caused an opposite\n\nbehavior; they inhibited the phagocytic ability of\n\nmacrophages leading to decreased recovery of viable\n\nyeasts. As a whole, secretion of IL-10, IL-12, MCP-1,\n\nand GM-CSF induced by P. brasiliensis infection was\n\ninhibited by the previous pre-incubation with all lipid\n\nfractions [36, F. V. Loures, I. Almeida and V. L. G.\n\nCalich, unpublished data]. The different behavior\n\nof the studied lipid fractions could be attributed to\n\nthe different physicochemical structures of these\n\ncomponents which would interact with macropha-\n\nges membranes through different PRR, and the\n\nsubsequent balance of pro- and anti-inflammatory\n\ncytokines and chemokines secreted. Indeed, a further\n\ncharacterization of these lipid fractions will permit\n\nus to better understand the innate host response to\n\nP. brasiliensis infection.\n\nToll Like and other macrophage receptors\n\nIn mammalian cells, the Toll-Like Receptors (TLR)\n\nare transmembrane proteins, which interact with\n\ninvariant molecular structures from pathogens\n\n(PAMP) and are involved in the activation of the\n\ninnate immune system. Several typical pathogen\n\ncomponents such as lipopolysaccharides, flagelin,\n\npeptidoglycans, DNA motifs, among others, are\n\nrecognized by different TLR [37\u201342]. Early TLR\n\nactivation results in the production of several inflam-\n\nmatory mediators and the final balance among pro-\n\nand anti-inflammatory components will regulate the\n\ntype of adaptative immune response [37\u201342]. The\n\nTLR 4 is the key receptor that recognizes bacterial\n\nlipopolysaccharides, whereas TLR 2 is involved in\n\nthe interaction with bacterial peptidoglycans and\n\nlipoproteins [38, 39]. TLR have been implicated in\n\nthe resistance of mammalian hosts to several micro-\n\norganisms [42\u201344] including fungal pathogens such\n\nas Candida albicans, Aspergillus fumigatus, and\n\nCryptococcus neoformans [5]. Interestingly, our pre-\n\nvious studies with P. brasiliensis infection showed\n\nthat the LPS-resistant, TLR 4 deficient, C3H/HeJ\n\nstrain is more resistant to i.p. infection than the\n\ncongenic LPS-susceptible, TLR 4 normal, C3HeB/\n\nFeJ strain [45]. Our recent in vitro studies with TLR\n\n4 normal (C3HeB/FeJ) and deficient (C3H/HeJ)\n\nmacrophages have demonstrated that this receptor\n\ninteracts with P. brasiliensis cells resulting in mac-\n\nrophage activation as shown by increased synthesis of\n\nnitric oxide, IL-12, MCP-1, and enhanced phagocytic\n\nactivity; this activation, however, was associated with\n\naugmented recovery of viable yeast cells from\n\ninfected macrophages. In the acute phase of pulmo-\n\nnary infection, the presence of TLR 4 induces a more\n\nsevere disease, with increased numbers of viable\n\nyeasts in the lungs associated with elevated synthesis\n\nof NO and IL-12. Moreover, even in the chronic\n\nphase, higher fungal burdens were seen in the lungs\n\nof TLR-4-normal mice, associated with increased\n\nlevels of pulmonary IL-12 and serum antibodies (IgM\n\nand IgG). Thus, the early macrophage activation\n\ninduced by TLR 4 usage is not able to control\n\nP. brasiliensis infection [36, F. V. Loures and V. L.\n\nG. Calich, unpublished observations]. As LPS unre-\n\nsponsiveness of C3H/HeJ mice was linked to a point\n\nmutation in the TLR 4 gene, it is tempting to suggest\n\nthat recognition of P. brasiliensis components (LPS\n\nlike?) by TLR 4 has a not yet described contribution\n\nto the control of PCM. We have also preliminary\n\nin vitro and in vivo studies with TLR 2 knockout\n\nmice in a C57Bl/6 background demonstrating a more\n\nsevere infection in TLR-normal hosts or cells.\n\nAltogether, our findings with TLR-deficient animals\n\nare unusual since PRR are most commonly used by\n\nphagocytes to recognize molecular patterns of patho-\n\ngens, and their interaction usually results in cell\n\nactivation, enhanced secretion of pro-inflammatory\n\ncytokines and chemokines, and increased microbi-\n\ncidal activity. In our model, the increase production\n\nof nitric oxide and IL-12 by TLR-normal macro-\n\nphages was not sufficient to control fungal growth\n\nand subsequent disease severity (F. V. Loures and V.\n\nL. G. Calich, unpublished results). These receptors\n\nappear to be used by P. brasiliensis yeast cells to gain\n\naccess into macrophages and to escape from other\n\nfungicidal or fungistatic mechanisms of innate\n\nimmunity.\n\nSome reports have described the importance of\n\nmannose receptors in P. brasiliensis ingestion by\n\nphagocytic cells. Phagocytosis of yeasts by adherent\n\nperitoneal macrophages of susceptible and resistant\n\nmice was inhibited by gp-43, a P. brasiliensis\n\nglycoprotein most recognized by patients antibodies,\n\nas well as by Saccharomyces cerevisiae derived\n\na-mannan. Gp 43 was also shown to inhibit NO\n\nMycopathologia (2008) 165:223\u2013236 227\n\n123\n\n\n\nproduction and killing ability of cytokine-stimulated\n\nmacrophages [46]. Immature dendritic cells of resis-\n\ntant mice appear to use mannose receptors to\n\ninternalize P. brasiliensis yeasts [47]. In addition,\n\ncomparative studies with Nramp1 gene congenic\n\nmacrophages (B10R and B10S) have demonstrated\n\nthat B10R cells were better inhibitors of conidia to\n\nyeast conversion and expressed more mannose\n\nreceptors than B10S macrophages, whereas both cell\n\nlines expressed similar levels of complement receptor\n\n3 (C3R) [20]. As described below, CR3 was also\n\nshown to play an important function in P. brasiliensis\n\nadherence and ingestion by phagocytic cells [23, 24].\n\nPolymorphonuclear leukocytes and NK cells\n\nDifferently from macrophages, murine PMN leuko-\n\ncytes are able to kill P. brasiliensis yeasts through the\n\noxidative metabolism [48, 49]. In an air-pouch model\n\nof infection and compared with PMN leukocytes\n\nfrom susceptible mice, cells from A/J mice presented\n\nsuperior fungicidal ability associated with their\n\nenhanced oxidative burst [50]. The antifungal activity\n\nof murine and human PMN leukocytes was shown to\n\nbe enhanced by IFN-c, GM-CSF, or IL-1b, but not by\nTNF-a or IL-8 [51]. In contrast, TNF-a was shown to\nbetter enhance P. brasiliensis killing by human\n\nmacrophages than IFN-c [52].\nComparing the early influx of inflammatory cells\n\nto the lungs of susceptible and resistant mice, Cano\n\n[53] demonstrated an equivalent mononuclear cell\n\ninflux, but a more prominent migration of neutrophil\n\nand eosinophil PMN cells into the lung of suscep-\n\ntible mice. This early PMN influx was also seen\n\nearly in the infection of BALB/c mice [54].\n\nFurthermore, only in susceptible mice this early\n\n(24 h after infection) PMN influx affects disease\n\noutcome and acquired immunity further established.\n\nInterestingly, the more severe disease of PMN-\n\ndepleted susceptible mice was associated with the\n\nincreased presence of pulmonary IL-12 and IFN-c\nsuggesting that the production of pro-inflammatory\n\nmediators not always leads to immunoprotection.\n\nDifferently from primary infection, neutrophil deple-\n\ntion did not alter immunoprotection in secondary\n\nparacoccidioidomycosis. As a whole, our data\n\nshowed that the genetic pattern of hosts exerts an\n\nimportant influence on the immunoprotective and\n\nimmunoregulatory functions of neutrophils which\n\nappear to be essential in situations devoid of cell-\n\nmediated immunity [55].\n\nThe role of NK cell has not been well studied in\n\nP. brasiliensis infection, but the few available\n\ninvestigations in this area suggest that this lympho-\n\ncyte subpopulation has a complex function in PCM\n\nthat varies according to the type of host or site where\n\nthese cells were obtained. In the peripheral blood of\n\nPCM patients, NK cells were found in elevated\n\nnumber but they displayed low cytotoxic activity\n\n[56]. In vitro studies showed a direct inhibitory effect\n\nof murine NK cells on P. brasiliensis growth [57] and\n\nin a hamster model of infection, NK cells were shown\n\nto be activated at the first weeks of infection followed\n\nby an impairment of its activity associated with\n\ndepressed cell-mediated immunity [58].\n\nOur findings of illness exacerbation after in vivo\n\ndepletion of IL-12 or IFN-c in euthymic and\nathymic BALB/c mice [59, 60] suggested that NK\n\ncells would have a protective role in pulmonary\n\nPCM. In vivo depletion of NK cells by anti-Asialo\n\nGM1 polyclonal antibody resulted in a more severe\n\ndisease of both mouse strains, but the depletion\n\neffect was more pronounced in the NK-depleted\n\nathymic than euthymic mice. Anti-NK cell treatment\n\nled to increased antibody production by the former\n\nstrain but did not modify the humoral immunity of\n\neuthymic animals, indicating that the isotype class\n\nswitch in T cell deficient mice is influenced by NK\n\ncells cytokines. In addition, NK cells were shown to\n\ncontrol PMN leukocytes influx to the lungs of\n\ninfected mice. Hence, NK cells seem to have a\n\nprotective effect in pulmonary PCM and their\n\nfunction appears to be more prominent in T-cell\n\ndeficient than in T-cell sufficient mice [61, R. C.\n\nValente-Ferreira and VLG Calich, unpublished\n\ndata].\n\nMacrophages and nitric oxide\n\nThe crucial role of the mononuclear phagocytic\n\nsystem in the resistance to P. brasiliensis infection\n\nwas demonstrated by the fact that reticuloendothelial\n\nsystem blockade, induced by colloidal carbon inoc-\n\nulation previous to P. brasiliensis infection (i.p.\n\nroute), increased the severity of the disease in both\n\nresistant and susceptible animals [62].\n\n228 Mycopathologia (2008) 165:223\u2013236\n\n123\n\n\n\nThe infection by P. brasiliensis occurs by inhala-\n\ntion of airborne propagules of the mycelial phase of\n\nthe fungus, which reach the lungs, eventually evade\n\nthe host defenses and disseminate via the bloodstream\n\nand/or lymphatics to virtually all parts of the body [4,\n\n8, 10, 19]. Alveolar macrophages (AM) are believed\n\nto be important in the initial containment of the\n\nmicroorganisms through nonspecific or innate\n\nimmune mechanisms. AM or dendritic cells (DC)\n\nalso phagocytose particles and microbial organisms\n\nand carry them via lymphatics to regional hilar lymph\n\nnodes, where specific immune responses are believed\n\nto be generated.\n\nP. brasiliensis proliferates ex vivo in a variety of\n\nmouse macrophages, including resident peritoneal\n\nalveolar and peripheral blood derived monocytes\n\nuntil the cells are lysed and killed by a yet unknown\n\nmechanism. However, the immunological activation\n\nof these cells efficiently inhibits fungal growth [48].\n\nWhen alveolar macrophages were analyzed after\n\npulmonary infection, absence of hydrogen peroxide\n\nproduction was observed with cells obtained from\n\nsusceptible mice, whereas macrophages from resis-\n\ntant mice produced increased levels of this metabolite\n\nin the course of disease [14]. These different activ-\n\nities parallel the DTH anergy and the evident DTH\n\nreactivity developed by susceptible and resistant\n\nmice, respectively.\n\nBrummer et al. [48, 63] have demonstrated that\n\nactivation of mouse peritoneal macrophages by IFN-c\nenhances the fungicidal activity of these cells but\n\nfungal killing is independent of the respiratory burst.\n\nFurther investigations showed the fundamental role\n\nof nitric oxide in the fungicidal ability of activated\n\nmacrophages, which appear to use an iron-restriction\n\nmechanism to inhibit the transformation of ingested\n\nconidia to yeast cells [64, 65]. We have confirmed the\n\nfundamental role of NO in the murine PCM [64]. In\n\nthe course of infection, peritoneal macrophages from\n\nresistant mice secrete low levels of NO associated\n\nwith high amounts of TNF-a; the opposite was seen\nwith glass adherent cells from susceptible mice.\n\nInterestingly, in vitro inhibition of NO production by\n\naminoguanidine treatment of B10.A macrophages led\n\nto increased production of TNF-a indicating the\ninhibitory role of NO on cytokine secretion. More\n\nimportantly, the disease of i.p. infected C57BL/6\n\nmice genetically deficient for inducible nitric oxide-\n\nsynthase (iNOS KO) and in resistant and susceptible\n\nmice in vivo treated with aminoguanidine and inca-\n\npable of secreting NO, is more severe [66].\n\nThe dual role of NO in murine PCM was further\n\nconfirmed in the pulmonary model of infection.\n\nCompared with wild type mice, a lower fungal load\n\nwas observed at week 2, although at week 10,\n\nincreased number of fungi was detected in the lungs\n\nof mice genetically deficient of inducible NO-\n\nsynthase (iNOS KO). The better control of fungal\n\nloads by iNOS KO mice at week 2 of infection\n\nappeared to be TNF-a mediated, since its in vivo\nneutralization abolished this difference [67, S. Ber-\n\nnardino and V. L. G. Calich, unpublished results). In\n\nagreement, Gonzales et al. [68] showed that TNF-a-\nactivated peritoneal macrophages, although not pro-\n\nducing NO, were able to inhibit the transition of P.\n\nbrasiliensis conidia to yeast cells. Interestingly, our\n\nstudies also demonstrated that iNOS KO mice,\n\ndespite the more intense fungal infection by week\n\n10 of infection, developed better organized granulo-\n\nmas. Thus, the increased secretion of TNF-a, the\nincreased influx of activated T cells to the lungs, and\n\nthe better organized lesions appear to compensate the\n\ngenetic deficiency of NO. This was further confirmed\n\nby the equivalent survival times showed by iNOS KO\n\nand WT mice, despite the higher fungal loads in the\n\nformer strain [67, S. Bernardino and V. L. G. Calich,\n\nunpublished data).\n\nRecent studies were also performed aimed to\n\nunderstand the interaction between alveolar macro-\n\nphages from resistant and susceptible mice and\n\nP. brasiliensis. Normal alveolar macrophages of\n\nB10.A mice, in vitro infected with P. brasiliensis\n\nyeasts, can be activated by small doses of exoge-\n\nnously added IFN-c, secrete high levels of IL-12,\nnitric oxide and display a very efficient fungal killing\n\nactivity. In contrast, macrophages from A/J mice\n\nwere poorly activated by low doses of IFN-c, secrete\nlow amounts of IL-12, NO and present a poor\n\nfungicidal ability concomitant with the production of\n\nhigh levels of active TGF-b. The fungicidal ability of\nB10.A macrophages was modulated by aminoguani-\n\ndine, whereas TGF-b was the main negative regulator\nof A/J macrophages. Thus, alveolar macrophages of\n\nsusceptible mice seem to be more efficient than those\n\nof resistant mice and interaction of P. brasiliensis\n\nwith these cells probably occurs through different\n\nmacrophage receptors [69 A. Pina and V. L. G.\n\nCalich, unpublished observations]. These findings\n\nMycopathologia (2008) 165:223\u2013236 229\n\n123\n\n\n\nappear to explain the apparently discrepant result we\n\nhad observed when the pulmonary model of infection\n\nwas first described: at the beginning of infection\n\nhigher number of viable yeast cells were recovered\n\nfrom lungs of resistant mice as compared with\n\nsusceptible ones [14]. Furthermore, IFN-c, the most\nefficient macrophage activator was found in higher\n\nlevels in the lung homogenates of susceptible mice\n\n[59]. Thus, the innate immunity appears to be much\n\nmore efficient in the susceptible strain than in the\n\nresistant one. This hyperactivity is concomitant with\n\nhigh levels of NO production that is able to restrain\n\nfungal growth but also interferes with acquired\n\nimmune responses leading to a subsequent immuno-\n\nsuppression of T-cell mediated immunity [66, A. Pina\n\nand V. L. G. Calich, unpublished data].\n\nDendritic cells and other APCs\n\nT cells have clonal receptors (TCR) educated to see\n\nantigen epitopes presented by major histocompatibil-\n\nity complex (MHC) molecules of antigen presenting\n\ncells (APC). Several cell types can exert the APC\n\nfunction such as macrophages, B cells and endothe-\n\nlial cells, but the dendritic cells (DC) are considered\n\nthe \u2018\u2018professional APC\u2019\u2019 due to their special ability to\n\nactivate T cells. DC are derived from hematopoietic\n\nstem cells in the bone marrow and form a network of\n\na heterogeneous cell populations. Many DC reside\n\nand traffic through nonlymphoid peripheral tissues,\n\ncontinuously surveying the environment for invading\n\nmicroorganisms [70]. During infection, DCs in the\n\nperiphery are activated by interaction with microor-\n\nganisms or inflammatory mediators to increase their\n\nexpression of MHC and co-stimulatory molecules\n\nsuch as CD80, CD86, and CD40. They also modify\n\ntheir expression of chemokines receptors and adhe-\n\nsion molecules, causing migration from the periphery\n\nto the T cell zone of draining lymph nodes. Activated\n\nDC then display pathogen encoded antigens to na??ve\n\nantigen-specific T cells which initiate primary T cell\n\nresponses [71, 72]. In the course of maturation, DC\n\nare subject to profound changes. The endocytic\n\ncapacity is downmodulated, while there is a marked\n\nup-regulation of MHC class II expression, from an\n\nalready high constitutive level [72].\n\nAs with other infectious pathologies, some studies\n\non the importance of different antigen presenting\n\ncells (DC, macrophages, and B cells) in the resistance\n\nto P. brasiliensis infection were reported. It was\n\nshown that gp43, the immunodominant antigen for\n\nhumoral immunity in PCM [73], was mainly pre-\n\nsented by macrophages and stimulated a preferential\n\nTh1 cytokine production in resistant mice. In con-\n\ntrast, in susceptible mice gp43 was predominantly\n\npresented by B lymphocytes and led to preferential\n\nsecretion of Th2 cytokines. In addition, no differ-\n\nences in T cell reactivity of resistant and susceptible\n\nmice were detected. [74]. Another report from the\n\nsame group showed that the s.c. injection of mature\n\nDC, macrophages and B cells primed na??ve suscep-\n\ntible and resistant mice and induced T cell\n\nproliferation. In this study, however, macrophages\n\nand B cells from both mouse strains displayed\n\nequivalent stimulatory activity inducing a preferential\n\nsecretion of IL-10 and IL-4; DC from resistant\n\nanimals, however, when compared with B10.A DC,\n\nstimulated a higher production of IFN-c, equivalent\nlevels of IL-12 and higher expression of MHC class II\n\nand CD80 molecules. B10.A macrophages were also\n\nshown to secrete high levels of IL-6 while IL-12 was\n\nsecreted in similar levels by DC of both strains.\n\nHence, it was suggested that DC of resistant mice\n\npreferentially drive Th1 development while B cells\n\nand macrophages from both mouse strains appeared\n\nto induce the differentiation of a Th0 or Th2\n\nphenotype [75]. Further studies with resistant [76]\n\nand susceptible mice derived DC [77] demonstrated\n\nan equivalent behavior of gp-43 stimulated DC. Thus,\n\ngp43 treatment as well as P. brasiliensis infection\n\ndown-regulated MHC class II, CD80, CD86, CD54,\n\nand CD40 expression as well as IL-12 and TNF-a\nsecretion by LPS-treated DC. So, no major differ-\n\nences were reported in the activities of DC obtained\n\nfrom resistant and susceptible mice, unless they were\n\npreviously activated by LPS. The i.v. infusion of DC\n\npreviously treated with gp-43 plus LPS, but not with\n\neach of these components individually, increased\n\npulmonary CFU counts and altered granulomas\n\nmorphology of P. brasiliensis-infected mice [77].\n\nWe have also preliminary results comparing the\n\nbehavior of DC from resistant and susceptible mice.\n\nBone marrow derived DC were obtained and acti-\n\nvated with LPS, P. brasiliensis yeast cells or a\n\nsoluble whole yeast cells antigen. DC from both\n\nmouse strains exhibited MHC class II and co-\n\nstimulatory molecules (CD80, CD86, CD11c,\n\n230 Mycopathologia (2008) 165:223\u2013236\n\n123\n\n\n\nCD40) when activated by LPS or fungal yeast cells\n\nalthough A/J DC presented higher CD11c and\n\nCD86 expression. Compared with A/J cells, B10.A\n\nDC secreted higher levels of IL-12, IL-10, and NO,\n\nwhereas the former are more able to produce active\n\nTGF-b. DC of susceptible mice induced a high\nproliferative activity of A/J T cells but not of\n\nB10.A lymphocytes while A/J DC stimulated T cell\n\nproliferation of both mouse strains. Thus, T cell\n\nanergy was only detected when B10.A DC were\n\nco-cultivated with homologous lymphocytes indi-\n\ncating that B10.A DC does not lack the ability to\n\nproperly present P. brasiliensis antigens and that\n\nB10.A lymphocytes are appropriately activated\n\nwhen P. brasiliensis antigens were presented by\n\nA/J DCs (A. Pina and V. L. G. Calich, unpublished\n\nresults).\n\nCytokines\n\nAs a more detailed review on the role of cytokines\n\nin PCM was reported elsewhere [10, 13], only a\n\nbrief analysis of those studies will be presented\n\nhere. IFN-c is the most important protective cytokine\nto susceptible, intermediate, and resistant mice to\n\nP. brasiliensis infection [59, 78]. TNF-a and IL-12\nare also very important protective cytokines [60, 78,\n\n79]. IL-4 has a dual role (protective or disease\n\npromoting) in pulmonary PCM depending on the\n\ngenetic pattern of the host [80, 81]. Despite the less\n\nsevere disease induced by administration of rIL-12\n\n[79], the strong inflammatory reaction in the lungs\n\ndemonstrated the harmful effect of this cytokine. IL-\n\n10 appears to be one important macrophage-deacti-\n\nvating cytokine in pulmonary PCM, and its genetic\n\nabsence appears to result in the aseptic cure of\n\ninfected mice (Fig. 3) (T. A. Costa and V. L. G.\n\nCalich, unpublished results). Altogether, studies with\n\ncytokine-deficient mice showed that the Th1/Th2\n\nparadigm can be applied to explain fungal growth (or\n\ndissemination) in liver and spleen: IL-4 and IL-10 are\n\ndisease-promoting cytokines while IL-12 and IFN-c\nare protective ones. However, the control of fungal\n\ngrowth in the lungs is more complex and both, Th1\n\n(e.g., IL-12) and Th2 cytokines (e.g., IL-4) can have\n\nantagonistic effects. IL-10 is a disease-promoting\n\ncytokine and appears to have a more prominent role\n\nin the control of pulmonary PCM than IL-4.\n\nSummarizing, our studies on innate immunity to\n\nP. brasiliensis infection suggest that a highly efficient\n\ninnate immunity can lead to severe paracoccidioid-\n\nomycosis. The following findings appear to support\n\nsuch inference: at the onset of infection, susceptible\n\nmice display a better control of lung fungal loads; IL-\n\n4 protects susceptible mice from severe infection;\n\nexogenous IL-12 leads to increased lung pathology;\n\nTLR usage leads to increased macrophage activation\n\nassociated with increased fungal loads; susceptible\n\nmice secrete higher levels of LT and its inhibition\n\nresults in milder pathology; PMN depletion causes\n\nmore severe PCM associated with increased secretion\n\nof pro-inflammatory cytokines; early NO secretion\n\ncan induce more severe infection. As a whole, it\n\nappears that \u2018\u2018the more reactive the host innate\n\nimmunity the more severe is the initial P. brasiliensis\n\ninfection.\u2019\u2019\n\nThe influence of innate immunity in the resistance\n\nto P. brasiliensis infection\n\nProtective immunity in paracoccidioidomycosis\n\n(PCM) is believed to be mainly mediated by cellular\n\nimmunity [82]. In the human disease the Th1/Th2\n\ndichotomy of CD4\n+\n\nT cells appears to partially\n\nexplain the behavior of PCM patients and healthy\n\ninfected individuals. So, the most evident Th1\n\nimmunity is observed when lymphocytes from\n\nhealthy infected subjects or cured patients are in vitro\n\nactivated by gp 43 and a clear production of IL-2 and\n\nIFN-c is concomitant with a vigorous lymphoprolif-\nerative response [83, 84]. The acute form of the\n\ndisease appears to be the Th2 pole of reactivity,\n\nwhere IL-4, IL-5, and IL-10 are produced and\n\nassociated with low T cell proliferation which,\n\nhowever, can be reverted by in vitro treatment with\n\nrIL-12 and anti-IL-10 antibodies [85]. The severe\n\nform of the chronic disease also appears to present a\n\nTh2 pattern of reactivity. Most individuals of the\n\nchronic form of PCM, however, do not display\n\npolarized Th1/Th2 immune responses and their\n\nhyporesponsiveness appears to be not linked to\n\nimbalanced cytokine synthesis and may be due to\n\nother immunoregulatory mechanisms such as T cell\n\nanergy, T cell deletion by apoptosis or suppressive\n\nactivity of natural regulatory T cells [10, 86\u201388].\n\nIndeed, a recent paper showed a direct correlation\n\nMycopathologia (2008) 165:223\u2013236 231\n\n123\n\n\n\nbetween the number of natural regulatory T cells in\n\nthe lesions and peripheral blood and the severity of\n\nPCM [88]. In human PCM the function of CD8\n+\n\nT\n\ncells, however, was poorly investigated.\n\nWe have some studies that characterized the\n\nfunction of CD4\n+\n\nand CD8\n+\n( T cells in the immunity\n\ndeveloped by susceptible (B10.A), intermediate\n\n(C57Bl/6) and resistant (A/J) mice after pulmonary\n\ninfection with P. brasiliensis yeasts. In susceptible\n\nmice, anti-CD4 treatment did not alter disease\n\nseverity and cellular immunity. However, anti-CD8\n\ntreatment led to increased fungal loads and DTH\n\nreactivity indicating the antagonistic effects of\n\nCD8a+ cells. In resistant mice, besides a protective\ntype 1 immunity mediated by CD8a+ T cells,\nneutralization studies revealed the concomitant pres-\n\nence of Th1 and Th2 cells. In addition, deficiency of\n\nwhole T and CD8a+ T cells but not of CD4+ T or B\ncells in the C57Bl/6 background led to more severe\n\nPCM and increased mortality rates. In conclusion, our\n\nstudies demonstrated that in pulmonary PCM: (a)\n\nfungal loads are mainly controlled by CD8a+ T cells;\n(b) genetic susceptibility of hosts appears to be\n\nassociated with deletion or anergy of CD4\n+\n\nT cells,\n\nand finally, (c) a balanced type1/type2 immunity is\n\nassociated with genetic resistance to P. brasiliensis\n\ninfection [10].\n\nThe concomitant analysis of innate and adaptative\n\nimmunity in murine PCM lead us to propose a\n\nmodel on the immunopathogenesis of pulmonary\n\nparacoccidioidomycosis. Alveolar macrophages of\n\nsusceptible mice are very reactive to P. brasiliensis\n\ncomponents and pro-inflammatory mediators are\n\nsecreted by cells involved in the innate immunity\n\nof lungs. The high production of IL-12 stimulates\n\nNK cells to secrete elevated amounts of IFN-c that\ninduces the secretion of high levels of nitric oxide\n\nand other pro-inflammatory mediators by macro-\n\nphages which develop a very efficient fungicidal\n\nability. Leukotrienes and the TLR expression appear\n\nto activate macrophages and to contribute with\n\nP. brasiliensis endocytosis. Anti-inflammatory cyto-\n\nkines such as IL-10 and/or TGF-b are secreted in\nlow levels. Although not extensively studied, equiv-\n\nalent activities were found with B10.A dendritic\n\ncells. This behavior results in a very effective innate\n\nimmunity and precocious control of fungal growth\n\nand would result in preferential activation of\n\nTh1 CD4\n+\n\ncells. The excessive and continuous\n\nproduction of NO, however, inhibits the initial\n\ndevelopment of CD4\n+\n\nT-cell-immunity by active\n\ninduction of T cell anergy or deletion. The elevated\n\nexpression of co-stimulatory molecules (MHC class\n\nI, CD40, CD80, for example) by macrophages or\n\nDC could directly activate CD8\n+\n\nT cells without the\n\nhelp of CD4\n+\n\nT lymphocytes [89, 90]. This pattern\n\nof immunity could explain the very efficient mech-\n\nanism of innate immunity resulting, however, in\n\nFig. 3 Photomicrographs of pulmonary lesions developed by\nwild type (WT, upper micrographs) and IL-10-deficient (IL-10\n\nKO, lower micrographs) C57BL/6 mice at week 8 after intra-\n\ntracheal infection with one million fungal cells. WT mice\n\npresented extensive, fungi rich, confluent lesions, occupying\n\nalmost all lung parenchyma, whereas in IL-10 KO mice a\n\ndiffuse inflammation, with no evident fungal cells, affected\n\nsmaller areas of lungs. Left, H&amp;E; right, Groccot stained\n\nlesions (100\u00b7)\n\n232 Mycopathologia (2008) 165:223\u2013236\n\n123\n\n\n\npoor T-cell mediated immunity (Fig. 4). It would\n\nalso explain the DTH anergy, the non-organized\n\nlesions, the high levels of antibodies, and the\n\nprogressive and severe disease developed by sus-\n\nceptible mice.\n\nAlveolar macrophages and DC from resistant mice\n\nrespond to P. brasiliensis infection by secreting low\n\namounts of IL-12, but high levels of TGF-b and TNF-\na. This results in poor NK cell activation, IFN-c\nproduction, NO secretion, and initial inefficient fungal\n\nkilling. This activity characterizes the low efficient\n\nnatural immunity of resistant mice. However, the\n\nproduction of cytokines and NO in low levels do not\n\nimpair T-cell immunity. So, resistant animals slowly\n\ndevelop P. brasiliensis specific CD4+ and CD8+ T\n\nlymphocytes, which control fungal growth and orga-\n\nnize lesion morphology (Fig. 5). This model does not\n\nexclude the previously proposed Th1/Th2 model of P.\n\nbrasiliensis control. It tries, however, to put together\n\nmany results obtained with studies on innate and\n\nadaptative immunity in the murine model of pulmo-\n\nnary infection, which eventually may contribute to\n\nenhance our knowledge on the immunopathogenesis\n\nof human paracoccidioidomycosis.\n\nAcknowledgments This work was supported by grants from\nFundac?a?o de Amparo a? Pesquisa do Estado de Sa?o Paulo\n\n(FAPESP) e Conselho Nacional de Pesquisas (CNPq).\n\nReferences\n\n1. Beutler B. Innate immunity: an overview. Mol Immunol\n\n2004;40:845\u201359.\n\n2. Zaas AK, Schwartz DA. Innate immunity and the lung:\n\ndefense at the interface between host and environment.\n\nTrends Cardiovasc Med 2005;15:195\u2013202.\n\n3. Janeway CAJR. The immune system evolved to discrimi-\n\nnate infectious nonself from noninfectious self. Immunol\n\nToday 1992;13:11\u20136.\n\n4. Janeway CAJR, Medzhitov R. Innate immune recognition.\n\nAnnu Rev Immunol 2002;20:197\u2013216.\n\nFig. 4 Hypothesis on the innate and acquired immunological\nmechanisms leading to susceptibility to P. brasiliensis\ninfection. At the initial stage of infection, macrophages from\n\nsusceptible mice secrete high amounts of IL-12 and nitric oxide\n\n(NO) resulting in efficient fungal clearance. The same\n\nsecretory pattern was seen with B10.A dendritic cells (DC).\n\nThe excessive NO secretion, however, induces anergy or\n\ndeletion of CD4\n+\n\nT cells. The expression of co-stimulatory\n\nmolecules such as CD40 by antigen presenting cells induces a\n\npreferential activation of CD8\n+\n\nT cells that is not sufficient to\n\nefficiently activate macrophages and to control disease\n\nprogression. (PRR, pattern recognition receptors; co-stimula-\n\ntory molecules: CD40, B7, CTLA-4; MHC, major\n\nhistocompatibility complex; KC, chemokine chemotactic for\n\nPMN cells; NK, natural killer cells; TGF-b, tissue growth\nfactor beta; Treg, natural regulatory CD4\n\n+\nT cells)\n\nFig. 5 Hypothesis on the innate and acquired immunological\nmechanisms leading to resistance to P. brasiliensis infection.\nAt the innate phase of immunity, macrophages, and dendritic\n\ncells (DC) from resistant mice secrete low amounts of IL-12\n\nassociated with high levels of TGF-b resulting in impaired\nnitric oxide (NO) secretion and inefficient fungal clearance.\n\nThis mild pattern of activation, however, results in slow\n\nactivation of Th1 and Th2 CD4\n+\n\nT cells and type1 CD8\n+\n\nT\n\nlymphocytes which are able to induce efficient macrophage\n\nactivation, controlled inflammation, and regressive disease.\n\n(PRR, pattern recognition receptors; co-stimulatory molecules:\n\nCD40, B7, CTLA-4; MHC, major histocompatibility complex;\n\nNK, natural killer cells; TGF-b, tissue growth factor beta; Treg,\nnatural regulatory CD4\n\n+\nT cells)\n\nMycopathologia (2008) 165:223\u2013236 233\n\n123\n\n\n\n5. Romani L. Immunity to fungal infections. Nat Rev\n\n2004;4:1\u201313.\n\n6. Franco M, Montenegro MR, Calich VLG, Bernard G.\n\nParacoccidioidomicose. In: Brasileiro Filho G, editor.\n\nBogliolo patologia. Rio de Janeiro, RJ: Guanabara koogan;\n\n2006. p. 1387\u201398.\n\n7. Borges-Walmsley MI, Chen D, Shu X, Walmsley AR. The\n\npathobiology of Paracoccidioides brasiliensis. Trends\nMicrobiol 2002;10:80\u20137.\n\n8. Brummer E, Castan?eda E, Restrepo A. Paracoccidioid-\n\nomycosis: an update. Clin Microbiol Rev 1993;6:89\u2013117.\n\n9. San-Blas G, Nin?o-Vega G, Iturriaga T. Paracoccidioides\nbrasiliensis and paracoccidioidmycosis: molecular\napproaches to morphogenesis, diagnosis, epidemiology,\n\ntaxonomy and genetics. Med Mycol 2002;40:225\u201342.\n\n10. Calich VLG, Blotta MHSL. Pulmonary paracoccidioid-\n\nomycosis In: Fidel PL, Huffnagle GB, editors. Fungal\n\nimmunology: from an organ perspective, New York, NY:\n\nSpringer; 2005. p. 201\u201327.\n\n11. Calich VLG, Singer-Vermes LM, Russo M, Vaz CAC,\n\nBurger E. Immunogenetics in paracoccidioidomycosis. In:\n\nFranco M, Lacaz CS, Restrepo-Moreno A, Del Negro G,\n\neditors. Paracoccidioidomycosis, Boca Raton, Florida:\n\nCRC Press; 1994. p. 151\u201373.\n\n12. Calich VLG, Vaz CAC, Burger E. Immunity to Paracoc-\ncidioides brasiliensis infection. Res Immunol\n1998;149:407\u201316.\n\n13. Calich VL, Kashino SS. Cytokines produced by susceptible\n\nand resistant mice in the course of Paracoccidioides bra-\nsiliensis infection. Braz J Med Biol Res 1998;31:615\u201323,\nReview.\n\n14. Cano LE, Singer-Vermes LM, Vaz CAC, Russo M, Calich\n\nVLG. Pulmonary paracoccidioidomycosis in resistant and\n\nsusceptible mice: relationship among progression of\n\ninfection, bronchoalveolar cell activation, cellular immune\n\nresponse and specific isotype patterns. Infect Immun\n\n1995;63:1777\u201383.\n\n15. Chiarella AP. Caracterizac?a?o da func?a?o das ce?lulas TCD4\n+\n\ne T CD8\n+\n\nna paracoccidioidomicose pulmonar de camun-\n\ndongos isoge?nicos. Caracter??sticas imunopatolo?gicas da\n\nparacoccidioidomicose experimental [M.Sc. Dissertation].\n\nSa?o Paulo, Instituto de Cie?ncias Biome?dicas, Universidade\n\nde Sa?o Paulo; 2002. 103 pp.\n\n16. Loose DS, Stover EP, Restrepo A, Stevens DA, Feldman\n\nD. Estradiol binds to a receptor-like cytosol binding protein\n\nand initiates a biological response in Paracoccidioides\nbrasiliensis. Proc Natl Acad Sci USA 1983;80:7659\u201363.\n\n17. Singer-Vermes LM, Burger E, Franco MF, Bacchi MM,\n\nMendes-Giannini MJ, Calich VL. Evaluation of the path-\n\nogenicity and immunogenicity of seven Paracoccidioides\nbrasiliensis isolates in susceptible inbred mice. J Med Vet\nMycol 1989;27:71\u201382.\n\n18. Aristizabal BH, Clemons KV, Cock AM, Restrepo A,\n\nStevens DA. Experimental Paracoccidioides brasiliensis\ninfection in mice: influence of the hormonal status of the\n\nhost on tissue responses. Med Mycol 2002;40:169\u201378.\n\n19. Restrepo A, McEwen JG, Castaneda E. The habitat of\n\nParacoccidioides brasiliensis: how far from solving the\nriddle? Med Mycol 2001;39:233\u201341.\n\n20. Calich VLG, Burger E, Kashino SS, Fazioli RA, Singer-\n\nVermes LM. Resistance to Paracoccidioides brasiliensis in\n\nmice is controlled by a single dominant autosomal gene.\n\nInfect Immun 1987;55:1919\u201323.\n\n21. Forbes JR, Gross P. Divalent-metal transport by NRAMP\n\nproteins at the interface of host-pathogen interactions.\n\nTrends Microbiol 2001;9:397\u2013403.\n\n22. Jimenez-Mdel P, Restrepo A, Radzioch D, Cano LE,\n\nGarcia LF. Importance of complement 3 and mannose\n\nreceptors in phagocytosis of Paracoccidioides brasiliensis\nconidia by Nramp1 congenic macrophages lines. FEMS\n\nImmunol Med Microbiol 2006;47:56\u201366.\n\n23. Calich VLG, Kipnis TL, Mariano M, Fava-Netto C, Dias\n\nda Silva W. The activation of the complement system by\n\nParacoccidioides brasiliensis in vitro. Its opsonic effect\nand possible significance for an in vivo model of infection.\n\nClin Immunol Immunopathol 1979;12:20\u201330.\n\n24. Munk ME, Kajdacsy-Balla A, Del Negro G, Cuce LC, Dias\n\nda Silva W. Activation of human complement system in\n\nparacoccidioidomycosis. J Med Vet Mycol 1992;30:317\u2013\n\n21.\n\n25. Calich VLG, Burger E, Vaz CAC. PMN chemotactic factor\n\nproduced by glass adherent cells in the acute inflammation\n\ncaused by Paracoccidioides brasiliensis. Brit J Exp Pathol\n1985;66:57\u201365.\n\n26. Luster AD. Chemokines: chemotactic cytokines that\n\nmediate inflammation. New Eng J Med 1998;12:436\u201345.\n\n27. Souto JT, Aliberti JC, Campanelli AP, Livonesi M, Maffei\n\nCML, Ferreira BR, et al. Chemokine production and leu-\n\nkocyte recruitment to the lungs of Paracoccidioides\nbrasiliensis-infected mice is modulated by interferon-c.\nAm J Pathol 2003;163:583\u201390.\n\n28. Peters-Golden M, Canetti C, Mancuso P, Coffey MJ.\n\nLeukotrienes: underappreciated mediators of innate\n\nimmune responses. J Immunol 2005;174:589\u201394.\n\n29. Machado ER, Ueta MT, Lourenco EV, Anibal FF, Sorgi\n\nCA, Soares EG, et al. Leukotrienes play a role in the\n\ncontrol of parasite burden in murine strongyloidiasis.\n\nJ Immunol 2005;175:3892\u20139.\n\n30. Ribeiro LRR. Caracterizac?a?o do papel dos leucotrienos na\n\nparacoccidioidomicose (PCM) pulmonar e na atividade\n\nfungicida e secretora de macro?fagos peritoneais infectados\n\npelo Paracoccidioides brasiliensis. [MSc.Dissertation].\nSa?o Paulo, Sa?o Paulo: Universidade de Sa?o Paulo; 2005.\n\n106 pp.\n\n31. Michelin MA, Figueiredo F, Cunha FQ. Involvement of\n\nprostaglandins in the immunosuppression occurring during\n\nexperimental infection by Paracoccidioides brasiliensis.\nExp Parasitol 2002;102:170\u20137.\n\n32. Soares AMVC, Calvi SA, Peracoli MT, Fernandez AC,\n\nDias LA, Dos Anjos AR. Modulatory effect of prosta-\n\nglandins on human monocyte activation for killing of high-\n\nand low-virulence strains of Paracoccidioides brasiliensis.\nImmunology 2001;102:480\u20135.\n\n33. Bordon AP, Dias-Melicio LA, Acorci MJ, Calvi SA,\n\nSerra?o Perac?oli MT, Soares AMVC. Prostaglandin E(2)\n\ninhibits Paracoccidioides brasiliensis killing by human\nmonocytes. Microbes Infect 2007;9(6):744\u20137.\n\n34. Almeida IC, Camargo MM, Procopio DO, Silva LS,\n\nMehlert A, Travassos LR, et al. Highly purified glyco-\n\nsylphosphatidylinositols from Trypanosoma cruzi are\npotent proinflammatory agents. EMBO J 2000;19:1476\u2013\n\n85.\n\n234 Mycopathologia (2008) 165:223\u2013236\n\n123\n\n\n\n35. Proudfoot L, O\u2019Donnell CA, Liew FY. Glycoinositol-\n\nphospholipids of Leishmania major inhibit nitric oxide\nsynthesis and reduce leishmanicidal activity in murine\n\nmacrophages. Eur J Immunol 1995;25:745\u201350.\n\n36. Loures FV. Caracterizac?a?o da func?a?o dos lip??dios do\n\nParacoccidioides brasiliensis e do receptor TLR4 na in-\nterac?a?o fungo-hospedeiro (M.Sc. Dissertation). Sa?o Paulo,\n\nInstituto de Cie?ncias Biome?dicas, Universidade de Sa?o\n\nPaulo; 2007. 116 pp.\n\n37. Yang RB, Mark MR, Gray A, Huang A, Xie NH, Zhang M,\n\net al. Toll-like receptor-2 mediates lipopolysaccharide-\n\ninduced cellular signaling. Nature 1998;395:284\u20138.\n\n38. Kirschning CJ, Wesche H, Ayres TM, Rothe M. Human\n\nToll-like receptor 2 confers responsiveness to bacterial\n\nlipopolysaccharide. J Exp Med 1998;188:2091\u20137.\n\n39. Chow JC, Young DW, Golenbock DT, Christ W J,\n\nGusovsky F. Toll-like receptor-4 mediates lipopolysac-\n\ncharide-induced signal transduction. J Biol Chem 1999;\n\n274:10689\u201392.\n\n40. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu\n\nRev Immunol 2003;21:335\u201376.\n\n41. Kopp EB, Medzhitov R. The Toll-like receptors family and\n\ncontrol of innate immunity. Curr Opin Immunol\n\n1999;168:2433\u201340.\n\n42. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H.\n\nDifferential roles of TLR2 and TLR4 in recognition of\n\ngram-negative and gram-positive bacterial cell wall com-\n\nponents. Immunity 1999;11:443\u201351.\n\n43. Akira S. Mammalian Toll-like receptors. Curr Opin\n\nImmunol 2003;15:5\u201311.\n\n44. Aderem A, Ulevitch RJ. Toll-like receptors in the induc-\n\ntion of the innate immune response. Nature 2000;406:782\u2013\n\n7.\n\n45. Calich VLG, Singer-Vermes LM, Burger E. Susceptibility\n\nand resistance of inbred mice to Paracoccidioides brasil-\niensis. Brit J Exp Path 1985;66:585\u201394.\n\n46. Popi AF, Lopes JD, Mariano M. GP43 from Paracoccid-\nioides brasiliensis inhibits macrophage functions. An\nevasion mechanism of the fungus. Cell Immunol 2002;218:\n\n87\u201394.\n\n47. Ferreira KS, Lopes JD, Almeida SR. Down-regulation of\n\ndendritic cell activation induced by Paracoccidioides\nbrasiliensis. Immunol Lett 2004;94:107\u201314.\n\n48. Brummer E. Interaction of Paracoccidioides brasiliensis\nwith host defense cells. In: Franco M, Lacaz CS, Restrepo\n\nA, Del Negro G, editors. Paracoccidioidomycosis. Boca\n\nRaton, Florida: CRC Press; 1994. p. 213\u201324.\n\n49. McEwen JG, Brummer E, Stevens DA, Restrepo A. Effect\n\nof murine polymorphonuclear leukocytes on the yeast form\n\nof Paracoccidioides brasiliensis. Am J Trop Med Hyg\n1987;36:603\u20138.\n\n50. Meloni-Bruneri LH, Campa A, Abdalla DSP, Calich VLG,\n\nBurger E. Neutrophils from air-pouches of resistant mice to\n\nParacoccidioides brasiliensis infection are more activated\nand efficient in killing the fungi than those of susceptible\n\nones. J Leuk Biol 1996;59:526\u201333.\n\n51. Kurita N, Oarada M, Miyaji M, Ito E. Effect of cytokines\n\non antifungal activity of human polymorphonuclear leu-\n\nkocytes against yeast cells of Paracoccidioides\nbrasiliensis. Med Mycol 2000;38:177\u201382.\n\n52. Soares AM, Calvi SA, Perac?oli MT, Fernandez AC, Dias\n\nLA, Dos Anjos AR. Modulatory effect of prostaglandins on\n\nhuman monocyte activation for killing of high- and low-\n\nvirulence strains of Paracoccidioides brasiliensis. Immu-\nnology 2001;102:480\u20135.\n\n53. Cano LER, Paracoccidioidomicose pulmonar experimen-\n\ntal. Caracterizac?a?o do modelo de infecc?a?o intratraqueal em\n\ncamundongos resistentes e suscept??veis; participac?a?o do\n\nIFN-c, das ce?lulas TCD4+ e CD8+ na resiste?ncia ao fungo.\n(Ph.D. Thesis). Sa?o Paulo, Instituto de Cie?ncias Biome?di-\n\ncas, Universidade de Sa?o Paulo; 2007. 191 pp.\n\n54. Gonzalez A, Sahaza JH, Ortiz BL, Restrepo A, Cano LE.\n\nProduction of pro-inflammatory cytokines during the early\n\nstages of experimental Paracoccidioides brasiliensis\ninfection. Med Mycol 2003;41:391\u20139.\n\n55. Pina A, Saldiva PH, Restrepo LE, Calich VL. Neutrophil\n\nrole in pulmonary paracoccidioidomycosis depends on the\n\nresistance pattern of hosts. J Leukoc Biol 2006;79:1202\u201313.\n\n56. Perac?oli MT, Soares AM, Mendes RP, Marques SA,\n\nPereira PC, Reskallah-Iwasso MT. Studies of natural killer\n\ncells in patients with paracoccidioidomycosis. J Med Vet\n\nMycol 1991;29:373\u201380.\n\n57. Jimenez BE, Murphy JW. In vitro effects of natural killer\n\ncells against Paracoccidioides brasiliensis. Infec Immun\n1984;46:552\u20138.\n\n58. Perac?oli MT, Fortes MR, Da Silva MF, Montenegro MR.\n\nNatural killer cell activity in experimental paracoccidi-\n\noidomycosis of the Syrian hamster. Rev Inst Med Trop S\n\nPaulo 1995;37:129\u201336.\n\n59. Cano LE, Kashino SS, Arruda C, Andre? D, Xidieh CF,\n\nSinger-Vermes LM, et al. Protective role of interferon-\n\ngamma in experimental pulmonary paracoccidioidomyco-\n\nsis. Infec Immun 1998;66:800\u20136.\n\n60. Deepe GS, Romani L, Calich VLG, Huffnagle G, Arruda\n\nC, Molinari-Madlum EEIW, et al. Knockout mice as\n\nexperimental models of virulence. Med Mycol\n\n2000;38:87\u201398.\n\n61. Valente-Ferreira RC. Caracterizac?a?o da importa?ncia do\n\nIFN-c, da IL-12, dos leuco?citos PMN e das ce?lulas NK na\nimunidade natural ao P. brasiliensis utilizando hospedeiros\nnormais e deficientes de ce?lulas T. [Ph.D. Thesis]. Sa?o\n\nPaulo, Sa?o Paulo: Universidade de Sa?o Paulo; 2005. 172\n\npp.\n\n62. Kashino SS, Fazioli RA, Moscardi-Bacchi M, Franco M,\n\nSinger-Vermes LM, Burger E, et al. Effect of macrophage\n\nblokade on the resistance mechanisms of inbred mice to\n\nParacoccidioides brasiliensis infection. Mycopathology\n1995;130:131\u201340.\n\n63. Brummer E, Hanson LH, Stevens DA. Gamma-interferon\n\nactivation of macrophages for killing of Paracoccidioides\nbrasiliensis: evidence for non-oxidative mechanisms.\nIntern J Immunopharmac 1998;10:945\u201352.\n\n64. Gonzalez A, de Gregori W, Velez D, Restrepo A, Cano LE.\n\nNitric oxide participation in the fungicidal mechanism of\n\ninterferon-gamma activated murine macrophages against\n\nParacoccidioides brasiliensis. Infect Immun 2000;68:\n2546\u201352.\n\n65. Cano LE, Go?mez B, Brummer E, Restrepo A, Stevens DA.\n\nInhibitory effect of deferoxamine or macrophage activation\n\non transformation of Paracoccidioides brasiliensis conidia\n\nMycopathologia (2008) 165:223\u2013236 235\n\n123\n\n\n\nby ingested macrophages: reversal by holotransferin. Infec\n\nImmun 1994;62:1494\u20136.\n\n66. Nascimento FR, Calich VLG, Rodriguez D, Russo M. Dual\n\nrole for nitric oxide in paracoccidioidomycosis: essential\n\nfor resistance, but overproduction associated with suscep-\n\ntibility. J Immunol 2002;168:4593\u2013600.\n\n67. Bernardino S. Paracoccidioidomicose pulmonar em ca-\n\nmundongos geneticamente deficientes da enzima o?xido\n\nn??trico sintase-induzida (iNOS). [M.Sc.Dissertation]. Sa?o\n\nPaulo, Sa?o Paulo, Universidade de Sa?o Paulo; 2006. 82 pp.\n\n68. Gonzalez A, Aristizabal BH, Gomez EC, Restrepo A, Cano\n\nLE. Short report: inhibition by tumor necrosis factor-alpha-\n\nactivated macrophages of the transition of Paracoccidio-\nides brasiliensis conidia to yeast cells through a\nmechanism independent of nitric oxide. Am J Trop Med\n\nHyg 2004;71:828\u201330.\n\n69. Pina A. Atividade fungicida e secretora de macro?fagos\n\nalveolares de camundongos suscept??veis e resistentes in-\n\nfectados pelo P. brasiliensis. [Ph.D. Thesis]. Sa?o Paulo,\nSa?o Paulo, Universidade de Sa?o Paulo; 2005. 118 pp.\n\n70. Banchereau J, Steinman RM. Dendritic cells and the con-\n\ntrol of immunity. Nature 1998;392:245\u201352.\n\n71. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen\n\nS, Julkunen I, et al. Distinct patterns and kinetics of\n\nchemokine production regulate dendritic cell function. Eur\n\nJ Immunol 1999;29:1617\u201325.\n\n72. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S,\n\nLiu YJ, et al. Immunobiology of dendritic cells. Annu Rev\n\nImmunol 2000;18:767\u2013811.\n\n73. Puccia R, Schenkman S, Gorin PAJ, Travassos LR. Exo-\n\ncellular components of Paracoccidioides brasiliensis:\nidentification of a specific antigen. Infect Immun\n\n1986;53:199\u2013207.\n\n74. Almeida SR, Moraes JZ, Camargo ZP, Gesztesi JL,\n\nMariano M, Lopes JD. Pattern of immune response to gp43\n\nfrom Paracoccidioides brasiliensis in susceptible and\nresistant mice is influenced by antigen-presenting cells.\n\nCell Immunol 1998;190:68\u201376.\n\n75. Ferreira KS, Lopes JD, Almeida SR. Regulation of T\n\nhelper cell differentiation in vivo by GP43 from Para-\ncoccidioides brasiliensis provided by different antigen-\npresenting cells. Scand J Immunol 2003;58:290\u20137.\n\n76. Ferreira KS, Lopes JD, Almeida SR. Down-regulation of\n\ndendritic cell activation induced by Paracoccidioides\nbrasiliensis. Immunol Lett 2004;94:107\u201314.\n\n77. Ferreira KS, Almeida SR. Immunization of susceptible\n\nmice with gp43-pulsed dendritic cells induces an increase\n\nof pulmonary Paracoccidioidomycosis. Immunol Lett\n\n2006;103:121\u20136.\n\n78. Souto JT, Aliberti JC, Campanelli APM, Livonesi CML,\n\nFerreira MBR, Travassos LR, et al. Chemokine production\n\nand leukocyte recruitment to the lungs of Paracoccidioides\nbrasiliensis-infected mice is modulated by interferon-c.\nAm J Pathol 2003;163:583\u201390.\n\n79. Arruda C, Franco MF, Kashino SS, Nascimento FRF,\n\nFazioli RA, Vaz CAC, et al. IL-12 protects mice against\n\ndisseminated infection caused by Paracoccidioides\n\nbrasiliensis but enhances pulmonary inflammation. Clin\nImmunol 2002;103:185\u201395.\n\n80. Pina A, Valente-Ferreira RC, Molinari-Madlum EE, Vaz\n\nCA, Keller AC, Calich VLG. Absence of interleukin-4\n\ndetermines less severe pulmonary paracoccidioidomycosis\n\nassociated with impaired Th2 response. Infect Immun\n\n2004;72:2369\u201378.\n\n81. Arruda C, Valente-Ferreira RC, Pina A, Kashino SS,\n\nFazioli RA, Vaz CAC, et al. Dual role of interleukin-4 (IL-\n\n4) in pulmonary paracoccidioidomycosis: endogenous IL-4\n\ncan induce protection or exacerbation of disease depending\n\non the host genetic pattern. Infect Immun 2004;72:3932\u2013\n\n40.\n\n82. Musatti CC, Perac?oli MTS, Soares AMVC, Reskallah-\n\nIwasso MT. Cell-mediated immunity in patients with\n\nparacoccidioidomycosis. In: Franco M, Lacaz CS, Restre-\n\npo A, Del Negro G, editors. Paracoccidioidomycosis.\n\nBocca Raton, Florida: CRC Press; 2004. p. 175\u201386.\n\n83. Mamoni RLR, Nouer AMS, Oliveira SA, Musatti CC,\n\nRossi CL, Camargo ZP, et al. Enhanced production of\n\nspecific IgG4, IgA and TGF-b in sera from patients with\nthe juvenile form of paracoccidioidomycosis. Med Mycol\n\n2002;40:1\u20137.\n\n84. Benard G, Romano CC, Cacere CR, Juvenale M, Mendes-\n\nGiannini MJ, Duarte AJ. Imbalance of IL-2, IFN-gamma\n\nand IL-10 secretion in the immunosuppression associated\n\nwith human paracoccidioidomycosis. Cytokine\n\n2001;13:248\u201352.\n\n85. Romano CC, Mendes-Giannini MJ, Duarte AJ, Benard G.\n\nThe role of interleukin-10 in the differential expression of\n\ninterleukin-12p70 and its beta2 receptor on patients with\n\nactive or treated paracoccidioidomycosis and healthy\n\ninfected subjects. Clin Immunol 2005;114:86\u201394.\n\n86. Cacere CR, Romano CC, Mendes Giannini MJ, Duarte AJ,\n\nBenard G. The role of apoptosis in the antigen-specific T\n\ncell hyporesponsiveness of Paracoccidioidomycosis\n\npatients. Clin Immunol 2002;105:215\u201322.\n\n87. Campanelli AP, Martins GA, Souto JT, Pereira MS, Li-\n\nvonesi MC, Martinez R, et al. Fas-Fas ligand (CD95-\n\nCD95L) and cytotoxic T lymphocyte antigen-4 engage-\n\nment mediate T cell unresponsivess in patients with\n\nparacoccidioidomycosis. J Infect Dis 2003;187:1496\u2013505.\n\n88. Cavassani KA, Campanelli AP, Moreira AP, Vancin JO,\n\nMamede RC, Martinez R, et al. Systemic and local char-\n\nacterization of regulatory T cells in a chronic fungal\n\ninfection in humans. J Immunol 2006;177:5811\u20138.\n\n89. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire\n\nantigen from apoptotic cells and induce class I-restricted\n\nCTLs. Nature 1998;392:86\u20139.\n\n90. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic\n\ncell can be a temporal bridge between a CD4\n+\n\nT-helper and\n\na T-killer cell. Nature 1998;393:474\u20138.\n\n236 Mycopathologia (2008) 165:223\u2013236\n\n123\n\n\n\nM I N I R E V I E W\n\nToll-like receptors and fungal infections: the role of TLR2,TLR4 and\nMyD88 in paracoccidioidomycosis\nVera L. G. Calich, Adriana Pina, Ma??ra Felonato, Simone Bernardino, Tania A. Costa &amp; Fla?vio V. Loures\n\nDepartamento de Imunologia, Instituto de Cie?ncias Biome?dicas, Universidade de Sa?o Paulo, Sa?o Paulo, SP, Brazil\n\nCorrespondence: Vera L. G. Calich,\n\nDepartamento de Imunologia, Instituto de\n\nCie?ncias Biome?dicas da Universidade de Sa?o\n\nPaulo, Av. Prof. Lineu Prestes 1730,\n\nCEP 05508-900, Sa?o Paulo, SP, Brazil.\n\nTel.: 155 11 30917397; fax: 155 11\n\n30917224; e-mail: vlcalich@icb.usp.br\n\nReceived 8 November 2007; accepted 17\n\nDecember 2007.\n\nFirst published online 1 April 2008.\n\nDOI:10.1111/j.1574-695X.2008.00378.x\n\nEditor: Willem van Leeuwen\n\nKeywords\n\ntoll-like receptors; fungal pathogens;\n\nparacoccidioidomycosis; TLR2; TLR4; MyD88.\n\nAbstract\n\nThe aim of this minireview is to present a concise view of the most important\n\npattern recognition receptors used by the innate immune system to sense and\n\ncontrol pathogen growth into host tissues. A brief review of the role of Toll-like\n\nreceptors (TLRs) in fungal infections followed by some recent results on the\n\nfunction of TLR4, TLR2 and the MyD88 adaptor molecule in the pathogenesis of\n\nparacoccidioidomycosis are presented.\n\nInnate immunity and pattern\nrecognition receptors\n\nCells of the innate immune system constantly sense the\n\npresence of invading microorganisms using several kind of\n\nconserved, transmembrane or intracytoplasmatic receptors\n\ncalled pattern recognition receptors (PRRs). These receptors\n\nrecognize conserved molecular structures shared by groups\n\nof microorganisms and known as pathogen-associated mo-\n\nlecular patterns (PAMPs). Because PAMPs are produced by\n\npathogens but not by the host cells, their recognition by\n\nPRRs allows for self\u2013nonself discrimination (Janeway &amp;\n\nMedzhitov, 2002). The most important types of PRR are\n\nthe Toll-like receptors (TLRs), the non-TLRs such as in-\n\ntracellular nucleotide-binding oligomerization domain\n\n(NOD)-like proteins and the C-type lectin receptors (CLRs)\n\n(Gordon, 2002; Brown &amp; Gordon, 2003; Inohara &amp; Nunez,\n\n2003; Akira et al., 2006). The interaction between PAMPs\n\nand PRRs leads to the activation of cells of the innate\n\nimmune system and subsequent production of mediators\n\nthat are used to eliminate the invading pathogen and to\n\ncontrol the adaptative immune responses. TLRs are crucial\n\nfor many aspects of microbial elimination, including re-\n\ncruitment of phagocytes to the site of infection, microbial\n\nkilling and activation of dendritic cells (DCs), which become\n\nimmunogenic and endowed with a unique ability to induce\n\nfull activation of T cells (Reis e Sousa, 2004). Interestingly,\n\nrecent findings indicate that direct recognition of PAMPs by\n\nDCsis critical for priming appropriate T-cell responses. TLR\n\nsignaling resulted in activated DCs that primed an effective\n\nT helper 1 (Th1) or Th2 response, whereas indirect activa-\n\ntion by inflammatory mediators alone (proinflammatory\n\ncytokines) induced DCs that, although supporting expan-\n\nsion of CD4\n1\n\nT-cell clones, did not promote Th1 or Th2\n\neffector differentiation (Spo?rri &amp; Reis e Sousa, 2005).\n\nThus far, 13 TLRs have been described that recognize a\n\nwide variety of pathogen structures including triacyl lipo-\n\npeptides (TLR1 in association with TLR2), lipoteichoic acid\n\nand lipoproteins of Gram-positive bacteria (TLR2), double-\n\nstranded RNA (TLR3), lipopolysaccharide of Gram-nega-\n\ntive bacteria (TLR4), bacterial flagellin (TLR5), diacyl\n\nlipopeptides (TLR6 in association with TLR2), single-\n\nstranded RNA (TLR7) and nonmethylated CpG of bacterial\n\nDNA (TLR9) (Takeda &amp; Akira, 2005). Intracellular NOD\n\nproteins sense the presence of intracellular muropeptides\n\n(Inohara &amp; Nunez, 2003). Upon ligand binding, innate\n\nFEMS Immunol Med Microbiol 53 (2008) 1\u20137 c? 2008 Federation of European Microbiological Societies\nPublished by Blackwell Publishing Ltd. All rights reserved\n\n\n\nimmune receptors engage intracellular signaling pathways\n\nthat result in the activation of conserved transcription\n\nfactors for cell activation. One key transcription factor used\n\nby TLR-mediated innate immunity is NFkB. Almost all\n\nTLRs signal via MyD88, an adaptor protein, for NFkB\n\nactivation, subsequent inflammatory cytokine production\n\nand control of adaptative immunity (Takeda &amp; Akira, 2005;\n\nAkira et al., 2006). Besides their well-described role in the\n\nimmunorecognition of conserved pathogen motifs, TLRs\n\ncan be used to enhance microbial pathogenicity. Thus,\n\nYersinia pestis was shown to evade the host\u2019s immune system\n\nby TLR2 activation and subsequent production of IL-10,\n\none important macrophage deactivating cytokine (Sing\n\net al., 2002). Furthermore, studies with whole pathogens or\n\npurified components have shown distinct patterns of TLR\n\nusage: TLR2 and TLR4 control in vivo Brucella abortus\n\ninfection whereas only TLR4 is activated by the purified\n\nbacterial lipopolysaccharide (Campos et al., 2004).\n\nTLR-activated DCs can induce the differentiation of\n\ndistinct T-cell-mediated effector mechanisms. Lipopolysac-\n\ncharide-stimulated DCs produce low levels of IL-10 but high\n\nlevels of IL-12 and tumor necrosis factor-a (TNF-a), favoring\nTh1 immunity. In contrast, peptidoglycan-activated DCs\n\nsecrete low levels of IL-12 associated with prevalent produc-\n\ntion of IL-10, resulting in prevalent Th2 immunity (Qi et al.,\n\n2003). Interestingly, the recognition of microbial products by\n\nTLRs was found to block the suppressive effect of T regulatory\n\n(Treg) cells on pathogen-specific adaptative immune re-\n\nsponse and this effect was partially due to the synthesis of\n\nIL-6 by TLR-stimulated DCs (Pasare &amp; Medzhitov, 2003).\n\nDendritic cell-specific intercelullar adhesion molecule-3-\n\ngrabbing nonintegrin (DC-SIGN), mannose receptor (MR)\n\nand dectin-1 are C-type lectins that recognize glycoproteins\n\nand carbohydrates in pathogen cells. This interaction con-\n\ntrols phagocytosis, microbicidal activity and signaling pro-\n\ncesses that direct cell adhesion and migration. As fungal cell\n\nwalls are carbohydrate-rich structures, these PRRs are\n\ndirectly involved in the host\u2019s innate immunity to these\n\npathogens. DC-SIGN as well as MRs are primarily activated\n\nby IL-4 and associated with the Th2 pattern of the immune\n\nresponse (Brown &amp; Gordon, 2003; Cambi et al., 2005;\n\nKoppel et al., 2005). Dectin-1 activation by Candida albicans\n\nor curdlan, a dectin-1-specific b-glucan, was recently shown\nto induce the preferential secretion of tumor growth factor\n\n(TGF)-b and IL-6 and the subsequent activation of Th17\nlymphocytes. This T-cell subset secretes IL-17, induces\n\nchemokine secretion at sites of infection, causes recruitment\n\nof neutrophils and is important in defense against extra-\n\ncellular pathogens, including Candida albicans (Leibund-\n\ngut-Landmann et al., 2007; Palm &amp; Medzhitov, 2007).\n\nUpon ligand binding, innate immunoreceptors engage\n\nintracellular signaling pathways that converge to the activa-\n\ntion of conserved transcription factors and subsequent cell\n\nactivation. Almost all TLRs signal via MyD88 for NFkB\n\nactivation, resulting in Th1 immunity associated with the\n\nprevalent IL-12 secretion. TLR2 activation, however, induces\n\nhigh levels of IL-10, and expansion of regulatory T cells\n\n(Treg) which further control T effector lymphocytes (Gor-\n\ndon, 2002; Akira et al., 2006; Sutmuller et al., 2006).\n\nInterestingly, recent work has shown that the preferential\n\nactivation of dectin-1 by the selective agonist curdlan, and\n\npossibly dectin-2 by Candida albicans hyphae, is mediated by\n\nthe caspase recruitment domain (CARD9) adaptor protein,\n\nresulting in increased IL-23 secretion and preferential induc-\n\ntion of Th17 cells (Gross et al., 2006; Leibundgut-Landmann\n\net al., 2007; Palm &amp; Medzhitov, 2007). The fungal morpho-\n\ntype is also recognized by different PRRs and this fact was\n\nsuggested to be exploited as an escape mechanism by fungal\n\ncells. For instance, Candida hyphae are recognized only by\n\nTLR2, inducing prevalent secretion of anti-inflammatory\n\ncytokines, whereas Candida blastoconidia interact with\n\nTLR4, Dectin-1 and TLR2, resulting in a complex pattern of\n\ncell activation (Romani, 2004; Netea et al., 2006).\n\nIn summary, PRR activation orchestrates the develop-\n\nment of innate and adaptative immune responses, which are\n\nnecessary for protection against infection, reinfection or\n\ncontainment of chronic infections. However, if activation of\n\ninnate immune receptors is excessive, high levels of proin-\n\nflammatory mediators [IFN-g, TNF-a, nitric oxide (NO)]\nare secreted and can exert a deleterious effect to the host.\n\nSeptic shock induced by lipopolysaccharide and TLR4\n\nactivation by Gram-negative bacteria is a good example of\n\ninadequate activation of immunity, which results in severe\n\nhost pathology.\n\nRecognition of fungi by TLR\n\nNetea et al. (2002) were the first to describe the use of TLRs\n\nby a fungal pathogen, Candida albicans. C3H/HeJ mice,\n\nwhich express a defective TLR4 gene, present an increased\n\nsusceptibility to disseminated candidiasis and impaired\n\nrecruitment of neutrophils to the site of infection when\n\ncompared with normal, C3H/HeN mice. In addition, the\n\nchemokines keratinocyte-derived chemokine (KC) and\n\nmacrophage inflammatory protein (MIP-2) were shown to\n\nbe released in lower amounts by TLR4-defective macro-\n\nphages. Following this pioneer work, other groups reported\n\ntheir studies on the role of TLRs and the MyD88 adaptor\n\nprotein in Candida albicans infections. The main biological\n\neffects observed in diverse experimental approaches are\n\nsummarized in Table 1. As can be seen, some discrepant\n\nfindings were obtained with TLR2- and TLR4-deficient\n\nhosts (Netea et al., 2002, 2004; Villamo?n et al., 2004b;\n\nMurciano et al., 2006), although MyD88 deficiency appears\n\nconsistently to lead to impaired protection or phagocyte\u2013\n\nfungus interaction. This adaptor protein was shown to be\n\nFEMS Immunol Med Microbiol 53 (2008) 1\u20137c? 2008 Federation of European Microbiological Societies\nPublished by Blackwell Publishing Ltd. All rights reserved\n\n2 V.L.G. Calich et al.\n\n\n\ninvolved in the induction of protective immune responses\n\nby DCs (Bellocchio et al., 2004a), as well as in the phagocy-\n\ntosis, killing and synthesis of cytokines by Candida-infected\n\ncells (Marr et al., 2003; Villamo?n et al., 2004a).\n\nTLR2 usage was shown to have protective or detrimental\n\neffects in models of Candida albicans infection; the conflict-\n\ning results, however, could be attributed to the use of\n\ndifferent experimental protocols (Netea et al., 2004;\n\nVillamo?n et al., 2004a, b), but brought important contribu-\n\ntions to the understanding of immunopathology of infec-\n\ntious processes. The deleterious effect of TLR2 signaling\n\nduring infection was associated with increased synthesis of\n\nIL-10 and an enhanced survival of CD4\n1\n\nCD25\n1\n\nTreg cells,\n\nresulting in deficient T-cell immunity and impaired fungal\n\nclearance (Netea et al., 2004).\n\nAs observed with Candida albicans, the role of TLR in\n\nCryptococcus neoformans infection needs to be further\n\nexplored (Table 2). Glucuronoxylomannan, the major com-\n\nponent of the polysaccharide capsule of Cryptococcus neofor-\n\nmans, is shed from the fungus and circulates in blood and\n\ncerebrospinal fluid of infected hosts. This polysaccharide\n\nwas reported to activate cells transfected with CD14 and\n\nTLR4 but this interaction results in incomplete activation\n\nof cells, and no secretion of TNF-a (Shoham et al., 2001).\nIn vivo, MyD88 and TLR2 but not TLR4 were shown to be\n\nrequired to induce protection against Cryptococcus neofor-\n\nmans infection (Yauch et al., 2004; Biondo et al., 2005). A\n\nmore recent report, however, suggests that TLR2 and TLR4\n\ndo not or only marginally contribute to the host response to\n\nthis pathogen (Nakamura et al., 2006).\n\nTLR2-, TLR4- and MyD88-dependent activation of host\n\ncells were shown to play a role in cytokine secretion,\n\npolymorphonuclear neutrophil (PMN) activation and\n\nsusceptibility to infection by another opportunistic fungal\n\npathogen, Aspergillus fumigatus (Wang et al., 2001; Marr\n\net al., 2003; Meier et al., 2003; Netea et al., 2003; Bellocchio\n\net al., 2004a, b; Braedel et al., 2004; Dubordeau et al., 2006).\n\nAs described for Candida albicans, the germination from\n\nconidia to hyphae was proposed as an escape mechanism of\n\nA. fumigatus as conidia cells are recognized by TLR4 and\n\nTLR2, resulting in the production of proinflammatory cyto-\n\nkines, while hyphae stimulate production of IL-10 using a\n\nTLR2-dependent mechanism (Netea et al., 2003). Although\n\nsome experimental approaches have revealed the important\n\nrole of MyD88 adaptor protein in cell signaling and protective\n\nresponses (Mambula et al., 2002; Bellocchio et al., 2004a),\n\nother reports claimed that MyD88 signaling and activation of\n\nNFkB are not important for fungal clearance (Marr et al.,\n2003; Dubordeau et al., 2006) (Table 3).\n\nAs a whole, several reports have illustrated the use of\n\ndifferent TLRs by a single fungal species, resulting in diverse\n\nbiological activities. Studies with purified components of\n\nfungal cell walls revealed the major PRR and signaling\n\npathways used by host cells to recognize fungal PAMPs;\n\nhowever, this picture is less clear when whole pathogens are\n\nused to infect normal or PRR-deficient hosts. The final\n\nactivation, although influenced by the missing receptor, is\n\nmediated by the remaining PRRs, which can compensate or\n\nnot the deficient receptor.\n\nPRR and Paracoccidioides brasiliensis\ninfection\n\nParacoccidioides brasiliensis, the causative agent of human\n\nparacoccidioidomycosis, is primarily a respiratory pathogen,\n\ninfecting the host through inhalation of airborne spores.\n\nTable 1. The role of TLRs and MyD88 adaptor protein in some experimental models of Candida albicans infection\n\nPRR deficiency Biological effect Reference\n\nTLR4 High susceptibility; normal PMN and macrophage killing activity; normal TNF-a, low KC, MIP-2\nand impaired PMN influx\n\nNetea et al. (2002)\n\nTLR4 No increased susceptibility to disseminated infection. TLR4-deficient mice mount Th1 immunity Murciano et al. (2006)\n\nTLR2 High resistance; TLR2 induces IL-10, Treg cells and suppressed immunity Netea et al. (2004)\n\nTLR2 High susceptibility; low TNF-a, MIP-2; decreased PMN influx; no effect phagocytosis and NO\nproduction\n\nVillamo?n et al. (2004a)\n\nMyD88 Hyphae: impaired phagocytosis, killing and cytokine secretion Marr et al. (2003)\n\nMyD88 High susceptibility, impaired production of cytokine, low type-1 CD41 and CD81 T cells Villamo?n et al. (2004b)\n\nMyD88, TLR4,\n\nTLR2, TLR9\n\nMyD88: high susceptibility. TLR signaling: depends on morphotypes, route of infection.\n\nTh1 response: DC-MyD-dependent\n\nBellocchio et al. (2004a)\n\nTable 2. The role of TLRs and MyD88 adaptor protein in some experimental models of Cryptococcus neoformans infection\n\nPRR deficiency Biological effect Reference\n\nTLR2, TLR4, CD14 Glucoronoxylomannan stimulates cells via CD14 and TLR4; no TNF-a synthesis Shoham et al. (2001)\nTLR-2, TLR4, MyD88, CD14 MyD88 has a major role in protection; CD14 and TLR2, minor roles; TLR4, no effect Yauch et al. (2004)\n\nTLR-2, TLR4, MyD88 MyD88 and TLR2 have a major role in protection; TLR4 not important Biondo et al. (2005)\n\nTLR2 and TLR4 Not important to protection Nakamura et al. (2006)\n\nFEMS Immunol Med Microbiol 53 (2008) 1\u20137 c? 2008 Federation of European Microbiological Societies\nPublished by Blackwell Publishing Ltd. All rights reserved\n\n3Toll-like receptors and fungal infections\n\n\n\nThe great majority of infected subjects develop an asympto-\n\nmatic pulmonary infection, although some individuals\n\npresent clinical manifestations, which give rise to the\n\nlocalized (benign) or disseminated (severe) forms of the\n\ndisease. Clinical and experimental evidence indicates that\n\ncell-mediated immunity plays a significant role in host\n\ndefense against P. brasiliensis infection, whereas high levels\n\nof specific antibodies are associated with the most severe\n\nforms of the disease (Borges-Walmsley et al., 2002; Calich\n\net al., 2008). Our laboratory developed a murine pulmonary\n\nmodel of infection in which A/Sn mice developed a chronic\n\nbenign, pulmonary-restricted paracoccidioidomycosis\n\nwhereas B10.A mice developed a progressive disseminated\n\ndisease. The main immunological characteristics of this\n\nmodel are described elsewhere (Calich &amp; Blotta, 2005).\n\nAlthough the importance of innate immunity in\n\nresistance to fungal infection is well recognized (Roeder\n\net al., 2004; Romani, 2004), the molecular mechanisms\n\nunderlying recognition of P. brasiliensis by innate immune\n\ncells are not well known (Calich &amp; Blotta, 2005; Calich\n\net al., 2008). C3b receptors (CR3, CD11b/CD18) are mem-\n\nbrane integrins that recognize iC3b of the complement\n\nsystem, several b-glucans and other cell-wall components\nexpressing high mannose content (Brown &amp; Gordon,\n\n2003). We were the first to demonstrate that P. brasiliensis\n\ninteraction with peritoneal macrophages was enhanced\n\nby iC3b opsonization of yeast cells (Calich et al., 1979).\n\nStudying murine macrophages, Jimenez et al. (2006) verified\n\nthat CR3 and MR were involved in the phagocytosis\n\nof P. brasiliensis spores (conidia). In addition, gp43, the\n\nimmunodominant antigen of P. brasiliensis, was shown to\n\nbind to MR and to inhibit the phagocytic and fungicidal\n\nability of peritoneal macrophages from resistant and suscep-\n\ntible mice (Popi et al., 2002). This finding led the authors to\n\npostulate the expression or secretion of gp43 as an escape\n\nmechanism of fungal cells.\n\nTLR4 and P. brasiliensis infection\n\nComparative studies of in vivo susceptibility of different\n\nmouse strains to P. brasiliensis intraperitoneal infection led\n\nus to verify that TLR4-deficient (C3H/HeJ) mice were more\n\nresistant than TLR4 normal (C3H/HePas) animals (Calich\n\net al., 1985). Recent findings from our laboratory (F.V.\n\nLoures, unpublished data) demonstrated that, compared\n\nwith the normal strain, macrophages from TLR4-deficient\n\nmice had a lower phagocytic ability, which appears to\n\ninfluence the decreased number of viable P. brasiliensis yeasts\n\nrecovered after cocultivation for a 72 h period. Deficient\n\nmacrophages secrete lower levels of NO, IL-12 and mono-\n\ncyte chemoattractant protein-1 (MCP-1) but produced\n\nequivalent amounts of TNF-a. In contrast, IL-10 was\nsynthesized in higher amounts by TLR4-deficient macro-\n\nphages. Consistent with in vitro results, 96 h after\n\nin vivo pulmonary infection, TLR4-deficient mice presented\n\ndecreased fungal loads in the lungs associated with lower\n\nlevels of NO and proinflammatory cytokines [IL-12, and\n\ngranulocyte macrophage colony-stimulating factor (GM-\n\nCSF)]. Similar results were observed at week 11 after\n\ninfection of TLR4-mutant mice: decreased CFU counts\n\nassociated with low IL-12 levels but high IFN-g secretion.\nParalleling its mild infection, the deficient strain secreted\n\nlow levels of IgG1, IgG2b and IgM P. brasiliensis-specific\n\nisotypes (F.V. Loures, unpublished data).\n\nCytospin preparations of lung-infiltrating leukocytes at\n\nweek 2 of infection showed an increased number of PMN\n\nneutrophils associated with decreased numbers of lympho-\n\ncytes and monocytes. Diminished expression of CD25\n1\n\n,\n\nCD86\n1\n\nand CD86\n1\n\nIA\nk1\n\ncells were also observed by fluor-\n\nescence-activated cell sorter (FACS) analysis of lung\n\nlymphocytes. In addition, by week 2 of infection no differ-\n\nences in the lymphoproliferative activity of TLR4-normal\n\nand TLR4-deficient spleen cells were detected. Although\n\nTable 3. The role of TLRs and MyD88 adaptor protein in some experimental models of Aspergillus fumigatus infection\n\nPRR deficiency Biological effect Reference\n\nTLR4, CD14, TLR2 TLR4 but not TLR2 recognizes hyphae Wang et al. (2001)\n\nTLR4, TLR2 TLR4 and TLR2 recognize conidia and hyphae, and induce TNF-a and MIP-2;\nimpaired PMN influx\n\nMeier et al. (2003)\n\nTLR4, TLR2 Fungal antigens recognized by TLR4 and TLR2; enhanced phagocytosis and\n\ncytokine synthesis; activation and maturation of DCs\n\nBraedel et al. (2004)\n\nTLR4, TLR2, TLR3, etc Individual TLRs activate human PMNs for specialized antifungal effector\n\nfunctions\n\nBellocchio et al. (2004b)\n\nTLR4, TLR2 Conidia use TLR4 and TLR2 to induce proinflammatory cytokines; hyphae use\n\nonly TLR2 to produce IL-10\n\nNetea et al. (2003)\n\nMyD88, TLR2, TLR4 MyD88 and TLR2 required for optimal signaling responses of cells Mambula et al. (2002)\n\nMyD88, TLR2, TLR4 TLR2, TLR4 and MyD88 signaling dispensable for fungal clearance Dubordeau et al. (2006)\n\nMyD88 Normal phagocytosis and killing of conidia; normal cytokine secretion Marr et al. (2003)\n\nMyD88 TLR4, TLR2, TLR9 MyD88: high susceptibility. TLR signaling: depends on morphotypes, route of\n\ninfection. Th1 response: DC-MyD-dependent\n\nBellocchio et al. (2004a)\n\nFEMS Immunol Med Microbiol 53 (2008) 1\u20137c? 2008 Federation of European Microbiological Societies\nPublished by Blackwell Publishing Ltd. All rights reserved\n\n4 V.L.G. Calich et al.\n\n\n\ndifferences in CFU counts and synthesis of some inflamma-\n\ntory mediators occur in TLR4-deficient mice, such differ-\n\nences were not sufficient to alter their mean survival times\n\n(Loures; F.V. Loures &amp; V.L.G. Calich, unpublished data).\n\nTLR2 and P. brasiliensis infection\n\nWe have also comparatively analyzed P. brasiliensis infection\n\nof TLR2-normal (WT) and TLR2-gene knockout (KO) mice\n\nin a C57BL/6 background (F.V. Loures &amp; V.L.G. Calich,\n\nunpublished data). In vitro infection of KO macrophages\n\nresulted in lower phagocytic indexes, decreased recovery of\n\nviable yeasts after 72 h of cocultivation and low levels of NO\n\nand MCP-1 in culture supernatants. Compared with WT\n\nmice, 48 h after infection KO mice presented diminished\n\npulmonary fungal loads and NO, but these findings were not\n\nassociated with differences in the levels of pro- and anti-\n\ninflammatory cytokines. Analysis of bronchoalveolar lavage\n\nfluids obtained 72 h after i.t. infection showed an increased\n\ninflux of neutrophils to the airspaces of TLR2 KO mice in\n\ncomparison with WT animals. Cytospin preparations of\n\nlung-infiltrating leukocytes at weeks 2 and 4 of infection\n\nshowed a decreased proportion of macrophages but an\n\nincreased number of PMN neutrophils and lymphocytes. In\n\naddition, a decreased number of IAk1 macrophages and\n\nCD41 CD251 T cells was detected in TLR2 KO mice.\n\nFurther studies are needed, however, to characterize this\n\nT-cell subset more completely, which can exert effector or\n\nregulatory functions. Indeed, in a previous report Netea\n\net al. (2004) showed that TLR2 KO mice are less susceptible\n\nto Candida albicans infection due to the decreased presence\n\nof regulatory T cells and a more efficient fungal-specific\n\nimmunity. At week 11 of infection TLR2-deficient and\n\nnormal mice presented similar humoral immunity but the\n\nformer strain presented increased fungal burden in the\n\nlungs. Despite this difference, both mouse strains exhibited\n\nequivalent mortality rates.\n\nMyD88 adaptor molecule and\nP. brasiliensis infection\n\nWhen macrophages were in vitro infected with P. brasiliensis\n\nyeasts for 72 h, an increased number of viable fungi was\n\nrecovered from MyD88 KO macrophages in comparison\n\nwith normal cells. This diminished fungicidal ability paral-\n\nleled a decreased synthesis of NO and IL-12. The early in\n\nvivo infection reproduced the in vitro findings: higher fungal\n\nloads were found in MyD88 KO mice associated with lower\n\nlevels of pulmonary NO and IL-12. This appears to indicate\n\nthat absence of MyD88 molecule causes profound effects in\n\ncell activation, resulting in more severe infection. Mortality\n\nstudies confirmed the higher susceptibility of MyD88 KO\n\nmice to P. brasiliensis infection, as their mean survival time\n\nwas significantly lower than that of WT controls (F.V. Loures\n\n&amp; V.L.G. Calich, unpublished data).\n\nConcluding remarks\n\nAn increasing number of reports document the primary\n\nimportance of innate immunity not only by providing the\n\nfirst line of defense against invading pathogens but also by\n\ncontrolling essential mechanisms that induce and regulate\n\nadaptative immunity. Our results on the role of TLRs in\n\nparacoccidioidomycosis suggest P. brasiliensis yeasts use\n\nTLR2 and TLR4 to gain entry into macrophages and infect\n\nmammalian hosts. Indeed, P. brasiliensis yeasts appear to be\n\nrecognized by TLR2 and TLR4, resulting in increased\n\nphagocytic ability, NO secretion and fungal infection of\n\nmacrophages. These data appear to be paradoxical, but the\n\nkilling activity usually associated with NO secretion was not\n\nable to reduce the fungal growth provided by the presence\n\nof TLRs. Thus, interaction with TLRs could be considered a\n\npathogenicity mechanism of P. brasiliensis, which would use\n\nhost receptors of innate immunity (TLR2 and TLR4) to\n\ninfect cells and to guarantee its own multiplication.\n\nThe in vivo infection of TLR-deficient mice resulted in\n\ndecreased fungal burdens, again suggesting that TLRs are\n\nused by P. brasiliensis yeasts to infect hosts. The opposite\n\nresult, however, was seen with MyD88-deficient macro-\n\nphages and mice as more severe infections were observed\n\nprobably due to the intact fungal recognition mediated by\n\nthe expression of normal PRR but impaired ability of cell\n\nactivation resulting in diminished fungicidal ability.\n\nAs a whole, TLR deficiency caused less severe infections\n\nassociated with altered secretion of NO, cytokines and\n\nchemokines, resulting in altered cellular influx to the site of\n\ninfection. In both PRR-deficient strains, the lung inflamma-\n\ntory infiltrate was composed of a diminished number of\n\nmacrophages associated with an increased presence of PMN\n\nneutrophils. The phagocytic and killing abilities of the latter\n\ncells perhaps contribute to the decreased fungal inoculum\n\nat the site of infection. Furthermore, the low level of MCP-1\n\nwas parallel to the decreased number of lung-infiltrating\n\nmonocytes.\n\nAn interesting observation was the decreased number of\n\nCD41CD251 T cells in the lungs of TLR2 KO mice,\n\nalthough an equivalent situation was not observed in\n\nTLR4-deficient animals.\n\nMortality studies have shown that TLR deficiency was not\n\nable to change the late course of infection as no differences\n\nwere observed between TLR-deficient and TLR-normal\n\nmice. Compensatory mechanisms appear to abolish the\n\nimmunological differences caused by PRR deficiencies. The\n\nsame was not true for MyD88 deficiency, which causes\n\nhigher mortality of infected mice.\n\nFEMS Immunol Med Microbiol 53 (2008) 1\u20137 c? 2008 Federation of European Microbiological Societies\nPublished by Blackwell Publishing Ltd. All rights reserved\n\n5Toll-like receptors and fungal infections\n\n\n\nIn summary, our studies suggest that MyD88 deficiency\n\nis more important than TLR2 or TLR4 deficiency and\n\nP. brasiliensis yeasts appear to use TLRs as a virulence\n\nmechanism, which facilitates the access of fungal cells into\n\nmurine macrophages. Despite their TLR-mediated activa-\n\ntion, macrophages are not able to control fungal growth,\n\nboth in vitro and in vivo. However, the final balance between\n\nfungal growth and activation of the immune system appears\n\nto control disease outcome as the low fungal loads and\n\nimpaired immunity of TLR-deficient mice and the high\n\nfungal burdens and enhanced immunity of normal-TLR\n\nmice result in equivalent survival times. Furthermore, our\n\nstudies have also suggested that, besides TLR, other PRRs\n\nplay a role in the host immune response against by\n\nP. brasiliensis infection.\n\nIn conclusion, studies aimed to characterize the role of\n\nTLRs in fungal infections are firmly demonstrating their\n\nimportant participation in the effector and regulatory\n\nmechanisms of innate and adaptative immunity against\n\nthese pathogens. TLR2, TLR4 and the adaptor molecule\n\nMyD88 appear to control the phagocytic rates, cell migra-\n\ntion and activation, cytokine and chemokine secretion as\n\nwell as the expression of costimulatory molecules that affect\n\ndendritic cell activation and their competence as antigen-\n\npresenting cell (APC) to na??ve T cells. The interaction\n\nbetween TLR and other PRRs, in a synergistic or antagonis-\n\ntic way with fungal agonists, can result in different effector\n\n(Th1, Th2 and Th17) and regulatory responses (Treg),\n\nwhich ultimately determine disease outcome. Despite the\n\nimportant information in the current literature, additional\n\ninvestigation is needed to characterize further the influence\n\nof TLRs in the immunopathology of fungal infections.\n\nAcknowledgements\n\nWe are grateful to Dr Shizuo Akira for providing TLR and\n\nMyD88 KO mice. This work was supported by grants from\n\nFundac?a?o de Amparo a? Pesquisa do Estado de Sa?o Paulo\n\n(FAPESP) e Conselho Nacional de Pesquisas (CNPq).\n\nReferences\n\nAkira S, Uematsu S &amp; Takeuchi O (2006) Pathogen recognition\n\nand innate immunity. Cell 124: 783\u2013801.\n\nBellocchio S, Montagnoli C, Bozza S, Gaziano R, Rossi G,\n\nMambula SS, Vecchi A, Mantovani A, Levitz SM &amp; Romani L\n\n(2004a) The contribution of the Toll-like/IL-1 receptor\n\nsuperfamily to innate and adaptive immunity to fungal\n\npathogens in vivo. J Immunol 172: 3059\u20133069.\n\nBellocchio S, Moretti S, Perruccio K, Fallarino F, Bozza S,\n\nMontagnoli C, Mosci P, Lipford GB, Pitzurra L &amp; Romani L\n\n(2004b) TLRs govern neutrophil activity in aspergillosis.\n\nJ Immunol 173: 7406\u20137415.\n\nBiondo C, Midiri A, Messina L, Tomasello F, Garufi G, Catania\n\nMR, Bombaci M, Beninati C, Teti G &amp; Mancuso G (2005)\n\nMyD88 and TLR2, but not TLR4, are required for host defense\n\nagainst Cryptococcus neoformans. Eur J Immunol 35: 870\u2013878.\n\nBorges-Walmsley MI, Chen D, Shu X &amp; Walmsley AR (2002) The\n\npathobiology of Paracoccidioides brasiliensis. Trends Microbiol\n\n10: 80\u201387.\n\nBraedel S, Radsak M, Einsele H, Latge? JP, Michan A, Loeffler J,\n\nHaddad Z, Grigoleit U, Schild H &amp; Hebart H (2004)\n\nAspergillus fumigatus antigens activate innate immune cells via\n\ntoll-like receptors 2 and 4. Br J Haematol 125: 392\u2013399.\n\nBrown GD &amp; Gordon S (2003) Fungal beta-glucans and\n\nmammalian immunity. Immunity 19: 311\u2013315.\n\nCalich VL, Kipnis TL, Mariano M, Neto CF &amp; Dias da Silva WD\n\n(1979) The activation of the complement system by\n\nParacoccidioides brasiliensis in vitro: its opsonic effect and\n\npossible significance for an in vivo model of infection. Clin\n\nImmunol Immunopathol 12: 21\u201330.\n\nCalich VLG &amp; Blotta MHSL (2005) Pulmonary\n\nParacoccidioidomycosis. Fungal Immunology, From an Organ\n\nPerspective (Fidel PL &amp; Huffnagle GB, eds), pp. 201\u2013228.\n\nSpringer, New York.\n\nCalich VLG, Singer-Vermes LM, Siqueira AM &amp; Burger E (1985)\n\nSusceptibility and resistance of inbred mice to Paracoccidioides\n\nbrasiliensis. Br J Exp Path 66: 585\u2013594.\n\nCalich VLG, Costa TA, Felonato M, Arruda C, Bernardino S,\n\nLoures FV, Rineiro LRR, Valente-Ferreira RC &amp; Pina A (2008)\n\nInnate immunity to Paracoccidioides brasiliensis infection.\n\nMycopathology DOI: 10.1007/s11046-007-9048-1.\n\nCambi A, Koopman M &amp; Figdor CG (2005) How C-type lectins\n\ndetect pathogens. Cell Microbiol 7: 481\u2013488.\n\nCampos MA, Rosinha GM, Almeida IC, Salgueiro XS, Jarvis BW,\n\nSplitter GA, Qureshi N, Bruna-Romero O, Gazzinelli RT &amp;\n\nOliveira SC (2004) Role of toll-like receptor 4 in induction of\n\ncell-mediated immunity and resistance to Brucella abortus\n\ninfection in mice. Infect Immun 72: 176\u2013186.\n\nDubordeau M, Athman R, Balloy V, Huerre M, Chignard M,\n\nPhilpott DJ, Latge? JP &amp; Ibrahim-Granet O (2006) Aspergillus\n\nfumigatus induces innate immune responses in alveolar\n\nmacrophages through the MAPK pathway independently of\n\nTLR2 and TLR4. J Immunol 177: 3994\u20134001.\n\nGordon S (2002) Pattern recognition receptors: doubling up for\n\nthe innate immune response. Cell 111: 927\u2013930.\n\nGross O, Gewies A, Finger K, Schafer M, Sparwasser T, Peschel C,\n\nForster I &amp; Ruland J (2006) Card9 controls a non-TLR\n\nsignaling pathway for innate anti-fungal immunity. Nature\n\n442: 651\u2013656.\n\nInohara N &amp; Nunez G (2003) NODs: intracellular proteins\n\ninvolved in inflammation and apoptosis. Nat Rev Immunol 3:\n\n371\u2013382.\n\nJaneway CA Jr &amp; Medzhitov R (2002) Innate immune\n\nrecognition. Annu Rev Immunol 20: 197\u2013216.\n\nJimenez MP, Restrepo A, Radzioch D, Cano LE &amp; Garcia LF\n\n(2006) Importance of complement 3 and mannose receptors\n\nin phagocytosis of Paracoccidioides brasiliensis conidia by\n\nFEMS Immunol Med Microbiol 53 (2008) 1\u20137c? 2008 Federation of European Microbiological Societies\nPublished by Blackwell Publishing Ltd. All rights reserved\n\n6 V.L.G. Calich et al.\n\n\n\nNramp1 congenic macrophages lines. FEMS Immunol Med\n\nMicrobiol 47: 56\u201366.\n\nKoppel EA, van Gisbergen KP, Geijtenbeek TB &amp; van Kooyk Y\n\n(2005) Distinct functions of DC-SIGN and its homologues\n\nL-SIGN (DCSIGNR) and mSIGNR1 in pathogen recognition\n\nand immune regulation. Cell Microbiol 7: 157\u2013165.\n\nLeibundgut-Landmann S, Gross O, Robinson MJ et al. (2007)\n\nSyk- and CARD9-dependent coupling of innate immunity to\n\nthe induction of T helper cells that produce interleukin 17. Nat\n\nImmunol 8: 630\u2013638.\n\nLoures FV (2007) The role of Paracoccidioides brasiliensis lipids\n\nand TLR4 in the fungus-host interaction. MSc thesis, Sa?o\n\nPaulo University, Sa?o Paulo.\n\nMambula SS, Sau K, Henneke P, Golenbock DT &amp; Levitz SM\n\n(2002) Toll-like receptor (TLR) signaling in response to\n\nAspergillus fumigatus. J Biol Chem 277: 39320\u201339326.\n\nMarr KA, Balajee SA, Hawn TR, Ozinsky A, Pham U, Akira S,\n\nAderem A &amp; Liles WC (2003) Differential role of MyD88 in\n\nmacrophage-mediated responses to opportunistic fungal\n\npathogens. Infect Immun 71: 5280\u20135286.\n\nMeier A, Kirschning CJ, Nikolaus T, Wagner H, Heesemann J &amp;\n\nEbel F (2003) Toll-like receptor (TLR) 2 and TLR4 are essential\n\nfor Aspergillus-induced activation of murine macrophages.\n\nCell Microbiol 5: 561\u2013570.\n\nMurciano C, Villamon E, Gozalbo D, Roig P, O\u2019Connor JE &amp; Gil\n\nML (2006) Toll-like receptor 4 defective mice carrying point or\n\nnull mutations do not show increased susceptibility to\n\nCandida albicans in a model of hematogenously disseminated\n\ninfection. Med Mycol 44: 149\u2013157.\n\nNakamura K, Miyagi K, Koguchi Y et al. (2006) Limited\n\ncontribution of Toll-like receptor 2 and 4 to the host response\n\nto a fungal infectious pathogen, Cryptococcus neoformans.\n\nFEMS Imnunol Med Microbiol 47: 148\u2013154.\n\nNetea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der\n\nMeer JW &amp; Kullberg BJ (2002) The role of toll-like receptor\n\n(TLR) 2 and TLR4 in the host defense against disseminated\n\ncandidiasis. J Infect Dis 186: 1377\u20131379.\n\nNetea MG, Warris A, Van der Meer JW, Fenton MJ, Verver-\n\nJanssen TJ, Jacobs LE, Andresen T, Verweij PE &amp; Kullberg BJ\n\n(2003) Aspergillus fumigatus evades immune recognition\n\nduring germination through loss of toll-like receptor-4-\n\nmediated signal transduction. J Infect Dis 188: 320\u2013326.\n\nNetea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der\n\nMeer JW, Van Krieken JH, Hartung T, Adema G &amp; Kullberg BJ\n\n(2004) Toll-like receptor 2 suppresses immunity against\n\nCandida albicans through induction of IL-10 and regulatory T\n\ncells. J Immunol 172: 3712\u20133718.\n\nNetea MG, Van der Meer JW &amp; Kullberg BJ (2006) Role of dual\n\ninteraction of fungal pathogens with pattern recognition\n\nreceptors in the activation and modulation of host defence.\n\nClin Microbiol Infect 12: 404\u2013409.\n\nPalm NW &amp; Medzhitov R (2007) Antifungal defense turns 17.\n\nNat Immunol 8: 549\u2013551.\n\nPasare C &amp; Medzhitov R (2003) Toll pathway-dependent\n\nblockade of CD41CD251 T cell-mediated suppression by\n\ndendritic cells. Science 299: 1030\u20131036.\n\nPopi AF, Lopes JD &amp; Mariano M (2002) GP-43 from\n\nParacoccidioides brasiliensis inhibits macrophages functions. An\n\nevasion mechanism of the fungus. Cell Immunol 218: 87\u201394.\n\nQi H, Denning TL &amp; Soong L (2003) Differential induction of\n\ninterleukin-10 and interleukin-12 in dentritic cells by\n\nmicrobial toll-like receptor activators and skewing of T-cell\n\ncytokine profiles. Infect Immun 71: 3337\u20133342.\n\nReis e Sousa C (2004) Activation of dendritic cells: translating\n\ninnate into adaptative immunity. Curr Opin Immunol 16: 21\u201325.\n\nRoeder A, Kirschning CJ, Rupec RA, Schaller Weindl G &amp; Korting\n\nHC (2004) Toll like receptors as key mediators in innate\n\nantifungal immunity. Med Mycol 42: 485\u2013498.\n\nRomani L (2004) Immunity to fungal infections. Nat Rev\n\nImmunol 4: 1\u201313.\n\nShoham S, Huang C, Chen JM, Golenbock DT &amp; Levitz SM\n\n(2001) Toll-like receptor 4 mediates intracellular signaling\n\nwithout TNF-alpha release in response to Cryptococcus\n\nneoformans polysaccharide capsule. J Immunol 166:\n\n4620\u20134626.\n\nSing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A,\n\nKirschning CJ, Aepfelbacher M &amp; Heesemann J (2002) Yersinia\n\nV-antigen exploits toll-like receptor 2 and CD14 for\n\ninterleukin 10-mediated immunosuppression. J Exp Med 196:\n\n1017\u20131024.\n\nSpo?rri R &amp; Reis e Sousa C (2005) Inflammatory mediators are\n\ninsufficient for full dendritic cell activation and promote\n\nexpansion of CD41 T cell populations lacking helper function.\n\nNat Immunol 6: 163\u2013170.\n\nSutmuller RP, Den Brok MH, Kramer M, Bennink EJ, Toonen LW,\n\nKullberg BJ, Joosten LA, Akira S, Netea MG &amp; Adema GJ\n\n(2006) Toll-like receptor 2 controls expansion and function of\n\nregulatory T cells. J Clin Invest 116: 485\u2013494.\n\nTakeda K &amp; Akira S (2005) Toll-like receptors in innate immunity.\n\nInt Immunol 1: 1\u201314.\n\nVillamo?n E, Gozalbo D, Roig P, Murciano C, O\u2019Connor JE,\n\nFradelizi D &amp; Gil ML (2004a) Myeloid differentiation factor 88\n\n(MyD88) is required for murine resistance to Candida albicans\n\nand is critically involved in Candida-induced production of\n\ncytokines. Eur Cytokine Netw 15: 263\u2013271.\n\nVillamo?n E, Gozalbo D, Roig P, O\u2019Connor JE, Ferrandiz ML,\n\nFradelizi D &amp; Gil ML (2004b) Toll-like receptor-2 is essential\n\nin murine defenses against Candida albicans infections.\n\nMicrobes Infect 6: 1\u20137.\n\nWang JE, Warris A, Ellingsen EA, Jorgensen PF, Flo TH, Espevik\n\nT, Solberg R, Verweij PE &amp; Aasen AO (2001) Involvement of\n\nCD14 and toll-like receptors in activation of human\n\nmonocytes by Aspergillus fumigatus hyphae. Infect Immun 69:\n\n2402\u20132406.\n\nYauch LE, Mansour MK, Shoham S, Rottman JB &amp; Levitz SM\n\n(2004) Involvement of CD14, toll-like receptors 2 and 4, and\n\nMyD88 in the host response to the fungal pathogen\n\nCryptococcus neoformans in vivo. Infect Immun 72: 5373\u20135382.\n\nFEMS Immunol Med Microbiol 53 (2008) 1\u20137 c? 2008 Federation of European Microbiological Societies\nPublished by Blackwell Publishing Ltd. All rights reserved\n\n7Toll-like receptors and fungal infections\n\n\n\nTLR2 Is a Negative Regulator of Th17 Cells and Tissue\nPathology in a Pulmonary Model of Fungal Infection1\n\nFla?vio V. Loures, Adriana Pina, Ma\u00edra Felonato, and Vera L. G. Calich2\n\nTo study the role of TLR2 in a experimental model of chronic pulmonary infection, TLR2-deficient and wild-type mice were\nintratracheally infected with Paracoccidioides brasiliensis, a primary fungal pathogen. Compared with control, TLR2?/? mice\ndeveloped a less severe pulmonary infection and decreased NO synthesis. Equivalent results were detected with in vitro-infected\nmacrophages. Unexpectedly, despite the differences in fungal loads both mouse strains showed equivalent survival times and severe\npulmonary inflammatory reactions. Studies on lung-infiltrating leukocytes of TLR2?/? mice demonstrated an increased presence\nof polymorphonuclear neutrophils that control fungal loads but were associated with diminished numbers of activated CD4? and\nCD8? T lymphocytes. TLR2 deficiency leads to minor differences in the levels of pulmonary type 1 and type 2 cytokines, but results\nin increased production of KC, a CXC chemokine involved in neutrophils chemotaxis, as well as TGF-?, IL-6, IL-23, and IL-17\nskewing T cell immunity to a Th17 pattern. In addition, the preferential Th17 immunity of TLR2?/? mice was associated with\nimpaired expansion of regulatory CD4?CD25?FoxP3? T cells. This is the first study to show that TLR2 activation controls innate\nand adaptive immunity to P. brasiliensis infection. TLR2 deficiency results in increased Th17 immunity associated with diminished\nexpansion of regulatory T cells and increased lung pathology due to unrestrained inflammatory reactions. The Journal of\nImmunology, 2009, 183: 1279 \u20131290.\n\nT he initial interaction between immune cells and microor-ganisms is mediated by several types of receptors thatrecognize molecular patterns of pathogens and are collec-\ntively called pathogen recognition receptors. The TLRs constitute\na molecular family that recognizes a wide range of microbes and\ntheir products known as pathogen-associated molecular patterns.\nTLRs are expressed in diverse innate immune cells such as poly-\nmorphonuclear neutrophils (PMN),3 macrophages, dendritic cells,\nand lymphocytes. Their activation triggers a signaling cascade that\nresults in an inflammatory response through production of proin-\nflammatory cytokines and up-regulation of costimulatory mole-\ncules expression leading to initiation of antigenic-specific adaptive\nimmune response (1\u20133).\n\nImportantly, the TLR expression was also shown to induce anti-\ninflammatory mediators and to discriminate the functional states of\ndistinct T cell subsets (4, 5). Naive CD4? T cells do not express\nsignificant levels of TLR2 and TLR4 mRNA and intracellular pro-\nteins, although activated and memory T cells express high levels of\nmembrane-bound TLR2 and TLR4 (5). Besides its influence in the\nactivation of innate immunity cells, recent evidences suggest that\nTLR2 signaling may regulate the expansion and function of\n\nCD4?CD25? regulatory T cells (Tregs) (5). Indeed, the adminis-\ntration of TLR2 ligands to wild-type (WT) mice results in in-\ncreased number CD4?CD25? Tregs and TLR2?/? mice were\nshown to contain significantly fewer CD4?CD25? Tregs than con-\ntrol mice (5\u2013 8).\n\nAs described for other microorganisms, TLRs were shown to be\ninvolved in host defense against different fungal pathogens. In vivo\nand in vitro studies demonstrated that Cryptococcus neoformans\n(9, 10), Candida albicans (11, 12), and Aspergillus fumigatus (13,\n14) may signal through members of the TLR family, mainly TLR2\nand TLR4. The contribution of individual TLRs to the immune\nresponse against pathogenic fungi depends on several factors such\nas the route of infection, the fungal morphotype, or the fungal\nspecies. Activation signals mediated by innate immunity receptors,\nhowever, are not always beneficial to the host and TLR activation\ncan be used by pathogenic fungi to promote more severe infections\n(15\u201317).\n\nParacoccidioidomycosis (PCM) is a systemic granulomatous\ndisease caused by the dimorphic fungus Paracoccidioides brasil-\niensis and constitutes the most prevalent deep mycosis in Latin\nAmerica (18). Individuals from endemic areas who have inhaled\nmycelial fragments or fungal spores usually develop PCM infec-\ntion which is characterized by positive delayed-type hypersensitive\nreactions but absence of specific Abs. The acute or severe form of\nthe disease is associated with deficient cell immunity, high levels\nof Abs, and preferential secretion of type 2 cytokines, whereas the\nbenign localized forms demonstrate preserved cell-mediated im-\nmunity, prevalent production of type 1 cytokines, and low levels of\nAbs (19, 20).\n\nOur studies on the genetic susceptibility of hosts to P. brasil-\niensis infection characterized B10.A as a susceptible mouse strain\ndue to its progressive and disseminated disease associated with\nimpaired macrophage activation and the presence of high fungal\nloads in nonorganized lesions. On the other hand, A/J mice showed\na regressive pattern of disease with well-organized lesions con-\ntaining low numbers of yeast cells, positive cellular immunity, and\n\nDepartamento de Imunologia, Instituto de Cie?ncias Biome?dicas, Universidade de Sa?o\nPaulo, Sa?o Paulo, Brazil\n\nReceived for publication May 19, 2008. Accepted for publication May 5, 2009.\n\nThe costs of publication of this article were defrayed in part by the payment of page\ncharges. This article must therefore be hereby marked advertisement in accordance\nwith 18 U.S.C. Section 1734 solely to indicate this fact.\n1 This work was supported by Fundac?a?o de Amparo a? Pesquisa and Conselho Na-\ncional de Pesquisas.\n2 Address correspondence and reprint requests to Dr. Vera L. G. Calich, Departa-\nmento de Imunologia, Instituto de Cie?ncias Biome?dicas da Universidade de Sa?o\nPaulo, Av. Prof. Lineu Prestes 1730, CEP 05508-900, Sa?o Paulo, SP, Brazil. E-mail\naddress: vlcalich@icb.usp.br\n3 Abbreviations used in this paper: PMN, polymorphonuclear neutrophil; KO, knock-\nout; Treg, regulatory T cell; PCM, paracoccidioidomycosis; PI, proliferation index;\nWT, wild type; i.t., intratracheal(ly); MFI, mean fluorescence intensity.\n\nCopyright \u00a9 2009 by The American Association of Immunologists, Inc. 0022-1767/09/$2.00\n\nThe Journal of Immunology\n\nwww.jimmunol.org/cgi/doi/10.4049/jimmunol.0801599\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nmacrophage activation. These features are similar to the severe and\nbenign forms of human PCM (20, 21).\n\nThe alveolar macrophages are the first host cells that interact\nwith P. brasiliensis cells and their activation is fundamental to\ncontrol pathogen growth. The molecular mechanisms controlling\nthe initial steps of P. brasiliensis and phagocytes interaction are\nnot well understood. It is known, however, that normal macro-\nphages are permissive to P. brasiliensis growth while cytokine-\nactivated macrophages are able to restrain P. brasiliensis multipli-\ncation (22). It was previously demonstrated that C3b, mannose\nreceptor, and gp43, the immunodominant Ag of P. brasiliensis,\nplay an important role in the initial interaction between P. brasil-\niensis cells and mouse peritoneal macrophages (23\u201325). Interest-\ningly, a recent work of our laboratory demonstrated that alveolar\nmacrophages from susceptible mice are easily activated by IL-12\nand IFN-? and display an efficient fungal killing associated with\nincreased secretion of NO and proinflammatory cytokines. In con-\ntrast, pulmonary macrophages from resistant mice are poorly ac-\ntivated by both cytokines, present inefficient killing activity and\nNO secretion, and this behavior was associated with the increased\nactivity of endogenous TGF-? (26). Despite their inefficient innate\nimmunity, A/Sn mice develop a balanced Th1/Th2 immunity\nwhich controls fungal growth without intense tissue pathology.\n\nSince the contribution of TLR in P. brasiliensis infection was\nnever studied before, we decided to investigate the role of TLR2 in\nmurine PCM using in vitro and in vivo models of infection. Using\nTLR2-normal and TLR2-deficient C57BL/6 mice, we were able to\ndemonstrate that, both in vitro and in vivo, the presence of TLR2\ncauses a more severe infection. Both approaches demonstrated that\nTLR2 are used by P. brasiliensis yeast to infect host cells inducing\nenhanced secretion of NO and cytokines. Unexpectedly, TLR2-\ndeficient and WT mice presented similar survival times and equiv-\nalent severe lesions in the lungs. The lower fungal loads of TLR2-\ndeficient mice were, however, associated with prevalent activation\nof Th17 immunity and exacerbated pulmonary inflammation con-\ntaining high numbers of PMN leukocytes but diminished presence\nof Tregs. Altogether, our data indicate that expression of TLR2 has\na beneficial effect on fungal pulmonary infection due to its nega-\ntive control on Th17 immunity and tissue pathology. Furthermore,\nthe present findings demonstrate that uncontrolled inflammatory\nresponse of hosts to P. brasiliensis infection is as deleterious as\nuncontrolled fungal growth by absence or inadequate activation of\nimmunity.\n\nMaterials and Methods\nFungus\n\nP. brasiliensis Pb18, a highly virulent isolate, was used throughout this\ninvestigation (27). Pb18 yeast cells were maintained by weekly subculti-\nvation in semisolid culture medium. Washed yeast cells were adjusted to\n20 ? 106 cells/ml (in vivo infection) and 4 ? 104 cells/ml (in vitro infec-\ntion) based on hemocytometer counts. Viability was determined with Janus\nGreen B vital dye (Merck) and was always higher than 85%.\n\nMice and intratracheal infection\n\nTLR2?/? mice on a C57BL/6 background were provided by S. Akira\n(Osaka University, Osaka, Japan). C57BL/6 control (WT) mice were ob-\ntained from our Isogenic Breeding Unit (Departmento de Imunologia, In-\nstituto de Cie?ncias Biome?dicas, Universidade de Sa?o Paulo) and used at\n8 \u201312 wk of age. Mice were anesthetized and submitted to intratracheal\n(i.t.) P. brasiliensis infection as previously described (28). Briefly, after i.p.\nanesthesia, the animals were i.t. infected with 106 P. brasiliensis yeast cells\ncontained in 50 ?l of PBS. Mice were studied at 48 h, 2 wk, and 11 wk\npostinfection. The experiments were approved by the ethics committee on\nanimal experiments of our institution.\n\nPhagocytic and fungicidal assays\n\nThioglycolate-induced peritoneal macrophages were isolated by adherence\n(2 h at 37oC in 5% CO2) to plastic-bottom tissue culture plates (1 ? 10\n\n6\n\ncells/well in 24-well plates for fungicidal assays) or plated onto 13-mm\nround glass coverslips (1 ? 106 cells/well in 24-well plates) for phagocy-\ntosis. Macrophages were washed to remove nonadherent cells and culti-\nvated overnight with fresh complete medium (DMEM (Sigma-Aldrich)\ncontaining 10% FCS, 100 U/ml penicillin, and 100 ?g/ml streptomycin) in\nthe presence or absence of recombinant IFN-? (20 ng/ml in culture me-\ndium; BD Pharmingen). Equivalent procedures were performed with alve-\nolar macrophages obtained from P. brasiliensis-infected mice at week 2 of\ninfection by bronchoalveolar lavage with 1.5 ml of warm PBS (26). For\nphagocytic assays, macrophage cultures were infected with P. brasiliensis\nyeast in a macrophage:yeast ratio of 50:1. The cells were cocultivated for\n4 h at 37oC in 5% CO2 to allow fungi adhesion and ingestion. Cells were\nwashed twice with PBS to remove any noningested or nonadhered yeast\ncells and samples were processed for microscopy. Cells were fixed with\nmethanol and stained with Giemsa (Sigma-Aldrich). Experimental condi-\ntions were performed in triplicate, and the number of phagocytosed or\nadhered yeast cells per 1000 macrophages was evaluated on at least five\nseparate slides. For fungicidal assays, IFN-?-primed and unprimed mac-\nrophage cultures were infected with P. brasiliensis yeast as above de-\nscribed. After 48 h of culture at 37oC in a CO2 incubator, plates were\ncentrifuged (400 ? g, 10 min, 4oC), supernatants were stored at ?70oC,\nand further analyzed for the presence of nitrite and cytokines. The wells\nwere washed with distilled water to lyse macrophages and suspensions\nwere collected in individual tubes. One hundred microliters of cell homog-\nenates were assayed for the presence of viable yeast cells. All assays were\ndone with five wells per condition in more than three independent\nexperiments.\n\nCFU assays, mortality rates, and histologic analysis to\ndetermine severity of infections\n\nThe numbers of viable microorganisms in cell cultures and infected organs\n(lungs, liver, and spleen) from experimental and control mice were deter-\nmined by counting the number of CFU. Animals from each group were\nsacrificed and the enumeration of viable organisms was done as previously\ndescribed (29). The numbers (log10) of viable P. brasiliensis per g of tissue\n(in vivo) or per ml of cell homogenates (in vitro) are expressed as the\nmeans ? SEs. Mortality studies were done with groups of 9 \u201311 mice\ninoculated i.t. with 1 ? 106 yeast cells or PBS. Deaths were registered daily\nfor a 250-day period and experiments were repeated twice. For histology\nexaminations, the left lung of infected mice was removed, fixed in 10%\nformalin, and embedded in paraffin. Five-micrometer sections were stained\nby H&amp;E for an analysis of the lesions and silver stained (Grocott stain) for\nfungal evaluation. Pathologic changes were analyzed based on the size,\nmorphology, and cell composition of granulomatous lesions, presence of\nfungi, and intensity of the inflammatory infiltrates.\n\nMeasurement of cytokines and NO\n\nSupernatants from lung homogenates or cell cultures were separated and\nstored at ?70\u00b0C. Cytokine (IL-2, IL-4, IL-5, IL-23, IL-17, IL-12, IL-10,\nIL-6, TNF-?, and IFN-?) and chemokine (MCP-1 and KC) levels were\nmeasured by capture ELISA with Ab pairs purchased from BD Pharmin-\ngen. Active and acid-activatable latent TGF-? forms were also measured\n(kits from R&amp;D Systems) in our biological fluids. The ELISA procedure\nwas performed according to the manufacturer\u2019s protocol and absorbances\nwere measured with a Versa Max Microplate Reader (Molecular Devices).\nNO production was quantified by the accumulation of nitrite in the super-\nnatants from in vitro and in vivo protocols by a standard Griess reaction.\nAll determinations were performed in duplicate and expressed as ?M NO.\n\nAssessment of leukocyte subpopulations in lung inflammatory\nexudates\n\nAfter 2 and 11 wk of infection, lungs from each mouse were digested\nenzymatically for 30 min with collagenase (1 mg/ml) and DNase (30 ?g/\nml) in culture medium (Sigma-Aldrich). Lung cell suspensions were cen-\ntrifuged in the presence of 20% Percoll (Sigma-Aldrich) to separate leu-\nkocytes from cell debris. Total lung leukocyte numbers were assessed in\nthe presence of trypan blue using a hemocytometer; viability was ?85%.\nFor differential leukocyte counts, samples of lung cell suspensions were\ncytospun (Shandon Cytospin) onto glass slides and stained by the Diff-\nQuik blood stain (Baxter Scientific). A total of 200 \u2013 400 cells was counted\nfrom each sample. For flow cytofluorometry, lung leukocytes were resus-\npended at 106 cells/ml in staining buffer (PBS plus 0.1% NaN3 plus and 1%\n\n1280 TLR2 INHIBITS Th17 IMMUNITY IN FUNGAL INFECTION\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nFCS). FcRs were blocked by unlabeled anti-CD16/32 Abs (BD Bio-\nsciences) and cells were stained for 20 min at 4\u00b0C. PE- labeled anti-CD40,\nanti-CD86, anti-CD11b, anti-CD25, and anti-CD69 and FITC-labeled anti-\nIAK, anti-CD80, anti-CD4, and anti-CD8 mAbs (BD Biosciences) were\nused. Cells were fixed with 1% paraformaldehyde (Sigma-Aldrich) and\nstored in the dark at 4\u00b0C until analyzed in a flow cytometer. The acquisition\nand analysis gates were restricted to the lymphocytes or macrophages.\nTregs were characterized by intracellular staining for Foxp3 using a Treg\nstaining kit from BD Biosciences. Surface staining of CD25? and intra-\ncellular FoxP3 expression were back-gated on the CD4? T cell population.\nFor intracellular cytokine staining, cells were stimulated for 6 h in com-\nplete medium in the presence of 50 ng/ml PMA, 500 ng/ml ionomycin\n(both from Sigma-Aldrich), and monensin (3 mM; eBioscience). After sur-\nface staining for CD4 and CD8, cells were fixed, permeabilized, and\nstained by PerCP-Cy5 anti-IL-17 Abs (eBioscience). The cell surface ex-\npression of leukocyte markers as well as intracellular expression of FoxP3\nand IL-17 in lung-infiltrating leukocytes were analyzed in a FACSCalibur\nflow cytometer (BD Pharmingen) using the FlowJo software (Tree Star).\n\nFungicidal ability of neutrophils\n\nTo study the role of neutrophils in the control of fungal growth, PMN\nleukocytes from WT and TLR2 KO mice were in vivo depleted by i.p.\nadministration of 0.5 ml of saline-diluted (1/5) rabbit anti-mouse PMN\npolyclonal Ab (Accurate Chemical &amp; Scientific) at days ?1, ?3, and ?5\nof i.t. infection (0 time) with 1 million P. brasiliensis yeast cells. Control\nmice received equivalent amounts of normal rat IgG. The number of blood\nPMN cells was evaluated before treatment (at day ?2) and 24 h after the\nmAb inoculation. Groups of IgG-treated and PMN-depleted mice (n ?\n4 \u2013 6) were sacrificed 2 and 6 days after P. brasiliensis infection and se-\nverity of disease evaluated by CFU counts. Mortality studies were done\nwith IgG-treated and PMN-depleted groups of eight to nine mice inocu-\nlated i.t. with 1 ? 106 yeast cells. Deaths were registered daily for a 10-day\nperiod and experiments were repeated twice. Alveolar neutrophils were\nobtained by bronchoalveolar lavage of mice infected 2 wk earlier with 1\nmillion yeast cells. The number of PMN leukocytes in the nonadherent\nfraction of lung cells was adjusted to 2 ? 105 cells, plated in 96-well plates,\nchallenged with 1 ? 105 yeast cells, and cocultivated for 1 h at 37oC. One\nhundred microliters of cell homogenates was assayed for the presence of\nviable yeast cells. All assays were done with three wells per condition in\nmore than two independent experiments.\n\nLymphoproliferation assay\n\nCells were assayed for proliferation using an in vitro fluorescence-based\nassay. Briefly, 1 ? 106 cells from spleens were stained with 1 ?l (5 mM)\nof CFSE (Molecular Probes) in PBS and 5% FCS for 15 min at room\ntemperature. Stained cells were cultured for 3 days in the presence of\nanti-CD3 Abs (0.3 ?g/ml), anti-CD28 (2.5 ?g/ml) mAbs (BD Bio-\nsciences), P. brasiliensis-soluble Ag (100 ?g/ml), or Con A (1 ?g/ml;\nSigma-Aldrich). A minimum of 20,000 events was acquired on a FACS-\nCalibur flow cytometer using CellQuest software (BD Pharmingen). The\nproliferation index (PI) was calculated as the mean fluorescence intensity\n(MFI) of unstimulated cultures/MFI of stimulated cultures.\n\nStatistical analysis\n\nData were analyzed by Student\u2019s t test or two-way ANOVA depending on\nthe number of experimental groups. Values of p ? 0.05 were considered\nsignificant.\n\nResults\nTLR2 deficiency leads to less severe fungal infection of\nmacrophages associated with decreased synthesis of NO,\nIL-10, and MCP-1\n\nBefore performing fungicidal studies, we asked whether the initial\ninteraction between P. brasiliensis yeast cells and peritoneal mac-\nrophages from TLR2?/? and WT mice was equivalent. Macro-\nphage cultures (1 ? 106/well), performed in round glass cover-\nslips, were preactivated or not with IFN-? (20 ng/ml) and infected\nwith 2 ? 104 viable yeast cells (1:50 fungus:macrophage ratio).\nAfter a 4-h incubation, supernatants were aspirated, the monolay-\ners were gently washed with PBS, and the cells were stained with\nGiemsa. An average of 1000 macrophages was counted and the\nnumber of ingested and/or adherent yeast cells was determined.\nCompared with WT macrophages, a lower number of yeast cells\n\nassociated (ingested/adhered) with TLR2?/? macrophages was\nobserved (Fig. 1A). Peritoneal macrophages were cultivated with\nP. brasiliensis yeast cells for an additional 48-h period. Superna-\ntants were removed and assayed for the presence of NO and cy-\ntokines and cell homogenates were plated for CFU determinations.\nAs shown in Fig. 1B, the presence of functional TLR-2 led to\nincreased recovery of viable yeast cells from untreated and IFN-\n?-primed macrophages (20 ng/ml). In addition, higher levels of\nNO were produced by macrophages from WT mice than those of\nTLR2?/? mice (Fig. 1B). Additional experiments were performed\nwith alveolar macrophages obtained from bronchoalveolar lavage\nfluids of normal, uninfected, WT, and TLR2-deficient mice (Fig.\n1C). Lower CFU counts were recovered from untreated TLR2-\ndeficient cells, although no significant differences were seen with\nIFN-?-activated macrophages. As observed with peritoneal cells,\nTLR2-deficient alveolar macrophages synthesized lower levels\nof NO.\n\nTo better characterize the role of TLR2 in P. brasiliensis infec-\ntion, culture supernatants of peritoneal macrophages were evalu-\nated for the presence of some macrophage-activating cytokines\n(IL-12 and TNF-?), a deactivating cytokine (IL-10), and for a\nchemokine involved in mononuclear cell chemotaxis, MCP-1. As\ndepicted in Fig. 2, IFN-?-treated and untreated macrophages from\nTLR2?/? mice secreted decreased levels of IL-10 and MCP-1 than\nthose from WT mice. IL-12 and TNF-?, however, appeared in\nsimilar levels.\n\nIn vivo, absence of TLR2 induces lower fungal loads but\nincreased lung pathology\n\nWe infected groups (n ? 6 \u2013 8) of TLR2?/? and WT mice i.t. with\n1 million P. brasiliensis yeast cells and evaluated parameters of\ninfection and local inflammatory pathology over the course of in-\nfection. Diminished fungal burdens were detected in the lung tis-\nsue of TLR2?/? mice at all postinfection periods (48 h and 2 and\n11 wk) assayed (Fig. 3A). These lower fungal burdens were ac-\ncompanied by lower NO levels in lung homogenates (Fig. 3B).\nEquivalent fungal counts were detected in the liver and spleen\ntissue (our unpublished data).\n\nTo assess the influence of TLR-2 deficiency in disease outcome,\nthe mortality of P. brasiliensis-infected TLR-2?/? and WT mice\nwas registered daily for a 250-day period and the median survival\ntime was calculated for each strain. Unexpectedly, despite the sig-\nnificant differences in fungal burdens, no differences between mor-\ntality data ( p ? 0.104) were detected (Fig. 4A). The mean survival\ntimes of TLR-2?/? and WT mice were 221 and 190 days, respec-\ntively. To better understand this result, histopathological exami-\nnation of lungs was done at weeks 2 and 11 of infection. As can be\nseen in Fig. 4, B\u2013E, an equivalent and severe pattern of inflam-\nmatory reactions was detected in the lungs of both mouse strains.\nThe pulmonary lesions replaced almost all of the normal paren-\nchyma and were composed of confluent granulomas of various\nsizes containing many fungal cells surrounded by a small ring of\nmononuclear cells. Some lesions were also surrounded by an ev-\nident fibrotic layer. Multinucleated cells were scarcely seen. Le-\nsions of TLR2-deficient mice showed a more prominent presence\nof inflammatory polymorphonuclear cells and decreased numbers\nof P. brasiliensis yeast cells (Fig. 4, D and E).\n\nTLR2?/? deficiency determines a sustained recruitment of PMN\ncells to the lungs\n\nTo better characterize the inflammatory reaction at the site of in-\nfection, leukocyte recruitment to the lung tissue of P. brasiliensis-\ninfected TLR2?/? and WT mice was studied at weeks 2 and 11 of\ninfection. As can be seen in Fig. 5, A and B, at both postinfection\n\n1281The Journal of Immunology\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nperiods, increased numbers of polymorphonuclear cells (PMN)\nwere observed in the lungs of TLR2?/? mice than in their normal\ncontrols. Consistent with these findings, 72 h after infection, sig-\nnificantly increased influx of PMN cells were detected in the bron-\nchoalveolar lavage fluids of TLR2?/? mice (our unpublished\ndata). At both postinfection periods, lower numbers of macro-\n\nphages were recovered from lungs of TLR2-deficient mice, but\nonly at week 2 was this difference significant. We further char-\nacterized the presence of neutrophil- and macrophage-mobiliz-\ning chemokines in the lung homogenates of WT and TLR2?/?\n\nmice. In good agreement with cell phenotypes detected at weeks\n2 and 11 of infection, increased levels of KC were detected in\n\nFIGURE 1. Macrophages (M?) from TLR2-defi-\ncient mice have a decreased ability to interact with fun-\ngal yeast cells. A, For phagocytic assays, IFN-?-primed\n(20 ng/ml, overnight) and unprimed peritoneal macro-\nphage cultures were infected with P. brasiliensis yeast\ncells in a macrophage:yeast ratio of 50:1. The cells were\ncocultivated for 4 h at 37oC in 5% CO2 to allow fungi\nadhesion and ingestion. Cells were washed, fixed. and\nstained with Giemsa; an average of 1000 macrophages\nwas analyzed and the number of macrophages with ad-\nhered or ingested yeast cells was determined. B, For\nfungicidal assays, IFN-?-primed and unprimed perito-\nneal macrophages were infected with yeast cells as\nabove described. After 48 h at 37oC in 5% CO2, plates\nwere centrifuged and supernatants were used to deter-\nmine the levels of nitrite and cytokines. The monolayers\nwere washed with distilled water to lyse macrophages\nand 100 ?l of cell homogenates was assayed for the\npresence of viable yeast cells by a CFU assay. Super-\nnatants from fungicidal assays were used to determine\nthe levels of nitrites using the Griess reagent. C, Alve-\nolar macrophages were collected from bronchoalveolar\nlavage fluids of normal mice and studied as in B for\nfungicidal activity and NO production. Data are the\nmean ? SEM of quintuplicate samples from one exper-\niment representative of three independent determina-\ntions. ?, p ? 0.05 between strains.\n\nFIGURE 2. Macrophages (M?) from TLR2?/?\n\nmice secrete diminished levels of IL-10 and MCP-1.\nIFN-? treated (20.00 ng/ml) or untreated macrophages\nof TLR2?/? and TLR2?/? C57BL/6 mice were chal-\nlenged with viable P. brasiliensis yeast cells (1:50, fun-\ngus:macrophage ratio) during 4 h, washed, and further\ncultivated for 48 h at 37\u00b0C in 5% CO2. Plates were then\ncentrifuged and supernatants used for cytokine mea-\nsurements using ELISA. Data are the means ? SEM of\ntriplicate samples from one experiment representative\nof three independent determinations. ?, p ? 0.05 be-\ntween strains.\n\n1282 TLR2 INHIBITS Th17 IMMUNITY IN FUNGAL INFECTION\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nthe lungs of deficient mice, whereas augmented levels of\nMCP-1 were found in WT supernatants (Fig. 5, C and D). Thus,\nTLR2 deficiency resulted in increased KC production and PMN\nrecruitment while in TLR2-normal mice a prevalent MCP-1\nsynthesis led to enhanced macrophage chemotaxis to the site of\ninfection.\n\nDepletion of PMN leukocytes increases fungal loads and\nmortality rates of TL2-deficient but not normal mice\n\nThe finding that PMN cells were abundantly recruited to the\nlungs of TLR2?/? mice in the presence of diminished fungal\ngrowth led us to verify whether these cells had a significant\nantifungal effector function in our model of pulmonary PCM.\nThus, TLR2?/? and TLR2?/? mice were in vivo depleted of\nPMN cells by a polyclonal Ab and infected i.t. with the fungus.\nBy days 2 and 6 after infection, PMN-depleted TLR2?/? but\nnot normal mice presented increased fungal burdens in the\nlungs (Fig. 6, A and B). The protective effect of PMN cells to\ndeficient mice was confirmed by the precocious mortality de-\nveloped by PMN-depleted mice. By day 5 of infection, 50% of\nPMN-depleted TLR2?/? mice died, although no deaths were\nobserved in the PMN-depleted WT group (Fig. 6C). We have\nalso evaluated the killing ability of alveolar PMN cells obtained\nfrom P. brasiliensis-infected mice. At week 2 of infection, air-\nway PMN cells were obtained from TLR2?/? and normal mice\nand in vitro challenged with yeast cells (2:1, PMN:yeast ratio)\nfor 1 h. As can be seen in Fig. 6C, equivalent numbers of viable\nyeast cells were recovered from both mouse strains, indicating\nthat PMN cells from TLR2-deficient mice did not have an in-\ncreased killing ability when compared with those from normal\nmice. Hence, the higher CFU counts detected in PMN-depleted\nTLR2?/? mice could be attributed to the higher influx of PMN\nleukocytes to the lungs but not to an intrinsically enhanced\nkilling ability of these cells.\n\nTLR deficiency determines diminished T cell reactivity and\ninflux to the lungs\n\nWe have further analyzed the phenotype and activity of lung in-\nflammatory cells of TLR2?/? and WT mice infected i.t. with 1\nmillion P. brasiliensis yeast cells. To determine the activation pro-\nfile of pulmonary macrophages, the expression of CD11b, MHC\nclass II (I-Ak), CD80, CD86, and CD40 Ags was assayed by flow\ncytometry. As can be seen in Fig. 7, no differences in lung mac-\nrophages were detected at weeks 2 and 11 of infection. The phe-\nnotypic analysis of lymphocyte subsets was also performed. Thus,\nthe expression of CD4, CD25, CD8, and CD69 molecules was\nstudied in lung-infiltrating lymphocytes. As depicted in Fig. 7A, at\nweek 2 of infection, no differences in the number and activation of\nT cells were observed. However, a decreased frequency of acti-\nvated CD4? T lymphocytes expressing CD25 (CD4?CD25?) was\ndetected in TLR2?/? animals at this period of infection (data not\nshown). By week 11, however, significantly decreased numbers of\nCD4?, CD8?, and CD8?CD69? T cells were detected in\nTLR2?/? animals (Fig. 7B).\n\nTo characterize the lymphoproliferative activity of spleen cells ob-\ntained from WT and TLR2?/? mice at week 4 of infection, CFSE-\nlabeled lymphocytes were in vitro stimulated with P. brasiliensis Ag,\n\nFIGURE 3. In vivo, absence of TLR2 induces lower fungal loads and\nNO synthesis. Depicted is the recovery of CFU (A) and NO (B) from the\nlungs of TLR2?/? and WT control mice infected i.t. with 1 ? 106 yeast\ncells. The bars represent means ? SEM of log10 CFU obtained from groups\nof six to eight mice at 48 h and 2 and 11 wk after infection. The results are\nrepresentative of three experiments. ?, p ? 0.05 between strains.\n\nFIGURE 4. Despite the different fungal burdens, TLR2?/? and\nTLR2?/? mice present equivalent survival times and lung histopathology.\nA, Survival times of TLR2?/? and WT control mice after i.t. infection with\n1 ? 106 P. brasiliensis yeast cells was determined in a period of 250 days.\nNo significant differences were seen in the median survival times of both\nmouse strains; the results are representative of two independent experi-\nments. Photomicrographs of pulmonary lesions of WT (B and C) and\nTLR2?/? (D and E) mice at week 11 of infection with 1 million P. bra-\nsiliensis yeast cells. At this period, despite the higher fungal loads detected\nin WT mice, no differences in the severity of lesions between TLR2-defi-\ncient and control mice were noted. Both mouse strains presented extensive\nand confluent lesions occupying almost all lung parenchyma which pre-\nsented an elevated number of yeast cells. H&amp;E (B and D; ?100) and\nGrocott-stained lesions (C and E; ?100).\n\n1283The Journal of Immunology\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nanti-CD3 plus anti-CD28 mAbs, or Con A and cultivated for 72 h. As\ndepicted in Table I, compared with TLR2-deficient mice, control mice\ndeveloped higher lymphoproliferative activity with all stimuli used,\nincluding the polyclonal T cell activator Con A. A similar result was\ndetected with unstimulated control lymphocytes, probably due to the\n\npresence of yeast cells in the spleens of infected mice at this postin-\nfection period. Together, these experiments demonstrated that TLR2-\ndeficient mice mount a deficient T cell response as revealed by the\ndiminished migration of T cells to the site of infection and the im-\npaired lymphoproliferative activity.\n\nFIGURE 5. TLR2?/? deficiency\ndetermines a sustained increased re-\ncruitment of PMN cells to the lungs.\nNumber of leukocyte subsets (macro-\nphages, PMN neutrophils, and lympho-\ncytes) in the lung-infiltrating leukocytes\n(LIL) from TLR2?/? and WT mice in-\noculated i.t. with 1 million P. brasilien-\nsis yeast cells. By 2 (A) and 11 (B) wk\nafter infection, lungs of TLR2?/? and\nWT mice (n ? 6 \u2013 8) were excised,\nwashed in PBS, minced, and digested\nenzymatically. Lung cells suspensions\nwere centrifuged in the presence of\n20% Percoll (Sigma-Aldrich) to sepa-\nrate leukocytes from cell debris. Cell\nsuspensions were cytospun onto glass\nslides and stained by the Diff-Quik\nblood stain. Lung cell homogenates\nwere also obtained after 2 and 11 wk of\ninfection and analyzed by ELISA for\nthe content of KC (C) and MCP-1 (D)\nchemokines. Data are expressed as\nmeans ? SEM. ?, p ? 0.05 between\nstrains.\n\nFIGURE 6. Fungicidal activity of PMN neutrophils. A and B, PMN leukocytes were in vivo depleted from WT and TLR2?/? mice by i.p. administration\nof 0.5 ml of a 1/5 dilution of a rabbit anti-mouse PMN polyclonal Ab at days ?1, ?3, and ? 5 of i.t. infection (0 time) with 1 million P. brasiliensis yeast\ncells. Control mice received equivalent amounts of normal rat IgG. This treatment resulted in 75 and 87% of PMN depletion at days 0 and 6 of infection,\nrespectively. IgG-treated and PMN-depleted mice (n ? 4 \u2013 6) were sacrificed at days 2 and 6 days after fungal infection and severity of disease evaluated\nby CFU counts in lung homogenates. C, Mortality data of PMN-depleted mice. Groups of mice (n ? 8 \u20139) were treated as above described and increased\nmortality was observed only in the PMN-depleted TLR2?/? group. Data were obtained from two independent experiments. D, Alveolar neutrophils were\nobtained by bronchoalveolar lavage of mice infected 2 wk earlier with 1 million yeast cells. The number of PMN leukocytes in the nonadherent fraction\nwas adjusted to 2 ? 105 cells, challenged with 1 ? 105 yeast cells, and cocultivated for 1 h at 37oC. One hundred microliters of cell homogenates were\nassayed for the presence of viable yeast cells. All assays were done with three wells per condition in over two independent experiments. ?, p ? 0.05\ncompared with WT mice; #, p ? 0.05 compared with IgG controls.\n\n1284 TLR2 INHIBITS Th17 IMMUNITY IN FUNGAL INFECTION\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nTLR2-deficient mice develop a Th17-skewed T cell response\n\nBecause the equilibrium between pro- and anti-inflammatory cy-\ntokines determines the efficiency and cellular composition of in-\nflammatory reactions (30) and because recent investigations have\ndemonstrated an increased presence of PMN cells associated with\nprevalent IL-17 secretion (31), cytokines associated with Th1 (IL-\n12, TNF-?, IL-2, and IFN-?), Th2 (IL-4, IL-5, and IL-10), and\nTh17 (TGF-?, IL-6, IL-17, and IL-23) immunity were assessed in\nlung homogenates obtained at different periods of infection (Figs.\n8 and 9A). However, 48 h after infection, at the innate phase of\nimmunity, higher levels of TGF-? and IL-17 were detected in the\nlungs of TLR2-deficient mice. At week 2, this strain produced\nhigher amounts of IL-6, TGF-?, IL-17, and IL-23. By week 11,\nTLR2?/? mice showed a sustained increase of IL-23 associated\nwith lowered concentrations of IL-10 and IL-12. We have further\ndefined the phenotype of IL-17-producing cells. As shown in Fig.\n9B, after 72 h and 2 wk of P brasiliensis infection, significantly\nincreased numbers of IL-17?CD4? T cells were detected in the\nlungs of TLR2?/? mice. No differences were observed in the total\nnumbers of CD8? T cells, although the frequency of this T cell\nsubset was significantly augmented in TLR2-deficient mice. These\nfindings demonstrate that TLR2 deficiency induces, since the early\nphase of pulmonary infection, a Th17-skewed immune response,\nwithout severely impairing Th1 and Th2 immunity.\n\nTLR2 deficiency results in lower expansion of\nCD4?CD25?FoxP3? Tregs\n\nIn murine candidiasis, TLR2 deficiency was associated with de-\ncreased IL-10 production and deficient expansion of CD4? Tregs\n(4, 32). In addition, differentiation of Tregs has an inhibitory effect\non Th17 expansion (33, 34). Although Th17 cells and Tregs re-\nquire TGF-? to their differentiation, the concomitant presence of\nsome proinflammatory cytokines such as IL-1 or IL-6 results in\npreferential development of Th17 cells and impaired Treg expan-\nsion (34). These findings led us to ask whether the prevalent Th17\n\nimmunity developed by TLR2-defficient mice was associated with\ndecreased expansion and recruitment of Tregs to the lungs. Thus,\nTLR2?/? and WT mice were sacrificed at weeks 2 and 11 after\ninfection and the presence of CD4?CD25?FoxP3? T cells was\ncharacterized by flow cytometry in the CD4? subpopulation of\nlung-infiltrating lymphocytes. Surface staining of CD25? and in-\ntracellular FoxP3? expression was back-gated on the CD4? T cell\npopulation. As can be seen in Fig. 10, no differences were detected\nat week 2 but, at week 11 a lower number of CD4?CD25?FoxP3?\n\nT cells was observed in the lung inflammatory lymphocytes of\nTLR2-deficient than in WT mice.\n\nDiscussion\nRecent studies have established the central role of TLRs in the\ninnate immune recognition of a wide variety of microorganisms,\nincluding fungal pathogens (12, 15, 17). Since the contribution of\nTLR in P. brasiliensis infection was never investigated, the present\nreport assessed the role of TLR2 in the innate and acquired phases\nof immunity to this pulmonary fungal pathogen. Data here pre-\nsented demonstrate that TLR2 promotes fungal infection, but it has\na concomitant beneficial effect to the host due to its inhibitory\neffect on the development of inflammatory reactions associated\nwith prevalent Th17 immunity. Furthermore, it was also shown\nthat TLR2 activation positively controls the expansion of Tregs,\nwhich modulate innate and adaptive immune cells and restrain\nlung inflammatory pathology.\n\nAlthough TLR usually do not mediate fungal uptake (35), our in\nvitro studies suggested that P. brasiliensis yeast cells use TLR2 to\ninteract with macrophages and to activate innate immunity cells. P.\nbrasiliensis yeast cells appear to be recognized by TLR2 mole-\ncules, resulting in increased adherence/ingestion and augmented\nproduction of NO and cytokines (IL-10 and MCP-1). Despite this\nincreased activation, 48 h after infection an increased number of\nviable fungi were recovered from TLR2-normal cells. This finding\n\nFIGURE 7. Characterization of\nmacrophages and T lymphocytes in\nthe pulmonary lesions of TLR2?/?\n\nmice. Equivalent numbers of macro-\nphages were detected in the lungs of\nTLR2?/? and WT mice but the latter\npresented increased numbers of\nCD4? and CD8? T lymphocytes.\nCharacterization of leukocyte subsets\nby flow cytometry in the lung-infil-\ntrating leukocytes (LIL) from\nTLR2?/? and WT mice inoculated i.t.\nwith 1 million P. brasiliensis yeast\ncells. Lungs of TLR2?/? and WT\nmice (n ? 6 \u2013 8) were excised,\nwashed in PBS, minced, and digested\nenzymatically. At weeks 2 (A) and 11\n(B) after infection lung cell suspen-\nsions were obtained and stained as de-\nscribed in Materials and Methods.\nThe acquisition and analysis gates\nwere restricted to lymphocytes or\nmacrophages. The data represent the\nmean ? SEM of the results from six\nto eight mice per group and are rep-\nresentative of two independent exper-\niments. ?, p ? 0.05 compared with\nWT mice.\n\n1285The Journal of Immunology\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nappears to be paradoxical, since the killing ability of murine mac-\nrophages was previously reported to be associated with NO pro-\nduction by cytokine-stimulated phagocytes (36). Although the kill-\ning mechanisms were not here addressed, it appears that the\nincreased NO secretion by TLR2-normal macrophages was not\nsufficient to abolish the increased fungal interaction mediated by\nTLR2 expression. Furthermore, the concomitant increase in IL-10\nproduction could have inhibited the fungicidal ability of TLR2-\nnormal macrophages. Along the same line, we could hypothesize\nthat the lower IL-10 synthesis by TLR2?/? macrophages would\n\nenhance IDO activity which would control P .brasiliensis growth\nand inhibit inducible NO synthase activity. This possibility is un-\nder investigation in our laboratory and would accommodate the\nlower fungal loads and NO production observed with TLR2?/?\n\nmacrophages (16, 30). Similarly to our results, TLR2-deficient\nmacrophages exhibited an increased ability to contain another fun-\ngal pathogen, C. albicans, but this fact was not associated with\ndifferent patterns of cytokine production (37).\n\nThe in vivo infection of TLR2-deficient mice resulted in de-\ncreased fungal burdens in all postinfection periods assayed. The\nless severe infection was always associated with low NO produc-\ntion. Again, the differences in fungal burdens could be explained\nby the different fungal interaction with alveolar macrophages at\nearly phases of infection and not by differences in NO secretion.\nForty-eight hours after infection, production of pulmonary cyto-\nkines was similar in both mouse strains, except for the augmented\nsynthesis of TGF-? and IL-17 by TLR2-deficient mice. Interest-\ningly, IL-17 is a cytokine involved with proinflammatory activity\nand increased PMN chemotaxis due to its ability to promote the\nsynthesis of CXC chemokines (38 \u2013 40). Consistent with the aug-\nmented IL-17 production, 72 h after infection increased PMN in-\nflux was detected in the alveolar spaces of TLR2?/? mice (our\nunpublished data) and these cells could have efficiently controlled\nfungal growth but also sustained the synthesis of IL-23 and IL-17\n\nFIGURE 8. Type 1 and type 2 cy-\ntokines in lung homogenates of\nTLR2?/? and WT mice. At 48 h and\n2 and 11 wk after i.t. infection with\n106 yeast cells of P. brasiliensis,\nlungs from TLR2?/? and WT control\nmice were collected and disrupted in\n5.0 ml of PBS and supernatants were\nanalyzed for cytokines content by\ncapture ELISA. The bars depict\nmeans ? SEM of cytokine levels\n(6 \u2013 8 animals per group). ?, p ? 0.05\nbetween strains.\n\nTable I. PI of spleen lymphocytes obtained from P. brasilienis-infected\nTLR2?/? and WT mice at week 4 of infectiona\n\nTreatment TLR2?/? (PI) WT (PIb)\n\nControl lymphocytes 0.78 2.82\nLymphocytes ? AgPb 0.99 2.43\nLymphocytes ? anti-CD28 0.66 2.66\nLymphocytes ? Con A 1.3 6\n\na Spleen cell suspensions were labeled with CFSE and cultured for 3 days in the\npresence of anti-CD3 (0.3) Ab, anti-CD28 (2.5 ?g/ml) Ab, P. brasiliensis-soluble Ag\n(100 ?g/ml), or Con A (1 ?g/ml). The intensity of CFSE was assessed by flow\ncytometry.\n\nb The PI was calculated as the MFI of unstimulated cultures/MFI of stimulated\ncultures. Data are representative of two independent experiments.\n\n1286 TLR2 INHIBITS Th17 IMMUNITY IN FUNGAL INFECTION\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\n(41). Consistent with this possibility, lung homogenates of PMN-\ndepleted TLR2?/? mice showed diminished levels of IL-23 (data\nnot shown), suggesting that neutrophils could have a positive in-\nfluence in the differentiation and expansion of Th17 cells. Al-\nthough IL-17 production is usually associated with the Th17 subset\nof CD4? T cells, this cytokine was also described to be pro-\nduced by innate immune cells such as ?? T cells, dendritic cells,\nPMN cells, or NKT lymphocytes (41\u2013 45). In our model, CD4?\n\nT cells were shown to be the main source of IL-17 because\nincreased numbers of IL-17?CD4? T cells were present in the\nlung inflammatory infiltrates of TLR2?/? mice since the early\nphase of infection. This fact led us to suppose that TLR2 sig-\nnaling could impair interactions of macrophages with fungal\n\nagonists that preferentially induce cytokines associated with the\nTh17 pathway of T cell differentiation, a fact not previously\ndescribed in PCM.\n\nAt week 2 of infection, TLR2-deficient mice produced low\nlevels of MCP-1 associated with augmented synthesis of pul-\nmonary TGF-?, IL-6, IL-17, and IL-23. This pattern of cytokine\nsecretion points to a preferential activation of Th17 cells with-\nout affecting other Th1/Th2 cytokines. Indeed, Th17 cell devel-\nopment occurs in the presence of TGF-? and IL-6 and is main-\ntained in the presence of IL-23, an IL-12-related cytokine (46,\n47). Interestingly, all of those mediators involved in the devel-\nopment and maintenance of Th17 immunity were found in lung\nhomogenates of TLR2-deficient mice and increased numbers of\n\nFIGURE 9. Lung homogenates of\nTLR2?/? mice presented increased\nlevels of Th17 cytokines and IL-17?\n\nCD4? T cells. A, At 48 h and 2 and 11\nwk after i.t. infection with 106 yeast\ncells of P. brasiliensis, lungs from\nTLR2?/? and WT control mice were\ncollected and disrupted in 5.0 ml of\nPBS and supernatants were analyzed\nfor cytokines content by capture\nELISA. Compared with WT controls,\nTLR2?/? mice showed increased lev-\nels of pulmonary IL-6, TGF-?, IL-23,\nand IL-17. The bars depict means ?\nSEM of cytokine levels (6 \u2013 8 ani-\nmals/group). B, Flow cytometry anal-\nysis of IL-17-producing cells. Lung\ncells were restimulated in vitro with\nPMA/ionomycin for 6 h and sub-\njected to intracellular staining for IL-\n17. The lymphocyte population was\ngated by forward/side scatters. Dot\nplots show a representative analysis\nfrom one of four to six mice. Results\nare from one experiment and are rep-\nresentative of two independent exper-\niments. ?, p ? 0.05 between strains.\n\n1287The Journal of Immunology\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nIL-17?CD4? T cells were found in the lungs of these mice after\n72 h and 2 wk of P. brasiliensis infection. This Th17-biased\nimmunity resulted in altered cellular influx to the site of infec-\ntion. At weeks 2 and 11 of infection, increased production of\nKC, a CXC chemokine involved in PMN chemotaxis, and\naugmented influx of neutrophils to the lungs of TLR2-KO mice\nwere detected; these findings are in agreement with previous\nreports showing increased participation of PMN leukocytes in\ninflammatory exudates governed by Th17 immunity (38 \u2013 40,\n48, 49). Consistent with our results, association of IL-17 syn-\nthesis and increased PMN influx to the site of infection was\nseen in bacterial pneumonia (50), inflammatory lung disorders\n(51), and other fungal infections (31, 52). In addition, the di-\nminished presence of MCP-1, a chemokine chemotactic for\nmacrophages, was associated with decreased numbers of these\ncells in the lung cell infiltrates of TLR2-deficient animals.\n\nThe Th17-induced PMN accumulation in inflammatory reac-\ntions can play antagonistic effects to the hosts, being protective due\nto its microbicidal ability or deleterious due to the release of tissue-\ndamaging components (41). In our model, the higher number of\nlung-infiltrating PMN associated with Th17 immunity was respon-\nsible, at least partially, by the better fungal clearance observed in\nTLR2?/? mice. This was shown by in vivo depletion of PMN cells\nthat led to increased fungal burdens only in TLR2?/? mice. The\nimmunoprotective effect of neutrophils was also verified by the\nearly mortality of PMN-depleted TLR2?/? mice. These data are\nconsistent with previous findings in murine candidiasis describing\na more severe systemic infection associated with deficient IL-17\nproduction and impaired influx of neutrophils to infected organs\n(53) However, as described in other models of prevalent Th17\nimmunity, we believe that PMN cells exerted a dual effect in mu-\nrine PCM. The protection granted by the increased influx and ef-\nficient fungicidal ability was probably accompanied by tissue dam-\nage caused by the release of protein-degrading enzymes such as\nneutrophil elastase, metalloproteinases, and other cytotoxic com-\npounds as reactive oxygen species (31, 41, 50 \u201354). Since equiv-\nalent fungicidal ability was detected in airway neutrophils from\n\nTLR2?/? and control mice, we believe that the increased number\nof PMN cells that migrate to the lungs and not the intrinsic acti-\nvation of neutrophils was responsible for the control of fungal\ngrowth.\n\nDespite the control of fungal growth, our data also suggest that\nTh17 immunity and PMN cells have also exerted a deleterious\neffect in TLR2 ?/? mice. Indeed, the diminished fungal burdens of\nTLR2?/? mice were concomitant with pulmonary lesions as\nsevere as those displayed by WT mice. In both mouse strains\nnonorganized inflammatory reactions replaced almost all lung\nparenchyma, suggesting that high fungal loads (developed by\nWT animals) or prevalent Th17 immunity (mounted by\nTLR2?/? mice) have similar deleterious effects to P.\nbrasiliensis-infected mice.\n\nThe phenotypic analysis of lymphocyte subsets performed\nafter 2 and 11 wk of infection showed a decreased frequency of\nCD4? and CD8? T cells in TLR2?/? mice. This fact could be\nattributed to the lower fungal burden detected in this mouse\nstrain or to the Th17-skewed immunity developed by the defi-\ncient animals. The early secretion of TGF-? and IL-6 by\nTLR2?/? mice appeared to have induced a precocious and\nprevalent Th17 immunity which resulted in diminished macro-\nphage and T cell migration to the lungs. These cells were, how-\never, partially replaced by PMN neutrophils which characterize\nTh17-mediated inflammatory exudates.\n\nBy week 11 of infection, TLR2?/? mice appear to maintain\ntheir prevalent Th17 immunity, whereas WT mice presented\nincreased fungal burdens associated with augmented production\nof IL-10, IL-12, and significant expansion of Tregs. It can be\nsupposed that those Tregs exerted an enhancing effect on fungal\ngrowth but an inhibitory activity on inflammatory reactions by\ndown-modulating innate and adaptive immunity. Consistent\nwith this interpretation, a recent work elegantly demonstrated\nthe association of Tregs and increased fungal burdens in an\nexperimental model of PCM using CXCR5 KO mice (55). The\nabsence of TLR2 associated with decreased differentiation of\nTregs here observed is also consistent with the increased secre-\ntion of TGF-?, which, associated with IL-6 (or other proinflam-\nmatory cytokine), could have inhibited FoxP3 production and\nexpansion of Tregs (30).\n\nIn murine candidiasis, TLR2-deficient mice were shown to de-\nvelop a more severe infection (56), a fact not subsequently con-\nfirmed (4, 16). The increased resistance of TLR2-deficient mice\nwas associated with diminished IL-10 production and a decreased\nexpansion of Tregs, which led to a more efficient Th1 immunity (4,\n16). Similarly to the candidiasis model, PCM in TLR2?/? mice\nresults in lower fungal loads and decreased expansion of Tregs.\nHowever, expression of TLR2 appears to be protective to pulmo-\nnary PCM because of its inhibitory activity on the development of\nTh17 immunity and tissue pathology. In addition, the decreased\nexpansion of Tregs could have contributed to the maintenance of\npathogenic inflammatory reactions.\n\nThe prevalent Th17 immunity developed by TLR2-deficient\nmice could be explained by the use of different pattern recognition\nreceptors at the initial phase of infection. Other experimental mod-\nels have implicated the use of Dectin-1 or TLR4 in the induction\nof Th17 immunity (57\u201359). Despite the initial pattern recognition\nreceptor used, our results add a new mechanistic pathway which\ncan lead to deleterious Th17 immunity in fungal infections in the\nabsence of TLR2 signaling.\n\nIn summary, we have demonstrated for the first time that TLR2\nare important innate receptors for P. brasiliensis which appears to\nuse TLR2 as a virulence mechanism, which facilitates the access of\nfungal cells into murine macrophages. Most important, this is the\n\nFIGURE 10. TLR2-deficient mice do not expand the number of Tregs.\nFoxP3 expression by lung lymphocytes from TLR2?/? and WT mice in-\noculated i.t. with 1 million P. brasiliensis yeast cells was determined by\nflow cytometric analysis. Lungs of TLR2?/? and WT mice (n ? 6 \u2013 8) were\nexcised, washed in PBS, minced, and digested enzymatically; 2 and 11 wk\nafter infection cell suspensions were obtained and stained as described in\nMaterials and Methods. The cell surface expression of leukocyte markers\nas well as intracellular FoxP3? expression in lung-infiltrating leukocytes\nwere analyzed by flow cytometry. Surface staining of CD25? and intra-\ncellular FoxP3 expression were back-gated on the CD4? T cell population.\nThe data represent the mean ? SEM of the results from six to eight mice\nper group and are representative of two independent experiments. ?, p ?\n0.05 compared with WT mice.\n\n1288 TLR2 INHIBITS Th17 IMMUNITY IN FUNGAL INFECTION\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nfirst study to demonstrate that TLR2 has a protective effect in pul-\nmonary fungal infections due to its ability to deviate T cell re-\nsponses from pathogenic Th17 immunity to a balanced Th1/Th2\nresponse modulated by Tregs.\n\nAcknowledgments\nWe are grateful to Tania A. Costa and Paulo Albee for her invaluable\ntechnical assistance and Prof. S. Akira for generously providing the\nTLR2?/? breeders used in this study. We also thank Dr. Julio Schaferstein\nfor the donation of anti-PMN Abs.\n\nDisclosures\nThe authors have no financial conflict of interest.\n\nReferences\n1. Janeway, C. A. Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu.\n\nRev. Immunol. 20: 197\u2013216.\n2. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Im-\n\nmunol. 21: 335\u2013376.\n3. Akira, A. TLR signaling. 2006. Curr. Top. Microbiol. Immunol. 311: 1\u201316.\n4. Netea, M. G., R. Sutmuller, C. Hermann, C. A. Van der Graaf,\n\nJ. W. Van der Meer, J. H. van Krieken, T. Hartung, G. Adema, and\nB. J. Kullberg. 2004. Toll-like receptor 2 suppresses immunity against Can-\ndida albicans through induction of IL-10 and regulatory T cells. J. Immunol.\n172: 3712\u20133718.\n\n5. Sutmuller, R. P., M. H. den Brok, M. Kramer, E. J. Bennink, L. W. Toonen,\nB. J. Kullberg, L. A. Joosten, S. Akira, M. G. Netea, and G. J. Adema. 2006.\nToll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin.\nInvest. 116: 485\u2013 494.\n\n6. Liu, G., and Y. Zhao. 2007. Toll-like receptors and immune regulation: their\ndirect and indirect modulation on regulatory CD4?CD25? T cells. Immunology\n122: 149 \u2013156.\n\n7. Liu, H., M. Komai-Koma, D. Xu, and F. Y. Liew. 2006. Toll-like receptor 2\nsignaling modulates the functions of CD4?CD25? regulatory T cells. Proc. Natl.\nAcad. Sci. USA 103: 7048 \u20137053.\n\n8. Sutmuller, R. P., A. Gaaristem, and G. J. Adema. 2007. Regulatory T cells and\nToll-like receptors: regulating the regulators. Ann. Rheum. Dis. 66: 91\u201395.\n\n9. Yauch, L. E., M. K. Mansour, S. Shoham, J. B. Rottman, and S. M. Levitz. 2004.\nInvolvement of CD14, Toll-like receptors 2 and 4, and MyD88 in the host re-\nsponse to the fungal pathogen Cryptococcus neoformans in vivo. Infect. Immun.\n72: 5373\u20135382.\n\n10. Biondo, C., A. Midiri, L. Messina, F. Tomasello, G. Garufi, M. R. Catania,\nM. Bombaci, C. Beninati, G. Teti, and G. Mancuso. 2005. MyD88 and TLR2, but\nnot TLR4, are required for host defense against Cryptococcus neoformans. Eur.\nJ. Immunol. 35: 870 \u2013 878.\n\n11. Netea, M. G., C. A. Van Der Graaf, A. G. Vonk, I. Verschueren,\nJ. W. Van Der Meer, and B. J. Kullberg. 2002. The role of Toll-like receptor\n(TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect.\nDis. 185: 1483\u20131489.\n\n12. Netea, M. G., G. Ferwerda, C. A. van der Graaf, J. W. Van der Meer, and\nB. J. Kullberg. 2006. Recognition of fungal pathogens by Toll-like receptors.\nCurr. Pharm. Des. 12: 4195\u2013 4201.\n\n13. Meier, A., C. J. Kirschning, T. Nikolaus, H. Wagner, J. Heesemann, and F. Ebel.\n2003. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced\nactivation of murine macrophages. Cell Microbiol. 5: 561\u2013570.\n\n14. Dubourdeau, M., R. Athman, V. Balloy, M. Huerre, M. Chignard, D. J. Philpott,\nJ. P Latge?, and O. Ibrahim-Granet. 2006. Aspergillus fumigatus induces innate\nimmune responses in alveolar macrophages through the MAPK pathway inde-\npendently of TLR2 and TLR4. J. Immunol. 177: 3994 \u2013 4001.\n\n15. Romani, L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4: 1\u201323.\n16. Bellocchio, S., C. Montagnoli, S. Bozza, R. Gaziano, G. Rossi, S. S. Mambula,\n\nA. Vecchi, A. Mantovani, S. M. Levitz, and L. Romani. 2004. The contribution\nof the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to\nfungal pathogens in vivo. J. Immunol. 172: 3059 \u20133069.\n\n17. Calich, V. L., A. Pina, M. Felonato, S. Bernardino, T. A. Costa, and F. V. Loures.\n2008. Toll-like receptors and fungal infections: the role of TLR2: TLR4 and\nMyD88 in paracoccidioidomycosis. FEMS Immunol. Med. Microbiol. 53: 1\u20137.\n\n18. Franco, M. 1987. Host-parasite relationships in paracoccidioidomycosis. J. Med.\nVet. Mycol. 25: 5\u201318.\n\n19. Borges-Walmsley, M. I., D. Chen, X. Shu, and A. R. Walmsley. 2002. The\npathobiology of Paracoccidioides brasiliensis. Trends Microbiol. 10: 80 \u2013 87.\n\n20. Calich, V. L. G., T. A. Costa, M. Felonato, C. Arruda, S. Bernardino,\nF. V. Loures, L. R. R. Ribeiro, R. C. Valente-Ferreira, and A. Pina. 2008. Innate\nimmunity to Paracoccidioides brasiliensis infection. Mycopathologia 165:\n223\u2013236.\n\n21. Calich, V. L. G., and M. H. S. L. Blotta. 2005. Pulmonary paracoccidioidomy-\ncosis. In Fungal Immunology: From an Organ Perspective. P. L. Fidel, and\nG. B. Huffnagle, eds. Springer, New York, pp. 201\u2013228.\n\n22. Brummer, E. 1994. Interaction of Paracoccidioides brasiliensis with host defense\ncells. In Paracaccidioidomycosis. M. Franco, C. Silva Lacaz, A. Restrepo, and\nG. Del Negro, editors. CRC, Boca Raton, FL, pp. 212\u2013223.\n\n23. Calich, V. L., T. L. Kipnis, M. Mariano, C. F. Neto, and W. D. Dias da Silva.\n1979. The activation of complement system by Paracoccidioides brasiliensis \u201cin\n\nvitro\u201d: its opsonic effect and possible significance for an in vivo model of infec-\ntion. Clin. Immunol. Immunopathol. 12: 20 \u201330.\n\n24. Jime?nez, M. del, P., A. Restrepo, D. Radzioch, L. E. Cano, and L. F. Garcia.\n2006. Importance of complement 3 and mannose receptors in phagocytosis of\nParacoccidioides brasiliensis conidia by Nramp1 congenic macrophages lines.\nImmunol. Med. Microbiol. 47: 56 \u2013 66.\n\n25. Popi, A. F., J. D. Lopes, and M. Mariano. 2002. Gp43 from Paracoccidioides\nbrasiliensis inhibits macrophage functions: An evasion mechanism of the fungus.\nCell. Immunol. 218: 87\u201394.\n\n26. Pina, A., S. Bernardino, and V. L. Calich. 2008. Alveolar macrophages from\nsusceptible mice are more competent than those of resistant mice to control initial\nParacoccidioides brasiliensis infection. J. Leukocyte Biol. 83: 1088 \u20131099.\n\n27. Kashino, S. S., R. A. Fazioli, C. Cafalli-Favati, L. H. Meloni-Bruneri, C. A. Vaz,\nE. Burger, L. M. Singer, and V. L. Calich. 2000. Resistance to Paracoccidioides\nbrasiliensis infection is linked to a preferential Th1 immune response, whereas\nsusceptibility is associated with absence of IFN-? production. J. Interferon. Cy-\ntokine Res. 20: 89 \u201397.\n\n28. Cano, L. E., L. M. Singer-Vermes, C. A. C. Vaz, M. Russo, and V. L. G. Calich.\n1995. Pulmonary paracoccidioidomycosis in resistant and susceptible mice: re-\nlationship among progression of infection, bronchoalveolar cell activation, cel-\nlular immune response, and specific isotype patterns. Infect. Immun. 63:\n1777\u20131783.\n\n29. Singer-Vermes, L. M., M. C. Ciavaglia, S. S. Kashino, E. Burguer, and\nV. L. G. Calich. 1992. The source of the growth-promoting factor(s) affects the\nplating efficiency of Paracoccidioides brasiliensis. J. Med. Vet. Mycol. 30:\n261\u2013264.\n\n30. Romani, L., and P. Puccetti. 2006. Protective tolerance to fungi: the role of IL-10\nand tryptophan catabolism. Trends Microbiol. 14: 183\u2013189.\n\n31. Zelante, T., A. De Luca, P. Bonifazi, C. Montagnoli, S. Bozza, S. Moretti,\nM. L. Belladonna, C. Vacca, C. Conte, P. Mosci, et al. 2007. IL-23 and the Th17\npathway promote inflammation and impair antifungal immune resistance. Eur.\nJ. Immunol. 37: 2695\u20132706.\n\n32. Netea, M. G., N. A. Gow, C. A. Munro, S. Bates, C. Collins, G. Ferwerda,\nR. P. Hobson, G. Bertram, H. B. Hughes, T. Jansen, et al. 2006. Immune sensing\nof Candida albicans requires cooperative recognition of mannans and glucans by\nlectin and Toll-like receptors. J. Clin. Invest. 116: 1642\u20131650.\n\n33. Zhou, L., J. E. Lopes, M. M. Chong, I. I. Ivanov, R. Min, G. D. Victora, Y. Shen,\nJ. Du, Y. P. Rubtsov, A. Y. Rudensky, et al. 2008. TGF-?-induced Foxp3 inhibits\nTH17 cell differentiation by antagonizing ROR?t function. Nature 453: 236 \u2013240.\n\n34. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger.\n2006. TGF-? in the context of an inflammatory cytokine milieu supports de novo\ndifferentiation of IL-17-producing T cells. Immunity 24: 179 \u2013189.\n\n35. Netea, M. G., G. D. Brown, B. J. Kullberg, and N. A. Gow. 2008. An integrated\nmodel of the recognition of Candida albicans by the innate immune system. Nat.\nRev. Microbiol. 6: 67\u201378.\n\n36. Cano, L. E., R. Arango, M. E. Salazar, E. Brummer, D. A. Stevens, and\nA. Restrepo. 1992. Killing of Paracoccidioides brasiliensis conidia by pulmo-\nnary macrophages and the effect of cytokines. J. Med. Vet. Mycol. 30: 161\u2013168.\n\n37. Blasi, E., A. Mucci, R. Neglia, F. Pezzini, B. Colombari, D. Radzioch,\nA. Cossarizza, E. Lugli, G. Volpini, G. Del Giudice, and S. Peppoloni. 2005.\nBiological importance of the two Toll-like receptors, TLR2 and TLR4, in mac-\nrophage response to infection with Candida albicans. FEMS Immunol. Med. Mi-\ncrobiol. 44: 69 \u201379.\n\n38. Wu, Q., R. J. Martin, J. G. Rino, R. Breed, R. M. Torres, and H. W. Chu. 2007.\nIL-23-dependent IL-17 production is essential in neutrophil recruitment and ac-\ntivity in mouse lung defense against respiratory Mycoplasma pneumoniae infec-\ntion. Microbes Infect. 9: 78 \u2013 86.\n\n39. Ley, K., E. Smith, and M. A. Stark. 2006. IL-17A-producing neutrophil-regula-\ntory T lymphocytes. Immunol. Res. 34: 229 \u2013242.\n\n40. Liang, S. C., A. J. Long, F. Bennett, M. J. Whitters, R. Karim, M. Collins,\nS. J. Goldman, K. Dunussi-Joannopoulos, C. M. Williams, J. F. Wright, and\nL. A. Fouser. 2007. An IL-17F/A heterodimer protein is produced by mouse Th17\ncells and induces airway neutrophil recruitment. J. Immunol. 179: 7791\u20137799.\n\n41. Romani, L., T. Zelante, A. De Luca, F. Fallarino, and P. Puccetti. 2008. IL-17 and\ntherapeutic kynurenines in pathogenic inflammation to fungi. J. Immunol. 180:\n5157\u20135162.\n\n42. Michel, M. L., A. C. Keller, C. Paget, M. Fujio, F. Trottein, P. B. Savage,\nC. H. Wong, E. Schneider, M. Dy, and M. C. Leite-de-Moraes. 2007. Identifi-\ncation of an IL-17-producing NK1.1neg iNKT cell population involved in airway\nneutrophilia. J. Exp. Med. 204: 995\u20131001.\n\n43. De Luca, A., C. Montagnoli, T. Zelante, P. Bonifazi, S. Bozza, S. Moretti, C.\nD\u2019Angelo, C. Vacca, L. Boon, F. Bistoni, P. Puccetti, F. Fallarino, and\nL. Romani. 2007. Functional yet balanced reactivity to Candida albicans requires\nTRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol. 179:\n5999 \u2013 6008.\n\n44. Bozza, S., T. Zelante, S. Moretti, P. Bonifazi, A. Deluca, C. D\u2019Angelo,\nG. Giovannini, C. Garlanda, L. Boon, F. Bistoni, et al. 2008. Lack of Toll IL-1R8\nexacerbates Th17 cell responses in fungal infection. J. Immunol. 180:\n4022\u2013 4031.\n\n45. Romani, L., F. Fallarino, A. De Luca, C. Montagnoli, C. D\u2019Angelo, T. Zelante,\nC. Vacca, F. Bistoni, M. C. Fioretti, U. Grohmann, B. H. Segal, and P. Puccetti.\n2008. Defective tryptophan catabolism underlies inflammation in mouse chronic\ngranulomatous disease. J. Immunol. 180: 5157\u20135162.\n\n46. Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. TH17 cells in the circle of\nimmunity and autoimmunity. Nat. Immunol. 8: 345\u2013350.\n\n47. Mangan, P. R., L. E. Harrington, D. B. O\u2019Quinn, W. S. Helms, D. C. Bullard,\nC. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006.\n\n1289The Journal of Immunology\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nTransforming growth factor-? induces development of the TH17 lineage. Nature\n441: 231\u2013234.\n\n48. Carlson, T., M. Kroenke, P. Rao, T. E. Lane, and B. Segal. 2008. The\nTh17?ELR? CXC chemokine pathway is essential for the development of cen-\ntral nervous system autoimmune disease. J. Exp. Med. 205: 811\u2013 823.\n\n49. Kobayashi, Y. The role of chemokines in neutrophil biology. 2008. Front. Biosci.\n13: 2400 \u20132407.\n\n50. Ye, P., F. H. Rodriguez, S. Kanaly, H. L. Stocking, J. Schurr,\nP. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. E. Shellito, et al. 2001.\nRequirement of interleukin 17 receptor signaling for lung CXC chemokine\nand granulocyte colony-stimulating factor expression, neutrophil recruitment,\nand host defense. J. Exp. Med. 194: 519 \u2013527.\n\n51. Linde?n, A., M. Laan, and G. P. Anderson. 2005. Neutrophils, interleukin-17A and\nlung disease. Eur. Respir. J. 25: 159 \u2013172.\n\n52. Cooper, A. M. 2007. IL-23 and IL-17 have a multi-faceted largely negative role\nin fungal infection. Eur. J. Immunol. 37: 2680 \u20132682.\n\n53. Huang, W., L. Na, P. L. Fidel, and P. Schwarzenberger. 2004. Requirement of\ninterleukin-17A for systemic anti-Candida albicans host defense in mice. J. In-\nfect. Dis. 190: 624 \u2013 631.\n\n54. Andersson, A., R. Kokkola, J. Wefer, H. Erlandsson-Harris, and R. A. Harris.\n2004. Differential macrophage expression of IL-12 and IL-23 upon innate im-\n\nmune activation defines rat autoimmune susceptibility. J. Leukocyte Biol. 76:\n1118 \u20131124.\n\n55. Moreira, A. P., K. A. Cavassani, F. S. Massafera Trista?o, A. P. Campanelli,\nR. Martinez, M. A. Rossi, and J. S. Silva. 2008. CCR5-dependent regulatory T\ncell migration mediates fungal survival and severe immunosuppression. J. Im-\nmunol. 180: 3049 \u20133056.\n\n56. Villamo?n, E., D. Gozalbo, P. Roig, J. E. O\u2019Connor, D. Fradelizi, and M. L. Gil.\n2004. Toll-like receptor-2 is essential in murine defenses against Candida albi-\ncans infections. Microbes Infect. 6: 1\u20137.\n\n57. LeibundGut-Landmann, S., O. Gross, M. J. Robinson, F. Osorio, E. C. Slack,\nS. V. Tsoni, E. Schweighoffer, V. Tybulewicz, G. D. Brown, J. Ruland, and\nC. Reis e Sousa. 2007. Syk- and CARD9-dependent coupling of innate immunity\nto the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:\n630 \u2013 638.\n\n58. Hara, H., C. Ishihara, A. Takeuchi, T. Imanishi, L. Xue, S. W. Morris, M. Inui,\nT. Takai, A. Shibuya, S. Saijo, et al. 2007. The adaptor protein CARD9 is es-\nsential for the activation of myeloid cells through ITAM-associated and Toll-like\nreceptors. Nat. Immunol. 8: 619 \u2013 629.\n\n59. Abdollahi-Roodsaz, S., L. A. Joosten, M. I. Koenders, I. Devesa, M. F. Roelofs,\nT. R. Radstake, M. Heuvelmans-Jacobs, S. Akira, M. J. Nicklin, F. Ribeiro-Dias,\net al. 2008. Stimulation of TLR2 and TLR4 differentially skews the balance of T\ncells in a mouse model of arthritis. J. Clin. Invest. 118: 205\u2013216.\n\n1290 TLR2 INHIBITS Th17 IMMUNITY IN FUNGAL INFECTION\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org\n\n\nof January 28, 2010 \nThis information is current as\n\ndoi:10.4049/jimmunol.0801599 \nonline Jun 24, 2009; \n\n 2009;183;1279-1290; originally publishedJ. Immunol.\n \nL. G. Calich \nFl\u00e1vio V. Loures, Adriana Pina, Ma\u00edra Felonato and Vera\n \n\n Pulmonary Model of Fungal Infection\nCells and Tissue Pathology in a \nTLR2 Is a Negative Regulator of Th17\n\n http://www.jimmunol.org/cgi/content/full/183/2/1279\n\n References\n\n es\nhttp://www.jimmunol.org/cgi/content/full/183/2/1279#otherarticl\n1 online articles that cite this article can be accessed at: \n \n\n http://www.jimmunol.org/cgi/content/full/183/2/1279#BIBL\n, 18 of which can be accessed free at:cites 57 articlesThis article \n\n Subscriptions\n http://www.jimmunol.org/subscriptions/online at \n\n isThe Journal of ImmunologyInformation about subscribing to \n\n Permissions\n http://www.aai.org/ji/copyright.html\n\nSubmit copyright permission requests at \n\n Email Alerts\n http://www.jimmunol.org/subscriptions/etoc.shtmlup at \n\nReceive free email alerts when new articles cite this article. Sign\n\nPrint ISSN: 0022-1767 Online ISSN: 1550-6606. \nImmunologists, Inc. All rights reserved.\nCopyright \u00a92009 by The American Association of\nRockville Pike, Bethesda, MD 20814-3994.\nThe American Association of Immunologists, Inc., 9650 \n\n is published twice each month byThe Journal of Immunology\n\n on January 28, 2010 \nw\n\nw\nw\n\n.jim\nm\n\nunol.org\nD\n\now\nnloaded from\n\n \n\nhttp://www.jimmunol.org:80/cgi/adclick/?ad=22727&amp;adclick=true&amp;url=http%3A%2F%2Fwww.biolegend.com\nhttp://www.jimmunol.org/cgi/content/full/183/2/1279\nhttp://www.jimmunol.org/cgi/content/full/183/2/1279#BIBL\nhttp://www.jimmunol.org/cgi/content/full/183/2/1279#otherarticles\nhttp://www.jimmunol.org/subscriptions/\nhttp://www.aai.org/ji/copyright.html\nhttp://www.jimmunol.org/subscriptions/etoc.shtml\nhttp://www.jimmunol.org\n\n\n 1 \n\nTLR4 signaling leads to a more severe fungal infection associated with 1 \n\nenhanced proinflammatory immunity and impaired expansion of 2 \n\nregulatory T cells 3 \n\n 4 \n\n 5 \n\nFl\u00e1vio V. Loures,\n1\n Adriana Pina,\n\n 1\n Ma\u00edra Felonato,\n\n 1 \nEliseu F. Ara\u00fajo, Katia R. M. 6 \n\nLeite,\n2\n and Vera L. G. Calich\n\n1*\n 7 \n\n \n8 \n\n \n9 \n\n1\nDepartamento de Imunologia, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o 10 \n\nPaulo, S\u00e3o Paulo, SP, Brazil, and \n2\n Servi\u00e7o de Patologia, Hospital S\u00edrio Liban\u00eas, S\u00e3o 11 \n\nPaulo, SP, Brazil 12 \n\n 13 \n\n 14 \n\nKeywords: Paracoccidioides brasiliensis; Pulmonary pathology; Innate immunity; 15 \n\nAdaptive immunity; Cytokines, T cells 16 \n\n 17 \n\n 18 \n\nCorresponding Author: Vera L. G. Calich, Departamento de Imunologia, Instituto de 19 \n\nCi\u00eancias Biom\u00e9dicas da Universidade de S\u00e3o Paulo, Av. Prof. Lineu Prestes 1730, CEP 20 \n\n05508-900, S\u00e3o Paulo, SP, Brazil. Phone: 55-11- 30917397. Fax: 55-11-30917224. E-21 \n\nmail: vlcalich@icb.usp.br 22 \n\n 23 \n\n 24 \n\nRunning Title: Role of TLR4 in pulmonary paracoccidioidomycosis 25 \n\n Copyright \u00a9 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.\nInfect. Immun. doi:10.1128/IAI.01198-09 \nIAI Accepts, published online ahead of print on 14 December 2009\n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 2 \n\nAbstract: 1 \n\nToll-like receptors (TLRs) present in innate immune cells recognize pathogen 2 \n\nmolecular patterns and influence immunity that control host-parasite interaction. 3 \n\nThe objective of this study was to characterize the involvement of TLR4 in the 4 \n\ninnate and adaptive immunity to Paraccocidioides brasiliensis, the most important 5 \n\nprimary fungal pathogen of Latin America. We compared the responses of 6 \n\nC3H/HeJ mice, which are naturally defective in TLR4 signaling, with C3H/HePas 7 \n\nmice, which express functional receptors, after in vitro and in vivo infection with 8 \n\nP.brasiliensis. Unexpectedly, we verified that TLR4-defective macrophages 9 \n\ninfected in vitro with P. brasiliensis presented decreased fungal loads associated 10 \n\nwith impaired synthesis of nitric oxide, IL-12 and MCP-1. After intratracheal 11 \n\ninfection with one million yeasts, TLR4-defective mice developed reduced fungal 12 \n\nburdens and decreased levels of pulmonary nitric oxide, proinflammatory 13 \n\ncytokines and antibodies. TLR4-competent mice produced elevated levels of IL-12 14 \n\nand TNF-????,,,, besides cytokines of the Th17 pattern indicating a proinflammatory 15 \n\nrole for TLR4 signaling.  The more severe infection of TLR4-normal mice resulted 16 \n\nin increased influx of activated macrophages and T cells to the lungs, progressive 17 \n\ncontrol of fungal burdens but impaired expansion of regulatory T cells. In 18 \n\ncontrast, TLR4-defective mice were not able of totally clearing their diminished 19 \n\nfungal burdens, associated with deficient activation of T cell immunity and 20 \n\nenhanced development of Treg cells. These divergent patterns of immunity, 21 \n\nhowever, resulted in equivalent mortality rates indicating that control of elevated 22 \n\nfungal growth mediated by vigorous  inflammatory reactions is as deleterious to 23 \n\nthe hosts as low fungal loads inefficiently controlled by limited inflammatory 24 \n\nreactions.  25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 3 \n\nINTRODUCTION 1 \n\n 2 \n\nPathogen recognition receptors (PRRs) are a group of receptors present in the membrane 3 \n\nand cytoplasm of innate immunity cells which recognize the presence of invading 4 \n\nmicrobes by interacting with conserved pathogen structures, the so called \u201cpathogen 5 \n\nassociated molecular patterns\u201d or \u201cPAMP\u201d. This initial event of innate immunity is 6 \n\ncrucial to control pathogen growth and to subsequently activate adaptative immunity. 7 \n\nToll like receptors (TLRs) constitute a major family of pattern recognition molecules 8 \n\nand, like other PRRs, are able to respond to different structural homologies conserved in 9 \n\nmany microorganisms (2, 62). The TLRs activation is crucial for many aspects of 10 \n\nmicrobe elimination, including microbial killing, recruitment of phagocytes to the site of 11 \n\ninfection and activation of dendritc cells (DCs) (52). Early TLR activation results in the 12 \n\nproduction of several inflammatory mediators and the final balance among pro- and 13 \n\nanti-inflammatory components will regulate the type of adaptative immune response. 14 \n\nRecent findings have shown that direct recognition of PAMPs by DCs is critical for 15 \n\npriming appropriate T cell responses resulting in T helper 1 (Th1), Th2  or Th17 16 \n\nimmunity (25, 31, 34, 60).  17 \n\nThe TLR4 is the key receptor that recognizes bacterial lipopolysaccharides 18 \n\nwhereas TLR2 is involved in the interaction with bacterial peptidoglycans and 19 \n\nlipoproteins (66). As described for other microorganisms, TLRs were shown to be 20 \n\ninvolved in host defense against different fungal pathogens.  In vivo and in vitro studies 21 \n\ndemonstrated that Cryptococcus neoformans (7, 67), Candida albicans (43, 45) and 22 \n\nAspergillus fumigatus (24, 39) may signal through members of the TLR family, mainly 23 \n\nTLR2 and TLR4. Different components of a certain pathogen can be used to stimulate 24 \n\nthe immune system. Thus, phospholipomannan of C. albicans is sensed by TLR2 (33) 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 4 \n\nwhile O-linked mannans are recognized by TLR4 (44).The contribution of individual 1 \n\nTLRs to the immune response against pathogenic fungi depends on several factors such 2 \n\nas the fungal morphotype, fungal species and route of infection. Activation signals 3 \n\nmediated by innate immunity receptors, however, are not always beneficial to the host 4 \n\nand TLR activation can be used by pathogenic fungi to promote more severe infections 5 \n\n(5, 53). 6 \n\n Paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused by 7 \n\nthe dimorphic fungus Paracoccidioides brasiliensis and constitutes de most prevalent 8 \n\ndeep mycosis in Latin America (28).  The alveolar macrophages are the first host cells 9 \n\nthat interact with P. brasiliensis cells and their activation is fundamental to control 10 \n\nfungal growth. The molecular mechanisms controlling the initial steps of P. brasiliensis 11 \n\nand phagocytes interaction are not well understood. It is known, however, that normal 12 \n\nmacrophages are permissive to P. brasiliensis growth while cytokine-activated 13 \n\nmacrophages are able to restrain P. brasiliensis multiplication (12).  Complement 14 \n\nreceptor 3 (CR3) and mannose receptor were shown to play an important role in the 15 \n\ninitial interaction between P. brasiliensis cells and mouse peritoneal macrophages (14, 16 \n\n32, 50). Interestingly, a recent work of our laboratory demonstrated that alveolar 17 \n\nmacrophages from susceptible mice (B10.A) are easily activated by P. brasiliensis 18 \n\ninfection, and show efficient fungal killing associated with nitric oxide production while 19 \n\npulmonary macrophages from resistant mice (A/Sn) are poorly activated and present 20 \n\ninefficient killing activity associated with increased levels of TGF-? (49). Despite their 21 \n\ninefficient innate immunity, A/Sn mice develop a balanced Th1/Th2 immunity which 22 \n\ncontrols fungal growth without intense tissue pathology. 23 \n\nIn a previous work, our group demonstrated the influence of TLR2 in pulmonary  24 \n\nPCM (15, 38) . Using TLR2-normal and TLR2-deficient mice we were able to show 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 5 \n\nthat the presence of TLR2 causes more severe in vitro and in vivo P.brasiliensis 1 \n\ninfections.  In addition, TLR2 deficiency results in increased Th17 immunity associated 2 \n\nwith diminished expansion of Treg cells and increased lung pathology due to 3 \n\nunrestrained inflammatory reactions (38). Characterizing the behavior of dendritic cells 4 \n\nin murine PCM, Ferreira et al. observed an increased expression of TLR2 by dendritic 5 \n\ncells of susceptible, but not resistant mice (26). Moreover, TLR2, TLR-4 and dectin-1 6 \n\nwere suggested to be involved in the recognition and internalization of P. brasiliensis 7 \n\nby human monocytes and neutrophils, indicating an important role of these pathogen 8 \n\nreceptors in the immune response against the fungus (10).  9 \n\nWe decided to investigate the role of TLR4 in murine PCM using in vitro and in 10 \n\nvivo models of infection. Using TLR-competent C3H/HePas and C3H/HeJ mice which 11 \n\npossess a missense mutation in the TLR4 gene, we were able to demonstrate that both, 12 \n\nin vitro and in vivo, TLR4 signaling causes a more severe infection associated with 13 \n\nincreased activation of innate and adaptive immunity, but decreased expansion of Treg 14 \n\ncells. This pattern of immunity, however, was not beneficial to the hosts due to the 15 \n\nincreased lung injury mediated by inefficient control of inflammatory reactions by Treg 16 \n\ncells. 17 \n\n 18 \n\nMATERIALS AND METHODS 19 \n\nFungus. P. brasiliensis Pb18, a highly virulent isolate was used throughout this 20 \n\ninvestigation (36). Pb18 yeast cells were maintained by weekly sub-cultivation\n \nin 21 \n\nsemisolid culture medium. Washed yeast cells were adjusted to 20 \u00d7 10\n6\n cells/ml (in 22 \n\nvivo infection) and 4 \u00d7 10\n4\n cells/ml (in vitro infection) based on hemocytometer counts. 23 \n\nViability was determined\n \nwith Janus Green B vital dye (Merck)\n\n \nand was always higher 24 \n\nthan 85%.  25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 6 \n\nMice and intra-tracheal infection.  C3H/HeJ and C3H/HePas were obtained 1 \n\nfrom our Isogenic Breeding Unit (Departmento de Imunologia, Instituto de Ci\u00eancias 2 \n\nBiom\u00e9dicas, Universidade de S\u00e3o Paulo, Brazil) and used at 8 to 12 weeks of age. 3 \n\nC3H/HeJ has a point mutation in the TLR4 gene and C3H/HePas has a functional TLR4 4 \n\ngene. In selected experiments, C57Bl/6 mice genetically deficient of TLR4 (TLR4 KO) 5 \n\nand their normal C57BL/6 counterparts were used. Mice were anesthetized and 6 \n\nsubmitted to intratracheal (i.t.) P. brasiliensis infection as previously described (18). 7 \n\nBriefly, after intraperitoneal anesthesia, the animals were i.t. infected with 10\n6  \n\nP. 8 \n\nbrasiliensis yeasts cells, contained in 50\u00b5 l of PBS. Mice were studied at 96h, 2 and 11 9 \n\nweeks postinfection. The experiments were approved by the ethics committee on animal 10 \n\nexperiments of our institution. 11 \n\nPhagocytic and fungicidal assays. Thioglycollate-induced peritoneal 12 \n\nmacrophages were isolated by adherence (2h at 37\no\n C in 5% CO2) to plastic-bottom 13 \n\ntissue-culture plates (1x10\n6\n cells/well in 24 well plates for fungicidal assays), or plated 14 \n\nonto 13-mm-round glass coverlips (1x10\n6\n cells/well in 24 well plates) for phagocytosis. 15 \n\nMacrophages were washed to remove nonadherent cells and cultivated overnight with 16 \n\nfresh complete medium (DMEM, Dulbecco\u2019s Modified Eagle\u2019s Medium, Sigma, 17 \n\ncontaining 10% fetal calf serum, 100 U/ml penicillin and 100 \u00b5g/ml streptomycin in the 18 \n\npresence or absence of recombinant IFN-? (20 ng/ml in culture medium, BD-19 \n\nPharmingen). Non-adherent cells were counted to evaluate the number of remaining 20 \n\nadherent cells used in phagocytic and killing assays. For phagocytic assays, macrophage 21 \n\ncultures were infected with P. brasiliensis yeasts in a macrophage:yeast ratio of 25:1. 22 \n\nThis ratio was previously determined and was shown to be no deleterious to 23 \n\nmacrophage cultures and adequate for phagocytosis and killing assays (18, 49).  The 24 \n\ncells were co-cultivated for 4h at 37\no\n C in 5% CO2 to allow fungi adhesion and 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 7 \n\ningestion.  Cells were washed twice with PBS to remove any non-ingested or non-1 \n\nadhered yeast, and samples were processed for microscopy. Cells were fixed with 2 \n\nmethanol and stained with Giemsa (Sigma). Experimental conditions were performed in 3 \n\ntriplicate, and the number of phagocytosed or adhered yeasts per 1000 macrophages was 4 \n\nevaluated on at least three separate slides. For fungicidal assays, IFN-?-primed and 5 \n\nunprimed macrophage cultures were infected with P.brasiliensis yeasts as above 6 \n\ndescribed. After 48 h of culture at 37\no \n\nC in a CO2 incubator, plates were centrifuged 7 \n\n(400x g, 10 min, 4\no \n\nC), supernatants stored at \u201370\no \n\nC and further analyzed for the 8 \n\npresence of nitrite and cytokines.  The wells were washed with distilled water to lyse 9 \n\nmacrophages, and suspensions collected in individual tubes. One hundred \u00b5l of cell 10 \n\nhomogenates were assayed for the presence of viable yeasts. All assays were done with 11 \n\nfive wells per condition in over three independent experiments. 12 \n\nCFU assay,  histological and morphometrical analyses. The numbers of 13 \n\nviable microorganisms in cell cultures and infected organs (lungs, liver and spleen) 14 \n\nfrom experimental and control mice were determined by counting the number of colony 15 \n\nforming units (CFU). Animals from each group were sacrificed, and the enumeration of 16 \n\nviable organisms was done as previously described (59).  The numbers (log10) of viable 17 \n\nP. brasiliensis per gram of tissue (in vivo) or per mL of cell homogenates (in vitro) are 18 \n\nexpressed as the means \u00b1 standard errors. For histological examinations, the left lung of 19 \n\ninfected mouse was removed, fixed in 10% formalin, and embedded in paraffin. Five 20 \n\n\u00b5m sections were stained by the hematoxilin-eosin (H&amp;E) for an analysis of the lesions, 21 \n\nand silver stained for fungal evaluation. Pathologic changes were analyzed based on the 22 \n\nsize, morphology and cell composition of granulomatous lesions, presence of fungi and 23 \n\nintensity of the inflammatory infiltrates. Morphometrical analysis was performed using 24 \n\na Nikon DXM 1200c digital camera (magnification of 10x), and Nikon NIS Elements 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 8 \n\nAR 2.30 software. The area of lesions was measured (in \u00b5 m\n2\n) in 10 microscopic fields 1 \n\nper slide in 10 animals per group. Results were expressed as the mean \u00b1 standard errors 2 \n\nof total area of lesions for each animal.  3 \n\nMeasurement of cytokines and NO. Supernatants from lung homogenates or 4 \n\ncell cultures were separated and stored at ?70\u00b0C. The levels of IL-2, IL-4, IL-5, IL-23, 5 \n\nIL-17, IL-12, IL-10, TNF-?, IFN-? and levels of the MCP-1 chemokine, were measured 6 \n\nby\n \ncapture enzyme-linked immunosorbent assay (ELISA) with antibody\n\n \npairs purchased 7 \n\nfrom BD Pharmingen. The ELISA procedure was performed according to the 8 \n\nmanufacturer's\n \nprotocol and absorbances were measured with Versa Max Microplate 9 \n\nReader (Molecular Devices). NO production was quantified by the accumulation of 10 \n\nnitrite in the supernatants from in vitro and in vivo protocols by a standard Griess 11 \n\nreaction. All determinations were performed in duplicate and expressed as \u00b5M NO. 12 \n\nMeasurement of Serum P. brasiliensis-Specific Isotypes. Specific isotypes 13 \n\nlevels (total IgG, IgM, IgA, IgG1, IgG2a, IgG2b, and IgG3) were measured by a 14 \n\npreviously described ELISA (18) employing a cell-free antigen  prepared by using a 15 \n\npool of different P. brasiliensis isolates (Pb339, Pb265 and Pb18). The average of the 16 \n\noptical densities obtained with sera from control mice (PBS inoculated) diluted 1:20, 17 \n\nwas considered the cutoff for each respective isotype. Optical densities for each dilution 18 \n\nof experimental sera were compared to the control values. The titer for each sample was 19 \n\nexpressed as the reciprocal of the highest dilution that presented an absorbance higher 20 \n\nthan the cutoff.  21 \n\n 22 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 9 \n\nAssessment of leukocyte subpopulations in lung inflammatory exudates. After 2 1 \n\nand 11 weeks of infection, lungs from each mouse digested enzymatically for 30 2 \n\nminutes with collagenase (1 mg/ml) and DNase (30 \u00b5g/ml) in culture medium (Sigma). 3 \n\nLung cells suspensions were centrifuged in presence of 20% percoll (Sigma) to separate 4 \n\nleukocytes from cell debris. Total lung leukocyte numbers were assessed in the presence 5 \n\nof trypan blue using a hemocytometer; viability was >85%. For differential leukocyte 6 \n\ncounts, samples of lung cell suspensions were cytospun (Shandon Cytospin) onto glass 7 \n\nslides and stained by the Diff-Quik blood stain (Baxter Scientific). A total of 200 to 400 8 \n\ncells were counted from each sample. For flow cytofluorometry, lung leukocytes were 9 \n\nresuspended at 10\n6\n cells/ml in staining buffer (PBS \n\n+\n 0.1% NaN3 \n\n+\n and 1% fetal calf 10 \n\nserum).  Fc receptors were blocked by unlabeled anti-CD16/32 antibodies (BD 11 \n\nBiosciences) and cells stained for 20 minutes at 4\u00b0C. Phycoerytrin- labeled (PE) anti-12 \n\nCD40, CD86, CD11b, CD25, CD69 and fluorescein isothiocyanate-labeled (FITC) anti-13 \n\nIA\nk\n, CD80, CD4, CD8 monoclonal antibodies (BD Biosciences) were used. Treg cells 14 \n\nwere characterized by intracellular staining for Foxp3, using the\n \nTreg staining kit of BD 15 \n\nBioscience. Surface staining of CD25\n+\n and intracellular FoxP3 expression were back-16 \n\ngated on the CD4\n+\n T cell population. \n\n \nCells were fixed with 1% paraformaldehyde 17 \n\n(Sigma) and stored in the dark at 4\u00b0C until analyzed in a flow cytometer. The aquisition 18 \n\nand analysis gates were restricted to the lymphocytes or macrophages. The cell surface 19 \n\nexpression\n \nof leukocyte markers as well as intracellular expression of FoxP3 in\n\n \nlung 20 \n\ninfiltrating leucocytes, were analyzed in a FACScalibur flow cytometer (BD 21 \n\nPharmingen) using the FlowJo software (Tristar).   22 \n\nLimulus amoebocyte lysate activity assay.  Solutions used to prepare yeast cell 23 \n\nsuspensions and macrophages cultivation were tested for the presence of LPS using the 24 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 10 \n\nLimulus amoebocyte lysate chromogenic assay (E-TOXATE\n\u00ae\n\n, Sigma) and always 1 \n\nshowed LPS levels  lower than 0.015 EU/mL (endotoxin units). 2 \n\nStatistical analyses.  Data were analyzed by Student's t test or two-way analysis 3 \n\nof variance depending on the number of experimental groups. P values under 0.05 were 4 \n\nconsidered significant. 5 \n\n 6 \n\nRESULTS 7 \n\n 8 \n\nTLR4-deficiency leads to less severe fungal infection of macrophages 9 \n\nassociated with decreased synthesis of NO, IL-12 and MCP-1. Before performing 10 \n\nfungicidal studies, we asked whether the initial interaction between P. brasiliensis 11 \n\nyeasts and peritoneal macrophages from C3H/HeJ and C3H/HePas mice was equivalent.  12 \n\nMacrophages cultures (1x10\n6\n/well), performed in round glass coverlips, were pre-13 \n\nactivated or not with IFN-? (20 ng/ml) and infected with 4x10\n4\n viable yeasts (1: 25 14 \n\nfungus: macrophage ratio). After 4h incubation supernatants were aspirated, the 15 \n\nmonolayers gently washed with PBS and the cells stained with Giemsa.  An average of 16 \n\n1,000 macrophages was counted and the number of ingested and/or adherent yeasts was 17 \n\ndetermined. As shown in Fig. 1A, when compared with normal macrophages, TLR4-18 \n\ndeficient macrophages presented a lower number of associated (ingested/adhered) 19 \n\nyeasts.  20 \n\nMacrophages were cultivated with P. brasiliensis yeasts for an additional 48h 21 \n\nperiod. Supernatants were removed and assayed for the presence of nitric oxide and 22 \n\ncytokines and cell homogenates plated for CFU determinations. As can be seen in Fig. 23 \n\n1B, TLR4-signaling resulted in increased recovery of viable yeasts from untreated and 24 \n\nIFN-?-primed macrophages. In addition, higher levels of NO were produced by IFN-?- 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 11 \n\nactivated macrophages from TLR4-normal mice than those of TLR4-defective mice 1 \n\n(Fig. 1C). P. brasiliensis infection of unprimed macrophages do not induce NO 2 \n\nproduction that was only detected in IFN-?-treated macrophages.  3 \n\nWe further asked if TLR4 expression or signaling was involved in the decreased 4 \n\nfungal loads observed with TLR4-defective macrophages. As C3H/HeJ mice have a 5 \n\ndefect in the intracellular signaling domain but a normal extracellular moiety, we 6 \n\ncomparatively assessed the behavior of macrophages genetically deficient for TLR4 7 \n\nexpression. Thus, TLR4\n-/-\n\n  from C57BL/6 mice were infected and compared with their 8 \n\nTLR4\n+/+\n\n counterparts.  TLR4-deleted macrophages showed decreased phagocytic ability 9 \n\n(Fig. 1D) and decreased numbers of viable yeasts were recovered from killing assays 10 \n\n(Fig. 1E). Similarly with C3H/HeJ macrophages, TLR4\n-/-\n\n  cells produced diminished 11 \n\nlevels of NO. This result suggested that TLR4 signaling appeared to influence the 12 \n\nendocytic and killing ability of P. brasiliensis infected macrophages.   13 \n\nTo further characterize the role of TLR4 in P. brasiliensis infection of C3H 14 \n\nmacrophages, culture supernatants obtained from killing assays were tested for the 15 \n\npresence of some macrophage activating cytokines (IL-12 and TNF-?), a deactivating 16 \n\ncytokine (IL-10) and for a chemokine involved in mononuclear cell chemotaxis, the 17 \n\nmacrophage chemotactic protein-1 (MCP-1). As depicted in Fig. 2, IFN-?-treated and 18 \n\nuntreated macrophages from TLR4-defective mice secreted decreased levels of IL-12 19 \n\nand MCP-1 than those of TLR4-normal mice. IL-10 and TNF??, however, appeared in 20 \n\nsimilar levels. 21 \n\nIn vivo, absence of TLR4 signaling induces lower fungal loads and 22 \n\ndiminished NO production.  To study the in vivo role of TLR4, groups (n = 6 to 8) of 23 \n\nC3H/HeJ and C3H/HePas mice were i.t. infected with one million P. brasiliensis yeast 24 \n\ncells and evaluated in the course of infection. Diminished fungal burdens were detected 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 12 \n\nin the lung tissue of mice lacking functional TLR4 at all postinfection periods (96h, 2 1 \n\nand 11 weeks) assayed, as can be seen in Fig. 3A. In both strains, no fungal growth was 2 \n\nobserved in liver and spleen tissue (data not shown). Decreased NO levels were detected 3 \n\n96 h and at week 11 after infection, although by week 2 similar levels were observed 4 \n\n(Fig. 3B).  5 \n\nDefective TLR4 signaling determines decreased inflammatory reactions 6 \n\ncomposed of lower numbers of activated macrophages and T cells. We have further 7 \n\nanalyzed the phenotype and activation of lung inflammatory cells at weeks 2 and 11 of 8 \n\nP.brasiliensis infection (Fig. 4). To determine the activation profile of pulmonary 9 \n\nmacrophages, the expression of CD11b, MHC class II (IA\nK\n), CD80, CD86 and CD40 10 \n\nantigens was assessed by flow cytometry. As can be seen in Fig. 4A, all activation 11 \n\nmarkers were expressed in lower levels by deficient macrophages, although significant 12 \n\ndifferences were noticed with CD11b, MHC class II antigen and CD86. To determine 13 \n\nthe lymphocyte influx and the activation profile of CD4\n+\n and CD8\n\n+\n T cells in the lungs 14 \n\nof P. brasiliensis infected mice, we determined the expression of the CD69 and CD25 15 \n\nby T cells freshly isolated from the lungs. The marker CD69 is a very early activation 16 \n\nantigen (70) as well as CD25, the ?-chain of the interleukin-2 receptor (56), which is 17 \n\nrapidly up-regulated on activated T cells. Compared with the control group, at week 2 of 18 \n\ninfection TLR4-deficient mice presented a significantly reduced recruitment of CD4\n+\n 19 \n\nand CD8\n+\n T cells to the lungs, and the latter subpopulation also showed a decreased 20 \n\nexpression of CD69 (Fig. 4B). Studies at week 11 postinfection confirmed those of 21 \n\nweek 2. TLR4-normal mice presented increased numbers of CD11b\n+\n, CD11c\n\n+ \nand 22 \n\nCD40\n+\n macrophages (Fig. 4C) besides augmented numbers of CD4\n\n+\n,  CD8\n\n+\n  and 23 \n\nCD8\n+\nCD69\n\n+ \nT lymphocytes in the inflammatory exudates of lungs (Fig. 4D). 24 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 13 \n\nThe limited inflammatory reaction of TLR4-deficient mice was associated 1 \n\nwith increased numbers of Treg cells. Because Treg cells control the expansion of 2 \n\neffector T cells, and the number and function of these cells were shown to be influenced 3 \n\nby TLR4 activation (34), we characterized the presence of CD4\n+\nCD25\n\n+\nFoxP3\n\n+\n T cells 4 \n\nin the lung cell infiltrates of TLR4-defective and normal mice (Fig. 5). At both 5 \n\npostinfection periods studied, TLR4-defective mice showed increased numbers of 6 \n\nCD4\n+\nCD25\n\n+\nFoxP3\n\n+\n Treg cells in their lungs (Fig.5). 7 \n\nTLR4 dysfunction leads to diminished production of proinflammatory and 8 \n\nTh17 cytokines. Cytokines associated with Th1, Th2 and Th17 cells were assessed in 9 \n\nlung homogenates obtained at different periods of infection. The production of type 1 10 \n\n(IL-12, TNF-?, and IFN-?), and type 2 (IL-4, IL-5 and IL-10) cytokines, as well as the 11 \n\nTh17-associated (IL-17, IL-6, TGF-? and IL-23) cytokines were studied 96h, 2 and 11 12 \n\nweeks after infection. Mice lacking the ability to signal through TLR4 showed an early 13 \n\n(96h) deficient production of IL-12, TNF-?, IL-17 and IL-6 (Fig. 6A). By week 2, IL-17 14 \n\nand IL-23 appeared in lower levels in the lungs of TLR4-defective mice (Fig. 6B). This 15 \n\ndecreased production of cytokines was confirmed at week 11 when these mice presented 16 \n\ndecreased amounts of IL-12, IL-17 and TGF-? (Fig. 6C). Interestingly, IL-17 and MCP-17 \n\n1 were constantly produced in higher levels by TLR4-normal mice (Fig. 6).  18 \n\nTLR4-defective mice produced lower levels of P.brasiliensis specific 19 \n\nantibodies. Although in some fungal infections specific antibodies may have a 20 \n\nprotective role (19) in human and experimental PCM antibody production is a marker of 21 \n\ndisease severity (13, 17).  As expression of TLRs were shown to influence B cell 22 \n\nactivation (30, 41) we decided to characterize humoral immunity of TLR4-deficient and 23 \n\nnormal mice at week 11 postinfection. The less severe infection of TLR4-deficient mice 24 \n\nwas associated with decreased production of IgG1, IgG2b and IgM  specific isotypes. 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 14 \n\nAbsence of TLR4 signaling does not increase mortality rates but results in 1 \n\nless severe inflammatory reactions in the lungs. To verify the influence of TLR4 2 \n\ndeficiency in the disease outcome, mortality of P.brasiliensis infected C3H/HeJ and 3 \n\nC3H/HePas mice was registered daily for a 250-days period, and the median survival\n \n\n4 \n\ntime was calculated for each strain. Surprisingly, despite the significant differences in 5 \n\nfungal burdens, no differences between mortality data (p= 0.9) were detected (Fig. 8A). 6 \n\nThe mean survival times of C3H/HeJ and C3H/HePas mice were 221 and 203 days, 7 \n\nrespectively. At day 250 (35 weeks postinfection), the remaining survivors were 8 \n\nsacrificed and the number of CFUs determined in organs. Compared with other 9 \n\npostinfection periods assayed, lower fungal burdens were detected in both mouse 10 \n\nstrains, but TLR4-normal mice remained with higher pulmonary fungal loads than toll-11 \n\ndefective mice (Fig. 8B). To further characterize the severity of P.brasiliensis infection, 12 \n\nhistopathological examination of lungs was done at week 11 of infection. As can be 13 \n\nseen in Fig. 8C and 8E, a similar pattern of inflammatory reactions was detected in the 14 \n\nlungs of both mouse strains, but more preserved lung tissue was seen in TLR4-defective 15 \n\nmice. The pulmonary tissue presented several confluent or isolated granulomas of 16 \n\nvarying sizes containing yeast cells with preserved morphology (Fig. 8D, 8F). Large 17 \n\naggregates of macrophages, rare epithelioid cells and a poor mantle of lymphocytes 18 \n\ncomposed the granulomas, which were usually placed in the interlobular septa. Plasma 19 \n\ncells, eosinophils and multinucleated cells were scarcely seen. The total area of lesions 20 \n\nwas quantified in histological sections and shown in Fig 8G. At week 11, the areas of 21 \n\nlesions of TLR4-normal mice were significantly larger than that presented by TLR4-22 \n\ndeficient mice. Thus, the higher influx of inflammatory cells observed in the lungs of 23 \n\nTLR4-normal mice was concomitant with increased pathology of lung tissue. 24 \n\nDISCUSSION 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 15 \n\nThe innate immune mechanisms of hosts infected with P.brasiliensis are poorly 1 \n\ndefined, but macrophages and their pathogen recognition receptors are thought to play a 2 \n\ncrucial role in the initial interaction of this fungus with the immune system (16, 26, 29, 3 \n\n49, 50). Despite several studies with diverse fungal pathogens (16, 43) the role played 4 \n\nby TLRs in paracoccidioidomycosis is still unclear. In a previous report we were able to 5 \n\nshow the dual role played by TLR2 in the immunity to P.brasiliensis infection. TLR2 6 \n\nactivation prevented uncontrolled inflammatory reactions in pulmonary 7 \n\nparacoccidioidomycosis associated with increased expansion of Th17 cells and 8 \n\ndiminished function of Treg cells (38).  9 \n\nInitially we characterized the influence of TLR4 in the phagocytic and fungicidal 10 \n\nability of macrophages. Both, absence of TLR4 expression by TLR4\n-/-\n\n C57BL/6 mice as 11 \n\nwell as defective TLR4 signaling (C3H/HeJ) resulted in deficient P.brasiliensis 12 \n\ningestion/adherence, and lower fungal loads recovered 48 hs after co-cultivation. In 13 \n\nboth deficient mouse strains, lower levels of nitric oxide (and cytokines with C3H/HeJ 14 \n\ncells) were  detected, indicating that the lower CFU counts recovered were not due to 15 \n\nincreased activation of phagocytes and enhanced fungal killing, but probably by the 16 \n\ndecreased endocytosis of P.brasiliensis yeasts. TLRs usually do not act as phagocytic 17 \n\nreceptors but their engagement by pathogen components results in strong activation of 18 \n\ninflammatory responses (8, 9). There are, however, several examples demonstrating that 19 \n\ncell signaling can influence endocytosis and vice-versa (20, 23). Indeed, TLR4 was 20 \n\nshown to actively participate in bacterial phagocytosis (4) and to be rapidly internalized 21 \n\nby human monocytes after in vitro interaction with P.brasiliensis yeasts or A. fumigatus 22 \n\nconidia (10, 21). In addition, a recent paper has clearly demonstrated that TLR4 and 23 \n\nTLR2 synergize with class-A scavenger receptor to mediate phagocytosis of Gram-24 \n\nnegative and Gram-positive bacteria, respectively (3). Thus, we can suppose that TLR 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 16 \n\nsignaling facilitated the endocytosis of P.brasiliensis and further induced the activation 1 \n\nof proinflammatory pathways which, however, were not sufficient to control the early 2 \n\nincreased fungal loads. As equivalent results were obtained with macrophages lacking 3 \n\nTLR4 expression, we believe that TLR4 signaling could have influenced the  4 \n\nphagocytosis mediated by another pathogen receptor. Although our experiments have 5 \n\nnot discriminated the main PRR involved in the initial P.brasiliensis recognition, 6 \n\n(particularly due to the number and complexity of components that comprise fungal cell 7 \n\nwalls), we have clearly demonstrated that TLR4 participate in the activation of innate 8 \n\nimmune cells required to the initial interaction with P.brasiliensis yeasts.  Our in vitro 9 \n\nfindings were validated by in vivo experiments, which demonstrated that early in 10 \n\ninfection TLR4-normal mice presented higher fungal loads than their TLR4-defective 11 \n\ncounterparts and this was accompanied by increased activation of the immune system. 12 \n\nAdditional experiments with PRR agonists and antagonists using TLR4 normal and 13 \n\ndeficient cells are needed, however, to further clarify the role of TLRs in pulmonary 14 \n\nPCM. 15 \n\nOur in vivo data showed that mice expressing a defective TLR4 developed a less 16 \n\nsevere infection associated with lower production of nitric oxide, cytokines and 17 \n\nmigration of inflammatory cells to the site of infection. A decreased presence of 18 \n\nactivated macrophages expressing CD11b, CD86, CD40 and MHC class II molecules 19 \n\nwas concomitant with a reduced synthesis of MCP-1. In addition, the diminished 20 \n\npresence of CD4\n+\n T cells and recently activated CD69\n\n+\n CD8\n\n+\n T cells in the lungs of 21 \n\nTLR4-defective mice demonstrates that TLR4 signaling is necessary to the proper 22 \n\nactivation of adaptive immunity to P.brasiliensis and enhanced migration of 23 \n\ninflammatory cells into the lungs. Consistent with these observations, several reports 24 \n\ndemonstrated that TLR4 signaling is needed to the activation and maturation of 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 17 \n\ndendritic cells, which acquire the competent phenotype to preferentially differentiate 1 \n\nna\u00efve T cells to the Th1 or Th17 patterns (57, 64, 65). No differences in Th1 and Th2 2 \n\ncytokines, however, were detected in lung homogenates. The increased production of 3 \n\nIL-12 and TNF-? concomitant with unaltered synthesis of Th2 cytokines (IL-4, IL-5 4 \n\nand IL-10) indicated, however, that TLR4 signaling promoted a cytokine milieu biased 5 \n\nto a proinflammatory balance. This cytokine response could have protected C3H/HePas 6 \n\nmice from high fungal burdens due to the enhanced fungicidal mechanisms of activated 7 \n\nphagocytes. Indeed, in experimental an human PCM, cytokine-activated phagocytes 8 \n\n(mainly by IFN??, IL-12 and TNF-?) were shown to be the most important  effector 9 \n\ncells against P.brasiliensis infection (36, 40, 46, 55). Our data on cytokines production 10 \n\nshowed an additional fact not previously reported in PCM. The expression of TLR4 11 \n\nfacilitated the expansion of IL-17-producing cells since the levels of IL-17 and other 12 \n\nTh17 associated cytokines (IL-6 and IL-23) appeared in higher levels in the lungs of 13 \n\nTLR4-competent mice. In our previous report, we could verify that absence of TLR2 14 \n\nsignaling induced enhanced expansion of Th17 cells and both CD4\n+\n and CD8\n\n+\n T cells 15 \n\ndisplayed intracellular IL-17 (38). Further studies in the TLR4-deficient model will help 16 \n\nus to characterize the phenotype of cells involved in IL-17 production.  17 \n\nTLR4 ligation is important to activate Th1 or Th17 responses (65) while TLR4-18 \n\ndeficiency can lead to increased expansion of CD4\n+\nCD25\n\n+\n regulatory T cells (47, 48). 19 \n\nAssessing the presence of Treg cells in the lungs of toll-deficient and control mice at 20 \n\nweeks 2 and 11 of infection, an increased number of CD4\n+\nCD25\n\n+\nFoxP3\n\n+\n cells was 21 \n\nfound in the lungs of TLR4-defective mice. This finding was associated with decreased 22 \n\nfungal loads and diminished influx of inflammatory cells to the site of infection. As 23 \n\nTreg cells were shown to control the inductive and effector phases of immunity against 24 \n\npathogens (6) we can suppose that Treg cells could have negatively controlled the 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 18 \n\nexpansion and migration of P.brasiliensis-specific T cells to the lungs. Thus, the 1 \n\nadvantage of low fungal loads conferred by TLR4 deficiency appeared to be negatively 2 \n\ncompensated by the deficient T cell immunity and increased numbers of Treg cells 3 \n\nwhich appear to hamper the total clearance of fungi cells from the lungs. 4 \n\nAt week 11 of infection, decreased levels of IL-12 were detected, probably due 5 \n\nto the decreased migration of macrophages to the lungs. Interestingly, in C3H/HeJ mice  6 \n\ndecreased levels of IL-17 were concomitant diminished levels of TGF-? indicating that 7 \n\nanother cytokine or costimulatory signal have participated in the increased expansion of 8 \n\nTreg cells (27).  9 \n\nAs expression of TLRs were shown to influence B cell activation (41), we 10 \n\ndecided to analyze the levels of anti-P.brasiliensis isotypes in our model and observed 11 \n\nan impaired humoral immune response in TLR4-defective mice. At week 11 of 12 \n\ninfection (Fig. 7) TLR4-deficient mice produced lower levels of IgG1, IgG2b and IgM 13 \n\nspecific antibodies. This could be due to the diminished fungal loads or the decreased 14 \n\nproduction of cytokines observed in this mouse strain. Alternatively, as almost all TLRs 15 \n\nligands were recently shown to induce expansion and differentiation of B cells (30), we 16 \n\ncan suppose that TLR4 agonists present in P.brasiliensis yeasts could have exerted an 17 \n\nstimulatory effect on B cells of TLR4-normal mice, resulting in increased humoral 18 \n\nimmunity. Independently of the mechanisms used, this is the first demonstration on the 19 \n\nstimulatory role of TLR4 in the humoral immunity of P.brasiliensis infected hosts. 20 \n\nTLR4 recognizes lipopolysaccharide (LPS) of Gram-negative bacteria and favor 21 \n\nTh1immunity due to the increased ability of LPS-stimulated DCs to produce IL-12 and 22 \n\nTNF-? (51). In some fungal infections, however, cell wall polysaccharides have been 23 \n\nreported to function as TLRs agonists (42, 63). To our knowledge, no studies in 24 \n\nparacoccidioidomycosis have addressed the characterization of TLR agonists. Although 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 19 \n\nLPS or LPS-like components in P.brasiliensis were not characterized, a few 1 \n\ninvestigations have described the presence of polysaccharides, lipids and glycolipids in 2 \n\nP.brasiliensis cell walls (35, 61). The alcali-soluble fraction of P.brasiliensis cell walls 3 \n\nwas shown to contain a high proportion of galactomannan (35) and is tempting to 4 \n\nsuppose that this component could play a role in TLR4 activation.   5 \n\nDectin and TLR4 signaling by microbial agonists have been reported to induce 6 \n\nprevalent expansion of Th17 cells (1, 22, 33, 37).  In our model, mice that possessed 7 \n\nfunctional TLR4 were shown to have increased levels of IL-17 and other Th17 8 \n\nassociated cytokines in their lungs. Although not investigated in the present work, IL-9 \n\n17-mediated immunity was shown to exert deleterious or protective effects in infectious 10 \n\nprocesses (54, 58).  Actually, Th17 immunity can protect hosts due to its 11 \n\nproinflammatory and chemotactic effect to PMN cells. Conversely, the enhanced 12 \n\noxidative metabolism and increased synthesis of metalloproteinases can result in tissue 13 \n\npathology and detrimental effect to the hosts (11, 68, 69). In our previous work on the 14 \n\nrole of TLR2 in pulmonary PCM we could demonstrate the dual role of Th17 immunity. 15 \n\nThe increased presence of inflammatory neutrophils conferred immunoprotection by 16 \n\nreducing fungal loads but also resulted in tissue pathology equivalent to that induced by 17 \n\nhigher fungal burdens (38). 18 \n\nMortality studies, unexpectedly, demonstrated that TLR4 signaling does not 19 \n\ninfluence disease outcome since TLR4-competent and deficient mice presented 20 \n\nequivalent survival times. In the course of the disease, both mouse strains were able to 21 \n\ncontrol fungal growth and to develop granulomatous reactions. However, the higher 22 \n\nfungal loads, the enhanced T cell immunity and the lower expansion of Treg cells 23 \n\nresulted in more extensive inflammatory lesions which exerted a deleterious effect to 24 \n\nthe lungs of TLR4-normal mice. On the other hand, the inefficient T cell immunity of 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 20 \n\nTLR4-deficient mice, tightly controlled by Treg cells, was not sufficient to totally clear 1 \n\nthe diminished fungal loads of TLR4-defective mice abolishing the initial advantage 2 \n\nconferred by their defective phagocytic ability. In sum, our findings indicate that high 3 \n\nfungal loads accompanied by enhanced inflammatory responses mediated by 4 \n\nuncontrolled T cell immunity are equivalent to low fungal loads poorly controlled by 5 \n\ndeficient T cell response. Both mechanisms of immunity result in the chronic evolution 6 \n\nof infection and equivalent mortality rates.       7 \n\n 8 \n\nACKNOWLEDGEMENTS 9 \n\nThis work was supported by grants from Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de 10 \n\nS\u00e3o Paulo ( Fapesp) e Conselho Nacional de Pesquisas (CNPq). We are grateful to 11 \n\nTania A. Costa and Paulo Albee for their invaluable technical assistance. 12 \n\n 13 \n\nREFERENCES 14 \n\n1. Abdollahi-Roodsaz, S., Joosten, L.A., Koenders, M.I., Devesa, I., Roelofs, 15 \n\nM.F., Radstake, T.R., Heuvelmans-Jacobs, M., Akira, S., Nicklin, M.J., 16 \n\nRibeiro-Dias, F., and W.B. van den Berg. 2008. Stimulation of TLR2 and 17 \n\nTLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. 18 \n\nClin. Invest. 118:205-216.  19 \n\n2. Akira, A. 2006. TLR signaling. Curr. Top. Microbiol Immunol. 311:1-16.  20 \n\n3. Amiel, E., Alonso, A., Uematsu, S., Akira, S., Poynter, M.E., and B. Berwin. 21 \n\n2009. Toll-like receptor regulation of scavenger receptor-A-mediated 22 \n\nphagocytosis. J. Leukoc. Biol. 85:595-605. 23 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 21 \n\n4. Anand, R.J., Kohler, J.W., Cavallo, J.A., Li, J., Dubowski, T., and  D.J. 1 \n\nHackam. 2007. Toll-like receptor 4 plays a role in macrophage phagocytosis 2 \n\nduring peritoneal sepsis. J. Pediatr. Surg.  42:927-932. 3 \n\n5. Bellocchio, S., Montagnoli, C., Bozza, S., Gaziano, R., Rossi, G., Mambula, 4 \n\nS.S., Vecchi, A., Mantovani, A., Levitz, S.M., and L. Romani. 2004. The 5 \n\ncontribution of the Toll-Like/IL-1 receptor superfamily to innate and adaptive 6 \n\nimmunity to fungal pathogens in vivo.  J. Immunol. 172:3059-3069. 7 \n\n6. Belkaid, Y., and B. T. Rouse. Natural regulatory T cells in infectious disease. 8 \n\n2005. Nat. Immunol. 6: 353-360. 9 \n\n7. Biondo, C., Midiri, A., Messina, L., Tomasello, F., Garufi, G., Catania, 10 \n\nM.R.,  Bombaci, M., Beninati, C., Teti, G., and G. Mancuso. 2005. MyD88 11 \n\nand TLR2, but not TLR4, are required for host defense against Cryptococcus 12 \n\nneoformans. Eur. J. Immunol. 35:870-878. 13 \n\n8. Blander, J.M. Signalling and phagocytosis in the orchestration of host defence. 14 \n\n2007. Cell. Microbiol. 92:290-9. 15 \n\n9. Blander, J.M., and R. Medzhitov. 2004. Regulation of phagosome maturation 16 \n\nby signals from toll-like receptors. Science 304:1014-1018. 17 \n\n10. Bonfim, C.V., Mamoni, R.L., Souza, M.H., and L. Blotta. 2009. TLR-2, 18 \n\nTLR-4 and dectin-1 expression in human monocytes and neutrophils stimulated 19 \n\nby Paracoccidioides brasiliensis. Med. Mycol. 17:1-12. 20 \n\n11. Bozza, S., Zelante, T., Moretti, S., Bonifazi, P., De Luca, A., D'Angelo, C., 21 \n\nGiovannini, G., Garlanda, C., Boon, L., Bistoni, F., Puccetti, P., Mantovani, 22 \n\nA., and L. Romani. 2008. Lack of Toll IL-1R8 exacerbates Th17 cell responses 23 \n\nin fungal infection. J. Immunol. 180:4022-4031. 24 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 22 \n\n12. Brummer, E. 1994. Interaction of Paracoccidioides brasiliensis with host 1 \n\ndefense cells. In Paracaccidioidomycosis. Franco, M., Lacaz, C.S., Restrepo, A., 2 \n\nDel Negro, G. editors. CRC Press, Boca Raton, FL.  3 \n\n13. Calich, V.L.G., and M.H.S.L. Blotta. 2005. Pulmonary 4 \n\nParacoccidioidomycosis, p. 201-208. In: Fungal Immunology: From an Organ 5 \n\nPerspective. P.L. Fidel, and G. B. Huffnagle (ed.), Springer Press, New York, 6 \n\nNY.  7 \n\n14. Calich, V.L.G., Kipnis, T.L., Mariano, M., Neto, C.F., and W.D. Silva. 1979. 8 \n\nThe activation of complement system by Paracoccidioides brasiliensis \u201cin 9 \n\nvitro\u201d: its opsonic effect and possible significance for an in vivo model of 10 \n\ninfection. Clin. Immunol. Immunopathol. 12:20-30. 11 \n\n15. Calich, V.L., da Costa, T.A., Felonato, M., Arruda, C., Bernardino, S., 12 \n\nLoures, F.V., Ribeiro, L.R, de C\u00e1ssia Valente-Ferreira, R., Pina, A. 2008. 13 \n\nInnate immunity to Paracoccidioides brasiliensis infection. Mycopathol. 14 \n\n165:223-36. 15 \n\n16. Calich, V.L.G, Pina, A., Felonato, M., Bernardino, S., Costa, T.A., and F.V. 16 \n\nLoures. 2008. Toll-like receptors and fungal infections: the role of TLR2, TLR4 17 \n\nand MyD88 in paracoccidioidomycosis. FEMS Immunol. Med. Microbiol. 53:1-18 \n\n7.  19 \n\n17. Camargo, Z.P., and L.E. Cano. 1994. Humoral Immunity, p. 187-197. In: M. 20 \n\nFranco, C. S. Lacaz, A. Restrepo-Moreno, and G. Del Negro (ed.), 21 \n\nParacoccidioidomycosis, 1th ed. CRC Press, Boca Raton, FL. 22 \n\n18. Cano, L.E., Singer-Vermes, L.M.,  Vaz, C.A.C., Russo, M., and V.L.G. 23 \n\nCalich. 1995. Pulmonary paracoccidioidomycosis in resistant and susceptible 24 \n\nmice: relationship among progression of infection, bronchoalveolar cell 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 23 \n\nactivation, cellular immune response, and specific isotype patterns. Infect. 1 \n\nImmun. 63:1777-1783. 2 \n\n19. Casadevall , A., Feldmesser, M., and L.A. Pirofski. 2002. Induced humoral 3 \n\nimmunity and vaccination against major human fungal pathogens.  Curr. Opin. 4 \n\nMicrobiol. 5:386-391. 5 \n\n20. Cavalli, V., Corti, M., and J. Gruenberg. 2001. Endocytosis and signaling 6 \n\ncascades: a close encounter. FEBS Lett. 498:190-196. 7 \n\n21. Chai, L.Y., Kullberg, B.J., Vonk, A.G., Warris, A., Cambi, A., Latg\u00e9, J.P., 8 \n\nJoosten, L.A., van der Meer, J.W., and M.G. Netea. 2009. Modulation of 9 \n\nToll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. 10 \n\nInfect. Immun. 77:2184-2192. 11 \n\n22. Dennehy, K.M., Willment, J.A., Williams, D.L., and G.D. Brown. 2009. 12 \n\nReciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 13 \n\nand TLR signaling pathways. Eur. J. Immunol. 39:1379-1386.  14 \n\n23. Di Fiore, P.P., and P. De Camilli. 2001. Endocytosis and signaling. an 15 \n\ninseparable partnership. Cell 106:1-4 16 \n\n24. Dubourdeau, M., Athman, R.,  Balloy, V., Huerre, M., Chignard, M., 17 \n\nPhilpott, D.J., Latg\u00e9, J.P., and O. Ibrahim-Granet. 2006. Aspergillus 18 \n\nfumigatus induces innate immune responses in alveolar macrophages through 19 \n\nthe MAPK pathway independently of TLR2 and TLR4. J. Immunol. 177:3994-20 \n\n4001. 21 \n\n25. Fedele, G., Nasso, M., Spensieri, F., Palazzo, R., Frasca, L., Watanabe, M., 22 \n\nand C.M. Ausiello. 2008. Lipopolysaccharides from Bordetella pertussis and 23 \n\nBordetella parapertussis differently modulate human dendritic cell functions 24 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 24 \n\nresulting in divergent prevalence of Th17-polarized responses. J. Immunol. 1 \n\n181:208-216.  2 \n\n26. Ferreira, K.S., Bastos, K.R., Russo, M., and S.R. Almeida. 2007. Interaction 3 \n\nbetween Paracoccidioides brasiliensis and pulmonary dendritic cells induces 4 \n\ninterleukin-10 production and toll-like receptor-2 expression: possible 5 \n\nmechanisms of susceptibility.  J. Infect. Dis. 196:1108-1115.  6 \n\n27. Feuerer, M., Hill, J.A., Mathis, D., and C. Benoist. 2009. Foxp3+ regulatory 7 \n\nT cells: differentiation, specification, subphenotypes. Nat. Immunol. 10:689-8 \n\n695. 9 \n\n28. Franco, M. 1987. Host-parasite relationships in paracoccidioidomycosis. J. 10 \n\nMed. Vet. Mycol. 25:5-18. 11 \n\n29. Gonz\u00e1lez, A., Y\u00e1\u00f1ez, A., Gozalbo, D., and M.L. Gil. 2008. MyD88 is 12 \n\ndispensable for resistance to Paracoccidioides brasiliensis in a murine model of 13 \n\nblood-borne disseminated infection. FEMS Immunol. Med. Microbiol. 54:365-14 \n\n374. 15 \n\n30. Garurajan, M., Jacob, J., and B. Pulendran. 2007.  Toll-like receptor 16 \n\nexpression and responsiveness of distinct murine splenic and mucosal B-cell 17 \n\nsubsets. PloS ONE, 2(9): e863. 18 \n\n31. Higgins, S.C., Jarnicki, A.G., Lavelle, E.C., and K.H. Mills. 2006. TLR4 19 \n\nmediates vaccine-induced protective cellular immunity to Bordetella pertussis: 20 \n\nrole of IL-17-producing T cells. J. Immunol. 177:7980-7989. 21 \n\n32. Jim\u00e9nez, M.P., Restrepo, A., Radzioch, D., Cano, L.E., and L.F. Garcia. 22 \n\n2006. Importance of complement 3 and mannose receptors in phagocytosis of 23 \n\nParacoccidioides brasiliensis conidia by Nramp1 congenic macrophages lines. 24 \n\nImmunol. Med. Microbiol. 47:56-66. 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 25 \n\n33. Jouault, T., Ibata-Ombetta, S., Takeuchi, O., Trinel, P.A., Sacchetti, P., 1 \n\nLefebvre, P., Akira, S., and D. Poulain. 2003. Candida albicans 2 \n\nphospholipomannan is sensed through toll-like receptors. J. Infect. Dis. 188:165-3 \n\n172. 4 \n\n34. Jordan, J.M., Woods, M.E., Olano, J., and D.H. Walker. 2008. Absence of 5 \n\nTLR4 signaling in C3H/HeJ mice predisposes to overwhelming rickettsial 6 \n\ninfection and decreased protective Th1 responses. Infect. Immun. 76:3717-24. 7 \n\n35. Kanetsuna, F., Carbonell, L.M., Moreno, R.E., and J. Rodriguez. 1969. Cell 8 \n\nwall composition of the yeast and mycelial forms of Paracoccidioides 9 \n\nbrasiliensis. J. Bacteriol. 97:1036-1041. 10 \n\n36. Kashino, S.S., Fazioli, R.A., Cafalli-Favati, C., Meloni-Bruneri, L.H., Vaz, 11 \n\nC.A., Burger, E., Singer, L.M., and V.L.G. Calich. 2000. Resistance to 12 \n\nParacoccidioides brasiliensis infection is linked to a preferential Th1 immune 13 \n\nresponse, whereas susceptibility is associated with absence of IFN-gamma 14 \n\nproduction. J. Interferon. Cytokine Res. 20:89-97. 15 \n\n37. Leibundgut-Landmann, S., Osorio, F., Brown, G.D., and C. Reis e Sousa. 16 \n\n2008. Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming 17 \n\nof cytotoxic T-cell responses. Blood 112:4971-4980. 18 \n\n38. Loures, F.V., Pina, A., Felonato, M., and V.L.G. Calich. 2009. TLR2 is a 19 \n\nnegative regulator of Th17 cells and tissue pathology in a pulmonary model of 20 \n\nfungal infection. J. Immunol. 183:1279-1290. 21 \n\n39. Meier, A., Kirschning, C.J.,   Nikolaus, T., Wagner, H., Heesemann, J., and 22 \n\nF. Ebel. 2003. Toll-like receptor (TLR) 2 and TLR4 are essential for 23 \n\nAspergillus-induced activation of murine macrophages. Cell Microbiol. 5:561-24 \n\n570. 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 26 \n\n40. Mamoni, R.L., and M.H. Blotta. 2006. Flow-cytometric analysis of cytokine 1 \n\nproduction in human paracoccidioidomycosis. Cytokine. 35:207-16. 2 \n\n41. Manicassamy, S. and B. Pulendran. 2009. Modulation of adaptive immunity 3 \n\nwith Toll-like receptors. Semin. Immunol., 21: 185-193.  4 \n\n42. Monari, C., Pericolini, E., Bistoni, G., Casadevall, A., Kozel, T.R., and A. 5 \n\nVecchiarelli. 2005. Cryptococcus neoformans capsular glucuronoxylomannan 6 \n\ninduces expression of fas ligand in macrophages. J Immunol. 174:3461-3468. 7 \n\n43. Netea, M. G., Ferwerda, G.,  van der Graaf, C.A.,  van der Meer, J. W.,  8 \n\nand B. J. Kullberg. 2006. Recognition of fungal pathogens by toll-like 9 \n\nreceptors. Curr. Pharm. Des. 12:4195-4201. 10 \n\n44. Netea, M.G., Gow, N.A., Munro, C.A., Bates, S., Collins, C., Ferwerda, G., 11 \n\nHobson, R.P., Bertram, G., Hughes, H.B., Jansen, T., Jacobs, L., Buurman, 12 \n\nE.T., Gijzen, K., Williams, D.L., Torensma, R., McKinnon, A., MacCallum, 13 \n\nD.M., Odds, F.C., Van der Meer, J.W., Brown, A.J., and B.J. Kullberg. 14 \n\n2006. Immune sensing of Candida albicans requires cooperative recognition of 15 \n\nmannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 116:1642-16 \n\n1650. 17 \n\n45. Netea, M. G., Van Der Graaf, C.A., Vonk, A.G., Verschueren, I., Van Der 18 \n\nMeer, J.W., and B.J. Kullberg. 2002. The role of toll-like receptor (TLR) 2 19 \n\nand TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 20 \n\n185:1483-1489. 21 \n\n46. Oliveira, S.J., Mamoni, R.L., Musatti, C.C., Papaiordanou, P.M., and M.H. 22 \n\nBlotta. 2002. Cytokines and lymphocyte proliferation in juvenile and adult 23 \n\nforms of paracoccidioidomycosis: comparison with infected and non-infected 24 \n\ncontrols. Microbes Infect. 4:139-144. 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 27 \n\n47. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of 1 \n\nCD4\n+\nCD25\n\n+\n T cell-mediated suppression by dendritic cells. Science 299:1033-2 \n\n1036. 3 \n\n48. Pasare, C., and R. Medzhitov. 2004. Toll-dependent control mechanisms of 4 \n\nCD4 T cell activation. Immunity. 21:733-741. 5 \n\n49. Pina, A., Bernardino, S., and V.L.G. Calich. 2008. Alveolar macrophages 6 \n\nfrom susceptible mice are more competent than those of resistant mice to control 7 \n\ninitial Paracoccidioides brasiliensis infection. J. Leukoc. Biol. 83:1088-1099. 8 \n\n50. Popi, A.F., Lopes, J.D., and M. Mariano. 2002. Gp43 from Paracoccidioides 9 \n\nbrasiliensis inhibits macrophage functions. An evasion mechanism of the 10 \n\nfungus. Cell Immunol. 218:87-94. 11 \n\n51. Qi, H., Denning, T.L., and L. Soong. 2003. Differential induction of 12 \n\ninterleukin-10 and interleukin-12 in dendritic cells by microbial toll-like 13 \n\nreceptor activators and skewing of T-cell cytokine profiles. Infect. Immun. 14 \n\n71:3337-3342. 15 \n\n52. Reis e Sousa, C. 2004. Activation of dendritic cells: translating innate into 16 \n\nadaptative immunity. Curr. Opin. Immunol. 16:21-25. 17 \n\n53. Romani, L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4:1-23. 18 \n\n54. Romani, L., Zelante, T., De Luca, A., Fallarino, F., and P. Puccetti. 2008. 19 \n\nIL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J. 20 \n\nImmunol. 180:5157-5162.  21 \n\n55. Romano, C.C., Mendes-Giannini, M.J., Duarte, A.J., and G. Benard. 2002. 22 \n\nIL-12 and neutralization of endogenous IL-10 revert the in vitro antigen-specific 23 \n\ncellular immunosuppression of paracoccidioidomycosis patients. Cytokine 24 \n\n18:149-157. 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 28 \n\n56. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and M. Toda. 1995. 1 \n\nImmunologic self-tolerance maintained by activated T cells expressing IL-2 2 \n\nreceptor alpha-chains (CD25). Breakdown of a single mechanism of self-3 \n\ntolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164. 4 \n\n57. Shen, H., Tesar, B.M., Walker, W.E., and D.R. Goldstein. 2008. Dual 5 \n\nsignaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic 6 \n\ncell maturation. J. Immunol. 181:1849-1858. 7 \n\n58. Sieve, A.N., Meeks, K.D., Bodhankar, S., Lee, S., Kolls, J.K., Simecka, J.W., 8 \n\nand R.E Berg. 2009. A novel IL-17-dependent mechanism of cross protection: 9 \n\nrespiratory infection with mycoplasma protects against a secondary listeria 10 \n\ninfection. Eur. J. Immunol. 39:426-438.  11 \n\n59. Singer-Vermes, L.M., Ciavaglia, M.C., Kashino, S.S., Burguer, E., and 12 \n\nV.L.G. Calich. 1992. The source of the growth-promoting factor (s) affects the 13 \n\nplating efficiency of Paracoccidioides brasiliensis. J. Med. Vet. Mycol. 30:261-14 \n\n264. 15 \n\n60. Sp\u00f6rri, R., and C. Reis e Sousa. 2005. Inflammatory mediators are insufficient 16 \n\nfor full dendritic cell activation and promote expansion of CD4\n+\n T cell 17 \n\npopulations lacking helper function. Nat. Immunol.  6:163\u2013170. 18 \n\n61. Tada, H., Nemoto, E., Shimauchi, H., Watanabe, T., Mikami, T., 19 \n\nMatsumoto, T., Ohno, N., Tamura, H., Shibata, K., Akashi, S., Miyake, K., 20 \n\nSugawara, S., and H. Takada. 2002.  Saccharomyces cerevisiae- and Candida 21 \n\nalbicans-derived mannan induced production of tumor necrosis factor alpha by 22 \n\nhuman monocytes in a CD14- and Toll-like receptor 4-dependent manner. 23 \n\nMicrobiol. Immunol. 46:503-512. 24 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 29 \n\n62. Takeda, K., Kaisho, T., and S. Akira. 2003. Toll-like receptors. Annu. Rev. 1 \n\nImmunol. 21:335-376.  2 \n\n63. Toledo, M.S., Suzuki, E., Straus, A.H., and H.K. Takahashi. 1995. 3 \n\nGlycolipids from Paracoccidioides brasiliensis. Isolation of a galactofuranose-4 \n\ncontaining glycolipid reactive with sera of patients with 5 \n\nparacoccidioidomycosis. J. Med. Vet. Mycol. 33:247-51. 6 \n\n64. Weighardt, H., Jusek, G., Mages, J., Lang, R., Hoebe, K., Beutler, B., and 7 \n\nB. Holzmann. 2004.  Identification of a TLR4- and TRIF-dependent activation 8 \n\nprogram of dendritic cells. Eur. J. Immunol. 34:58-564.  9 \n\n65. Wynn, T.A. 2005. T(H)-17: a giant step from T(H)1 and T(H)2. Nat. Immunol. 10 \n\n6:1069-1070.  11 \n\n66. Yang, R.B., Mark, M.R., Gray, A., Huang, A., Xie, N.H., and M. Zhang. 12 \n\n1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular 13 \n\nsignaling. Nature 395:284-288. 14 \n\n67. Yauch, L.E., Mansour, M. K., Shoham, S., Rottman, J.B., and S.M. Levitz.  15 \n\n2004.   Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host 16 \n\nresponse to the fungal pathogen Cryptococcus neoformans in vivo. Infect. 17 \n\nImmun. 72:5373-5382. 18 \n\n68. Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., 19 \n\nBelladonna, M.L., Vacca, C., Conte, C., Mosci, P., Bistoni, F., Puccetti, P., 20 \n\nKastelein, R.A., Kopf, M., and L. Romani. 2007. IL-23 and the Th17 pathway 21 \n\npromote inflammation and impair antifungal immune resistance. Eur. J. 22 \n\nImmunol. 37: 2695-2706.  23 \n\n69. Zelante, T., De Luca, A., D'Angelo, C., Moretti, S., and L. Romani. 2009. 24 \n\nIL-17/Th17 in anti-fungal immunity: what's new? Eur. J. Immunol. 39:645-648. 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 30 \n\n70. Ziegler, S.F., Levin, S.D., Johnson, L., Copeland, N.G., Gilbert, D.J., 1 \n\nJenkins, N.A., Baker, E., Sutherland, G.R., Feldhaus, A.L., and F. 2 \n\nRamsdell. 1994. The mouse CD69 gene. Structure, expression, and mapping to 3 \n\nthe NK gene complex. J. Immunol. 152:1228-1236. 4 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 31 \n\nLEGENDS TO FIGURES  1 \n\nFig. 1. TLR4-deficiency leads to less severe fungal infection of macrophages 2 \n\nassociated with decreased synthesis of NO. The phagocytic and fungicidal ability or 3 \n\nmacrophages with defective TLR4-signaling (C3H/HeJ) or TLR4 expression (C57BL/6 4 \n\nTLR4\n-/-\n\n) were compared with their TLR4-normal controls (C3H/HePas and C57BL/6 5 \n\nTLR4\n+/+\n\n, respectively)  (A) For phagocytic assays, IFN-?-primed (20ng/ml, overnight) 6 \n\nand unprimed macrophage cultures were infected with P. brasiliensis yeasts in a 7 \n\nmacrophage:yeast ratio of 25:1. The cells were co-cultivated for 4h at 37\no\n C in 5% CO2 8 \n\nto allow fungi adhesion and ingestion. Cells were washed, fixed and stained with 9 \n\nGiemsa; an average of 1,000 macrophages was analyzed, and the number of 10 \n\nmacrophages with adhered or ingested yeasts was determined. (B) For fungicidal 11 \n\nassays, IFN-?-primed and unprimed macrophages were infected with yeast cells as 12 \n\nabove described. After 48 h at 37\no\n C in 5% CO2, plates were centrifuged and 13 \n\nsupernatants used to determine levels of nitrite and cytokines.  The monolayers were 14 \n\nwashed with distilled water to lyse macrophages, and 100 \u00b5l of cell homogenates were 15 \n\nassayed for the presence of viable yeasts by a CFU assay. (C) Supernatants from 16 \n\nfungicidal assays were used to determine the levels of nitrites using the Griess reagent.  17 \n\nData are the mean \u00b1 SEM of quintuplicate samples from one experiment representative 18 \n\nof 3 independent determinations. *P &lt;0.05.  19 \n\n 20 \n\nFig. 2. Macrophages from TLR4-defective mice secrete diminished levels of IL-12 and 21 \n\nMCP-1. IFN-? treated (20.00 ng/ml) or untreated macrophages of TLR4-competent 22 \n\n(C3H/HePas) and defective (C3H/HeJ) mice were challenged with viable P. brasiliensis 23 \n\nyeasts (1:25, fungus:macrophage ratio) during 4h, washed, and further cultivated for 24 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 32 \n\n48h at 37\u00b0C in 5% CO2. Plates were then centrifuged and supernatants used for 1 \n\ncytokine measurements using ELISA. Data are the means \u00b1 SEM of triplicate samples 2 \n\nfrom one experiment representative of 3 independent determinations. *P &lt;0.05 . 3 \n\n 4 \n\nFig. 3.  In vivo, TLR4 dysfunction leads to less severe fungal infection. Depicted is the 5 \n\nrecovery of CFU from the lungs TLR4-defective and TLR4-normal control mice 6 \n\ninfected i.t. with 1 x 10\n6\n yeasts. Lung homogenates were used to determine the levels of 7 \n\nnitrites using the Griess reagent.  The bars represent means \u00b1 SEM of log10 CFU 8 \n\nobtained from groups of six to eight mice at 96h, 2 and 11 weeks after infection. The 9 \n\nresults are representative of three independent experiments. *P &lt;0.05. 10 \n\n 11 \n\nFig. 4. Increased numbers of activated macrophages, CD4\n+\n and CD8\n\n+\n T lymphocytes 12 \n\nwere detected in the lungs of TLR4-competent mice at weeks 2 and 11 of infection. 13 \n\nCharacterization of leukocyte subsets by flow cytometry in the lung infiltranting 14 \n\nleucocytes (LIL) from TLR4-defective  and TLR4-normal mice inoculated i.t. with 1 15 \n\nmillion P. brasiliensis yeast cells. Lungs of  C3H/HePas and C3H/HeJ mice (n=6\u20138) 16 \n\nwere excised, washed in PBS, minced, and digested enzymatically. At weeks 2 and 11 17 \n\nafter infection lung cell suspensions were obtained and stained as described in Materials 18 \n\nand Methods. The aquisition and analysis gates were restricted to lymphocytes or 19 \n\nmacrophages. The data represent the mean \u00b1 SEM of the results from 6-8 mice per 20 \n\ngroup and are representative of two independent experiments. *P &lt;0.05. 21 \n\n 22 \n\nFig. 5. TLR4-defective mice presented increased numbers of Treg cells in the 23 \n\nlungs.  FoxP3 expression by lung lymphocytes from TLR4-defective (C3H/HeJ) and 24 \n\nnormal (C3H/HePas) mice inoculated i.t. with 1 million P. brasiliensis yeast cells was 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 33 \n\ndetermined by flow cytometric analysis. Lungs of mice (n=6\u20138) were excised, washed 1 \n\nin PBS, minced, and digested enzymatically;  2 and 11 weeks after infection cell 2 \n\nsuspensions were obtained and stained as described in Materials and Methods. The cell 3 \n\nsurface expression\n \nof leukocyte markers as well as intracellular FoxP3\n\n+\n expression in\n\n \n4 \n\nlung infiltrating leucocytes were analyzed by flow cytometry . Surface staining of 5 \n\nCD25\n+\n and intracellular FoxP3 expression were back-gated on the CD4\n\n+\n T cell 6 \n\npopulation. The data represent the number of CD4\n+\nCD25\n\n+\nFoxP3\n\n+\n cells for individual 7 \n\nmice (n=5-6) and are representative of two independent experiments.  8 \n\n 9 \n\nFig. 6. Lung homogenates of TLR4-competent mice presented increased levels of 10 \n\nproinflammatory cytokines. At 96h, 2 and 11 weeks  after i.t. infection with 10\n6\n yeast 11 \n\ncells of P. brasiliensis, lungs from TLR4-defective and TLR4-competent mice were 12 \n\ncollected and disrupted in 5.0 ml of PBS and supernatants were analyzed for cytokines 13 \n\ncontent by capture ELISA. The bars depict means \u00b1 SEM of cytokine levels (6\u20138 14 \n\nanimals per group). The results are representative of three independent experiments.*P 15 \n\n&lt;0.05. 16 \n\n 17 \n\nFig. 7. TLR4 deficiency determines impaired humoral immunity. Levels of 18 \n\nP.brasiliensis-specific antibodies in the sera of TLR4-defective (C3H/HeJ) and normal  19 \n\nmice (C3H/HePas) at week 11 after i.t. infection with 1 x 10\n6\n yeast cells. Sera were 20 \n\nassayed for total IgG, IgM, IgA, IgG1, IgG2a, IgG2b and IgG3 by using an isotype-21 \n\nspecific ELISA as detailed in methods. The bars depict means (log 2) \u00b1 SE of serum 22 \n\ntiters (6 to 8 mice per group). * (P<0.05) compared with controls. 23 \n\n 24 \n\n 25 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n 34 \n\nFig. 8. Compared with TLR4-normal mice, TLR4-defective mice present increased 1 \n\nfungal loads and lung pathology but equivalent survival times. (A) Survival times of 2 \n\nTLR4-defective and control mice after i.t. infection with 1 \u00d7 10\n6\n P. brasiliensis yeast 3 \n\ncells was determined in a period of 250 days. No significant differences were seen in the 4 \n\nmedian survival times of both mouse strains; the results are representative of two 5 \n\nindependent experiments. (B) By 250 days after infection survivor (n=3-6) mice were 6 \n\nsacrificed and tissue CFU determined. No viable yeasts were recovered from livers and 7 \n\nspleens. (C-F) Photomicrographs of pulmonary lesions of TLR4-competent C3H/HePas 8 \n\nmice (C, D) and TLR4-defective C3H/HeJ mice (E, F) mice at week 11 of infection 9 \n\nwith 1 million P. brasiliensis yeasts. At this period, the morphology of lesions was 10 \n\nequivalent in both mouse strains; fungal cells were surrounded by confluent or isolated 11 \n\ngranulomas scattered through the lung tissue. H&amp;E (C, E) and Groccot (E, F,) stained 12 \n\nlesions (100X). (G) Total area of lesions in the lungs of mice (n=10) at week 11 after 13 \n\ninfection. *P &lt;0.05. 14 \n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\n a\nt S\n\niste\nm\n\na\n In\n\nte\ng\nra\n\nd\no\n d\n\ne\n B\n\nib\nlio\n\nte\nca\n\ns - U\nS\n\nP\n o\n\nn\n Ja\n\nn\nu\na\nry 2\n\n8\n, 2\n\n0\n1\n0\n \n\nia\ni.a\n\nsm\n.o\n\nrg\nD\n\no\nw\n\nn\nlo\n\na\nd\ne\nd\n fro\n\nm\n \n\nhttp://iai.asm.org\n\n\tANEXO D.pdf\n\tInnate immunity to Paracoccidioides brasiliensis infection\n\tAbstract\n\tIntroduction\n\tThe isogenic murine model of resistance/susceptibility of paracoccidioidomycosis mimics the human disease\n\tInnate immunity \n\tGenetic control of susceptibility\n\tComplement system and chemokines\n\tLipid mediators (Eicosanoids) and P. brasiliensis lipids\n\tToll Like and other macrophage receptors\n\tPolymorphonuclear leukocytes and NK cells\n\tMacrophages and nitric oxide\n\tDendritic cells and other APCs\n\tCytokines\n\n\tThe influence of innate immunity in the resistance to P. brasiliensis infection\n\tAcknowledgments\n\tReferences"}]}}}